Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AC013477.1		ENSG00000288637	"Novel protein"		4	153152435-153415081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 2.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;AN3-CA: 1.0;CACO-2: 1.1;RPTEC TERT1: 1.4;SH-SY5Y: 1.0"									"HPA035853, HPA035854, HPA043499"	Uncertain		Approved	Centrosome		NA	NA					"Cluster 35: RPTEC-TERT1 - Kidney processes"		Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659, HPA043499: AB_2732506"																		0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.3	1.8	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.7	1.4	0.1	0.0	0.0	0.0	2.1	1.0	0.1	0.8	0.0		0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	1.5	0.0	0.5	0.0	0.0	0.1		2.7	0.1	0.0	1.0	1.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	1.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.3	1.8	0.7	1.4	2.1	1.0	1.0	0.5	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACADL	"ACAD4, LCAD"	ENSG00000115361	"Acyl-CoA dehydrogenase long chain"	P28330	2	210187126-210225447	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.0;pancreas: 28.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.9;Early spermatids: 85.6;Late spermatids: 69.4;Leydig cells: 46.9;Peritubular cells: 46.6;Proximal tubular cells: 31.5"	"Group enriched"	"Detected in many"	8	"liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;RPTEC TERT1: 2.6;SuSa: 2.3;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011990	Enhanced	Supported				NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"			"HPA011990: AB_1844465"	"unprognostic (6.29e-3)"	"unprognostic (7.61e-2)"		"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.58e-11)"	"unprognostic (4.22e-3)"	"unprognostic (1.18e-4)"	"unprognostic (8.81e-3)"	"unprognostic (1.06e-1)"	11.9	1.1	0.8	0.1	0.8	0.0	8.0	0.7	1.1	3.4	0.9	0.5	0.0	0.7	1.1	0.5	4.0	0.6	3.1	0.7	1.2	19.8	28.0	10.1	0.0	0.8	0.8	12.7	28.4	4.5	2.9	1.0	0.8	20.6	0.1	0.0	6.8	4.8	9.5	2.8	0.4	0.1	0.8	0.0	5.6	3.1	0.7	1.5	23.7	5.0	0.0	1.0	3.8	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.6	0.5	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.1	0.7	1.2	0.8	0.8	0.8	0.8	0.7	0.9	0.2	28.9	70.9	1.0	0.0	0.6	1.4	1.1	1.2	0.2	1.3	0.5	1.1	8.6	7.6	22.0	2.1	8.8	0.0	0.0	15.6	4.0	85.6	7.1	0.4	0.2	0.0	0.0	0.2	11.9	0.3	4.9	3.6	5.9	2.5	0.8	0.7	23.0	0.5	0.0	13.3	0.0	0.0	0.3	0.4	69.4	46.9	0.4	0.0	4.7	0.0	0.2	0.0	7.5	0.3	3.9	0.0	46.6	0.0	8.2	0.0	31.5	2.4	0.2	0.0	7.6	13.7	0.7	0.7	0.7	1.0	6.3	0.4	0.1	0.0	0.7
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27168135-27243046	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Transport"		Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavorable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	14.6	25.1	31.0	13.5	37.0	18.2	12.3	36.2	37.1	13.2	24.2	20.3	39.8	9.4	9.7	12.0	12.0	15.4	40.4	27.6	33.1	37.3	73.8	14.7	14.7	37.2	34.0	9.9	11.1	31.2	6.4	13.4	38.1	15.2	20.9	36.2	10.3	11.4	31.0	17.3	39.2	8.8	36.7	14.7	21.0	19.3	36.1	12.2	27.8	36.6	12.7	13.5	7.5	38.8	25.8	76.5	17.1	18.0	19.1	17.3	20.1	32.3	12.1	28.1	33.5	19.4	39.9	10.7	27.0	22.4	23.4	21.1	23.2	16.3	23.0	26.2	23.9	16.5	23.1	15.2	20.6	11.0	20.9	16.7	17.7	23.5	12.8	24.9	20.5	16.7	13.6	19.5	35.7	20.0	21.1	9.4	13.1	35.2	10.0	17.4	42.5	20.2	44.1	22.4	21.3	45.5	35.4	38.3	17.9	18.9	18.8	11.5	30.4	27.2	15.2	43.7	25.9	19.4	28.1	20.7	27.4	24.6	12.0	12.5	13.0	10.2	15.3	12.7	15.2	6.4	7.5	12.4	13.0	7.0	5.0	11.0	11.1	10.3	15.1	8.5	7.4	8.0	31.0	37.0	36.2	37.1	27.6	33.1	37.2	34.0	38.1	36.7	36.1	38.8	23.3	25.6	29.9	17.9	16.0	9.7	4.1	14.5	7.4	30.8	14.5	10.8	83.0	15.7	25.2	31.3	25.0	9.6	27.4	22.4	33.2	22.1	43.1	33.7	20.2	18.7	10.2	8.6	20.6	16.2	12.6	16.4	19.4	41.1	12.6	11.5	12.8	56.9	19.0	23.5	26.9	30.4	10.2	25.5	12.5	16.9	16.4	22.4	21.4	15.9	22.4	47.7	29.9	17.6	24.8	17.8	26.1	16.6	14.2	11.7	64.4	48.2	32.7	47.2	19.7	20.9	16.1	41.0	8.3	16.5	15.5	10.4	22.3	27.1	26.5	9.2
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838616-134902034	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 141.1;liver: 162.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 120.2;Proximal tubular cells: 408.1"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"RPTEC TERT1: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010533, HPA011179"	Enhanced		Approved	Cytosol		NA	NA		12000	"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	7.1	0.2	0.0	0.3	141.1	162.5	0.1	0.3	0.8	0.2	0.7	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.3	0.8	0.3	1.2	0.2	0.5	0.1	0.6	0.3	26.7	0.4	1.0	0.3	0.1	0.3	0.4	0.8	0.2	0.7	1.0	0.0	0.4	0.2	0.8	0.2	0.1	0.5	0.2	0.3	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.8	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.2	50.1	0.0	9.2	0.0	0.0	0.0	0.0	54.8	0.2	0.0	0.0	0.1	0.0	0.0	2.7	8.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	120.2	0.0	0.0	7.3	0.0	0.0	1.9	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.0	0.0	2.5	1.9	0.1	0.0	0.0	0.0	0.0	0.0	408.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0
ACP6	"ACPL1, LPAP"	ENSG00000162836	"Acid phosphatase 6, lysophosphatidic"	Q9NPH0	1	147629652-147670524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 108.9;RPTEC TERT1: 119.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028560	Uncertain				"Intracellular and membrane"	NA	NA		64000	"Cluster 35: T-regs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA028560: AB_10602427"	"unprognostic (3.17e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.44e-4)"	6.3	13.6	6.2	4.2	6.3	5.0	17.8	5.6	6.6	11.8	7.9	11.4	7.4	8.3	16.2	7.8	12.7	6.8	8.4	5.9	6.3	17.5	13.2	7.3	3.9	6.3	6.9	9.3	11.0	21.9	15.2	4.2	6.2	12.6	9.7	3.6	10.4	11.2	6.7	9.3	8.8	6.0	6.0	6.0	12.4	5.7	6.1	7.9	15.2	6.0	6.9	11.2	6.7	5.7	21.1	8.5	7.1	12.7	4.5	4.3	20.2	4.8	14.8	14.8	17.5	10.2	31.9	6.1	17.4	10.4	11.4	35.6	9.6	32.0	15.4	8.2	16.1	21.9	11.8	19.4	13.2	3.9	0.8	6.3	23.3	7.7	15.4	17.6	15.2	30.2	10.5	3.4	17.0	15.8	16.5	10.0	17.0	108.9	62.9	11.7	6.1	70.9	119.7	41.3	5.8	7.1	17.5	12.5	36.5	15.9	20.3	6.0	10.7	4.6	8.6	0.9	15.1	13.4	21.3	2.8	8.7	0.3	25.8	0.1	2.3	13.4	4.6	0.8	7.9	2.6	7.5	6.1	5.4	2.8	8.2	7.0	3.5	0.3	0.3	3.4	14.8	2.7	6.2	6.3	5.6	6.6	5.9	6.3	6.3	6.9	6.2	6.0	6.1	5.7	2.1	19.2	13.9	74.4	2.9	1.1	6.1	7.4	7.4	3.1	6.3	6.3	7.0	10.0	6.7	16.5	0.0	19.7	7.0	3.7	17.6	7.5	6.0	9.1	2.3	2.4	9.1	4.2	14.2	15.3	7.2	2.4	10.7	9.4	1.3	15.2	5.3	10.9	4.6	0.0	20.6	8.5	8.2	4.8	6.7	1.5	5.9	2.9	3.6	15.0	3.4	8.8	4.1	18.1	10.4	18.7	5.4	4.1	3.8	4.9	6.3	14.4	11.9	1.1	13.1	5.7	7.7	7.5	4.7	9.1	1.3	8.1	9.6	7.3	8.5	5.8
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADHFE1	FLJ32430	ENSG00000147576	"Alcohol dehydrogenase iron containing 1"	Q8IWW8	8	66432492-66468907	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 31.2;skeletal muscle: 29.2;tongue: 31.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cardiomyocytes: 41.6;Syncytiotrophoblasts: 116.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.2;RPTEC TERT1: 1.5"					"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	7.0	2.3	8.7	0.3	8.5	0.0	3.9	7.2	11.7	2.3	10.4	3.9	0.6	2.0	1.3	1.3	5.6	0.7	24.5	8.2	8.2	6.6	31.2	2.1	0.3	8.3	8.5	5.1	9.4	5.0	2.6	1.1	8.1	5.2	0.7	1.5	2.3	1.5	29.2	1.1	2.5	0.2	7.8	1.8	11.0	1.7	8.7	0.3	2.7	31.3	0.3	4.4	1.8	8.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	8.7	8.5	7.2	11.7	8.2	8.2	8.3	8.5	8.1	7.8	8.7	8.5	1.5	9.6	20.1	76.4	1.8	1.0	4.1	2.7	3.4	1.7	4.6	4.6	41.6	14.3	9.6	9.2	10.4	8.8	6.5	1.0	11.7	1.5	0.5	2.5	1.6	3.3	3.6	2.5	8.3	0.6	0.9	5.3	8.6	2.5	8.8	6.1	6.1	27.1	2.5	0.0	13.2	2.0	4.1	2.1	2.8	1.6	23.9	2.1	0.0	14.0	2.0	7.6	6.2	21.6	19.2	0.9	5.8	27.1	3.0	3.5	4.1	14.8	14.3	8.5	0.0	7.8	5.2	0.5	0.6	1.9	1.0	116.4	10.0	2.5	2.4	2.5
AF241726.1		ENSG00000250349	"Novel proline rich Gla (G-carboxyglutamic acid) 1 (PRRG1) and tetraspanin 7 (TSPAN7) protein"		X	37349330-38687674	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	5	"brain: 3.1;skeletal muscle: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;JURKAT: 1.4;RPTEC TERT1: 2.1"									HPA003140	Uncertain					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA003140: AB_1078454"																		0.6	0.2	0.7	0.0	1.4	0.0	0.0	2.1	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.1	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.1	0.1	0.0	4.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.1	0.0	3.1	1.1	0.2	0.2	0.1	0.4	0.2	0.0	0.2	0.6	0.1	0.3	1.4	0.2	0.0	0.9	0.2	0.1	0.1	1.2	0.7	0.1	0.3	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.7	0.4	0.2	0.2	0.1	0.4	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.1	0.0	0.2	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	2.1	0.9	0.8	0.8	1.9	1.2	1.9	1.9	1.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AIF1L	"C9orf58, FLJ12783, IBA2"	ENSG00000126878	"Allograft inflammatory factor 1 like"	Q9BQI0	9	131096476-131123152	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.4;kidney: 313.2;lymphoid tissue: 206.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 122.9;Collecting duct cells: 356.8;Distal tubular cells: 289.5;Extravillous trophoblasts: 383.2;Proximal tubular cells: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 140.3;MCF7: 96.7;NTERA-2: 106.7;RPTEC TERT1: 299.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020522, HPA056852"	Enhanced					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA020522: AB_2670463, HPA056852: AB_2683256"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.54e-6)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.20e-2)"	44.7	4.8	165.6	4.7	199.6	2.3	39.9	179.6	284.4	20.2	101.5	7.2	1.3	13.5	9.3	105.8	10.8	8.3	41.8	145.4	160.9	313.2	1.6	12.2	1.9	209.2	204.2	5.1	6.5	80.6	18.2	23.8	196.2	6.6	5.7	6.9	32.1	36.6	14.6	15.9	7.9	10.0	172.9	206.8	9.0	6.5	188.0	3.9	91.9	21.9	5.8	9.2	35.3	225.1	0.5	2.2	140.3	24.1	0.0	0.0	59.5	0.0	0.3	0.1	0.3	26.8	11.3	0.0	63.5	0.0	3.0	13.5	21.2	1.5	0.8	0.3	30.0	15.7	7.4	51.4	0.3	0.1	7.6	1.2	6.6	0.5	0.7	0.4	6.7	39.3	10.6	0.1	0.0	96.7	9.3	1.9	106.7	9.0	10.1	0.2	1.9	39.6	299.9	8.5	54.3	8.7	7.4	60.0	20.4	82.7	57.6	0.9	0.9	3.8	10.2	0.5	30.8	0.4	0.5	0.4	6.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	165.6	199.6	179.6	284.4	145.4	160.9	209.2	204.2	196.2	172.9	188.0	225.1	122.9	0.0	0.0	5.9	2.8	4.1	2.1	1.5	1.2	0.1	45.0	29.5	6.6	0.0	3.5	356.8	0.0	4.5	1.3	0.8	289.5	1.5	1.0	4.1	3.5	35.0	3.6	0.0	0.3	0.8	383.2	15.5	0.5	15.0	0.0	10.1	33.5	0.0	7.0	0.0	0.3	2.1	2.0	0.3	2.0	3.5	37.6	2.3	67.6	21.5	0.0	15.1	0.0	8.0	36.3	2.9	0.3	59.0	0.0	7.7	0.0	201.5	0.6	0.2	0.0	3.3	10.3	0.2	5.3	4.4	2.4	21.1	1.7	29.9	1.3	2.0
AJAP1	"MOT8, SHREW-1, SHREW1"	ENSG00000196581	"Adherens junctions associated protein 1"	Q9UKB5	1	4654609-4792534	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;ovary: 4.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Excitatory neurons: 52.0;Inhibitory neurons: 52.6;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 18.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;EFO-21: 6.3;hTERT-HME1: 3.8;RPTEC TERT1: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.11e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.89e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.49e-2)"	0.5	0.4	8.4	0.1	6.8	0.1	0.3	0.0	11.3	1.9	0.0	0.4	0.2	1.2	0.7	0.2	1.2	0.1	0.1	10.6	1.2	3.0	0.2	0.9	0.1	2.3	2.6	4.8	2.1	0.6	0.5	0.3	0.0	1.0	0.1	1.8	0.2	2.2	0.2	0.4	0.3	0.3	3.7	1.8	0.5	1.0	0.1	0.2	0.7	0.0	0.1	0.5	0.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	1.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.9	0.0	0.0	0.0	0.0	0.8	24.1	0.0	1.2	0.7	0.0	2.3	0.0	2.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.4	6.8	0.0	11.3	10.6	1.2	2.3	2.6	0.0	3.7	0.1	2.8	0.6	0.0	0.0	3.6	0.1	3.7	0.0	1.6	0.0	23.3	0.0	0.5	1.2	11.5	1.5	1.8	0.0	2.1	8.1	0.0	0.0	1.4	5.0	0.1	1.6	0.6	0.0	0.0	52.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	52.6	0.0	0.0	0.0	0.3	4.9	0.3	0.2	1.8	6.5	0.0	1.4	0.0	20.6	18.6	0.2	0.0	6.0	0.0	0.0	0.0	5.2	2.3	1.1	0.0	0.5	4.3	0.2	1.1	0.0	2.4	1.8	0.2	0.1	0.0	0.1
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135467-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 56.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Cholangiocytes: 177.3;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 27.2;RPTEC TERT1: 23.5;RT4: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.56e-4)"	9.0	56.6	15.8	6.4	16.3	10.9	6.7	17.7	20.7	8.1	11.5	19.1	29.8	6.4	5.7	4.2	6.8	9.9	6.7	16.0	16.7	8.1	24.4	6.6	11.2	15.3	16.2	9.8	42.0	4.0	4.3	4.0	15.3	14.0	18.9	7.6	4.6	6.4	15.9	2.8	16.5	5.9	16.7	9.6	5.3	8.8	17.0	11.9	5.9	14.4	7.6	8.7	5.6	15.8	1.2	2.1	7.8	3.8	4.4	9.0	5.4	3.3	5.3	5.5	7.3	2.8	2.2	0.1	6.1	5.7	4.1	0.1	2.3	3.6	4.0	0.0	3.3	8.0	2.7	12.2	6.1	0.4	2.5	7.8	2.4	3.6	4.6	5.1	5.8	4.6	1.4	11.7	5.3	2.1	3.6	2.1	27.2	0.8	2.9	7.3	5.1	0.1	23.5	27.2	0.1	2.7	4.5	0.4	11.1	4.5	1.8	17.1	2.1	2.5	3.5	7.5	8.3	10.5	0.1	2.0	6.3	8.1	5.9	15.2	1.9	0.3	8.1	3.8	12.8	3.7	11.1	11.0	2.4	5.5	17.6	11.0	0.5	4.4	4.7	0.1	4.3	6.0	15.8	16.3	17.7	20.7	16.0	16.7	15.3	16.2	15.3	16.7	17.0	15.8	11.7	19.2	9.1	88.8	16.4	6.2	6.5	0.8	6.8	22.3	10.1	13.2	10.4	177.3	1.6	5.5	16.7	8.2	18.0	22.1	19.6	35.7	8.2	31.6	13.4	6.5	1.2	63.8	44.7	4.2	10.2	7.4	6.1	35.6	10.8	22.9	9.7	39.9	8.6	8.4	79.1	14.8	10.2	20.8	9.9	2.7	8.4	12.9	1.8	68.4	9.8	38.2	25.7	123.6	62.7	2.2	33.2	5.7	3.4	8.2	13.6	26.5	1.4	13.2	0.0	12.6	6.9	4.6	10.0	7.0	4.1	4.7	23.9	26.0	22.0	4.9
AL365214.2		ENSG00000281613	"Novel ret finger protein-like 4B"		6	112236806-112350094	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	12	"testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"RPTEC TERT1: 3.4"									HPA059324	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA059324: "																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917393-134950115	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"kidney: 72.2;liver: 247.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 142.5;Proximal tubular cells: 136.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		110000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	1.3	1.3	6.4	0.7	7.1	2.4	1.2	6.9	9.8	1.5	2.2	3.3	0.8	1.2	2.1	0.8	1.0	0.9	0.7	6.5	3.8	72.2	247.2	0.9	0.6	5.3	4.4	0.5	0.9	0.4	0.8	0.5	6.2	1.7	0.8	2.8	0.8	0.8	3.6	1.7	1.1	0.9	3.1	1.3	1.2	0.5	5.4	0.7	0.6	0.3	0.6	1.9	0.9	8.3	0.1	0.5	0.8	0.5	0.2	0.1	0.6	0.2	0.2	0.0	0.5	0.2	0.3	0.1	0.2	0.0	0.1	0.6	0.6	0.0	0.4	0.6	2.9	2.0	2.1	2.9	0.3	0.8	1.0	0.8	0.9	0.2	0.4	0.6	0.2	0.8	3.0	1.1	0.1	0.0	0.9	1.0	0.2	0.2	0.3	0.0	0.2	0.2	3.3	0.4	0.8	0.2	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.2	1.6	0.6	0.8	2.8	1.0	0.5	0.3	0.7	0.2	2.5	0.3	0.3	0.4	0.1	0.1	0.4	0.4	0.2	0.0	0.4	0.3	0.3	0.8	0.8	0.1	0.4	0.5	0.3	6.4	7.1	6.9	9.8	6.5	3.8	5.3	4.4	6.2	3.1	5.4	8.3	0.3	3.2	0.6	3.6	0.8	0.0	0.2	0.2	0.0	2.6	0.7	0.9	0.6	1.5	0.7	31.3	0.0	0.2	0.3	0.1	19.6	0.2	0.1	0.4	0.4	0.7	0.0	0.0	14.3	0.0	1.7	0.4	0.0	1.6	0.0	0.5	2.5	142.5	0.1	3.3	12.9	0.1	0.0	2.5	0.3	0.0	0.0	0.8	0.0	1.0	0.7	0.3	0.0	3.0	9.6	0.0	0.1	0.0	0.3	0.1	0.0	136.9	0.0	1.8	0.0	1.2	0.5	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.2	0.1
ANKDD1B		ENSG00000189045	"Ankyrin repeat and death domain containing 1B"	A6NHY2	5	75611182-75681773	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Endometrial ciliated cells: 13.6;Gastric mucus-secreting cells: 8.6;Intestinal goblet cells: 8.4;Proximal tubular cells: 8.4;Respiratory ciliated cells: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;PC-3: 1.0;RPMI-8226: 1.5;RPTEC TERT1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059722	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA059722: AB_2684112"	"unprognostic (5.11e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.30e-7)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	0.1	0.4	1.0	1.0	1.9	0.1	0.9	1.2	1.3	0.4	3.3	3.4	0.1	0.6	0.6	0.1	4.3	0.5	0.2	1.2	1.3	3.6	0.1	1.0	0.5	1.8	2.2	0.1	0.7	0.7	0.2	0.5	1.2	0.8	3.3	0.2	0.1	0.1	0.0	1.7	0.9	0.2	1.7	0.3	1.9	0.6	1.9	0.2	0.3	0.0	0.5	0.2	0.2	1.4	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.0	1.5	2.6	0.2	0.3	0.6	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	1.0	1.9	1.2	1.3	1.2	1.3	1.8	2.2	1.2	1.7	1.9	1.4	0.3	0.0	2.4	2.0	0.6	0.5	0.7	1.4	0.0	0.0	1.0	0.6	0.4	0.0	2.5	3.7	0.0	2.5	0.3	2.9	9.8	1.0	0.6	13.6	0.6	1.1	0.0	0.8	6.8	1.0	0.5	0.2	8.6	0.6	0.0	0.5	2.2	0.1	0.4	0.0	4.9	8.4	0.0	0.8	0.7	0.2	2.1	1.3	1.8	3.7	0.1	0.0	2.1	2.0	3.5	0.4	1.4	1.5	0.1	0.5	0.0	8.4	23.4	0.0	0.0	0.1	0.3	0.5	0.5	0.0	0.6	0.5	0.8	2.1	4.3	0.2
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"brain: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.0;Collecting duct cells: 3.7;Enteroendocrine cells: 1.8;Inhibitory neurons: 6.0;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enhanced"	"Detected in many"		"thalamus: 40.7"	"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.0	0.0	2.8	0.4	15.8	1.7	0.0	3.4	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	7.4	0.7	0.0	0.1	0.9	4.0	2.4	0.0	0.0	0.1	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.2	40.7	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	97.9	0.1	0.3	0.4	0.0	0.3	0.0	0.1	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	2.8	15.8	3.4	3.6	1.1	7.4	4.0	2.4	2.0	1.6	40.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.0	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	1.8	0.0	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	6.0	0.0	0.0	1.2	0.0	0.7	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827112	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 569.9;pancreas: 356.8"	"Cell type enhanced"	"Detected in all"		"Cholangiocytes: 2344.8;Ductal cells: 1469.8;Proximal enterocytes: 657.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 414.2;Hep G2: 456.9;RPTEC TERT1: 623.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol		NA	NA		550000	"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavorable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	48.2	21.6	14.5	33.6	15.4	30.8	45.9	14.9	18.9	62.4	52.4	101.7	271.3	50.9	30.3	43.0	68.6	569.9	26.1	14.4	15.2	104.0	120.9	81.6	21.1	15.6	15.1	38.8	356.8	78.0	11.9	52.7	15.8	46.3	92.3	30.0	39.2	52.1	17.2	61.0	232.4	52.0	15.7	24.2	108.2	9.7	15.2	23.0	43.6	20.4	24.0	61.3	50.2	16.6	69.6	249.4	3.4	31.0	185.0	158.3	11.3	66.0	101.5	27.1	38.0	37.9	121.7	22.8	414.2	109.5	78.9	104.7	23.8	108.1	27.6	65.2	20.3	35.0	20.5	456.9	131.2	12.5	43.0	95.9	104.8	36.5	87.3	62.9	71.1	11.0	2.0	20.1	74.7	63.8	18.3	22.8	6.1	280.0	34.3	19.4	6.8	28.3	623.2	99.1	5.1	22.9	72.9	99.5	103.8	35.6	33.3	156.3	100.9	49.2	23.8	65.5	37.7	8.2	9.7	1.3	75.8	59.7	34.1	80.4	34.7	29.6	23.1	42.5	17.5	40.6	11.7	17.5	50.6	46.7	2.0	12.5	4.9	9.5	58.7	15.5	14.5	24.2	14.5	15.4	14.9	18.9	14.4	15.2	15.6	15.1	15.8	15.7	15.2	16.6	66.4	205.1	154.8	47.3	27.3	74.2	98.5	148.2	68.9	8.2	36.8	36.4	10.6	2344.8	139.4	84.6	6.2	86.4	27.2	315.1	221.1	1469.8	14.6	257.9	79.0	49.1	18.6	12.6	29.9	344.4	370.1	103.6	196.7	488.8	111.5	24.3	33.9	68.5	227.6	8.4	17.7	193.8	240.1	46.1	80.4	11.2	64.7	54.5	92.5	63.7	87.2	48.7	45.3	17.6	106.0	245.7	268.6	92.2	6.9	55.6	657.1	400.4	230.2	59.9	6.6	27.6	64.6	15.8	3.7	61.3	79.6	439.6	32.5	19.1	174.1	96.9
ARHGEF35	"ARHGEF5L, CTAGE4, FLJ43692"	ENSG00000213214	"Rho guanine nucleotide exchange factor 35"	A5YM69	7	144186083-144195833	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 107.0;Urothelial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 39.9;HBEC3-KT: 21.8;hTCEpi: 33.7;OE19: 32.2;RPTEC TERT1: 46.4;WM-115: 23.5"									"HPA044188, HPA045619, HPA045699"	Supported					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.97e-2)"	2.5	0.9	0.4	2.1	0.5	1.1	14.5	0.4	0.4	5.5	2.7	11.0	12.2	2.3	3.9	16.5	5.8	5.0	1.8	0.3	0.4	11.1	5.4	3.5	1.3	0.6	0.7	1.6	7.5	7.2	3.4	3.8	0.6	5.6	14.3	1.0	10.4	4.1	0.2	17.9	8.6	1.1	0.6	1.6	10.5	0.6	0.6	1.3	20.5	0.7	3.4	5.7	7.0	0.4	39.9	0.8	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.2	13.0	13.6	0.0	0.0	1.6	3.3	11.0	0.0	21.8	0.4	0.1	0.0	0.0	2.7	0.0	3.6	0.0	0.0	3.4	33.7	0.2	8.1	2.9	0.1	0.0	0.0	0.0	1.4	6.9	0.0	0.0	4.4	32.2	3.7	0.1	0.0	0.0	46.4	9.8	0.0	0.0	8.0	14.8	3.5	2.3	18.1	0.8	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.5	0.4	0.4	0.3	0.4	0.6	0.7	0.6	0.6	0.6	0.4	3.3	9.6	11.5	0.0	2.5	46.5	107.0	27.0	18.2	0.8	29.9	32.5	1.0	35.8	32.6	62.5	16.7	49.0	1.5	46.4	17.6	44.4	4.3	46.1	5.9	2.0	19.2	0.0	0.0	29.7	72.2	3.9	18.8	49.9	0.0	2.9	1.1	19.4	5.3	0.0	0.0	24.8	12.2	1.3	3.2	1.4	4.7	1.4	16.0	0.0	0.0	3.9	0.0	0.0	0.0	43.8	46.1	3.0	3.1	27.4	56.6	28.8	17.1	5.6	0.0	1.0	4.3	0.8	2.1	21.5	47.0	59.9	2.5	1.7	23.6	91.8
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 7.8;pancreas: 6.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	7.8	0.0	0.0	2.5	0.0	2.6	1.9	0.2	5.5	0.1	0.6	3.2	0.0	0.0	0.0	3.9	0.1	3.6	0.0	0.0	0.0	0.0	6.5	0.0	2.0	0.0	0.0	5.7	4.2	0.0	4.9	0.4	0.3	0.5	2.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	48.5	0.0	0.2	0.0	1.1	1.1	0.0	0.0	17.9	6.1	1.8	4.3	12.6	12.9	0.0	0.2	0.2	9.8	9.8	6.8	1.9	12.6	0.5	0.3	8.4	0.0	0.3	5.8	0.1	0.3	9.2	7.8	0.0	0.0	0.0	0.1	0.1	0.0	0.3	14.8	10.2	0.0	0.2	0.4	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	2.4	6.4	0.0	0.1	9.4	4.8	0.5	31.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.8
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497081	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 610.9;Langerhans cells: 474.5;NK-cells: 437.7;T-cells: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 149.4;RPTEC TERT1: 284.8;U-2197: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.99e-5)"	15.1	10.6	15.4	31.7	14.6	65.0	17.3	17.8	18.6	11.4	45.3	9.1	6.6	5.8	9.5	23.2	11.9	31.8	5.1	13.1	21.9	12.2	12.8	16.1	55.3	21.9	17.1	2.1	5.5	10.8	7.4	16.5	21.3	10.3	11.2	9.7	21.6	5.4	1.5	24.1	13.2	5.9	12.8	51.0	13.6	1.2	18.5	74.0	3.7	1.7	32.1	25.5	18.0	13.8	32.3	97.4	12.0	1.6	10.4	3.0	31.6	3.2	13.8	3.8	6.6	45.4	60.4	0.1	8.0	7.7	109.0	23.5	12.0	66.4	4.1	30.4	4.2	0.0	0.6	0.6	10.7	0.1	2.8	6.4	42.2	36.6	21.2	149.4	6.4	78.4	0.4	102.4	16.4	4.4	93.7	0.3	12.6	22.5	21.9	0.3	54.1	18.0	284.8	35.2	44.1	8.1	1.1	7.1	4.7	18.2	0.9	1.9	14.8	60.0	23.2	168.2	61.6	51.1	19.7	1.6	101.9	0.1	32.0	79.8	1.2	27.4	86.7	1.6	85.6	18.1	60.0	69.5	10.3	18.3	53.5	59.1	2.2	61.2	0.9	55.2	83.8	30.0	15.4	14.6	17.8	18.6	13.1	21.9	21.9	17.1	21.3	12.8	18.5	13.8	12.3	73.7	15.9	8.8	63.6	124.8	120.7	18.4	145.1	156.6	40.4	64.6	10.9	67.2	27.0	14.7	8.4	30.0	610.9	2.3	0.0	19.6	7.8	73.9	19.2	23.4	1.8	6.1	15.5	5.7	5.4	23.7	19.9	186.3	27.8	1.1	11.0	3.4	31.4	107.7	103.0	2.5	0.0	208.4	474.5	6.5	0.3	182.1	42.7	6.5	41.8	32.2	437.7	6.0	2.5	16.5	0.1	0.0	132.6	60.4	0.1	0.9	4.7	13.1	0.0	7.0	19.3	0.7	1.9	65.4	42.9	14.6	349.8	0.4	1.2	46.6
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084937-69106092	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	157.7	130.6	91.0	109.9	95.9	67.8	139.7	100.6	156.0	123.0	83.1	87.3	59.1	72.8	104.4	78.3	90.5	102.1	216.3	91.1	105.6	88.5	80.3	125.5	138.3	100.6	93.4	74.2	55.3	83.4	47.6	88.8	106.8	129.6	85.2	135.0	159.6	90.5	183.2	48.5	66.1	100.4	104.1	100.3	72.5	34.9	98.3	92.3	71.2	186.8	130.0	111.8	61.0	113.3	86.9	59.0	71.1	52.8	361.4	335.2	89.7	87.9	196.5	66.7	77.4	30.1	205.9	17.0	28.9	151.1	124.8	67.0	59.2	100.8	57.0	339.5	55.2	59.6	91.1	45.8	92.9	51.4	280.5	243.6	177.5	61.5	77.3	235.0	206.0	55.7	26.6	156.7	163.6	50.3	56.0	67.0	18.5	200.2	55.1	48.6	65.0	159.1	330.5	143.1	17.8	47.0	87.0	93.5	119.5	69.7	61.7	80.2	203.7	44.1	34.8	112.5	96.1	139.4	208.5	31.7	146.0	126.0	72.8	697.4	388.2	650.2	332.4	357.6	257.1	397.7	462.4	427.6	275.7	336.1	391.2	409.5	162.0	298.4	315.1	176.0	530.4	933.9	91.0	95.9	100.6	156.0	91.1	105.6	100.6	93.4	106.8	104.1	98.3	113.3	101.1	176.3	132.0	34.6	183.6	72.8	70.6	275.5	108.7	201.9	214.9	174.5	422.0	95.8	185.0	93.8	187.7	305.8	212.7	146.7	25.4	281.4	20.8	144.9	79.5	121.4	42.0	89.8	45.9	214.4	379.2	254.8	64.2	233.4	336.6	75.7	150.3	72.5	292.0	122.8	70.7	57.1	270.6	260.0	402.1	18.9	207.2	275.4	272.1	35.6	476.6	235.7	272.9	49.8	97.0	244.2	95.7	261.8	93.4	93.6	91.7	77.8	155.0	272.4	190.7	190.3	125.4	7.3	4.3	207.8	73.9	178.4	292.2	133.6	77.8	94.0
ARMC7	FLJ22160	ENSG00000125449	"Armadillo repeat containing 7"	Q9H6L4	17	75109952-75130272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024229, HPA053076"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA024229: AB_2059152, HPA053076: AB_2682036"	"unprognostic (1.35e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (7.73e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-2)"	7.4	6.7	7.3	5.8	7.5	4.1	7.4	12.7	9.0	7.7	7.7	12.4	9.6	7.0	4.8	11.2	6.6	4.7	8.8	7.6	7.7	39.5	13.2	12.3	7.0	7.3	7.1	5.2	7.0	6.6	7.0	5.8	7.6	11.8	6.9	2.7	8.9	6.4	5.5	12.0	11.9	4.0	7.0	14.0	11.4	7.3	7.9	8.2	9.9	3.9	6.4	8.7	9.3	7.9	15.2	30.2	8.9	8.5	7.0	4.3	9.4	8.3	9.0	15.9	14.3	25.3	14.7	9.0	10.8	7.7	8.7	12.4	14.6	6.1	7.6	8.7	23.2	17.5	13.4	15.9	15.5	13.5	16.1	5.6	11.4	10.0	5.8	7.7	14.6	14.5	15.8	17.6	5.3	21.7	25.9	14.8	4.5	32.8	22.6	14.6	18.0	16.8	35.6	27.4	8.3	11.9	15.6	15.7	18.6	15.2	18.4	12.9	11.3	16.1	14.9	6.4	13.1	14.7	5.5	12.7	7.2	9.6	11.8	31.7	13.7	28.5	18.0	9.9	15.8	13.4	12.9	15.1	12.7	10.0	9.8	14.9	18.6	15.7	7.9	11.1	20.8	11.7	7.3	7.5	12.7	9.0	7.6	7.7	7.3	7.1	7.6	7.0	7.9	7.9	6.6	12.8	8.8	1.3	10.4	4.6	2.8	5.8	2.2	6.0	6.0	5.1	2.5	7.2	5.2	22.0	0.0	14.1	10.1	28.6	35.2	8.7	6.2	4.6	3.0	9.0	6.0	1.7	3.0	9.4	8.3	4.1	8.6	5.1	10.8	4.4	14.3	4.6	15.2	0.0	2.9	9.8	6.1	7.5	3.3	12.2	5.3	9.7	12.4	1.9	13.9	3.3	11.3	2.5	1.8	11.3	27.1	3.8	6.4	4.8	15.8	15.4	7.2	3.4	19.7	2.2	4.6	3.8	5.9	4.4	4.5	4.9	8.7	6.6	12.4	3.8
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217141-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352, HPA052703"	Approved		Supported	Nucleoplasm		NA	NA		6600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB001994: , HPA008352: AB_1854887, HPA052703: "	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	205.4	121.8	114.0	361.4	125.6	544.1	163.5	109.4	130.8	163.1	117.4	252.8	200.3	153.3	161.8	460.5	146.3	211.3	167.3	135.2	123.1	155.0	152.8	259.7	505.2	115.1	114.7	121.3	122.1	115.4	94.7	295.0	116.4	132.1	274.8	77.4	163.6	176.0	385.3	293.4	226.5	291.2	117.8	294.6	251.5	149.7	118.2	298.3	115.3	250.8	626.0	402.0	231.7	125.4	438.3	188.3	264.1	198.0	346.6	463.6	489.4	680.5	640.7	551.2	549.5	588.6	452.0	358.6	347.6	764.7	396.8	492.3	362.6	985.4	645.4	284.2	296.5	362.1	279.0	325.8	386.8	764.2	968.9	310.2	784.1	552.0	454.6	515.1	731.3	294.1	179.5	681.4	858.6	304.3	416.8	888.6	310.8	500.8	201.1	307.2	235.0	488.7	556.8	787.8	156.3	278.8	246.7	265.8	590.0	544.4	192.7	689.2	642.1	709.5	268.1	321.9	507.8	359.8	418.8	624.7	515.1	472.9	548.2	1728.0	1318.5	1975.5	930.7	1773.7	626.1	785.9	720.7	913.6	1330.1	658.5	505.7	750.0	2200.3	698.9	2060.4	734.3	1039.0	2503.2	114.0	125.6	109.4	130.8	135.2	123.1	115.1	114.7	116.4	117.8	118.2	125.4	334.8	285.2	326.6	21.2	506.7	928.5	691.0	1140.2	425.2	89.8	150.3	189.7	145.3	200.1	465.4	172.9	56.3	944.5	902.3	595.0	342.4	585.8	604.0	220.6	288.5	363.5	319.7	144.9	48.5	658.7	1509.4	301.7	242.6	222.4	414.5	600.6	281.3	98.4	1094.0	58.9	33.1	329.4	364.2	779.9	1321.0	759.3	214.0	896.1	414.4	53.4	1721.9	175.3	1336.7	30.7	33.7	919.8	604.5	326.5	529.9	762.7	510.9	342.8	249.6	95.3	302.4	131.6	571.2	324.4	227.9	645.2	970.6	1045.8	694.1	285.6	337.6	1126.5
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Golgi apparatus"	"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	10.2	10.4	12.3	8.9	22.0	18.2	6.1	18.3	16.8	13.0	5.7	4.4	9.9	10.1	5.8	7.0	8.7	15.0	21.4	9.7	12.5	12.7	10.1	39.5	5.8	25.3	22.2	6.5	12.4	23.1	16.2	10.1	22.9	4.3	3.2	14.9	9.0	3.9	13.1	8.9	8.3	9.1	15.7	8.9	5.3	8.9	21.9	8.2	13.9	17.3	6.1	6.5	5.9	40.2	28.0	14.0	17.5	20.5	8.7	11.7	30.9	13.0	7.6	10.9	8.8	44.5	31.5	14.1	15.5	11.0	14.0	23.2	15.8	10.8	10.5	14.2	14.9	16.3	11.9	23.3	13.6	30.8	25.5	7.9	8.2	13.2	8.0	8.8	29.0	12.6	11.4	2.3	7.7	10.5	14.1	19.4	7.5	31.8	9.9	12.2	7.1	8.1	59.3	6.4	27.8	7.7	12.7	16.3	10.7	22.4	6.2	40.4	19.2	0.0	23.3	14.1	9.9	7.4	15.5	5.9	4.8	28.3	12.2	0.0	1.1	1.7	0.4	1.6	0.3	0.6	0.2	0.2	0.6	1.8	0.3	0.2	3.1	0.0	1.5	0.5	0.0	0.3	12.3	22.0	18.3	16.8	9.7	12.5	25.3	22.2	22.9	15.7	21.9	40.2	25.6	218.0	215.0	22.2	11.3	10.8	3.4	4.9	1.2	42.0	5.2	3.7	42.3	31.5	29.4	16.5	235.6	1.7	7.0	2.4	5.9	32.7	0.9	51.2	24.2	34.2	12.0	3.8	35.0	11.4	32.2	16.5	8.6	176.3	12.0	62.2	27.1	16.5	20.7	13.5	32.5	3.5	14.2	33.6	16.9	1.9	11.1	29.3	10.6	48.7	36.9	11.0	6.2	33.7	138.3	24.3	6.1	4.9	7.7	7.7	10.5	15.7	13.3	44.8	0.0	9.5	12.8	4.0	10.1	6.3	9.7	8.6	8.4	8.7	5.9	3.9
ATP5F1C	"ATP5C, ATP5C1, ATP5CL1"	ENSG00000165629	"ATP synthase F1 subunit gamma"	P36542	10	7788147-7807815	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 895.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 517.1;Distal tubular cells: 890.2;Ductal cells: 453.9;Extravillous trophoblasts: 428.5;Hofbauer cells: 423.4;Proximal tubular cells: 938.6;Theca cells: 413.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060949	Approved					NA	NA		70000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA060949: AB_2684395"	"unprognostic (1.81e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.12e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.08e-2)"	123.7	265.0	82.8	103.2	82.4	149.0	164.8	111.3	111.0	122.5	102.6	240.9	254.7	100.9	150.1	145.9	114.7	112.6	710.9	81.5	94.3	399.9	368.6	93.5	133.0	85.4	83.2	86.8	182.2	411.4	76.7	147.5	86.4	117.5	274.7	161.6	168.3	136.2	537.8	110.7	205.7	146.1	88.8	96.4	174.3	71.1	89.1	192.5	161.7	895.1	175.3	163.8	91.0	90.9	301.2	266.8	255.2	219.3	212.5	276.7	241.2	211.1	176.1	365.7	351.6	511.4	293.8	323.8	163.3	248.0	95.3	337.9	318.3	342.8	325.5	222.3	381.6	351.7	169.3	479.8	172.2	193.6	249.6	222.9	234.1	224.7	134.5	315.7	426.7	321.8	283.4	230.1	352.6	419.0	451.9	217.7	173.3	623.4	201.8	301.9	179.1	460.6	637.5	301.0	141.3	168.2	186.0	417.5	417.1	287.3	437.9	315.9	202.7	151.7	205.3	349.2	229.8	159.2	194.7	265.5	224.7	286.2	127.3	373.0	273.8	241.9	158.5	363.1	185.3	199.2	180.7	174.5	370.4	158.6	146.4	159.6	88.5	226.9	428.2	237.8	261.4	349.3	82.8	82.4	111.3	111.0	81.5	94.3	85.4	83.2	86.4	88.8	89.1	90.9	196.2	118.6	95.4	0.0	30.4	0.0	0.0	0.0	0.0	0.0	156.2	239.3	0.0	0.0	60.7	215.2	0.0	517.1	85.3	0.0	890.2	453.9	0.0	160.9	125.4	76.7	0.0	0.0	0.0	381.8	428.5	89.5	0.0	170.4	97.1	163.2	0.0	0.0	423.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.6	0.0	0.0	140.6	0.0	0.0	0.0	0.0	304.4	0.0	0.0	12.0	0.0	0.0	938.6	64.8	0.0	0.0	0.0	102.0	0.0	0.0	0.0	0.0	371.9	49.1	413.9	0.0	0.0
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 196.4;Intestinal goblet cells: 47.4;Paneth cells: 72.5;Proximal enterocytes: 94.1;Undifferentiated cells: 57.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 23.5;RPTEC TERT1: 27.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.6"	"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.0	0.3	2.5	0.9	8.6	0.0	2.6	0.7	3.7	2.2	1.9	22.4	27.3	0.7	1.3	1.6	1.3	5.5	0.0	2.4	4.6	0.2	0.1	0.1	0.0	2.0	2.1	0.3	3.3	0.0	1.8	0.0	1.3	0.4	37.4	0.8	4.5	0.1	0.0	0.8	33.7	0.8	1.3	0.0	5.0	0.4	6.9	1.0	1.2	0.3	2.0	1.3	2.3	0.7	0.0	0.9	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	23.5	0.0	0.2	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.3	0.2	0.6	0.0	2.7	0.1	27.1	1.7	4.6	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.7	0.2	1.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	8.6	0.7	3.7	2.4	4.6	2.0	2.1	1.3	1.3	6.9	0.7	0.1	0.0	0.0	6.5	0.3	0.0	0.5	0.1	0.0	7.4	8.0	8.1	2.2	10.0	5.3	5.5	0.0	0.0	0.2	196.4	0.0	7.5	0.4	0.2	5.9	0.4	28.9	0.0	3.6	4.7	0.0	0.2	13.3	0.2	4.5	0.8	0.0	0.0	0.0	0.0	4.8	47.4	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.4	0.0	11.1	1.0	9.2	72.5	0.0	0.0	0.6	94.1	0.1	1.5	0.2	0.0	0.1	0.4	0.1	1.7	0.5	0.0	0.0	0.5	0.0	57.7	9.7
BABAM2	"BRCC4, BRCC45, BRE"	ENSG00000158019	"BRISC and BRCA1 A complex member 2"	Q9NXR7	2	27889941-28338901	"Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"adrenal gland: 380.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Distal tubular cells: 84.1;Ductal cells: 53.4;Proximal tubular cells: 84.1;Syncytiotrophoblasts: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017926, HPA048867"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017926: AB_1845443, HPA048867: "	"unprognostic (1.28e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.22e-2)"	30.9	380.0	22.1	21.2	25.2	41.6	27.5	22.9	28.4	31.8	24.6	27.2	18.3	32.1	33.5	24.5	31.0	32.0	54.2	27.4	28.4	54.2	28.6	24.9	20.5	22.4	23.4	36.3	21.7	35.1	32.8	23.3	30.9	24.9	26.2	26.2	20.5	29.0	73.8	25.9	23.0	36.9	18.6	28.6	25.2	27.2	21.1	21.4	24.0	54.8	26.3	31.2	25.3	21.6	39.5	42.8	33.6	35.7	42.4	56.5	33.2	19.4	49.0	36.0	37.2	36.5	39.4	44.4	64.1	47.3	28.9	25.7	27.7	50.9	52.5	37.8	37.1	53.2	17.5	40.9	61.3	28.1	41.5	139.0	43.6	50.3	51.9	45.1	38.7	41.0	27.7	47.3	50.7	33.3	32.8	34.2	25.7	51.4	27.8	29.9	53.6	42.9	104.2	20.4	22.0	35.0	23.0	39.9	40.3	33.9	28.6	36.5	31.7	34.1	45.2	31.7	27.1	53.5	55.8	57.7	63.5	75.6	36.4	106.3	65.6	27.8	57.9	53.1	64.6	50.6	48.7	55.3	86.3	37.6	45.7	43.6	34.3	59.0	55.3	34.4	62.2	56.9	22.1	25.2	22.9	28.4	27.4	28.4	22.4	23.4	30.9	18.6	21.1	21.6	26.7	3.2	19.6	0.0	7.0	0.0	0.0	0.0	0.0	0.0	16.0	18.0	0.0	0.0	5.6	40.5	0.0	46.1	19.0	0.0	84.1	53.4	0.0	22.6	17.4	10.0	0.0	0.0	0.0	44.3	36.8	11.0	0.0	32.5	31.5	23.1	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	25.8	0.0	0.0	0.0	0.0	20.2	0.0	0.0	4.0	0.0	0.0	84.1	8.7	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	48.2	9.7	44.5	0.0	0.0
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238689-81291142	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.0;intestine: 14.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Distal enterocytes: 4.8;Excitatory neurons: 8.0;Intestinal goblet cells: 5.5;Proximal enterocytes: 13.6;Proximal tubular cells: 8.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.5;EFO-21: 8.7;HAP1: 3.3;NTERA-2: 4.6;RPTEC TERT1: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments, Centriolar satellite"		"HPA043811: AB_10962487"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	1.8	0.2	1.3	0.0	0.1	0.0	1.2	0.2	5.0	2.6	9.3	0.6	0.2	0.3	0.4	1.2	0.0	2.5	0.2	3.5	0.8	0.2	0.0	0.4	0.4	0.9	0.3	0.0	0.7	0.0	0.1	0.5	3.0	0.2	0.5	1.5	0.1	0.3	14.6	0.3	0.1	0.0	1.9	0.1	0.7	0.2	0.1	0.0	0.0	0.2	0.4	0.6	0.0	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.3	0.0	8.7	0.0	0.3	0.1	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.6	0.8	0.0	0.0	0.0	0.0	8.6	0.3	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	1.2	2.5	0.2	0.4	0.4	0.1	0.1	0.7	0.6	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.5	0.0	4.8	0.0	0.6	0.1	0.9	1.1	0.1	1.2	0.0	8.0	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.4	0.3	0.1	0.0	3.7	5.5	0.0	0.0	0.0	0.3	1.5	0.1	0.0	1.0	0.0	0.0	0.0	2.5	1.0	0.6	2.1	1.2	0.0	0.1	13.6	8.8	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.7	0.0	0.3	0.1	0.0	3.0	0.7
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103077592-103099870	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 162.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 211.3;Proximal tubular cells: 795.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	45.0	96.6	23.3	4.3	25.8	3.5	39.7	27.0	27.3	46.6	27.1	31.8	39.4	31.2	16.6	27.2	43.4	14.9	46.6	20.3	27.8	162.1	70.5	35.9	6.7	28.4	26.5	54.8	23.2	30.8	29.2	7.7	27.0	31.9	10.3	8.5	32.8	14.1	24.6	26.1	39.6	9.6	25.2	21.2	38.9	14.8	28.2	17.5	62.9	16.7	7.3	37.1	37.3	26.5	3.1	5.3	26.5	10.0	30.4	29.4	3.4	6.7	17.8	6.9	10.6	3.4	11.8	12.4	11.1	10.2	2.1	1.5	17.3	10.1	8.2	8.2	8.5	1.5	6.4	8.1	15.0	7.4	2.1	24.8	9.1	10.6	2.6	23.0	20.7	14.3	8.0	5.5	24.1	1.0	37.2	6.3	9.6	2.0	2.1	24.5	30.7	7.9	46.4	3.6	4.5	12.0	12.8	6.7	7.9	9.6	5.7	5.3	9.9	10.7	3.4	5.5	3.7	8.1	7.9	12.5	11.8	8.9	5.4	2.6	2.5	0.2	7.6	1.4	8.8	4.8	6.6	6.0	3.2	6.7	9.8	10.4	0.4	6.5	0.2	5.0	10.2	4.0	23.3	25.8	27.0	27.3	20.3	27.8	28.4	26.5	27.0	25.2	28.2	26.5	37.7	32.1	57.8	33.6	10.2	30.3	47.1	59.4	36.5	2.5	31.9	36.1	9.6	64.3	46.9	108.5	0.0	7.9	19.0	18.0	211.3	58.2	1.9	60.6	45.5	30.3	22.9	16.4	1.2	21.3	18.5	75.2	41.8	27.9	19.6	39.1	27.8	71.6	20.4	3.3	3.8	24.4	46.8	10.9	16.9	4.8	69.9	12.5	23.2	14.0	14.9	50.4	14.4	3.5	21.8	23.0	18.6	77.8	8.0	18.9	162.3	795.7	48.7	3.8	13.1	40.9	36.5	0.9	4.0	25.9	26.7	3.4	18.2	52.6	37.6	37.5
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427295-66493529	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.8;Early spermatids: 10.7;Excitatory neurons: 9.9;Extravillous trophoblasts: 10.9;Inhibitory neurons: 7.7;Late spermatids: 13.6;Oligodendrocyte precursor cells: 7.5;Spermatocytes: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.2;BEWO: 4.2;RPTEC TERT1: 9.1;U-87 MG: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Centrosome	"HPA053851: AB_2682280"	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	0.7	0.3	1.3	0.3	1.2	0.8	0.6	2.4	4.1	0.8	0.0	0.6	0.2	0.8	0.3	0.6	1.1	0.4	0.9	2.4	0.7	0.5	0.7	0.6	0.2	5.1	1.6	0.9	0.5	0.6	0.3	1.5	5.0	0.4	0.2	1.7	0.5	0.1	1.0	0.9	0.4	0.2	0.7	0.4	0.4	1.1	3.0	0.0	0.7	0.1	0.2	0.6	0.6	1.7	0.5	0.8	0.8	9.2	0.1	0.1	4.2	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.4	0.6	0.0	0.0	0.3	1.6	0.4	0.1	1.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.4	0.0	0.1	0.3	9.1	0.3	0.0	0.1	0.1	0.1	1.4	0.5	0.1	0.0	0.1	0.2	2.0	0.0	0.3	0.3	0.0	0.0	4.8	0.1	1.0	0.2	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.9	0.0	0.0	1.3	1.2	2.4	4.1	2.4	0.7	5.1	1.6	5.0	0.7	3.0	1.7	0.1	0.0	0.0	2.0	0.0	0.1	0.3	0.2	0.0	0.6	0.2	0.6	1.4	0.0	0.2	0.0	0.0	5.8	0.0	0.1	0.0	0.4	10.7	0.2	0.2	0.4	0.0	0.0	9.9	0.0	10.9	0.4	0.0	0.2	0.0	0.3	0.7	0.0	1.0	0.0	7.7	0.0	0.0	0.8	0.4	13.6	0.3	0.1	3.6	3.7	0.0	0.0	1.0	7.5	2.6	1.7	0.0	2.2	0.0	1.7	0.0	0.1	0.1	1.4	0.0	0.2	0.3	6.6	0.3	0.0	0.1	2.9	0.1	0.5	0.0	0.8
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 5.7;NK-cells: 17.5;Spermatogonia: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;RPTEC TERT1: 19.5;SK-BR-3: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"amygdala: 2.5;cerebral cortex: 3.2;hippocampal formation: 3.6"	"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	1.1	1.3	2.0	0.5	2.2	0.4	1.1	1.6	2.1	1.3	2.0	1.3	0.3	1.8	1.4	1.1	1.3	1.3	0.7	2.2	2.1	3.7	0.3	1.7	0.3	1.7	1.8	1.5	1.9	1.0	0.9	1.9	1.8	1.2	0.5	0.4	1.5	1.1	0.3	1.0	0.7	1.1	1.5	0.4	0.9	3.8	2.1	0.2	2.5	0.4	0.3	1.3	0.9	2.4	0.8	8.1	2.6	0.3	0.7	2.6	0.4	2.0	9.5	1.3	1.2	3.7	7.0	0.0	1.6	1.2	5.1	1.2	2.8	1.6	1.0	1.8	2.1	0.6	1.2	1.1	1.5	0.5	0.9	3.1	4.9	0.7	2.3	10.8	5.7	0.5	0.3	0.4	4.2	1.6	0.0	1.2	6.1	5.2	2.2	0.0	1.8	0.4	19.5	1.5	2.7	0.3	2.4	10.6	4.3	1.2	5.2	1.8	6.5	0.3	0.6	0.7	2.0	0.0	0.1	0.0	1.4	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.2	2.0	2.2	1.6	2.1	2.2	2.1	1.7	1.8	1.8	1.5	2.1	2.4	3.8	3.2	1.7	0.7	0.0	0.9	0.5	0.7	0.0	0.2	1.9	1.5	1.2	1.5	0.4	0.0	0.0	1.2	2.6	0.1	1.9	0.8	1.3	1.1	0.4	3.1	0.0	0.8	2.1	0.9	1.7	1.2	1.5	0.6	0.0	0.2	3.9	0.2	0.5	0.0	1.2	0.2	0.0	0.0	0.8	5.7	1.8	0.2	1.8	2.8	0.0	1.0	17.5	0.5	1.1	0.8	0.0	0.0	0.4	0.4	0.0	0.3	1.8	0.1	0.0	0.5	1.0	1.1	11.9	1.1	0.9	0.4	1.0	0.4	0.3	0.5
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58512872-58831435	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2"	"Group enriched"	"Detected in all"	4	"pancreatic cancer: 9.2;renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	10.6	6.1	0.3	4.0	0.5	0.3	8.7	0.0	1.6	5.8	1.9	4.5	1.2	4.9	4.0	3.5	7.5	11.6	10.5	0.6	1.0	28.6	2.4	5.8	2.4	1.2	0.6	13.9	16.9	0.8	3.6	3.6	0.2	3.8	4.1	1.4	4.3	4.2	7.6	6.1	2.7	4.7	1.2	2.9	2.7	3.1	0.7	1.4	4.6	6.2	2.7	5.5	5.6	0.7	0.0	59.1	0.8	0.0	17.9	23.0	0.0	38.5	61.4	34.4	40.4	93.1	12.3	0.0	39.8	39.3	8.8	0.8	6.1	7.0	47.4	0.1	5.9	0.0	7.4	0.1	11.5	0.0	0.0	36.0	2.2	26.9	28.6	42.3	0.1	0.0	0.0	0.2	13.4	0.1	0.0	0.0	0.5	0.0	3.8	0.0	14.3	0.0	140.8	7.1	0.2	7.3	0.1	0.4	3.4	2.4	0.0	0.6	0.0	8.2	7.7	1.4	5.0	0.0	0.0	0.1	23.8	0.0	7.8	6.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.5	0.1	0.0	0.3	0.5	0.0	1.6	0.6	1.0	1.2	0.6	0.2	1.2	0.7	0.7	4.1	0.0	0.5	120.5	1.5	7.1	1.3	1.3	0.6	0.6	1.1	4.3	3.3	158.7	1.7	86.5	0.0	0.4	0.1	0.3	78.2	98.5	5.2	43.8	14.4	1.4	3.6	0.0	70.4	3.5	0.2	79.6	0.5	7.2	0.0	4.2	3.3	1.4	3.5	0.0	37.2	1.2	0.0	0.6	18.5	3.2	71.1	1.7	21.4	165.8	1.1	10.1	0.0	25.6	2.7	35.3	1.2	50.0	0.3	2.4	0.0	148.2	14.1	0.2	6.6	40.0	9.8	0.1	3.9	0.3	4.7	4.1	1.5	8.7	1.6	0.1
BIVM	FLJ20159	ENSG00000134897	"Basic, immunoglobulin-like variable motif containing"	Q86UB2	13	102799119-102841533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA050126	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA050126: AB_2681027"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.89e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-2)"	7.4	7.1	8.2	3.6	8.6	3.6	8.8	10.9	10.6	8.6	7.6	7.1	6.3	9.2	11.5	5.5	7.7	6.9	19.4	8.3	7.8	16.3	18.8	6.7	4.5	7.5	7.9	9.2	10.4	9.1	8.9	7.7	7.7	7.8	8.2	9.0	6.1	7.6	17.8	7.2	6.3	8.9	6.8	7.4	8.6	2.3	8.5	10.4	8.0	18.9	4.3	7.4	6.5	9.1	16.8	4.6	19.9	18.7	24.2	37.4	4.1	19.3	23.9	14.5	16.5	6.1	7.7	0.1	8.2	22.1	10.3	11.5	17.9	16.3	17.5	17.1	16.3	14.7	14.2	8.8	19.5	16.8	22.2	28.2	18.8	7.9	20.5	25.4	20.2	22.7	14.4	0.0	25.7	3.7	19.3	16.1	4.3	24.1	12.9	0.0	9.0	6.4	50.0	7.2	23.8	21.1	8.5	9.2	12.3	7.2	13.3	22.7	12.9	13.0	4.3	9.4	11.8	12.5	5.6	0.1	21.2	0.0	25.9	5.5	0.4	1.1	2.2	0.2	5.2	0.5	1.4	2.9	1.6	0.5	0.7	1.4	0.3	7.6	0.0	0.4	1.0	1.0	8.2	8.6	10.9	10.6	8.3	7.8	7.5	7.9	7.7	6.8	8.5	9.1	9.3	9.6	12.8	2.9	2.6	3.7	3.8	7.0	11.4	19.0	7.7	6.1	30.7	21.5	11.2	18.4	14.6	7.1	3.8	5.6	29.4	6.5	0.5	5.1	11.8	11.0	21.8	9.2	13.9	5.5	7.8	11.8	6.1	4.9	6.3	15.2	17.2	34.0	7.0	23.5	16.8	15.3	6.1	5.0	3.4	0.4	13.7	3.3	3.6	4.7	2.4	8.1	5.2	9.0	6.3	4.1	9.3	11.3	4.5	4.9	9.7	30.8	8.9	12.4	19.7	10.4	9.8	2.0	12.6	11.4	4.8	2.5	8.1	10.3	15.2	3.4
BIVM-ERCC5		ENSG00000270181	"BIVM-ERCC5 readthrough"		13	102799110-102875994	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.3;Club cells: 2.5;Excitatory neurons: 6.4;granulocytes: 2.5;Inhibitory neurons: 7.5;Oligodendrocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.3;HMC-1: 1.3;hTERT-RPE1: 1.3;RPTEC TERT1: 2.5;SK-MEL-30: 1.4"									"HPA045845, HPA050126, HPA050374"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106"													"unprognostic (6.01e-2)"					10.2	9.5	0.2	0.1	0.0	0.0	9.5	0.4	0.2	10.1	0.0	9.9	0.0	9.7	0.0	8.7	8.6	0.3	8.6	0.1	0.0	9.7	12.4	9.1	0.0	0.0	0.2	10.5	11.7	0.1	9.3	0.0	0.0	8.8	0.2	0.2	9.3	0.0	12.5	9.7	9.9	0.1	0.0	9.4	9.4	3.2	0.1	0.0	9.9	0.0	0.0	9.2	9.2	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.4	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	1.3	0.9	0.6	0.7	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.3	0.5	1.3	0.3	0.5	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.5	0.5	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40769980-40772449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.0;skin 1: 17.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.6;Club cells: 5.0;Glandular and luminal cells: 6.3;Ionocytes: 6.1;Prostatic glandular cells: 5.5;Squamous epithelial cells: 4.7;Urothelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.7;SK-BR-3: 5.7"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in all"			HPA044636	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.8	1.3	0.7	1.5	1.0	1.7	2.3	4.4	1.5	3.5	0.0	2.0	1.9	1.7	0.1	26.0	2.1	1.3	1.4	0.7	0.2	2.0	4.0	1.8	2.1	0.7	0.5	2.5	2.0	0.1	2.1	0.4	0.8	2.4	0.1	2.4	8.3	0.1	2.0	17.1	2.6	0.0	0.1	2.3	1.9	0.6	0.8	0.7	2.0	0.1	5.0	1.8	6.9	1.2	0.5	0.4	1.6	2.0	0.6	0.1	0.4	0.7	0.1	0.0	0.2	1.9	2.2	1.0	1.8	0.0	1.3	4.1	0.7	0.0	0.0	1.5	1.6	1.0	4.4	0.6	0.0	0.9	1.2	0.2	0.8	0.0	0.1	1.8	0.6	0.7	0.9	1.2	0.0	0.5	1.3	1.6	0.7	2.8	0.8	1.4	0.3	0.5	17.7	1.5	3.6	0.8	0.6	5.7	0.2	0.6	2.0	1.3	0.8	2.0	0.9	1.8	0.6	1.4	1.0	0.9	0.6	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.4	1.5	0.7	0.2	0.7	0.5	0.8	0.1	0.8	1.2	0.2	0.0	0.0	0.3	0.3	0.0	3.6	2.1	0.6	0.3	1.7	0.6	0.7	0.0	5.0	0.0	0.0	0.1	0.2	0.1	0.0	0.5	0.0	1.6	0.9	0.3	0.0	0.0	0.1	0.2	0.0	0.2	0.0	6.3	0.0	0.1	0.0	0.8	0.2	3.3	0.1	0.1	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.1	0.0	0.0	5.5	0.3	0.3	1.3	0.5	0.0	0.0	0.3	0.0	0.0	4.7	1.0	0.0	0.2	0.0	0.3	11.6
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806278	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA037663	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	2.7	10.7	5.2	1.3	5.6	2.0	4.2	5.3	7.8	4.0	6.2	3.1	2.6	3.7	5.8	1.7	3.9	2.3	6.1	5.5	5.5	6.2	3.1	3.3	1.6	5.4	5.5	4.5	6.7	7.5	4.9	1.3	5.4	4.4	2.3	2.7	3.2	3.9	4.9	1.3	2.2	3.3	5.4	2.3	3.1	4.1	5.8	1.5	8.7	4.4	1.0	2.7	2.5	5.4	5.5	7.5	3.6	4.9	0.3	4.4	1.5	2.4	3.5	2.2	5.2	2.6	6.9	0.9	5.3	2.3	3.3	0.8	3.7	0.0	3.9	2.7	5.4	3.3	1.0	7.0	6.0	4.8	1.1	3.4	4.0	2.4	4.6	2.8	3.8	5.5	5.4	2.4	3.8	4.1	4.9	4.0	4.6	5.2	1.8	4.8	1.8	5.2	12.2	2.7	2.6	3.6	5.3	6.7	4.6	1.8	9.8	5.7	2.3	2.5	1.8	5.5	5.9	4.1	4.3	0.0	1.8	4.4	2.6	2.1	1.2	0.2	4.0	1.1	5.1	1.8	3.1	3.6	2.1	1.4	3.9	4.1	0.1	4.0	0.8	1.7	2.2	2.1	5.2	5.6	5.3	7.8	5.5	5.5	5.4	5.5	5.4	5.4	5.8	5.4	1.6	3.2	6.7	13.7	1.5	1.3	5.2	4.7	5.2	8.5	3.1	2.7	11.9	5.7	6.7	0.0	6.2	4.2	0.9	1.8	5.9	3.7	6.6	1.5	2.7	2.3	3.6	3.8	14.9	3.3	3.1	4.8	1.1	1.4	7.0	2.8	2.5	3.3	2.4	6.7	14.9	3.8	4.1	0.3	2.0	5.4	6.2	1.4	1.8	3.7	0.6	15.6	6.2	11.6	10.7	1.4	2.5	7.9	2.2	5.1	1.0	7.0	3.5	7.6	0.0	8.4	4.1	14.5	14.8	2.7	1.4	3.7	2.8	3.8	3.7	2.5
C5orf24	FLJ37562	ENSG00000181904	"Chromosome 5 open reading frame 24"	Q7Z6I8	5	134845680-134859735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057749, HPA062502"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA057749: AB_2683515, HPA062502: AB_2684785"	"unprognostic (8.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.33e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.45e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (4.75e-2)"	24.1	25.9	17.3	17.8	20.7	24.9	20.2	26.3	31.2	20.2	16.2	21.2	22.1	28.9	15.8	21.0	17.5	21.3	19.5	18.4	18.3	41.0	43.2	22.9	16.3	19.5	18.7	20.0	13.2	26.8	15.4	28.6	18.9	21.5	18.4	19.3	18.3	18.3	21.5	19.1	17.1	26.7	19.8	16.7	16.1	12.4	18.7	15.0	29.8	26.6	14.6	22.1	16.8	23.4	26.0	21.5	43.8	63.7	53.0	62.3	15.7	54.7	38.5	29.6	35.3	28.7	29.0	24.0	46.4	39.1	37.6	17.3	25.0	37.9	51.3	18.0	35.3	27.1	50.4	33.9	40.1	11.8	30.8	51.6	45.0	42.9	48.9	59.5	55.2	39.5	19.0	29.1	64.7	14.8	26.0	20.4	9.8	16.1	21.8	29.4	41.6	27.4	75.4	23.9	27.0	51.5	56.7	15.0	82.2	19.4	30.8	38.1	61.4	59.4	25.7	43.8	39.5	30.3	23.2	30.3	43.6	33.2	44.9	4.5	9.0	9.6	5.5	6.9	4.4	6.7	3.7	4.5	7.8	6.4	6.9	4.3	1.7	5.5	5.7	10.5	4.9	4.2	17.3	20.7	26.3	31.2	18.4	18.3	19.5	18.7	18.9	19.8	18.7	23.4	71.8	86.6	34.1	21.2	44.1	43.1	34.7	50.0	56.9	47.2	64.3	56.8	33.2	64.3	34.8	106.7	37.5	33.4	45.9	26.4	58.7	52.0	18.6	33.0	85.6	83.6	53.9	45.0	31.1	43.7	35.4	60.1	27.0	48.2	21.5	48.0	78.1	94.4	32.2	69.0	33.9	32.4	28.5	33.6	47.9	10.8	70.5	33.3	64.0	22.5	40.3	28.2	68.0	22.6	44.3	83.9	34.7	71.5	32.3	44.7	42.4	132.8	29.1	45.9	72.3	61.3	88.0	66.9	44.6	67.8	49.3	22.2	37.6	34.6	35.0	25.0
CAAP1	"C9orf82, CAAP, FLJ13657"	ENSG00000120159	"Caspase activity and apoptosis inhibitor 1"	Q9H8G2	9	26840685-26892803	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA020404, HPA024029, HPA024100"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.94e-9)"	"unprognostic (2.74e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-2)"	7.0	20.4	4.3	10.5	4.5	7.7	10.8	4.8	6.2	9.1	11.0	18.6	17.4	8.2	16.9	11.3	9.2	9.8	5.7	4.4	5.1	16.3	23.8	7.8	14.7	4.4	4.3	6.6	10.8	18.9	7.4	9.7	4.3	10.6	19.5	8.6	11.2	9.5	7.1	10.2	12.7	10.0	4.0	8.5	11.2	12.6	4.6	14.2	27.4	7.5	15.1	10.6	6.8	4.7	24.2	14.9	24.3	23.9	15.9	13.4	18.5	17.4	17.1	16.4	20.1	4.4	14.9	28.6	17.5	14.9	9.4	12.8	25.3	17.0	22.4	39.0	15.4	49.6	22.6	28.2	26.4	21.7	23.9	13.7	21.4	12.7	29.7	18.5	27.8	18.4	14.1	21.0	19.1	13.9	33.8	9.0	32.2	23.8	12.3	23.1	10.9	19.0	42.6	17.7	19.4	38.5	15.9	17.5	16.3	21.5	14.9	25.6	16.7	0.0	24.5	10.1	16.4	9.6	19.2	33.0	8.0	22.3	10.3	14.9	11.3	8.2	16.2	17.6	20.9	18.8	17.7	18.9	18.4	18.7	14.7	15.3	1.4	20.1	15.7	17.2	18.8	16.0	4.3	4.5	4.8	6.2	4.4	5.1	4.4	4.3	4.3	4.0	4.6	4.7	13.9	22.4	21.6	42.1	20.3	9.9	11.3	18.4	15.9	10.8	18.2	14.6	9.7	14.3	27.6	31.3	8.4	18.3	16.4	28.1	58.7	20.6	18.8	25.6	15.3	14.9	15.5	21.7	34.0	19.8	14.7	13.4	18.8	25.5	18.3	15.8	10.4	34.3	12.1	8.4	42.5	26.0	26.4	11.1	10.3	5.4	8.4	17.7	8.8	26.2	15.6	22.1	12.3	41.2	33.8	22.6	23.1	6.4	26.0	17.5	13.4	29.5	23.7	12.7	13.1	16.9	14.8	41.9	18.4	31.6	14.6	10.8	20.1	28.0	32.1	12.6
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139953-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006872	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		9000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	425.4	357.9	363.0	171.4	374.4	235.7	371.7	359.4	507.1	368.1	353.9	371.4	263.2	303.5	193.8	761.7	306.6	197.8	692.5	379.8	411.1	488.5	273.5	396.7	167.4	401.0	392.3	267.6	250.9	330.9	317.9	147.3	401.0	357.0	287.6	136.2	374.9	281.4	491.3	211.9	341.4	290.0	356.5	363.6	311.1	273.6	400.3	200.8	329.9	373.4	275.1	354.8	402.5	384.1	395.2	977.6	240.0	342.7	566.3	683.0	48.2	315.8	673.4	631.3	488.1	223.3	572.2	141.9	463.7	1067.5	225.6	207.0	291.3	780.8	514.7	592.4	142.9	166.0	259.7	373.0	655.0	166.7	393.9	740.8	477.9	411.1	577.5	767.3	699.8	173.5	204.4	554.4	978.6	522.7	295.4	301.4	137.9	754.6	490.6	156.5	194.7	262.3	1208.8	368.7	159.1	199.4	385.1	532.0	155.5	279.4	308.6	261.4	460.6	555.5	424.3	188.1	318.7	198.4	277.6	126.8	630.4	225.9	480.8	24.8	50.1	22.6	44.4	75.6	28.5	29.4	30.9	36.4	46.1	32.3	18.7	25.2	25.2	24.6	83.4	58.7	34.7	21.1	363.0	374.4	359.4	507.1	379.8	411.1	401.0	392.3	401.0	356.5	400.3	384.1	172.7	125.0	98.6	10.4	49.3	30.7	76.2	69.1	29.6	21.1	91.7	75.1	149.5	130.1	85.9	163.7	0.0	74.9	107.1	250.1	62.6	226.3	102.9	168.5	118.3	136.6	107.8	47.3	13.4	251.3	87.8	83.3	66.8	234.4	63.4	84.7	157.1	78.4	155.1	16.8	11.9	220.3	52.9	244.6	86.9	230.2	93.2	130.5	39.2	15.9	208.4	78.2	109.2	6.6	21.9	254.2	187.5	76.0	50.2	98.0	243.5	135.3	74.6	33.1	46.0	64.3	92.9	120.1	6.5	109.1	28.8	70.1	62.8	132.2	165.6	112.4
CC2D2A	"JBTS9, KIAA1345, MKS6"	ENSG00000048342	"Coiled-coil and C2 domain containing 2A"	Q9P2K1	4	15469865-15601552	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 84.7"	"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044124	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA044124: AB_10969197"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.01e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.42e-9)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.18e-2)"	8.3	9.3	13.5	2.7	13.0	2.7	8.8	14.2	16.5	14.2	22.1	17.3	4.9	12.8	11.1	8.3	34.2	12.4	7.4	13.2	13.5	23.6	2.9	10.7	2.0	13.7	14.6	11.7	5.1	10.0	12.7	8.5	12.6	10.0	5.9	84.7	3.3	12.5	2.5	2.3	5.0	15.4	12.0	3.3	8.2	4.9	14.7	1.2	8.2	11.1	1.4	9.3	6.4	12.7	5.4	11.3	15.6	7.0	18.4	34.4	3.8	6.8	11.5	12.7	15.5	5.1	13.2	0.5	7.3	13.1	27.7	3.4	13.1	8.7	15.9	0.0	7.3	5.5	10.1	7.1	13.5	0.5	0.1	25.0	22.8	20.7	15.5	23.3	5.9	0.2	14.7	0.4	24.4	3.9	0.2	0.9	25.9	0.2	23.3	3.5	4.9	1.1	32.1	2.6	9.7	11.1	4.3	3.1	32.2	14.6	4.9	1.3	2.2	20.2	12.0	8.6	14.4	0.4	0.5	0.3	24.3	0.3	13.1	1.9	2.4	0.2	0.4	1.6	0.6	0.3	0.3	0.1	3.8	0.3	0.2	0.4	4.8	0.9	0.8	0.2	0.9	0.6	13.5	13.0	14.2	16.5	13.2	13.5	13.7	14.6	12.6	12.0	14.7	12.7	8.4	12.8	14.6	39.8	0.7	2.2	5.6	5.7	14.2	15.1	6.5	9.0	22.9	10.0	23.5	25.8	569.2	10.2	0.3	0.8	33.2	6.6	12.0	96.8	14.0	7.0	6.0	2.7	20.9	0.9	3.1	18.7	4.1	9.0	0.0	15.2	8.9	1.6	5.0	8.4	43.4	0.9	8.2	5.7	4.6	6.7	9.3	4.4	12.4	16.9	1.2	18.4	0.0	62.8	19.5	1.0	0.5	16.6	1.3	4.4	2.1	57.1	128.4	136.4	6.6	14.7	17.7	2.6	0.7	6.4	1.3	1.5	1.9	12.9	2.9	4.0
CCDC157		ENSG00000187860	"Coiled-coil domain containing 157"	Q569K6	22	30356635-30378658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.0;Late spermatids: 142.4;Respiratory ciliated cells: 44.9;Spermatocytes: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA042943	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA042943: AB_10794767"	"unprognostic (3.69e-3)"	"unprognostic (1.72e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.74e-3)"	"unprognostic (8.72e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.89e-4)"	"unprognostic (2.33e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.45e-2)"	0.7	1.4	3.9	0.9	3.5	1.8	1.2	2.9	3.8	1.5	7.3	0.9	0.9	1.0	1.8	1.1	7.4	1.2	0.7	3.8	4.1	3.0	0.9	2.2	1.1	4.3	5.9	1.2	1.9	2.2	5.0	0.5	3.3	1.7	0.4	1.9	1.5	0.9	0.6	1.0	1.2	0.4	3.6	1.6	1.1	27.6	5.0	0.8	3.6	0.5	0.7	0.9	1.0	2.7	1.8	2.0	1.8	3.4	1.0	0.6	2.2	0.9	1.1	1.7	1.7	2.6	1.3	1.6	1.1	0.9	2.6	1.9	1.0	1.2	0.9	1.1	4.3	0.9	2.0	1.4	1.1	1.7	1.4	0.6	0.8	3.1	0.5	1.1	1.0	2.3	1.5	1.4	1.4	1.6	2.2	1.8	2.4	1.2	1.0	1.9	1.0	1.4	4.2	1.8	6.1	4.0	2.8	1.1	1.2	1.3	3.3	0.8	1.8	1.8	2.2	1.1	0.8	1.2	0.7	1.2	2.7	1.0	1.4	0.8	0.6	0.8	0.7	0.4	0.8	0.4	0.7	0.8	0.3	0.5	0.4	0.6	2.5	0.7	0.6	0.9	0.7	0.5	3.9	3.5	2.9	3.8	3.8	4.1	4.3	5.9	3.3	3.6	5.0	2.7	2.6	3.2	3.3	2.0	2.6	1.3	2.4	4.2	0.6	6.2	6.6	5.2	0.9	4.3	7.3	9.2	12.5	2.5	7.0	3.0	0.0	5.5	118.0	31.3	3.3	2.8	1.2	0.4	4.2	2.3	2.3	2.6	2.0	5.0	2.5	3.8	5.7	0.9	2.0	6.7	3.1	1.5	8.2	3.8	3.9	142.4	3.7	3.4	0.0	1.0	2.2	4.4	4.1	1.0	0.6	3.0	3.2	2.6	6.6	1.4	1.7	6.9	44.9	28.3	0.0	6.7	3.8	59.3	16.5	1.5	1.7	3.4	4.8	4.5	1.8	1.9
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469300-57493867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 27.5;kidney: 97.3;liver: 36.8;pancreas: 34.0"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 57.0;Distal tubular cells: 68.4;Proximal tubular cells: 191.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 25.1"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"A549: 11.5;RPTEC TERT1: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA029202: AB_10600754"		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favorable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.5	0.5	0.7	0.6	0.0	1.0	0.6	1.3	0.0	0.2	1.5	0.5	1.9	0.1	27.5	16.8	0.2	0.4	0.4	97.3	36.8	0.1	0.1	0.7	0.5	0.1	34.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.0	1.5	0.2	0.6	0.2	0.0	0.4	0.1	0.4	0.1	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.0	11.5	0.0	0.0	0.0	0.6	0.2	0.1	0.1	0.0	0.0	1.1	0.9	0.1	2.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.2	0.2	0.0	0.2	0.1	0.0	0.2	34.3	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.1	0.0	0.3	0.3	0.3	1.6	0.4	0.0	1.7	0.3	0.2	0.7	0.1	0.9	0.6	1.4	1.0	0.0	1.2	1.2	1.9	1.5	1.0	0.3	0.5	2.2	1.9	0.5	0.7	1.0	0.6	0.4	0.4	0.7	0.5	0.8	0.4	0.8	1.6	0.0	3.2	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.1	0.0	68.4	22.2	0.0	19.7	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.1	0.0	0.0	191.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7043001	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 65.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.7;Endometrial ciliated cells: 59.7;Late spermatids: 93.4;Respiratory ciliated cells: 53.4;Spermatocytes: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 5.3"									HPA047546	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047546: AB_2680082"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	2.0	2.0	0.5	2.4	1.3	1.2	2.4	2.1	1.1	6.0	0.8	0.9	0.8	0.7	1.3	10.7	0.8	0.6	2.5	2.1	1.4	0.5	1.7	0.8	3.4	3.7	0.7	1.3	1.0	3.3	0.5	3.0	1.0	0.6	1.8	1.0	1.1	1.1	1.7	0.8	0.6	2.7	0.8	1.1	65.4	2.6	0.7	1.5	0.7	0.6	0.7	0.9	1.9	1.0	2.7	1.4	1.1	1.8	1.2	0.3	2.7	1.6	3.0	1.8	0.9	2.4	0.6	0.7	1.5	3.9	1.2	0.5	1.2	0.9	0.1	0.4	0.6	1.1	0.7	0.9	0.8	1.5	1.1	1.3	1.8	0.2	0.3	1.2	1.9	0.4	0.2	1.9	2.4	1.6	1.0	0.5	0.9	1.6	0.6	0.9	0.1	5.3	1.0	3.8	0.8	2.2	1.0	0.5	1.3	1.0	1.5	1.3	2.5	0.7	1.5	2.1	0.0	0.1	0.5	1.9	0.0	0.8	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.5	0.1	0.1	1.0	0.0	0.0	0.1	2.0	2.4	2.4	2.1	2.5	2.1	3.4	3.7	3.0	2.7	2.6	1.9	3.1	0.0	4.8	0.0	1.0	0.6	0.8	2.8	0.6	4.0	3.7	3.2	0.9	0.0	6.9	3.7	12.5	0.6	0.7	2.5	1.9	2.2	76.7	59.7	4.0	2.3	5.4	0.0	0.0	1.1	0.6	1.5	0.5	2.4	0.0	0.6	2.9	0.9	1.2	0.0	0.0	1.9	4.1	2.2	0.9	93.4	3.1	1.7	1.8	0.0	1.1	6.9	0.0	0.0	0.0	1.7	2.7	4.1	0.1	1.2	0.2	4.5	53.4	19.6	0.0	4.6	2.3	30.6	3.6	1.2	1.0	0.5	0.8	2.7	0.8	0.9
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157207-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	46.4	23.6	15.5	35.6	18.2	88.0	81.5	64.3	20.8	39.6	8.3	33.5	28.0	39.2	26.7	136.0	18.8	32.8	14.9	17.5	11.4	71.0	11.0	26.3	73.5	13.5	14.7	37.4	14.7	46.3	8.8	64.6	13.5	78.1	34.4	81.2	34.3	31.4	12.3	29.2	25.1	33.8	13.1	48.1	25.4	11.2	15.2	67.3	53.2	34.4	73.5	53.5	37.1	19.2	30.9	3.9	66.5	35.5	43.1	54.9	45.0	25.4	72.6	19.4	36.0	4.6	43.8	61.7	40.0	23.7	18.4	21.7	17.6	83.8	37.2	43.2	11.8	5.2	18.1	9.1	22.4	9.3	62.1	46.9	40.8	9.1	19.9	64.6	29.4	35.9	3.0	36.7	36.0	12.0	42.9	19.7	6.8	15.0	4.1	24.3	64.8	4.1	121.9	84.1	17.7	56.1	30.0	46.7	18.0	39.4	34.9	13.8	27.6	26.3	26.0	19.1	4.2	26.9	21.9	43.8	18.4	14.4	13.4	14.8	1.7	21.0	0.9	2.7	2.1	3.2	1.3	1.0	1.9	6.3	1.0	0.6	8.0	2.1	3.1	2.8	6.1	0.8	15.5	18.2	64.3	20.8	17.5	11.4	13.5	14.7	13.5	13.1	15.2	19.2	25.0	12.8	12.3	14.7	55.8	37.1	29.0	27.8	113.8	112.4	101.1	53.6	4.7	8.6	25.4	55.2	22.9	29.7	35.5	57.6	86.1	33.7	0.8	50.4	44.6	35.7	16.7	1.7	13.8	19.6	98.7	61.5	18.3	107.7	39.3	20.3	35.3	3.9	32.3	25.2	26.7	38.0	50.8	45.3	56.7	2.3	27.7	35.8	56.9	10.3	61.8	28.4	17.5	17.1	13.9	49.2	24.6	27.4	20.5	74.3	29.6	70.9	15.3	46.8	65.7	61.3	41.5	9.2	10.1	40.8	26.7	15.7	31.1	17.1	16.1	57.8
CD24	CD24A	ENSG00000272398	"CD24 molecule"	P25063	6	106969831-106975627	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 1630.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1572.7;Distal tubular cells: 1590.6;Exocrine glandular cells: 3454.1;Glandular and luminal cells: 1441.8;Pancreatic endocrine cells: 1694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"eosinophil: 86.2;memory B-cell: 61.1;naive B-cell: 39.7"	"Group enriched"	"Detected in many"	237	"B-cells: 61.1;granulocytes: 86.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 989.4;RPTEC TERT1: 4702.6;RT4: 931.5;SK-BR-3: 1352.5"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	7.1	61.9	23.3	139.1	28.8	704.5	468.1	6.4	30.0	288.0	36.7	1071.8	89.0	181.5	229.6	1456.5	242.9	874.3	5.1	45.0	29.2	775.6	30.2	61.6	77.8	26.6	26.0	2.2	1383.4	2.5	12.5	151.7	17.2	148.8	740.8	2.6	952.4	546.9	1.4	77.2	69.8	117.7	19.5	29.6	601.7	4.9	38.6	15.2	1630.2	1.1	445.0	168.9	468.3	50.7	363.2	225.2	3.9	28.6	0.7	0.3	405.8	0.4	2.6	2.0	1.2	3.3	1.9	35.4	106.0	0.1	14.6	730.6	124.1	275.6	1.5	1.0	1.7	1.0	254.2	16.3	0.2	5.1	1.8	2.1	316.1	3.6	18.0	16.9	1.6	1.4	8.3	0.8	6.6	465.6	2.4	2.6	989.4	800.1	85.6	846.8	0.5	3.5	4702.6	931.5	612.4	448.7	250.0	1352.5	1.4	437.1	635.6	2.1	1.6	0.8	4.0	3.1	11.8	1.0	2.0	475.2	5.0	2.9	1.6	0.3	0.1	86.2	0.0	0.0	0.0	61.1	0.0	0.0	0.0	39.7	0.0	0.1	2.1	0.1	0.3	0.1	0.0	2.0	23.3	28.8	6.4	30.0	45.0	29.2	26.6	26.0	17.2	19.5	38.6	50.7	10.2	157.0	83.5	0.7	157.5	0.0	70.4	0.0	7.4	5.8	1109.4	325.4	1.5	1112.3	98.4	1302.1	2.1	749.2	13.7	1572.7	1590.6	1274.1	22.5	1237.6	254.2	38.6	575.4	5.3	0.6	3454.1	885.0	29.9	567.2	1441.8	10.8	0.6	97.5	9.7	70.8	0.0	5.7	463.6	0.0	7.6	0.0	53.4	10.2	17.6	0.0	1.0	32.6	1.0	0.0	0.0	0.1	1694.3	865.2	2.2	1.0	810.2	12.3	538.5	376.8	0.7	6.6	2.9	18.1	0.6	7.2	587.7	0.0	558.3	28.1	0.0	932.8	1043.7
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
CDH16		ENSG00000166589	"Cadherin 16"	O75309	16	66908122-66918917	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 250.0"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 617.9"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 96.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	99	"RPTEC TERT1: 225.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB013526, HPA036260"	Enhanced					NA	NA		130000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB013526: , HPA036260: AB_2675027"		"unprognostic (1.07e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"		"unprognostic (9.81e-2)"	"unprognostic (4.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-2)"		"prognostic favorable (1.02e-7)"	"unprognostic (2.19e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.3	0.3	4.7	0.3	11.0	0.3	0.1	0.0	0.0	250.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.4	6.7	0.0	0.0	617.9	0.0	0.1	0.0	0.4	74.3	0.1	2.9	18.0	2.1	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	1.9	124.4	0.0	0.0	0.0	0.6	0.9	0.0	0.2	1.9	0.0	1.0	0.8	0.0	0.7	0.0
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194537-84219621	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 313.8;skin 1: 214.0"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 379.5;Rod photoreceptor cells: 240.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 7.5"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 7.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.2;HEK 293: 5.2;HEL: 6.3;K-562: 4.6;NTERA-2: 4.4;RPTEC TERT1: 16.3"	"Region enriched"	"Detected in many"	21	"olfactory bulb: 333.0"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"	NA	NA		55000	"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.2	1.9	7.4	1.0	18.3	0.4	4.5	2.3	8.7	5.3	46.2	29.2	0.1	0.6	4.4	10.7	0.5	0.4	1.2	6.6	7.5	0.4	0.5	0.2	0.9	13.4	2.3	1.1	0.1	0.0	3.0	0.2	13.9	1.4	53.2	313.8	1.5	4.2	1.0	214.0	12.2	1.2	0.1	7.0	0.2	0.3	3.2	3.3	0.2	0.0	1.1	0.1	3.5	3.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	10.2	2.0	0.0	0.0	5.2	6.3	0.0	0.0	0.2	0.0	0.2	0.0	2.2	0.0	0.7	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	4.4	0.0	0.0	0.0	0.0	1.4	16.3	0.0	3.4	0.8	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	7.4	18.3	2.3	8.7	6.6	7.5	13.4	2.3	13.9	0.1	3.2	3.5	0.0	0.0	0.5	1.3	0.1	51.2	0.3	1.4	3.4	24.1	0.0	0.1	1.8	0.0	0.7	0.0	379.5	0.0	2.1	47.9	0.0	0.1	0.0	2.7	0.7	1.8	12.7	0.0	4.9	0.0	0.0	0.6	0.0	3.1	0.0	3.7	0.4	0.4	0.0	5.0	7.7	46.9	0.0	0.3	5.2	0.2	0.0	0.1	3.6	1.0	0.0	26.3	1.0	7.5	4.4	0.0	31.2	0.0	0.7	0.3	23.0	0.2	0.1	240.4	0.0	0.2	0.3	0.6	0.3	3.0	67.5	0.0	3.0	0.3	52.9	0.2
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75576496-75630716	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;choroid plexus: 8.6;retina: 9.6;testis: 11.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 76.4;Early spermatids: 57.8;Excitatory neurons: 32.8;Inhibitory neurons: 40.9;Oligodendrocytes: 46.4;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HHSteC: 1.9;RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.1	1.0	6.3	0.3	6.7	0.0	0.3	4.1	8.3	0.6	8.6	0.7	0.1	0.6	0.9	0.8	1.6	0.4	0.3	6.5	6.1	5.9	0.0	4.7	0.3	6.0	4.8	1.6	0.5	2.5	1.5	0.0	6.5	0.6	0.9	9.6	0.3	0.6	0.0	0.2	0.1	0.4	4.9	0.1	0.6	11.6	5.8	0.0	3.1	0.0	0.6	0.2	0.3	8.3	2.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.8	1.0	0.9	0.1	0.5	0.0	0.3	0.0	1.0	0.2	0.0	0.2	0.9	0.1	1.5	0.0	0.1	0.0	1.9	0.0	0.0	0.6	1.0	0.1	0.3	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.2	0.1	1.1	0.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	6.7	4.1	8.3	6.5	6.1	6.0	4.8	6.5	4.9	5.8	8.3	0.2	25.6	76.4	5.9	0.4	0.1	0.5	0.6	0.6	17.7	0.7	3.0	0.9	1.5	4.7	9.2	4.2	0.1	0.3	3.0	7.9	1.9	57.8	11.6	1.4	0.2	1.8	0.0	32.8	0.2	0.6	1.2	1.1	2.5	1.3	1.0	0.4	0.0	0.1	10.1	40.9	2.3	0.0	0.0	0.4	20.7	1.8	0.5	1.8	3.7	0.0	11.6	0.0	5.5	46.4	0.1	1.0	1.2	0.3	0.2	0.0	29.5	18.6	20.2	0.0	0.4	1.1	101.7	4.1	0.8	0.3	0.3	2.7	0.2	2.7	0.2
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444635-183449064	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 207.0;Glandular and luminal cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 161.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA041397: AB_10794297, HPA062142: AB_2684696"	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	11.7	11.7	10.1	11.9	10.7	38.0	15.5	13.4	13.4	12.8	9.9	14.3	19.0	15.7	12.3	22.2	11.8	12.9	10.3	9.8	10.4	18.3	17.5	11.2	19.8	10.2	10.2	22.6	18.5	15.4	11.4	13.9	10.1	12.8	13.6	13.1	12.8	13.0	9.0	12.0	17.3	9.7	10.9	14.3	17.8	20.1	10.8	24.0	13.5	14.2	18.8	11.8	12.3	12.3	14.4	8.1	23.2	16.8	19.0	14.0	17.7	23.9	19.9	23.9	16.0	11.9	13.5	47.1	4.9	16.1	10.0	11.3	21.0	17.3	25.1	19.4	12.6	49.7	39.4	15.9	14.8	37.3	19.5	16.3	15.6	14.3	18.7	12.6	19.1	18.0	25.1	50.4	16.5	7.8	41.6	30.5	17.0	5.5	16.2	36.1	11.2	19.5	161.1	13.5	23.9	20.7	17.2	72.0	29.9	14.9	10.5	32.0	11.0	8.5	12.3	7.9	19.6	24.4	10.9	25.0	13.3	31.4	13.9	61.0	8.0	18.6	14.4	9.7	14.9	12.2	17.4	15.4	7.7	14.1	22.6	20.8	9.7	15.0	10.3	5.2	19.2	14.6	10.1	10.7	13.4	13.4	9.8	10.4	10.2	10.2	10.1	10.9	10.8	12.3	49.6	16.0	33.1	3.6	58.9	35.9	38.5	9.1	130.3	21.2	35.5	40.1	18.9	17.2	24.2	16.5	10.4	21.8	51.8	36.4	17.6	12.5	150.8	207.0	48.9	33.5	30.4	32.0	5.8	15.5	14.7	38.8	62.2	333.9	62.1	29.7	16.4	13.5	15.7	21.9	5.8	25.5	20.3	12.6	24.2	70.5	21.1	25.7	21.4	7.5	13.2	24.3	22.6	7.5	9.9	17.6	21.1	17.3	47.2	31.5	37.8	13.1	28.8	21.2	13.1	60.8	37.5	36.6	40.3	124.7	39.8	18.7	55.3	22.4	33.3	60.9
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537620	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 31.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Basal respiratory cells: 28.1;Club cells: 31.1;Endometrial ciliated cells: 31.8;Glandular and luminal cells: 42.6;Respiratory ciliated cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 68.4;RPTEC TERT1: 48.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		280000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	0.7	0.8	0.4	3.1	0.9	0.8	7.8	1.5	0.5	9.9	1.2	1.6	0.9	3.7	10.2	11.5	15.4	1.4	3.4	1.0	0.4	17.1	5.2	12.5	5.9	2.4	3.9	0.2	2.6	6.3	2.4	1.0	1.4	5.0	1.8	0.5	12.0	3.9	0.2	31.5	1.6	1.1	1.6	3.3	5.4	1.3	2.2	2.4	3.7	0.1	7.9	3.9	3.7	1.0	22.3	68.4	11.3	10.6	0.0	0.0	6.5	2.3	3.4	2.3	1.3	21.7	21.9	0.2	32.1	1.3	22.0	35.0	7.5	28.7	2.0	0.0	10.2	0.0	25.6	2.0	1.0	3.2	1.8	0.0	43.5	0.0	26.2	31.6	0.4	1.7	0.3	0.4	0.0	38.4	0.1	11.9	4.5	12.1	8.1	0.1	0.1	8.1	48.7	13.5	0.7	0.9	16.1	17.3	3.7	7.9	39.7	16.7	0.9	0.1	0.3	0.0	0.4	10.6	1.1	10.5	15.2	0.1	12.9	0.0	0.0	0.0	0.2	0.1	0.2	2.2	0.1	0.1	0.0	1.9	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.9	1.5	0.5	1.0	0.4	2.4	3.9	1.4	1.6	2.2	1.0	0.5	41.7	23.5	0.0	5.8	17.1	4.1	28.1	8.0	0.2	14.2	5.2	12.7	2.8	31.1	5.5	0.0	1.9	2.3	0.8	0.0	1.8	2.3	31.8	5.0	5.6	1.2	0.0	1.2	0.7	1.9	1.0	2.6	42.6	0.0	0.6	1.8	1.5	2.4	0.0	1.2	2.8	6.1	0.0	4.1	10.3	0.0	1.1	5.4	1.0	1.1	1.1	0.0	0.5	0.7	4.0	0.3	0.0	1.1	4.3	0.0	8.2	60.3	0.3	0.0	0.1	2.8	0.4	0.6	12.6	15.6	0.8	1.1	0.0	1.7	5.1
CFAP221	"FAP221, PCDP1"	ENSG00000163075	"Cilia and flagella associated protein 221"	Q4G0U5	2	119544432-119662251	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.6;testis: 25.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 182.9;Endometrial ciliated cells: 96.5;Excitatory neurons: 93.3;Late spermatids: 292.7;Respiratory ciliated cells: 97.7;Spermatocytes: 64.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;HeLa: 2.3;RPTEC TERT1: 5.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.98e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.62e-3)"	"unprognostic (6.26e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.90e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.19e-1)"	0.3	1.6	0.5	0.2	0.9	1.0	0.1	0.0	5.9	1.2	12.0	0.2	8.6	1.1	1.8	0.2	29.6	2.0	0.6	1.9	0.7	13.1	1.3	7.8	0.4	5.7	6.8	0.5	9.9	1.8	3.2	0.6	3.2	0.5	0.2	5.2	0.2	0.6	0.2	1.0	1.0	0.1	2.9	0.4	2.2	25.4	1.4	0.1	2.5	0.2	0.3	0.2	0.2	1.5	0.1	0.3	1.1	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	1.8	0.2	0.2	1.1	0.0	0.7	0.1	0.0	0.1	0.1	0.2	1.0	0.1	2.3	0.3	0.3	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.6	0.0	0.3	0.4	0.7	0.2	0.2	0.1	0.4	0.0	0.1	5.4	0.5	0.6	0.7	0.1	0.1	0.0	0.4	1.4	0.4	0.3	0.2	0.5	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.7	0.3	0.2	0.2	0.1	0.0	0.5	0.9	0.0	5.9	1.9	0.7	5.7	6.8	3.2	2.9	1.4	1.5	0.0	0.0	35.3	24.8	0.0	0.0	0.1	0.0	0.0	3.4	0.4	0.0	2.4	10.0	13.0	7.3	29.2	0.1	0.0	0.0	27.4	19.6	182.9	96.5	1.7	0.4	0.0	0.0	93.3	18.6	0.0	0.9	0.0	3.0	0.0	0.5	0.0	2.4	0.1	0.0	36.7	0.1	0.0	0.0	0.0	292.7	2.8	0.7	0.0	1.0	0.6	3.7	0.0	1.0	2.5	8.4	0.0	2.2	0.0	0.2	0.1	8.7	97.7	31.0	0.0	1.2	1.0	64.7	15.2	0.0	0.0	0.0	0.4	1.4	0.4	0.0
CFAP300	"C11orf70, FBB5, MGC13040"	ENSG00000137691	"Cilia and flagella associated protein 300"	Q9BRQ4	11	102047437-102084554	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.2;testis: 30.2"	"Cell type enriched"	"Detected in some"	4	"Endometrial ciliated cells: 142.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038585	Enhanced		Approved	Centrosome		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome		"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.7	3.4	2.3	0.4	2.6	0.0	2.6	2.2	2.1	5.4	10.9	1.3	0.8	4.3	10.7	1.8	29.2	3.3	1.3	2.5	3.3	1.7	0.1	3.0	0.9	5.8	6.7	4.1	0.8	2.7	4.0	3.3	5.5	4.0	0.8	1.4	0.8	6.6	0.2	1.3	0.8	2.9	4.7	0.1	1.8	30.2	3.3	0.6	3.6	0.0	0.5	3.0	1.9	4.0	0.1	8.5	8.5	0.0	7.5	17.9	0.2	3.4	8.6	4.6	6.5	0.6	11.1	0.0	2.0	6.7	2.3	2.1	2.1	1.0	3.3	0.0	1.3	0.0	1.3	0.0	5.3	0.0	0.0	7.8	10.5	11.9	8.0	8.9	0.1	0.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.0	12.6	2.4	9.4	0.0	11.0	0.1	0.0	0.0	9.6	0.0	1.3	1.1	3.5	11.2	2.8	0.1	0.0	0.0	3.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	2.6	2.2	2.1	2.5	3.3	5.8	6.7	5.5	4.7	3.3	4.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	29.5	0.0	7.1	0.1	0.0	1.9	4.0	0.0	142.5	9.8	0.2	0.0	0.0	0.0	0.0	0.5	3.4	0.0	2.1	0.0	2.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.2	6.0	0.0	0.0
CFAP36	"BARTL1, CCDC104, MGC15407"	ENSG00000163001	"Cilia and flagella associated protein 36"	Q96G28	2	55519604-55545079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1342.4;Late spermatids: 262.5;Spermatocytes: 346.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008994, HPA017061"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies"	Cytosol	"HPA008994: AB_2275429, HPA017061: AB_1846129"	"unprognostic (8.11e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.66e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.96e-1)"	39.1	42.7	72.7	20.2	74.8	16.5	48.9	61.8	98.8	49.8	82.8	52.3	15.1	47.1	77.0	21.9	62.3	40.9	35.7	75.0	78.5	63.2	17.7	33.9	21.7	71.8	70.4	58.9	33.6	78.0	106.7	20.6	72.1	41.6	23.2	124.3	28.7	45.0	19.2	18.8	25.2	37.4	65.9	18.2	42.1	145.2	73.6	22.8	78.0	27.1	19.7	40.7	33.6	70.1	59.5	47.3	50.2	66.3	64.4	119.4	30.4	36.6	73.4	54.9	46.6	34.6	21.2	21.3	82.3	48.9	81.9	38.4	39.3	51.4	67.7	51.9	76.2	31.0	43.9	38.1	70.0	59.4	38.4	58.1	82.7	74.0	92.1	146.8	58.9	42.5	40.1	18.2	66.1	44.4	35.7	67.5	25.2	38.7	44.8	27.2	59.7	21.7	112.1	33.7	74.1	36.6	49.4	25.6	68.5	26.2	42.1	19.7	32.5	57.6	33.7	58.5	50.8	29.9	14.2	7.3	94.0	26.7	26.8	15.5	4.3	13.6	18.3	5.0	35.4	16.9	50.6	29.6	5.8	11.7	41.1	26.0	5.2	12.3	6.4	13.5	30.5	15.9	72.7	74.8	61.8	98.8	75.0	78.5	71.8	70.4	72.1	65.9	73.6	70.1	51.3	48.1	30.6	15.7	14.5	0.0	52.6	0.0	22.2	39.6	48.7	77.2	37.9	38.6	27.2	35.0	8.4	14.3	14.8	6.4	92.0	61.9	1342.4	184.4	51.8	42.9	17.0	21.0	51.6	60.7	27.0	44.7	21.9	36.3	39.1	27.1	42.1	10.7	23.6	23.5	41.1	12.2	0.0	8.7	0.0	262.5	75.2	12.8	0.0	14.0	16.9	145.0	16.5	21.6	13.3	37.0	11.5	67.7	11.4	41.3	7.6	146.9	99.1	92.4	59.2	43.0	43.4	346.0	29.8	16.1	0.0	7.8	24.7	36.0	9.9	35.6
CFAP46	"bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40"	ENSG00000171811	"Cilia and flagella associated protein 46"	Q8IYW2	10	132808392-132942823	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 22.5;skeletal muscle: 33.4;testis: 41.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Endometrial ciliated cells: 70.8;Excitatory neurons: 42.8;Respiratory ciliated cells: 59.0;Rod photoreceptor cells: 74.4;Spermatocytes: 53.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037786, HPA038034, HPA038867, HPA038868"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: AB_2676246, HPA038868: AB_2676247"	"unprognostic (2.83e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.11e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.64e-4)"	"unprognostic (1.21e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.08e-2)"	0.0	0.2	5.9	0.0	7.0	0.0	0.1	4.2	10.0	1.5	22.5	0.0	0.1	0.1	1.3	0.2	16.1	0.1	0.7	6.5	6.1	1.0	0.2	3.4	0.0	13.5	17.3	0.2	0.4	1.1	2.2	0.0	8.5	0.2	0.0	3.9	0.4	0.4	33.4	0.1	0.1	0.0	9.4	0.1	2.4	41.8	6.6	0.0	4.2	10.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	5.9	7.0	4.2	10.0	6.5	6.1	13.5	17.3	8.5	9.4	6.6	4.6	0.2	0.0	4.8	9.8	0.3	0.0	0.5	0.0	0.6	6.3	1.3	1.1	3.7	0.0	9.3	7.3	95.9	0.0	0.0	0.0	5.9	4.8	18.0	70.8	0.9	0.9	0.0	0.0	42.8	0.2	0.0	1.5	5.1	1.5	3.8	4.3	5.0	0.2	0.6	1.7	22.0	0.0	0.0	0.6	0.0	11.3	1.2	0.3	0.0	1.0	0.0	4.7	0.0	2.0	0.9	1.6	0.0	2.2	0.2	0.7	0.0	5.6	59.0	74.4	0.0	0.4	0.4	53.7	7.2	0.7	0.0	0.0	0.3	7.3	0.0	0.6
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CHST9	"GALNAC-4-ST2, GALNAC4ST-2"	ENSG00000154080	"Carbohydrate sulfotransferase 9"	Q7L1S5	18	26906481-27185308	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 13.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 115.2;Muller glia cells: 69.2;Oligodendrocyte precursor cells: 167.4;Respiratory ciliated cells: 311.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;Hep G2: 13.8;RPTEC TERT1: 41.8;SCLC-21H: 9.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA011393	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011393: AB_1846733"	"unprognostic (9.24e-3)"	"unprognostic (1.13e-2)"		"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.53e-3)"	"unprognostic (9.98e-3)"	"unprognostic (9.21e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"		"unprognostic (3.93e-3)"	0.0	0.2	0.8	0.1	0.9	0.0	2.9	0.7	2.4	2.8	0.0	1.6	0.2	0.1	0.4	1.6	10.3	3.1	2.6	2.7	1.2	1.6	8.2	4.3	0.0	3.5	2.3	0.0	9.3	0.0	1.9	0.0	1.2	3.5	0.2	7.3	13.8	1.8	0.2	0.1	0.3	0.1	2.0	5.7	0.7	6.9	1.2	1.0	0.0	0.9	0.6	1.5	0.7	1.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	41.8	0.0	9.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	2.4	2.7	1.2	3.5	2.3	1.2	2.0	1.2	1.9	0.1	0.0	2.7	24.8	0.0	0.6	32.6	56.6	4.6	1.3	8.2	8.0	9.2	35.8	115.2	5.5	0.0	0.4	0.1	0.0	11.7	13.0	7.1	49.9	0.7	0.3	3.5	0.0	10.1	0.6	0.1	4.2	0.0	1.8	5.1	0.1	0.0	10.7	0.3	0.0	29.3	0.1	22.4	0.0	0.0	4.4	0.6	0.5	7.2	1.0	0.0	69.2	0.0	167.4	1.0	1.3	0.0	0.4	0.0	8.9	0.0	0.3	311.6	3.2	0.0	3.2	3.7	0.9	1.3	4.7	0.0	0.3	0.4	0.0	0.0	40.3
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540905	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.7;lymphoid tissue: 52.3"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 128.8;neutrophil: 448.8"	"Group enriched"	"Detected in many"	17	"granulocytes: 448.8;monocytes: 128.8"	"Group enriched"	"Detected in some"	4	"NB-4: 4.3;RPTEC TERT1: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004935	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	13.3	5.4	2.3	37.5	2.1	75.7	4.5	1.8	4.4	5.8	2.2	2.2	0.4	2.3	0.4	3.2	5.5	11.8	2.5	2.3	2.9	3.6	6.6	22.4	7.6	1.3	1.3	1.7	6.2	1.7	1.9	2.1	1.2	2.3	1.0	1.3	1.4	1.2	0.7	0.9	3.1	5.7	0.7	52.3	2.5	1.1	2.0	2.2	10.5	5.0	2.3	9.6	1.7	2.9	0.1	0.4	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.1	0.1	2.0	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.1	0.0	1.5	0.0	0.5	0.2	0.2	0.2	0.2	0.0	0.1	0.0	4.3	0.3	0.0	0.0	0.0	0.2	0.1	12.4	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.4	1.0	0.5	0.1	1.0	0.1	0.2	0.1	0.1	1.3	0.4	0.1	0.2	128.8	0.5	0.1	18.1	0.3	0.1	0.1	0.1	16.9	0.1	0.0	0.1	448.8	0.0	0.7	0.7	0.0	30.3	2.3	2.1	1.8	4.4	2.3	2.9	1.3	1.3	1.2	0.7	2.0	2.9	6.2	0.0	4.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	5.7	1.8	1.8	0.0	0.0	0.3	0.0	0.0	9.0	0.3	2.1	4.4	3.5	0.0	0.0	0.0	0.0	0.1	1.4	0.0	31.9	0.0	0.0	7.1	2.1	5.6	0.0	0.0	0.0	0.0	158.0	9.0	2.9	0.9	115.2	0.0	0.0	109.5	0.0	4.1	0.0	0.0	0.4	0.0	0.4	1.3	0.0	0.0	0.2	0.7	0.0	13.1	0.2	0.4	0.2	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.1
CLIC1	"CLCNL1, G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		22000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	292.8	156.5	6.9	43.4	6.8	64.0	256.7	7.1	11.0	222.2	8.7	291.6	37.0	197.9	20.9	395.9	190.5	43.7	183.7	6.7	10.2	318.5	102.6	330.4	44.1	9.4	7.7	149.8	148.1	20.1	111.5	45.5	8.9	217.0	64.0	2.6	251.3	22.3	47.3	324.8	231.6	32.7	8.9	332.6	247.8	41.0	9.6	35.2	180.8	11.1	58.1	257.7	246.8	8.9	119.5	54.1	87.0	45.6	56.6	118.6	43.3	52.8	105.4	92.6	77.9	125.2	87.2	48.7	73.6	186.0	116.9	70.2	65.8	154.9	124.4	38.9	34.4	93.0	43.4	109.3	73.0	164.3	125.9	74.3	80.5	157.0	148.4	101.7	157.9	44.6	109.4	149.5	181.0	79.2	77.2	213.2	7.7	128.9	78.4	13.5	47.5	115.3	210.2	73.0	16.5	19.5	43.1	49.1	71.5	60.4	33.7	228.3	105.0	128.6	91.2	39.0	166.8	48.3	98.3	66.0	62.4	122.0	136.6	244.3	179.4	239.3	165.6	194.3	135.8	186.1	98.0	155.5	143.8	150.3	30.5	92.3	341.1	176.3	174.3	80.5	149.2	414.2	6.9	6.8	7.1	11.0	6.7	10.2	9.4	7.7	8.9	8.9	9.6	8.9	514.8	70.5	67.0	0.7	382.5	960.8	589.1	869.7	331.2	0.4	274.3	300.5	18.6	296.0	457.7	237.3	0.0	545.5	472.2	730.7	602.6	1096.2	31.8	271.1	212.7	490.1	381.4	208.6	0.0	1008.9	912.5	296.6	370.5	301.3	554.1	431.2	300.9	54.2	1047.6	0.0	0.0	665.6	516.8	533.7	1529.8	17.3	233.9	685.7	524.7	13.1	426.4	86.8	706.5	0.5	0.0	1470.4	997.1	188.1	420.2	851.1	707.7	572.1	473.6	6.9	203.8	136.1	554.0	28.7	16.2	464.1	928.0	572.7	522.2	283.3	675.0	1005.9
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15675012	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 486.4"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 885.4"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.5	0.8	0.5	0.0	0.6	0.3	2.0	0.7	0.8	1.0	16.6	0.6	1.3	1.5	3.1	0.6	2.4	3.7	1.1	0.7	0.6	486.4	61.5	1.7	0.4	0.6	0.5	3.2	5.3	10.5	0.6	0.5	0.6	1.5	0.3	1.2	0.8	1.3	0.1	1.2	0.4	0.4	0.4	0.2	10.9	1.0	0.5	0.8	4.1	0.1	0.3	0.8	0.4	0.9	2.3	1.8	1.1	0.3	0.7	1.0	0.7	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.6	0.2	0.2	8.5	0.7	2.3	0.0	0.3	0.7	0.2	0.0	0.8	1.0	0.0	0.0	0.2	2.0	0.3	5.2	0.6	0.0	2.1	0.5	0.4	0.2	2.8	0.1	0.3	2.9	0.8	2.6	0.2	0.3	0.9	8.5	0.1	1.1	1.0	0.6	0.1	1.8	5.1	0.6	0.2	0.0	0.2	0.4	0.3	0.0	0.4	0.2	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.7	0.8	0.7	0.6	0.6	0.5	0.6	0.4	0.5	0.9	0.1	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	1.8	27.6	0.0	2.1	0.0	0.0	54.8	25.1	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.6	0.5	0.3	0.0	3.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	885.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.7	0.5	0.0	0.0
CLUAP1	"CFAP22, FAP22, FLJ13297, IFT38, KIAA0643"	ENSG00000103351	"Clusterin associated protein 1"	Q96AJ1	16	3500976-3539048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 215.5;Endometrial ciliated cells: 119.2;Respiratory ciliated cells: 181.3;Rod photoreceptor cells: 116.8;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036976, HPA044191"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Vesicles	"HPA036976: AB_10602209, HPA044191: AB_2678852"	"unprognostic (1.78e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.12e-2)"	9.7	10.7	11.1	5.9	12.6	3.9	14.7	14.2	14.5	21.1	17.8	11.0	4.2	24.2	16.0	11.1	31.8	10.6	11.4	11.2	11.6	18.6	7.7	12.1	7.4	10.4	12.7	24.6	12.2	31.4	11.7	10.6	9.1	17.0	9.8	28.9	9.1	19.9	9.9	5.6	5.4	20.2	9.8	6.6	9.0	40.0	12.0	12.4	22.0	11.6	6.0	10.8	7.8	10.4	15.7	18.3	20.8	28.9	31.4	32.0	11.0	19.9	26.7	31.4	23.7	5.1	31.3	8.2	16.5	33.7	18.8	16.8	14.7	23.6	26.2	6.6	13.1	6.9	10.3	10.5	36.7	12.5	7.2	21.1	25.4	29.1	29.4	33.1	17.2	16.4	21.7	1.0	23.6	19.3	12.0	14.0	21.5	6.6	11.1	25.9	14.3	15.7	45.7	4.9	23.2	19.8	11.6	8.8	14.3	16.0	18.7	28.8	11.5	20.8	13.8	17.1	15.0	12.8	10.9	2.2	8.0	7.3	15.3	6.2	3.6	1.2	6.2	4.2	12.1	7.3	17.8	10.8	6.8	6.1	26.9	18.4	1.3	9.0	2.4	6.6	10.3	5.8	11.1	12.6	14.2	14.5	11.2	11.6	10.4	12.7	9.1	9.8	12.0	10.4	14.5	22.4	20.5	17.0	3.5	5.6	12.3	29.1	14.8	41.0	13.4	13.8	11.7	11.5	30.6	14.7	108.4	20.7	7.5	3.3	43.0	24.3	215.5	119.2	49.7	12.4	17.5	4.6	23.6	8.0	7.7	21.9	6.6	26.4	5.1	28.1	13.6	9.2	10.4	38.7	26.3	7.9	18.3	4.9	5.7	63.4	31.4	5.0	3.6	5.6	18.1	40.7	12.3	11.1	10.3	8.6	5.3	33.1	3.5	9.4	5.3	34.6	181.3	116.8	6.6	24.7	22.7	150.0	58.4	6.4	4.1	9.3	12.1	36.7	9.0	6.5
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10307902	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 172.4;skeletal muscle: 164.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 185.2;Distal tubular cells: 215.2;Proximal enterocytes: 716.0;Proximal tubular cells: 465.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 48.5;K-562: 51.4;PC-3: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					NA	NA		580000		"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	11.3	31.5	8.9	3.8	8.7	4.0	10.6	7.2	10.2	7.2	8.1	53.6	95.8	8.5	9.9	3.8	13.5	14.2	22.9	8.5	8.5	168.5	172.4	6.8	1.2	8.5	8.9	23.3	16.6	26.6	10.6	2.1	9.0	14.3	34.7	1.3	9.6	7.4	164.4	2.8	85.0	6.4	8.0	2.7	28.5	3.2	10.0	2.9	9.8	42.4	0.5	9.7	6.4	7.7	5.9	7.2	8.2	20.3	32.0	35.7	41.2	9.7	11.1	3.0	4.5	3.0	30.9	0.1	15.4	7.8	14.5	0.1	19.7	12.8	4.1	0.3	13.4	27.4	28.6	24.3	9.8	0.2	0.2	48.5	8.5	6.7	6.1	11.7	9.4	0.0	51.4	0.4	11.6	1.3	0.1	1.1	12.1	0.0	46.0	5.9	0.0	0.6	32.2	3.8	6.3	9.7	23.1	2.2	0.7	9.7	16.7	1.0	2.7	4.6	6.0	7.6	0.1	0.2	0.1	0.1	8.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	8.9	8.7	7.2	10.2	8.5	8.5	8.5	8.9	9.0	8.0	10.0	7.7	4.0	25.6	17.2	2.9	2.2	3.7	17.8	6.3	14.8	2.0	40.1	16.8	86.0	55.8	14.8	23.9	4.2	15.3	0.9	185.2	215.2	10.7	3.2	26.5	25.8	7.1	19.2	56.1	5.0	15.6	10.6	37.1	133.0	19.2	13.3	47.4	14.3	161.2	12.1	0.0	6.9	100.5	2.0	4.1	3.8	3.5	47.8	5.5	1.8	1.9	0.4	17.5	1.0	4.0	0.4	16.1	118.6	41.3	0.5	17.5	716.0	465.4	13.0	3.1	0.0	31.0	12.7	1.0	5.9	5.2	3.8	4.9	4.4	145.0	162.7	15.6
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450787-47463702	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	13.4	15.5	9.7	20.3	9.8	21.4	13.6	10.0	14.6	11.8	13.0	17.7	18.4	10.4	22.6	24.1	11.3	13.7	27.2	9.5	12.2	45.3	12.7	13.5	30.4	9.9	10.3	10.2	10.4	26.8	13.4	19.0	10.0	10.6	18.1	13.5	8.4	10.0	8.8	17.5	19.0	15.0	10.4	18.1	14.3	24.1	10.3	21.6	21.3	12.6	25.4	16.8	11.8	10.3	32.6	17.6	15.2	7.8	31.6	44.8	21.1	47.8	31.5	30.7	41.5	29.9	37.4	51.7	39.0	45.3	69.4	17.0	49.4	39.1	55.0	30.8	22.1	29.8	17.7	23.2	43.0	73.6	36.8	38.7	51.6	29.2	32.3	28.5	39.5	33.7	22.5	20.6	75.8	18.1	44.1	59.4	10.4	21.8	22.8	21.8	34.7	11.2	88.1	26.3	29.8	15.2	19.9	16.1	39.6	26.5	29.5	48.0	32.7	43.6	41.8	39.2	57.9	21.6	27.6	42.1	47.3	95.2	32.2	114.3	58.2	68.9	44.6	80.4	48.1	48.1	40.5	44.9	74.0	43.4	37.5	43.2	29.0	57.4	89.4	34.3	51.2	71.4	9.7	9.8	10.0	14.6	9.5	12.2	9.9	10.3	10.0	10.4	10.3	10.3	31.3	22.4	16.5	3.3	41.6	22.6	11.4	60.5	21.6	18.2	12.8	16.6	46.1	18.6	32.6	29.5	4.2	86.6	39.1	20.9	107.6	42.8	68.4	43.0	21.6	26.7	21.0	14.5	5.5	46.3	116.3	28.6	16.8	19.2	33.0	11.3	22.5	12.7	90.9	6.7	7.3	19.4	42.7	54.4	42.1	18.9	54.3	50.7	12.4	4.7	82.0	37.2	72.1	2.5	5.3	25.1	23.8	40.6	22.9	8.6	28.0	231.8	57.4	23.8	19.7	16.9	29.9	141.5	59.0	37.3	30.0	105.8	53.9	36.9	28.8	10.2
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002481-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 127.6;Oligodendrocytes: 406.5;Suprabasal keratinocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA072513: AB_2686529"	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	9.6	6.0	13.2	5.1	21.9	26.5	12.3	18.8	21.9	9.8	5.6	11.5	8.4	7.4	8.3	13.3	6.0	9.5	7.3	14.6	15.0	12.0	17.6	8.4	5.6	22.4	16.6	6.3	4.4	16.3	4.2	6.4	20.7	8.4	9.7	16.1	8.1	10.7	5.8	23.5	8.7	8.6	18.7	5.8	10.7	37.9	17.3	4.5	4.8	6.2	6.4	8.0	13.2	45.5	2.9	18.1	1.9	0.7	13.1	26.2	3.6	10.8	6.7	5.8	4.6	0.3	4.2	1.9	2.1	10.1	11.8	3.5	3.9	2.6	3.6	4.8	1.5	0.5	16.3	3.5	6.1	1.0	2.6	12.3	12.5	15.6	14.7	8.7	6.1	0.3	0.4	13.2	26.9	1.5	0.2	4.7	1.7	5.9	2.8	0.3	1.8	0.8	57.3	2.6	1.7	11.1	3.1	2.4	10.6	8.7	1.5	12.2	11.7	24.0	2.1	15.3	6.1	9.0	1.3	1.0	19.3	10.6	9.5	0.0	0.2	0.6	0.1	0.1	0.5	0.0	0.2	0.1	0.2	0.1	0.3	0.1	1.1	0.5	0.1	0.1	0.1	0.1	13.2	21.9	18.8	21.9	14.6	15.0	22.4	16.6	20.7	18.7	17.3	45.5	24.9	32.1	14.2	55.8	8.1	85.8	12.2	6.8	58.1	8.6	31.2	17.8	22.3	12.8	9.3	31.3	27.1	1.4	10.7	26.4	1.9	4.6	64.5	38.4	9.9	14.7	10.2	3.8	58.2	4.9	1.8	13.4	15.3	50.7	10.8	1.8	13.2	23.8	11.2	15.2	127.6	13.1	4.1	14.1	31.0	20.3	6.2	20.3	53.4	39.4	6.6	8.5	3.1	89.5	406.5	7.0	16.9	8.2	17.5	11.8	18.7	14.8	5.1	19.3	0.0	20.7	16.5	16.6	4.6	77.0	129.4	1.4	11.0	3.6	8.1	17.0
CPNE8		ENSG00000139117	"Copine 8"	Q86YQ8	12	38646822-38907430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 115.5;Microglial cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 66.8;THP-1: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038600	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038600: AB_10674690"	"unprognostic (1.57e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.93e-3)"	"unprognostic (6.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.40e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.21e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.73e-3)"	12.0	8.3	7.0	5.4	7.6	4.6	9.6	3.1	11.5	7.8	9.2	8.1	3.3	5.1	3.5	5.4	5.0	9.0	12.2	10.1	8.9	11.2	15.5	10.1	5.4	5.0	6.5	5.7	3.2	2.5	3.3	12.0	4.6	3.7	10.2	6.0	3.2	8.9	2.9	6.1	4.6	9.1	8.8	10.6	3.7	5.8	8.0	3.1	7.8	5.3	3.2	10.1	5.3	5.5	3.1	18.7	1.3	18.5	17.0	14.3	8.6	1.6	0.1	0.0	0.0	9.4	18.2	0.0	26.3	12.7	6.8	1.0	10.8	5.6	0.0	0.0	11.3	9.9	26.3	2.2	11.3	0.0	7.8	6.7	14.2	4.2	14.9	12.9	14.3	0.0	6.0	0.0	0.0	0.0	0.0	0.1	13.8	11.5	19.0	0.0	0.0	4.3	66.8	0.5	0.0	0.5	26.0	4.7	14.1	18.8	2.3	38.8	13.6	0.0	12.7	21.6	0.1	6.5	19.3	0.2	17.2	17.8	11.0	2.7	12.0	0.0	1.6	9.4	0.3	0.2	2.1	1.8	7.7	0.6	0.9	1.5	0.7	4.5	6.3	2.5	2.1	2.5	7.0	7.6	3.1	11.5	10.1	8.9	5.0	6.5	4.6	8.8	8.0	5.5	68.8	12.8	8.2	66.3	1.6	31.1	5.9	40.8	19.9	2.1	0.6	6.5	20.3	15.7	23.3	12.9	0.0	29.2	6.9	35.8	15.6	7.6	68.9	2.7	9.4	55.9	11.5	7.4	115.5	4.9	27.2	27.1	0.0	3.0	3.8	18.5	36.0	16.5	25.7	0.0	36.3	9.1	6.1	34.1	42.4	14.5	9.6	19.4	46.2	77.8	19.8	36.4	2.1	25.6	2.9	3.6	51.3	8.2	3.3	7.4	0.0	20.9	17.0	2.7	0.0	24.5	16.9	2.7	2.1	6.1	11.2	7.8	4.3	8.6	8.9	3.5
CPVL		ENSG00000106066	"Carboxypeptidase vitellogenic like"	Q9H3G5	7	28995235-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 219.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5"	"Group enriched"	"Detected in all"	52	"dendritic cells: 1319.5;monocytes: 1136.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		760000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	44.0	23.5	7.5	66.3	8.7	59.8	24.9	48.9	12.0	28.5	39.6	28.9	32.8	17.1	34.6	25.4	19.8	42.1	79.3	6.8	9.9	96.7	52.9	57.6	92.9	15.2	11.4	18.1	7.9	5.4	10.1	84.9	15.4	17.9	25.7	0.9	5.3	21.3	12.5	19.3	46.5	34.1	11.8	219.0	15.5	34.4	8.8	66.7	128.4	8.3	35.8	50.6	15.8	23.4	1.5	0.2	20.3	0.1	0.1	0.0	190.8	0.0	0.0	1.9	0.4	59.8	0.1	0.0	90.3	0.8	94.4	3.2	51.8	4.2	0.6	0.4	47.9	67.0	1.2	144.5	0.0	0.0	0.3	0.3	5.9	0.7	1.6	0.0	0.6	27.5	45.5	0.1	1.6	0.0	63.4	0.4	31.6	0.1	16.0	0.3	0.0	0.6	801.1	22.8	11.9	9.4	53.6	125.5	101.7	97.0	15.1	49.6	0.0	0.4	0.8	0.5	12.0	17.5	205.5	1.0	0.2	25.0	20.8	19.5	1136.9	5.7	2.6	953.5	3.4	1.8	1.3	1.9	1319.5	1.2	1.2	1.2	23.4	5.8	327.8	34.8	1.5	1142.7	7.5	8.7	48.9	12.0	6.8	9.9	15.2	11.4	15.4	11.8	8.8	23.4	12.3	6.4	16.0	3.3	7.2	12.5	1.3	0.7	5.7	0.0	2.6	3.4	69.1	10.0	2.5	71.7	0.0	138.0	2.1	0.2	35.2	0.5	24.7	3.7	0.3	21.1	1.8	34.1	3.7	15.6	118.3	29.4	1.1	0.6	5.1	2.3	6.8	1.1	306.1	0.0	1.7	1.2	0.0	290.3	531.0	7.6	9.3	266.2	10.6	45.9	176.8	0.2	2.1	2.0	1.3	0.8	0.4	3.0	2.9	0.5	0.4	30.6	1.5	0.4	0.0	31.0	3.0	27.1	92.8	27.2	8.8	118.5	3.3	3.6	1.2	0.9
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.7;heart muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 82.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 82.0"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 100.3"	"Group enriched"	"Detected in all"	11	"amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.9	0.8	37.4	0.9	78.7	1.0	2.7	40.6	62.2	3.7	13.6	6.9	1.6	1.0	0.2	7.6	1.1	7.0	175.3	54.0	31.6	64.4	14.2	8.5	1.1	13.9	19.8	0.3	1.8	8.9	55.6	0.4	15.6	35.4	8.4	54.7	20.6	0.2	13.4	4.1	2.6	0.3	14.1	0.3	1.3	5.1	20.5	0.3	0.4	0.9	3.8	21.8	3.6	31.3	0.2	4.0	0.0	0.0	0.2	0.4	0.7	0.0	2.1	0.1	0.2	0.2	0.2	0.3	1.0	0.0	1.8	0.6	5.4	0.0	0.0	0.0	0.8	23.2	0.1	2.3	0.0	0.1	2.2	0.8	0.0	0.8	1.0	0.0	0.0	0.5	0.0	0.4	0.7	0.3	0.0	0.9	9.7	1.6	0.1	0.1	0.0	0.5	100.3	0.1	3.7	5.2	0.2	0.1	2.6	4.8	0.1	0.0	0.0	0.5	0.7	6.8	0.0	0.2	0.0	0.5	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	3.9	0.0	0.0	0.3	0.0	0.0	82.0	0.0	1.2	37.4	78.7	40.6	62.2	54.0	31.6	13.9	19.8	15.6	14.1	20.5	31.3	0.3	0.0	20.1	5.2	4.1	2.3	25.4	16.3	0.0	6.3	0.4	11.7	126.0	2.8	56.1	14.7	4.2	0.0	11.4	7.1	17.6	0.1	19.7	3.2	1.5	3.0	13.1	4.8	43.8	0.0	0.0	7.1	6.1	7.7	1.3	1.3	0.4	8.3	0.1	1.7	5.9	20.6	114.0	1.6	0.7	12.4	0.0	1.5	33.8	10.3	0.7	640.7	0.0	7.1	6.6	0.4	2.8	0.0	0.3	19.0	7.5	190.1	19.9	26.2	0.0	0.2	4.3	6.7	7.3	0.2	1.3	0.1	1.1	0.1	8.2	68.0
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 331.0;liver: 282.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 160.0;Distal tubular cells: 226.9;Hepatocytes: 200.6;Proximal tubular cells: 526.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 439.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	19.8	34.2	19.2	12.9	19.8	2.2	39.0	19.3	36.0	54.6	54.2	21.4	51.2	40.8	120.6	29.0	50.0	68.9	45.6	21.6	23.3	331.0	282.9	32.4	24.4	21.3	24.9	31.6	64.6	52.9	17.0	16.8	24.4	38.8	22.0	15.3	25.0	56.9	25.1	22.2	44.0	40.1	21.1	19.4	25.1	9.2	24.5	33.9	44.5	23.0	23.8	40.8	21.7	24.9	12.1	112.2	57.6	16.3	64.4	70.2	38.6	36.5	57.1	51.8	57.4	88.9	46.1	64.9	62.0	71.3	92.2	31.0	47.2	46.0	83.6	75.2	19.2	27.0	32.2	179.0	33.8	23.1	52.6	33.1	40.0	82.8	15.1	49.1	43.7	35.9	85.9	22.8	109.2	27.0	42.3	38.6	43.1	93.6	72.6	26.8	53.6	23.7	439.4	36.0	15.9	27.9	8.5	60.1	41.2	64.3	54.0	7.7	21.9	12.3	30.7	38.8	55.7	16.2	33.3	32.1	99.4	9.0	35.6	13.1	9.4	1.9	32.1	15.1	26.2	32.8	31.6	30.3	17.1	26.5	27.4	29.5	1.5	30.3	17.9	14.4	42.3	18.8	19.2	19.8	19.3	36.0	21.6	23.3	21.3	24.9	24.4	21.1	24.5	24.9	6.9	28.9	22.6	4.9	20.4	17.8	28.0	32.4	24.5	4.0	16.8	16.8	32.3	84.4	15.7	160.0	2.1	13.5	8.6	6.6	226.9	53.8	0.2	54.8	7.8	8.0	6.7	8.4	4.5	32.4	18.1	20.7	20.9	27.0	14.5	7.8	12.8	200.6	18.5	0.0	4.4	12.0	8.2	15.7	13.7	2.1	20.8	11.4	10.6	4.7	7.1	7.7	11.3	7.1	9.1	31.2	14.5	20.7	20.5	10.2	79.1	526.6	17.3	2.9	0.0	10.6	16.2	1.7	7.4	19.7	21.2	7.3	16.9	13.8	16.2	17.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 494.3;Excitatory neurons: 144.4;Granulosa cells: 214.1;Microglial cells: 224.9;Oligodendrocyte precursor cells: 355.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 62.6"	"Group enriched"	"Detected in all"	5	"B-cells: 44.5;granulocytes: 24.9;T-cells: 62.6"	"Cell line enhanced"	"Detected in many"		"A549: 57.8;BJ hTERT+: 32.3;GAMG: 22.9;RPTEC TERT1: 39.6;U-2197: 36.8;U-87 MG: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	19.4	12.5	20.3	8.8	15.7	11.1	7.4	4.8	18.3	18.0	0.7	4.7	3.5	7.0	5.4	31.2	11.8	16.1	35.8	16.3	11.5	6.0	2.8	11.7	7.6	6.3	11.2	57.0	7.9	11.4	3.0	38.8	7.6	31.8	2.5	2.5	6.8	9.8	5.8	4.8	4.7	12.3	6.7	8.7	6.9	2.8	8.9	11.7	86.7	11.0	8.8	23.4	8.1	10.7	2.1	57.8	0.5	0.0	9.3	2.1	7.9	1.4	32.3	0.3	0.3	3.1	1.0	0.0	0.3	0.0	22.9	0.7	0.0	0.0	0.4	7.5	0.4	0.2	16.2	1.9	4.1	0.0	0.1	0.9	1.6	0.7	0.3	0.4	11.6	0.2	0.0	0.1	0.1	2.6	2.9	0.2	0.3	8.3	1.7	0.3	0.1	0.0	39.6	1.6	0.2	0.3	17.2	6.9	2.4	1.5	0.1	0.4	1.0	1.1	1.3	36.8	0.9	0.3	0.0	0.0	26.0	3.4	11.4	0.1	2.9	24.9	5.6	0.1	0.6	44.5	25.7	8.5	2.8	15.9	44.6	11.6	15.6	8.4	0.4	4.2	62.6	11.7	20.3	15.7	4.8	18.3	16.3	11.5	6.3	11.2	7.6	6.7	8.9	10.7	33.3	3.2	1.1	494.3	27.3	4.5	7.4	0.2	0.6	0.3	4.1	0.8	45.8	0.0	0.9	12.9	10.4	1.9	6.2	0.0	1.9	5.7	6.9	7.5	1.2	38.5	3.0	3.2	144.4	1.7	14.6	20.9	2.0	2.0	0.0	214.1	26.7	0.2	15.8	18.5	76.5	0.0	16.2	27.4	6.5	7.4	5.3	14.1	12.4	224.9	3.5	1.0	6.2	355.9	4.6	3.1	0.0	12.0	21.3	21.8	0.0	0.1	1.5	1.0	6.6	2.1	12.0	0.7	0.1	0.5	3.1	8.3	9.6	77.0	0.1	2.8
CTAGE4	"cTAGE-4, FLJ43692"	ENSG00000225932	"CTAGE family member 4"	Q8IX94	7	144183466-144186053	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 14.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.6;Club cells: 1.3;Early spermatids: 1.1;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 15.3;hTCEpi: 12.9;RPTEC TERT1: 11.6;T-47d: 8.3;WM-115: 8.0"									"HPA000387, HPA000922"	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 71: Testis - DNA repair"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.17e-2)"		"unprognostic (2.80e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.15e-1)"		"unprognostic (1.26e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.68e-1)"	1.5	0.5	0.2	0.4	0.3	0.6	4.5	0.2	0.2	2.7	1.1	4.5	4.7	0.8	3.0	8.6	1.5	2.6	0.8	0.1	0.2	10.5	5.7	2.9	0.7	0.4	0.4	1.8	5.6	0.7	2.7	1.5	0.3	4.3	4.0	1.2	4.6	1.0	0.1	11.9	3.9	0.3	0.2	1.6	4.1	14.9	0.3	0.5	10.0	0.1	0.6	1.5	4.0	0.2	15.3	0.1	0.0	0.0	0.0	0.0	6.2	0.4	0.2	0.0	0.1	1.4	4.9	0.0	0.0	0.5	0.3	0.4	0.0	2.7	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.3	12.9	0.4	4.0	0.7	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.0	11.6	3.7	0.0	0.0	6.1	5.8	0.4	2.3	8.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.2	0.1	0.2	0.4	0.4	0.3	0.2	0.3	0.2	0.0	3.2	5.6	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.1
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 780.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 3435.4;Basal squamous epithelial cells: 3284.9;Breast myoepithelial cells: 1544.3;Fibroblasts: 2220.8;Glandular and luminal cells: 1201.1;Proximal tubular cells: 3662.8;Suprabasal keratinocytes: 2115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HAP1: 61.6;hTCEpi: 79.9;RPTEC TERT1: 222.2;SuSa: 115.2;U-2 OS: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"	NA	NA	800000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 33: Fibroblasts - ECM organization"			"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favorable (1.71e-4)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	366.1	5.2	77.6	76.2	84.5	0.6	229.1	70.6	102.7	166.3	74.8	152.4	214.0	6.9	66.6	92.9	32.9	19.8	14.0	83.7	73.8	345.6	58.5	7.4	90.7	72.4	91.0	5.5	11.6	1.9	122.0	170.7	72.4	10.1	181.3	17.5	293.5	17.6	81.1	780.3	247.0	6.3	68.7	87.5	107.3	3.7	90.2	26.6	55.2	36.5	128.5	76.6	96.3	77.9	0.0	0.0	2.7	0.0	0.2	0.2	0.7	2.9	0.8	0.2	0.0	0.0	9.1	0.0	2.7	0.1	3.8	0.2	61.6	1.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	79.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	4.0	0.0	0.0	0.2	0.0	1.1	222.2	0.0	1.1	0.7	0.2	0.2	0.0	115.2	0.1	0.0	0.0	0.1	84.9	0.4	0.1	0.3	0.0	0.0	1.4	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	77.6	84.5	70.6	102.7	83.7	73.8	72.4	91.0	72.4	68.7	90.2	77.9	123.8	0.0	1.1	32.7	13.1	3435.4	14.4	276.9	3284.9	245.7	47.5	1544.3	4.1	0.0	5.1	283.3	0.0	35.9	6.1	0.0	563.4	0.0	0.8	45.0	140.8	45.9	0.0	0.0	1.0	0.0	25.4	2220.8	0.5	1201.1	0.0	0.0	43.5	0.2	63.6	6.7	150.8	0.0	240.1	0.9	887.9	1.3	20.8	35.3	439.4	8.4	0.0	6.7	0.0	4.5	4.2	0.1	0.0	0.4	13.3	10.6	0.0	3662.8	2.1	19.0	0.0	889.8	99.2	0.4	5.2	69.3	2115.0	77.2	43.4	0.3	0.1	9.3
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.8;cervix: 20.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2244.7;Club cells: 738.5;Ionocytes: 724.2;Langerhans cells: 2366.2;Macrophages: 718.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4;stomach cancer: 18.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.5;hTEC/SVTERT24-B: 75.0;RPTEC TERT1: 43.8"														"Secreted to blood"	NA	NA	28700			"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (2.12e-3)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	20.8	1.0	0.7	14.4	0.4	15.8	1.6	0.4	2.2	20.7	0.6	4.1	0.7	0.7	0.0	1.0	1.3	6.9	6.4	0.5	0.6	1.4	3.9	15.8	0.7	0.6	0.6	1.0	1.8	0.1	0.5	0.6	0.5	1.7	9.2	0.1	5.9	0.3	0.5	0.5	2.5	1.6	0.5	2.0	8.9	0.3	2.7	2.0	0.7	1.0	0.7	15.9	0.6	0.7	0.5	3.7	1.5	0.0	0.8	1.4	0.0	5.3	48.5	1.3	2.9	0.1	5.9	0.0	5.2	0.0	17.6	0.2	0.3	1.7	10.5	0.0	0.0	4.1	0.6	0.0	5.7	0.5	0.0	1.1	1.2	75.0	7.3	1.2	1.1	0.8	0.9	0.0	2.1	0.0	1.1	0.2	0.7	7.0	1.5	0.1	1.7	0.0	43.8	1.3	0.0	0.0	0.5	0.0	1.1	0.7	0.2	0.0	2.0	10.5	0.6	5.3	13.7	0.0	0.0	0.0	11.9	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.4	0.4	2.2	0.5	0.6	0.6	0.6	0.5	0.5	2.7	0.7	34.2	99.3	244.9	1.6	10.1	228.4	205.6	2244.7	340.9	0.0	123.0	79.9	14.8	125.8	738.5	5.5	0.0	0.7	5.9	137.1	0.0	217.6	1.7	103.4	24.3	113.7	52.9	0.0	0.0	96.7	1.1	161.0	408.7	157.2	27.3	0.2	15.7	1.4	72.2	0.0	0.0	168.3	724.2	162.9	2366.2	5.6	14.0	718.0	188.5	1.0	28.1	0.0	0.0	0.0	0.0	186.1	33.5	0.4	5.1	225.9	95.7	0.2	144.2	0.0	39.5	78.5	92.6	1.7	8.3	50.3	148.6	8.1	14.0	0.1	197.5	79.7
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998677	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 35.9;salivary gland: 50.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 64.6;Ductal cells: 94.0;Macrophages: 222.6;Pancreatic endocrine cells: 245.4"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 56.2;stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 191.9;EFO-21: 157.0;HSkMC: 111.4;hTEC/SVTERT24-B: 81.6;RPTEC TERT1: 603.6"									HPA065474	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1110000	1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	2.1	0.2	1.5	35.9	0.9	1.2	3.2	0.6	8.8	7.7	0.4	0.7	0.8	0.2	0.0	0.1	0.2	4.8	0.6	0.8	2.6	0.2	1.3	10.0	6.3	1.4	2.1	0.0	0.5	0.0	0.1	0.2	3.1	1.3	0.3	0.0	50.2	0.5	0.1	0.0	2.1	0.2	1.1	2.1	8.5	0.4	5.7	0.6	0.0	0.2	0.6	8.4	0.0	0.7	0.1	191.9	0.7	0.0	0.3	6.9	0.0	3.5	2.9	1.5	3.0	0.6	1.6	0.0	157.0	0.1	34.0	0.4	0.0	0.0	17.6	0.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	111.4	0.0	81.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	603.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	1.0	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.0	1.5	0.9	0.6	8.8	0.8	2.6	1.4	2.1	3.1	1.1	5.7	0.7	0.2	3.2	0.0	0.0	0.0	0.9	0.7	64.6	0.0	0.0	8.0	4.4	1.2	15.7	33.2	0.0	0.0	0.0	0.1	1.3	0.0	94.0	0.7	0.7	0.1	1.8	0.0	0.0	0.3	1.4	0.1	3.6	15.3	1.2	0.0	0.0	0.7	0.0	0.5	0.0	0.3	0.7	4.1	0.3	30.4	0.3	0.0	222.6	0.0	1.0	2.1	0.0	0.0	0.0	0.1	245.4	0.0	0.0	0.3	3.1	0.0	0.1	4.3	0.0	0.0	0.6	4.0	0.1	0.6	0.0	0.3	0.0	0.3	0.0	1.1	2.0
CYS1		ENSG00000205795	"Cystin 1"	Q717R9	2	10056780-10080944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 124.6;pancreas: 33.6"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 32.9;Collecting duct cells: 51.5;Distal tubular cells: 70.5;Muller glia cells: 48.0;Proximal tubular cells: 54.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"RPTEC TERT1: 111.5"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (8.48e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (2.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.20e-2)"	3.1	1.6	6.0	1.2	5.7	0.0	1.9	5.3	7.8	8.4	15.5	11.7	2.5	7.8	3.6	3.9	6.3	9.1	6.1	5.5	5.5	124.6	1.0	6.1	1.1	6.9	6.0	12.4	33.6	1.7	7.2	0.1	5.6	4.9	1.8	2.2	2.9	7.2	1.0	1.5	3.4	5.9	6.4	2.9	3.9	1.0	5.2	0.5	5.6	2.1	2.1	3.5	6.6	5.9	0.0	0.3	0.0	0.0	0.5	2.6	0.1	0.4	1.6	0.2	0.1	0.2	0.0	0.0	0.4	4.4	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	111.5	0.0	0.0	0.5	0.4	0.3	0.0	1.3	2.0	0.2	0.0	6.0	3.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.7	5.3	7.8	5.5	5.5	6.9	6.0	5.6	6.4	5.2	5.9	0.9	6.4	1.1	1.0	1.0	0.5	0.1	0.6	0.0	10.3	0.5	5.5	7.3	32.9	0.0	51.5	0.0	0.0	0.2	0.0	70.5	7.0	0.1	0.3	0.9	0.6	0.0	0.0	2.9	1.1	0.6	8.8	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.3	0.0	3.4	1.0	0.0	2.8	0.0	48.0	0.0	3.0	0.6	0.4	0.0	4.5	0.1	0.3	0.0	54.1	0.0	1.9	0.0	0.5	3.9	0.0	1.4	0.0	0.1	0.0	0.3	0.1	0.0	0.1
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DENND2A	"FAM31D, KIAA1277"	ENSG00000146966	"DENN domain containing 2A"	Q9ULE3	7	140518420-140673993	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 114.9;Horizontal cells: 89.2;Oligodendrocyte precursor cells: 72.4;Paneth cells: 69.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 28.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 57.7;BJ hTERT+: 60.8;PC-3: 29.1;RPTEC TERT1: 72.7;U-2197: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (5.02e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (3.05e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.38e-3)"	15.4	3.9	28.9	2.5	32.5	0.6	11.0	23.5	25.8	25.0	46.9	12.0	3.9	26.2	5.1	9.6	30.7	11.1	16.1	25.2	28.8	14.5	3.1	17.6	2.3	43.7	39.7	21.7	2.2	5.0	26.3	15.5	33.7	11.4	5.6	11.5	2.6	5.4	7.1	3.9	8.9	16.0	34.6	12.2	6.6	2.1	32.1	0.8	3.7	7.8	1.8	12.1	11.4	26.2	0.2	0.9	57.7	0.5	6.2	1.1	12.4	2.2	60.8	9.5	15.3	0.0	0.1	0.1	0.4	0.6	10.2	0.2	11.0	0.8	17.8	0.0	1.0	0.0	0.2	0.0	1.6	0.2	0.1	2.8	0.6	13.9	2.1	24.9	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.3	12.3	0.1	29.1	2.1	3.7	0.2	72.7	0.1	4.6	14.5	0.0	0.0	0.0	16.7	0.1	0.6	0.0	10.9	2.2	32.1	5.9	0.3	0.0	0.1	0.9	0.1	3.9	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	1.2	0.3	0.1	0.2	0.1	0.0	28.9	32.5	23.5	25.8	25.2	28.8	43.7	39.7	33.7	34.6	32.1	26.2	13.8	0.0	3.0	34.9	0.5	1.3	1.9	0.1	0.6	7.4	1.9	1.0	4.3	0.0	1.3	0.0	8.4	1.0	0.3	114.9	7.9	0.0	1.4	0.4	8.3	4.6	9.6	0.0	10.0	0.0	4.9	14.8	1.1	0.3	11.4	22.4	9.7	0.7	2.4	89.2	23.2	37.1	0.0	0.3	2.1	1.0	18.6	0.6	1.8	32.8	0.1	16.2	0.0	72.4	42.3	0.1	69.5	10.5	0.0	2.2	3.8	0.1	1.0	10.5	13.1	11.8	11.3	0.1	0.9	0.2	0.4	0.4	1.1	0.2	42.7	1.2
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"skin 1: 4799.0"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 8514.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.7;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"A-431: 150.1;CACO-2: 182.0;CAPAN-2: 153.9;HBEC3-KT: 236.4;RPTEC TERT1: 232.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 51.9"	"Low region specificity"	"Detected in all"			HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		47000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	13.8	9.3	6.5	1.1	11.7	1.7	195.4	7.3	7.0	262.7	16.1	11.0	5.6	16.1	14.4	221.3	73.9	1.8	11.9	5.9	7.0	50.3	4.7	22.3	1.2	18.4	7.2	35.0	59.7	87.1	58.1	2.2	17.8	19.3	4.9	1.9	69.5	14.6	20.1	4799.0	8.4	4.2	6.6	2.9	19.9	4.1	6.6	12.2	60.0	0.2	50.6	14.1	378.5	6.2	150.1	24.0	0.0	0.1	5.7	8.7	40.5	0.5	19.6	1.0	1.4	182.0	153.9	0.0	57.5	1.4	7.3	81.8	44.5	236.4	1.9	0.7	43.0	0.0	0.0	41.3	6.8	0.0	0.5	77.6	62.3	4.2	133.2	13.4	0.0	0.0	0.8	0.2	0.5	130.2	0.1	0.0	129.2	107.9	9.7	0.2	0.0	6.2	232.2	97.4	0.4	0.0	35.6	0.1	14.9	36.7	58.5	0.0	0.3	22.3	67.1	0.8	0.6	0.9	0.3	1.1	18.8	0.3	1.4	0.0	0.0	0.0	6.4	0.0	5.5	1.7	0.5	3.1	0.0	0.1	0.1	2.0	0.0	11.7	0.0	0.2	0.0	1.3	6.5	11.7	7.3	7.0	5.9	7.0	18.4	7.2	17.8	6.6	6.6	6.2	13.9	105.8	115.3	1.0	5.9	1623.7	143.2	169.9	39.3	1.7	71.8	164.3	20.4	100.1	107.6	204.1	0.0	1.0	6.7	6.0	230.9	138.0	15.9	181.5	9.0	27.7	49.3	2.7	6.9	140.2	1.5	47.1	27.0	107.8	7.6	2.4	12.1	4.0	1.0	0.0	5.3	8.0	46.8	0.3	287.0	98.0	13.1	2.8	305.9	0.0	2.6	15.1	28.8	0.0	0.4	146.1	9.3	15.8	3.4	94.0	0.2	7.6	270.2	0.8	0.0	0.9	22.9	7.6	31.4	34.0	8514.1	2.3	15.0	0.2	14.2	77.4
DNAAF4	"CILD25, DYX1C1, EKN1, FLJ37882"	ENSG00000256061	"Dynein axonemal assembly factor 4"	Q8WXU2	15	55410525-55508234	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 171.5;Proximal tubular cells: 34.4;Respiratory ciliated cells: 102.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051048	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA051048: AB_2681325"	"unprognostic (5.97e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.30e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	1.0	2.0	4.7	1.1	4.7	1.2	3.3	3.6	6.8	2.8	8.4	0.9	0.6	3.7	10.6	1.2	11.1	2.2	1.0	4.8	5.8	5.0	0.5	4.3	1.1	5.1	5.0	2.6	2.1	8.5	3.5	0.7	3.8	2.0	0.9	27.5	1.5	2.0	0.8	1.7	0.8	2.0	3.6	1.3	1.0	11.3	6.7	0.7	8.6	0.5	0.9	1.4	0.7	3.7	7.0	4.8	4.9	10.4	2.0	3.5	1.5	1.0	2.6	3.2	3.6	1.0	2.9	0.6	4.4	2.1	5.2	2.1	1.9	2.7	3.7	2.4	2.5	2.6	3.2	1.7	1.8	5.4	4.2	2.2	5.7	7.6	2.9	5.1	7.2	2.2	0.8	0.3	4.8	2.9	1.3	4.7	2.9	11.0	3.7	1.1	2.3	0.9	17.6	2.3	4.9	10.7	4.3	1.3	6.5	4.2	6.2	1.4	2.5	5.0	2.5	4.4	5.2	2.1	5.4	1.7	8.3	1.3	1.5	0.1	0.7	0.5	0.3	0.5	0.3	1.4	0.5	0.5	0.6	1.3	0.7	0.5	1.4	0.4	0.5	1.9	0.7	0.3	4.7	4.7	3.6	6.8	4.8	5.8	5.1	5.0	3.8	3.6	6.7	3.7	4.1	12.8	15.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	7.9	9.8	0.0	0.0	15.5	12.9	0.0	2.0	0.4	0.0	5.9	13.6	0.0	171.5	9.0	2.8	0.0	0.0	0.0	5.1	1.5	3.4	0.0	13.3	2.5	9.7	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.4	0.0	0.0	34.4	102.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.7	7.2	0.0	0.0
DNAI4	"DIC4, FLJ23129, WDR78"	ENSG00000152763	"Dynein axonemal intermediate chain 4"	Q5VTH9	1	66812885-66924856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.7;testis: 35.2"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.0;RPTEC TERT1: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (4.26e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (9.60e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.79e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.69e-1)"	1.5	1.7	3.3	0.5	3.0	0.1	3.0	2.0	1.8	4.0	19.4	5.4	0.7	3.0	5.0	0.5	27.7	2.5	1.2	2.6	4.1	6.3	1.2	4.2	1.0	12.6	10.2	3.0	1.4	7.0	2.8	2.1	7.4	1.8	4.1	4.1	1.1	2.0	0.5	1.0	0.6	1.3	9.5	0.9	0.8	35.2	3.8	2.3	5.9	0.3	0.7	0.9	0.9	8.6	2.9	1.2	1.6	2.1	4.8	7.0	0.6	1.3	2.2	1.6	1.7	0.3	2.4	1.5	0.3	1.3	5.0	0.2	1.1	0.3	2.5	0.2	0.4	0.4	0.7	0.2	1.6	0.1	0.0	3.3	3.5	6.0	1.2	5.8	0.6	1.5	0.4	0.1	2.8	1.1	0.7	0.5	2.1	1.0	0.6	0.7	0.0	0.0	11.4	0.0	1.9	0.9	1.4	0.5	1.1	1.7	0.5	1.0	0.2	0.7	0.0	4.7	0.7	0.5	0.0	3.2	1.4	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.1	0.0	0.9	0.5	0.2	0.1	3.8	0.0	0.0	0.1	0.1	3.3	3.0	2.0	1.8	2.6	4.1	12.6	10.2	7.4	9.5	3.8	8.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73951026-73970366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 53.2;testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.1	0.1	1.5	1.2	1.5	4.4	0.2	1.0	1.4	5.5	12.2	0.1	0.6	2.0	5.2	0.1	53.2	2.2	0.1	2.0	1.9	1.0	0.1	3.1	2.1	4.8	5.7	0.3	0.8	0.1	1.1	0.5	3.6	0.9	0.0	0.4	0.6	2.9	0.3	0.1	2.9	0.1	4.0	1.3	0.2	18.9	2.4	0.0	0.2	0.0	0.0	0.2	0.1	1.8	0.0	0.4	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.7	0.2	0.9	2.1	0.2	0.3	0.5	0.1	0.0	0.0	2.7	0.3	1.0	0.9	0.3	0.0	0.2	0.6	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.2	2.6	0.4	0.3	0.6	0.9	0.2	0.2	1.5	0.4	1.2	1.1	4.5	0.5	0.3	1.0	0.5	2.2	0.2	0.4	0.3	0.7	0.0	0.0	0.6	0.6	0.0	2.2	2.0	1.9	0.0	0.3	0.1	0.7	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.1	1.5	1.5	1.0	1.4	2.0	1.9	4.8	5.7	3.6	4.0	2.4	1.8	0.2	3.2	0.0	2.0	0.0	0.0	1.9	11.1	0.0	0.2	0.1	0.3	0.2	0.0	7.6	1.8	0.0	0.1	0.0	0.1	0.0	1.7	90.6	114.8	2.4	0.2	0.0	0.0	0.4	0.0	0.1	0.5	0.0	13.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	10.2	0.0	0.0	62.9	1.2	0.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	1.2	0.0	1.3	1.4	1.0	104.2	0.9	0.0	1.1	3.3	19.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	1.2
DNAJC5B	"CSP-beta, MGC26226"	ENSG00000147570	"DnaJ heat shock protein family (Hsp40) member C5 beta"	Q9UF47	8	66021553-66101245	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 65.4"	"Group enriched"	"Detected in some"	71	"Early spermatids: 1010.5;Late spermatids: 2756.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 5.7"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.7"	"Group enriched"	"Detected in some"	5	"HDLM-2: 13.9;RPTEC TERT1: 20.4;THP-1: 12.9;U-266/70: 11.3;U-937: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.01e-1)"	"unprognostic (7.29e-3)"	"unprognostic (7.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.53e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.84e-2)"	0.3	0.0	0.1	3.0	0.1	0.4	0.6	0.0	0.7	0.3	0.1	1.1	1.1	0.2	0.2	0.3	0.4	0.6	0.4	0.1	0.0	0.3	1.7	6.1	7.7	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.3	1.3	0.0	0.3	0.3	0.7	0.0	1.5	0.1	0.1	1.5	0.7	65.4	0.3	1.1	0.1	3.2	3.8	1.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	12.9	0.0	0.5	0.0	0.0	0.0	11.3	0.0	0.4	0.2	11.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	5.7	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.7	0.1	0.0	0.4	0.1	0.2	0.1	0.3	0.6	0.2	0.0	0.0	0.7	7.5	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1010.5	0.0	0.0	1.3	0.0	2.7	0.3	0.0	0.1	0.4	0.5	0.2	1.3	0.0	0.4	0.3	6.8	0.0	1.0	0.0	2.0	10.1	1.0	2756.7	13.4	6.3	1.8	1.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	12.8	1.1	0.3	0.0	0.0	2.3	0.0	26.3	0.4	0.2	18.4	7.2	0.0	0.1	0.0	0.3	0.0	0.0	0.7
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 55.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.3"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	NA	NA		190000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	13.3	3.1	0.2	5.3	0.2	0.6	8.4	0.1	0.6	10.9	0.1	14.6	107.0	3.6	4.0	3.0	7.4	6.7	3.4	0.2	0.1	94.9	57.2	16.0	5.8	0.2	0.2	3.5	3.5	155.7	0.1	134.1	0.3	107.3	16.9	0.1	84.5	23.5	1.5	5.7	137.9	3.0	0.1	11.2	7.6	1.3	0.8	12.4	5.0	3.9	4.4	5.7	3.5	0.4	0.2	0.2	1.0	0.0	194.4	212.6	0.6	37.7	207.0	10.9	37.2	38.0	1.0	0.0	13.6	71.0	30.2	1.1	0.4	0.0	6.2	12.3	0.0	0.0	0.0	57.1	77.0	0.0	0.0	22.0	0.1	66.3	0.5	9.1	6.6	0.7	0.0	0.0	3.6	0.0	3.6	0.5	2.0	1.3	72.7	0.0	0.0	0.6	263.3	0.0	0.1	0.4	0.0	0.0	0.0	4.4	0.0	0.3	37.0	21.8	1.1	0.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	52.3	0.2	16.2	10.7	1.2	0.0	15.7	6.6	0.4	5.3	0.0	4.0	2.0	4.7	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.2	0.3	0.1	0.8	0.4	10.8	6.4	26.0	0.3	2.1	4.1	0.4	0.1	0.0	1.8	0.2	0.8	3.3	12.8	2.8	14.7	10.4	140.3	10.4	27.4	1.9	3.0	15.0	2.3	7.1	9.4	55.2	0.4	31.6	0.0	59.1	35.3	2.0	68.0	13.9	5.3	9.3	34.5	14.5	0.0	6.3	16.4	0.0	0.9	7.6	7.9	0.0	4.8	5.4	3.7	1.1	0.0	1.0	2.5	0.7	1.4	23.8	0.0	2.1	32.7	291.1	101.4	2.2	0.1	0.0	2.1	1.5	4.0	1.1	0.1	4.1	172.0	25.8	29.2	29.1	0.3
DRC3	"CFAP134, DKFZP586M1120, LRRC48"	ENSG00000171962	"Dynein regulatory complex subunit 3"	Q9H069	17	17972813-18016889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 61.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 125.1;Early spermatids: 41.8;Endometrial ciliated cells: 121.8;Respiratory ciliated cells: 130.4;Rod photoreceptor cells: 88.7;Spermatocytes: 48.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036040, HPA036041"	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036040: AB_10602349, HPA036041: AB_2674915"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-3)"	"unprognostic (9.48e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.64e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.33e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-2)"	0.8	1.0	1.8	0.2	2.1	0.1	2.4	1.6	1.7	5.0	18.7	1.0	0.9	4.5	11.9	0.6	61.4	2.4	1.1	3.0	4.2	4.4	1.1	5.3	0.5	9.1	11.4	3.3	4.1	6.6	9.9	0.4	5.9	2.0	0.5	9.1	1.5	2.1	1.5	1.2	0.3	1.3	7.1	0.8	0.7	11.9	3.2	1.0	8.5	0.7	0.3	0.8	1.1	3.1	0.5	2.1	0.3	1.0	0.2	0.7	0.1	0.5	0.2	1.0	1.0	0.3	2.2	0.0	1.7	0.3	0.6	1.8	0.6	0.2	0.5	0.1	1.5	0.1	0.1	0.0	0.7	0.3	0.1	0.6	0.6	1.6	0.2	1.1	0.3	0.2	0.0	0.2	1.2	0.6	0.1	0.0	0.4	0.1	0.4	0.1	0.6	0.0	3.1	0.6	0.6	1.7	0.8	0.0	1.9	1.2	2.0	0.0	0.5	0.5	0.4	0.1	0.2	0.3	0.1	0.1	2.7	0.0	1.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.6	1.7	3.0	4.2	9.1	11.4	5.9	7.1	3.2	3.1	1.9	3.2	3.1	0.0	0.6	0.0	3.6	0.0	1.8	10.7	6.6	7.2	0.0	2.8	13.6	11.0	125.1	0.5	1.5	0.1	5.9	3.0	41.8	121.8	5.3	3.4	0.0	0.0	0.0	0.8	2.7	3.1	3.6	5.4	0.0	3.3	4.6	0.2	0.4	20.2	0.0	0.3	0.0	3.5	0.0	11.1	5.0	0.8	0.0	0.0	0.8	8.6	0.0	0.0	0.0	1.1	1.1	4.5	0.0	1.7	0.5	10.6	130.4	88.7	0.0	8.2	1.3	48.7	13.3	0.9	0.0	0.8	1.4	2.7	0.5	1.1
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972290	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 467.9;Late spermatids: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	6.6	17.8	8.2	3.9	8.1	1.4	6.9	8.2	8.5	10.7	9.6	7.1	4.5	8.1	5.8	5.7	8.5	4.2	9.6	8.1	8.4	12.3	13.0	6.4	4.6	9.3	8.6	13.4	10.8	11.8	13.0	4.4	8.7	10.3	3.9	4.8	6.7	6.0	5.3	4.9	5.8	4.8	8.6	9.7	8.6	31.3	8.3	7.0	11.5	7.1	3.0	7.9	7.4	8.5	12.9	6.3	5.8	23.1	9.5	6.4	6.7	7.5	12.0	16.2	15.5	7.6	5.9	5.2	8.5	16.6	5.2	8.7	10.1	16.8	9.4	9.6	12.9	9.3	15.8	16.4	18.7	0.0	4.6	9.7	16.3	10.5	13.5	9.9	21.3	6.6	8.3	11.9	9.8	14.7	1.5	11.1	4.4	8.4	1.3	4.0	4.1	8.2	21.2	4.5	30.1	17.0	6.6	7.3	16.9	4.1	0.0	14.8	7.0	4.7	12.6	4.6	12.3	9.1	9.4	10.2	4.6	14.4	5.2	0.0	1.9	1.0	2.2	1.6	3.9	2.4	2.3	1.4	4.3	2.1	1.6	2.3	0.3	2.1	1.4	1.3	1.6	1.8	8.2	8.1	8.2	8.5	8.1	8.4	9.3	8.6	8.7	8.6	8.3	8.5	11.2	6.4	9.6	11.8	16.8	8.5	15.3	14.3	19.9	13.3	13.6	11.4	7.1	11.5	10.5	3.7	16.7	14.5	14.1	5.0	19.6	8.4	467.9	9.3	10.6	9.8	16.2	4.4	4.4	12.6	9.5	10.9	15.8	8.7	6.3	12.1	8.6	10.9	6.6	5.0	6.2	9.0	12.2	5.9	4.9	242.8	17.7	6.9	12.4	1.9	4.3	16.0	11.3	7.5	6.6	6.9	10.5	12.4	14.7	10.8	10.6	13.3	8.9	15.6	13.1	7.1	14.3	78.4	16.1	11.8	5.5	20.1	15.4	22.6	8.3	11.5
DYNC2LI1	"CGI-60, D2LIC, DKFZP564A033, LIC3"	ENSG00000138036	"Dynein cytoplasmic 2 light intermediate chain 1"	Q8TCX1	2	43774039-43810010	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 197.5;Respiratory ciliated cells: 133.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062905	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA062905: AB_2684899"	"unprognostic (3.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.60e-2)"	16.2	23.2	20.2	7.5	21.3	6.8	32.6	16.1	23.6	28.3	34.9	15.4	19.0	35.6	46.6	11.0	53.4	20.7	15.5	20.0	21.9	50.2	13.4	23.4	10.2	20.4	19.3	39.7	16.2	42.2	31.2	13.6	18.7	20.8	17.9	44.0	16.3	20.0	10.2	15.8	16.3	19.8	17.9	11.0	17.1	44.9	21.3	10.8	34.3	8.5	9.7	15.0	13.9	20.6	21.2	12.0	20.5	13.1	32.5	64.5	17.6	11.5	24.8	13.3	12.4	4.0	14.4	12.0	24.8	15.2	17.0	13.8	9.9	16.5	15.4	15.4	21.1	9.4	5.5	15.3	31.3	18.7	14.8	38.3	23.4	26.5	12.1	40.6	18.5	14.1	29.0	5.6	18.7	10.8	9.2	20.6	9.4	27.3	12.0	12.2	19.0	3.8	110.1	18.0	14.0	25.1	13.0	7.1	15.5	19.4	19.7	16.9	13.1	11.6	10.5	14.4	9.8	21.0	12.3	3.0	25.8	4.7	12.6	14.8	2.3	2.1	1.7	3.9	1.8	3.7	2.2	2.4	3.1	2.1	2.7	2.3	0.8	2.6	3.1	1.8	1.4	1.4	20.2	21.3	16.1	23.6	20.0	21.9	20.4	19.3	18.7	17.9	21.3	20.6	11.9	19.2	16.8	58.1	6.4	9.7	18.2	42.9	7.4	21.7	19.3	22.4	13.9	21.5	31.3	53.3	29.2	19.7	2.3	10.2	90.1	21.7	197.5	71.7	42.2	8.1	12.7	5.5	96.8	22.0	9.1	27.8	15.3	24.2	17.7	26.2	14.6	7.3	12.4	16.8	64.9	20.3	50.8	4.5	5.3	39.4	33.2	5.9	23.2	22.5	3.3	29.3	4.1	33.7	43.4	14.5	32.1	33.8	4.7	9.6	52.4	84.1	133.8	36.9	19.7	14.8	14.8	102.1	15.9	9.1	9.1	9.3	4.9	30.1	17.5	12.8
DYNLT1	TCTEL1	ENSG00000146425	"Dynein light chain Tctex-type 1"	P63172	6	158636474-158644743	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 946.1;Ionocytes: 830.0;Respiratory ciliated cells: 1335.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046559			Approved	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA046559: AB_2679698"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	80.8	114.4	65.9	71.2	66.6	40.7	114.7	69.4	87.5	109.8	83.8	126.9	109.3	100.5	144.2	155.3	165.3	84.6	131.1	64.7	71.0	171.2	100.6	96.6	62.8	73.1	72.2	79.6	52.8	115.1	72.4	81.1	72.6	101.8	129.6	34.3	99.5	115.1	125.3	52.4	123.2	164.5	70.7	80.7	90.7	129.3	67.6	54.3	119.7	94.9	84.7	127.8	98.8	75.1	188.4	130.6	211.8	208.2	214.3	216.7	87.3	190.6	152.7	229.9	270.2	155.8	165.5	45.1	77.5	398.0	172.7	169.1	134.4	205.6	277.5	64.3	187.2	71.2	115.8	182.7	225.4	33.4	48.1	187.9	217.5	190.0	188.8	198.7	295.1	62.2	139.0	52.4	342.4	166.7	14.9	86.6	116.0	336.5	106.0	29.7	113.9	41.3	323.7	126.9	421.7	211.1	268.1	216.7	83.0	178.8	147.7	73.6	258.9	113.6	143.9	123.2	174.8	31.6	42.2	75.7	161.6	136.9	125.9	158.9	383.6	39.2	106.0	374.8	119.5	76.4	112.7	122.1	192.6	51.7	93.8	96.8	681.1	92.4	290.9	93.4	146.0	254.2	65.9	66.6	69.4	87.5	64.7	71.0	73.1	72.2	72.6	70.7	67.6	75.1	91.4	96.1	96.1	7.5	56.7	54.0	253.2	946.1	62.0	16.9	186.0	206.5	150.7	160.2	610.7	211.5	12.5	227.8	84.5	227.3	416.7	422.0	137.3	710.6	152.7	107.3	172.6	43.7	16.4	274.4	197.9	124.8	86.2	271.7	60.8	137.7	116.4	93.6	155.1	23.5	19.4	238.6	830.0	108.7	67.9	68.4	107.8	126.1	113.8	13.1	201.3	114.1	143.2	16.1	19.3	451.4	317.4	127.9	51.8	291.4	379.8	661.2	1335.9	42.0	138.1	55.2	241.5	452.0	177.7	172.3	61.1	215.1	106.8	187.5	168.6	443.0
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.3;testis: 83.8"	"Group enriched"	"Detected in many"	12	"Early spermatids: 179.4;Late spermatids: 580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	9.5	19.6	4.8	2.7	4.8	4.7	10.9	4.1	6.2	12.5	4.8	12.4	5.3	11.9	7.8	11.7	13.8	3.3	20.0	4.7	3.6	16.2	7.5	8.8	4.6	3.5	3.4	11.6	10.3	6.5	31.5	2.7	3.6	13.0	2.1	4.1	14.3	3.3	131.3	14.8	10.2	2.6	1.2	14.0	12.1	83.8	3.6	5.2	16.5	49.9	2.5	11.4	10.5	3.0	0.4	9.3	8.8	6.2	4.9	4.6	0.7	2.9	1.8	2.6	2.3	0.9	3.6	1.4	11.0	3.4	0.1	3.2	1.3	2.0	2.3	5.4	7.8	0.6	5.9	0.9	4.1	0.3	1.9	6.2	1.2	0.8	2.9	8.6	0.6	3.5	1.5	2.0	0.4	4.7	2.1	0.8	2.2	2.7	2.1	1.0	0.2	0.6	5.7	2.2	12.7	14.5	4.5	4.4	0.2	4.6	4.4	0.5	4.5	1.1	2.0	1.0	0.9	3.2	1.1	1.0	7.4	0.9	0.4	0.7	1.6	1.8	3.0	1.7	3.6	2.4	2.0	3.1	1.9	1.6	1.0	1.7	2.5	3.3	1.6	4.5	2.2	1.7	4.8	4.8	4.1	6.2	4.7	3.6	3.5	3.4	3.6	1.2	3.6	3.0	6.0	0.0	0.6	6.2	10.9	3.4	3.8	8.4	10.2	15.2	9.0	6.1	6.1	7.2	3.4	16.5	20.9	2.1	21.7	10.3	9.8	13.1	179.4	15.4	6.7	7.3	20.4	19.8	4.6	4.3	1.7	5.1	7.7	10.1	1.3	11.9	12.1	3.9	5.9	10.1	6.3	9.8	10.2	8.2	3.0	580.2	7.2	4.7	5.4	7.5	5.7	8.3	10.3	5.0	3.2	9.7	9.7	5.3	5.0	4.8	11.5	17.4	10.7	13.0	0.0	11.1	4.8	30.1	13.4	6.1	2.8	1.4	10.8	20.2	7.4	3.6
EFCAB5	FLJ46247	ENSG00000176927	"EF-hand calcium binding domain 5"	A4FU69	17	29929200-30108452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 136.5;Late spermatids: 101.0;Spermatocytes: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.4;eosinophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.1;RPTEC TERT1: 2.9;SK-MEL-30: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.08e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.77e-3)"	"unprognostic (9.86e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.11e-5)"	0.0	0.1	0.4	0.2	0.1	1.2	0.0	1.1	0.4	0.0	0.2	0.8	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.9	0.3	0.0	0.1	0.4	0.2	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1	0.3	8.5	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.9	0.3	0.4	0.3	0.0	0.4	0.6	0.0	0.6	0.1	0.0	0.4	0.0	0.9	0.5	0.3	0.9	0.3	0.4	0.1	0.6	0.5	0.2	1.7	0.0	1.1	0.4	0.2	0.5	0.3	0.0	0.0	0.1	0.0	0.7	0.2	0.7	0.0	0.1	0.0	0.0	2.1	1.0	0.1	0.4	0.0	0.7	0.8	0.8	2.9	1.2	1.3	0.2	0.8	0.5	2.3	0.3	0.0	0.2	0.6	0.1	0.3	0.4	0.0	0.0	0.0	0.8	0.2	0.2	1.1	2.4	0.0	3.2	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.4	0.1	1.1	0.4	0.1	0.9	0.2	0.4	0.2	0.0	0.3	0.9	0.3	0.0	2.0	0.7	1.5	0.3	0.2	0.1	0.0	0.8	0.7	0.6	0.7	1.5	0.1	3.7	0.0	0.3	1.7	1.4	1.9	0.0	136.5	1.7	0.2	0.4	0.0	0.4	23.3	0.2	0.2	0.3	0.5	1.1	5.1	0.2	1.4	0.4	0.2	0.0	15.0	0.8	0.0	0.0	0.2	101.0	1.8	0.6	7.2	2.8	0.1	0.0	0.0	10.6	11.1	0.3	0.2	0.7	0.2	0.2	1.3	1.4	0.6	0.2	0.0	3.1	0.8	65.9	5.0	0.4	0.0	0.0	0.7	0.5	0.8	0.3
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.5;fallopian tube: 17.1;testis: 15.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 77.2;Endometrial ciliated cells: 49.9;Late spermatids: 25.7;Respiratory ciliated cells: 93.6;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"RPTEC TERT1: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA034835			Approved	Vesicles,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Vesicles	"HPA034835: "	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	0.5	0.7	1.6	0.1	1.5	0.2	0.9	1.0	1.4	0.9	2.6	0.2	0.0	1.1	0.6	0.4	17.1	0.6	0.2	1.4	1.6	1.0	0.2	2.0	0.2	6.5	5.0	1.5	0.2	0.4	0.4	0.4	3.4	0.4	0.3	0.8	0.2	0.5	0.2	0.4	0.2	0.5	3.7	0.5	0.2	15.5	1.6	0.3	0.5	0.2	0.3	0.3	0.2	2.2	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	19.5	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	1.5	1.0	1.4	1.4	1.6	6.5	5.0	3.4	3.7	1.6	2.2	1.0	0.0	1.1	5.5	0.3	0.1	0.5	1.9	0.6	0.8	1.8	1.4	0.3	5.7	12.4	3.7	2.1	0.9	1.6	0.5	5.9	0.3	77.2	49.9	1.8	0.7	1.2	3.6	1.7	0.2	0.5	1.3	0.0	1.8	3.8	1.8	1.8	0.6	0.5	1.7	2.2	0.2	4.1	1.3	0.3	25.7	2.5	1.0	0.0	1.9	0.2	5.3	0.0	3.0	1.7	0.6	0.1	2.2	0.0	0.3	1.2	8.3	93.6	0.8	0.0	3.6	1.7	32.7	4.3	0.1	0.1	0.8	0.3	1.0	0.4	0.3
EFNA5	"AF1, EPLG7, LERK7"	ENSG00000184349	"Ephrin A5"	P52803	5	107376894-107670937	"Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Astrocytes: 291.2;Excitatory neurons: 798.5;Inhibitory neurons: 373.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 35.2;RPTEC TERT1: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013282, HPA054047"	Approved		Approved	Vesicles,Cytosol		NA	Yes		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"CAB013282: AB_2533353, HPA054047: AB_2682355"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.98e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (9.46e-3)"	"unprognostic (4.92e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.92e-7)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.27e-1)"	4.1	1.1	4.5	2.0	6.5	0.1	4.0	1.3	13.6	10.1	0.0	2.3	0.8	1.1	2.0	7.1	2.9	2.7	6.8	3.1	10.2	3.4	0.3	2.4	0.8	0.9	0.3	4.0	0.5	2.5	2.7	2.4	0.6	4.3	2.3	2.5	5.6	4.7	0.5	9.7	0.8	2.2	0.0	5.3	2.5	1.4	2.1	1.4	1.0	1.4	2.5	3.5	4.8	5.4	12.7	22.2	35.2	0.0	16.7	14.2	3.6	0.3	6.3	4.5	11.6	0.2	13.9	0.0	20.5	2.4	7.1	13.1	19.4	18.0	3.6	0.0	12.9	0.1	11.9	0.0	3.1	0.6	0.0	16.0	15.4	0.0	14.4	3.9	13.8	0.0	0.0	0.0	8.3	12.0	0.0	0.0	4.6	0.1	1.9	0.0	16.9	0.4	50.9	15.5	5.8	14.7	6.0	8.9	3.8	11.2	3.9	2.2	0.2	28.3	5.0	17.4	7.1	1.2	0.0	8.3	12.4	0.8	31.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.7	0.0	0.0	0.0	0.1	4.5	6.5	1.3	13.6	3.1	10.2	0.9	0.3	0.6	0.0	2.1	5.4	1.1	9.6	24.4	291.2	0.0	15.9	22.5	18.5	6.2	4.3	11.8	8.5	30.6	11.5	26.0	14.7	0.0	20.3	3.3	4.3	23.5	1.7	1.8	3.2	14.8	8.2	12.0	0.0	798.5	1.3	3.3	16.9	5.6	6.3	0.0	0.1	9.7	0.0	1.7	6.7	373.1	8.5	18.3	0.3	7.0	3.7	18.3	0.4	8.8	37.5	3.6	4.7	2.1	26.2	8.7	13.9	4.9	21.8	1.7	14.1	0.0	0.1	19.6	1.4	0.0	1.3	3.7	0.1	4.0	14.9	24.2	3.8	2.2	2.3	5.9	23.1
EMC2	"KIAA0103, TTC35"	ENSG00000104412	"ER membrane protein complex subunit 2"	Q15006	8	108443601-108489196	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022838	Approved					NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA022838: AB_2670967"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.15e-3)"	40.8	38.2	20.1	5.3	21.4	3.5	36.7	20.7	25.3	33.9	19.7	42.9	6.0	27.7	10.1	39.8	31.0	6.7	49.0	19.3	20.4	40.1	34.6	35.5	6.2	21.9	20.2	29.5	41.0	9.6	32.3	9.3	21.3	27.2	8.5	10.2	33.0	7.5	57.3	30.9	27.6	7.3	21.0	26.6	35.1	38.7	20.0	4.6	30.2	10.9	6.1	33.7	33.8	26.3	10.5	5.8	5.0	6.0	9.0	10.1	4.5	4.1	6.5	7.1	6.5	4.8	6.7	4.9	8.7	6.8	5.2	4.6	9.8	10.7	9.0	10.4	9.7	7.9	12.0	7.0	13.7	4.6	4.8	10.7	13.2	6.1	12.0	10.9	9.3	5.6	7.3	5.2	9.4	11.8	6.4	7.0	4.6	17.1	9.9	2.8	6.0	8.0	16.0	5.6	5.4	3.4	4.8	1.3	10.0	7.4	8.3	7.7	5.4	5.0	4.4	9.2	5.4	5.3	11.8	4.9	12.6	10.8	7.7	11.6	6.1	10.4	9.0	5.9	8.1	6.3	8.1	10.7	6.3	6.0	9.6	9.6	7.9	6.9	6.8	10.3	8.5	5.6	20.1	21.4	20.7	25.3	19.3	20.4	21.9	20.2	21.3	21.0	20.0	26.3	47.3	32.1	49.5	50.9	22.8	27.5	52.5	157.7	27.3	17.9	18.6	20.8	66.8	37.1	98.7	36.8	14.6	57.2	25.8	19.8	86.1	52.0	72.8	48.4	28.4	37.4	21.1	9.9	30.9	46.5	47.6	43.9	17.3	28.7	35.5	20.8	32.9	24.7	47.7	18.5	37.8	23.6	93.6	20.5	16.1	24.6	36.7	21.3	32.0	24.4	38.6	57.9	16.5	44.7	102.1	34.2	27.5	37.2	27.6	31.4	40.3	102.4	98.6	30.5	65.7	39.3	64.6	190.8	71.6	20.5	27.3	73.5	24.4	45.9	22.2	42.5
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542445-117549546	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 79.0;epididymis: 104.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1"	"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favorable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	10.4	0.1	23.2	0.2	25.6	0.2	2.8	16.9	31.3	58.2	16.7	0.4	0.1	79.0	104.3	0.4	53.0	1.5	0.8	26.9	16.5	39.1	0.1	0.1	0.6	15.8	18.0	11.9	0.0	0.1	1.8	0.4	16.4	1.1	0.1	0.3	2.4	52.6	10.8	10.5	0.1	45.0	14.7	0.2	0.1	1.2	19.6	0.1	0.3	5.2	0.4	4.7	4.4	22.9	0.0	0.0	0.0	2.6	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	25.4	31.6	0.0	0.1	0.6	0.0	0.0	0.1	2.8	0.8	0.1	0.2	0.0	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.2	31.1	9.4	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	2.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	23.2	25.6	16.9	31.3	26.9	16.5	15.8	18.0	16.4	14.7	19.6	22.9	4.6	0.0	0.0	43.4	1.0	10.7	2.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	239.1	0.0	0.2	0.0	0.1	90.1	0.0	1.4	75.6	126.5	3.1	0.0	0.0	0.1	0.0	0.3	18.0	0.0	68.6	0.0	88.3	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	8.0	2.6	60.3	2.5	21.4	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	41.0	0.0	2.5	0.1	185.0	0.0	0.1	52.6	8.6	32.1	0.3	0.3	0.0	7.5	0.1	2.2	2.2	0.3	1.7
EPHX4	"ABHD7, EH4, EPHXRP, FLJ90341"	ENSG00000172031	"Epoxide hydrolase 4"	Q8IUS5	1	92029985-92063538	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9;choroid plexus: 5.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 55.3;Inhibitory neurons: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 12.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.4;CAPAN-2: 13.0;EFO-21: 25.9;RPTEC TERT1: 36.1;U-251 MG: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035067	Uncertain		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA035067: AB_10601465"	"unprognostic (1.27e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (6.10e-8)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (5.36e-3)"	"unprognostic (2.72e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.44e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.36e-6)"	"unprognostic (6.93e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	0.5	0.5	4.0	0.5	9.2	0.0	1.4	1.9	10.9	0.9	5.7	0.6	0.6	0.6	0.5	0.8	0.4	0.4	0.5	6.9	2.3	0.4	0.0	0.6	0.2	3.1	2.3	0.1	0.0	0.4	1.1	0.8	3.1	0.9	0.5	2.1	0.2	1.8	0.1	0.5	0.4	1.1	1.8	0.0	0.3	1.2	2.8	0.0	1.8	0.1	0.2	0.7	0.2	5.5	15.4	0.5	2.9	0.0	0.0	0.0	0.7	0.3	5.5	0.5	0.3	0.0	13.0	0.0	25.9	0.0	3.9	0.2	0.5	1.2	0.5	0.0	8.0	0.0	0.1	0.0	0.2	1.1	0.0	0.9	0.7	0.0	0.0	9.4	4.5	0.0	0.1	0.0	0.4	0.9	2.2	0.6	2.8	0.0	5.2	0.5	0.3	0.0	36.1	3.0	1.8	2.2	9.1	0.0	2.9	0.2	0.0	2.2	0.2	0.0	0.1	0.0	10.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	2.0	0.1	1.4	3.0	0.0	0.0	0.3	2.8	0.0	0.5	0.0	0.0	0.0	1.5	4.0	9.2	1.9	10.9	6.9	2.3	3.1	2.3	3.1	1.8	2.8	5.5	2.0	0.0	0.0	4.9	0.0	0.1	0.1	2.0	0.0	2.0	6.7	4.6	1.0	0.0	1.5	0.0	2.1	0.4	3.2	0.1	0.0	0.4	1.7	1.0	0.1	6.2	0.0	0.0	55.3	0.9	0.7	0.3	0.0	1.3	0.0	0.3	0.4	0.0	0.2	1.7	32.5	0.0	0.0	0.0	0.4	0.1	0.0	0.2	3.6	4.7	0.1	8.6	0.0	5.5	2.7	5.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.6	0.0	0.1	0.8	6.0	0.7	0.1	0.4	0.0	1.1	0.2	0.3	0.3
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;fallopian tube: 11.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.3	0.4	10.0	0.0	13.3	0.0	5.6	10.5	11.5	2.9	0.0	0.1	0.0	0.2	0.0	0.1	11.2	0.0	3.0	9.9	12.7	5.1	0.0	0.8	0.0	4.9	16.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.7	1.2	1.5	0.3	0.0	0.0	4.3	0.0	0.4	3.3	8.0	0.0	1.6	1.7	0.0	0.1	0.1	6.1	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.3	10.5	11.5	9.9	12.7	4.9	16.9	7.6	4.3	8.0	6.1	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 59.4;stomach 1: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 126.0;RPTEC TERT1: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	1.0	1.3	0.8	6.2	0.9	1.7	8.0	0.5	0.8	3.6	8.9	59.4	45.8	2.9	4.8	8.2	8.2	29.9	4.6	0.5	0.8	31.8	7.1	4.1	1.4	1.7	2.2	0.5	23.6	5.2	1.5	3.9	1.4	5.0	53.0	2.6	8.9	11.5	0.3	37.5	41.0	2.7	1.0	3.8	44.0	0.6	0.9	1.1	8.3	0.2	1.6	27.5	5.8	0.8	32.7	52.1	4.3	0.2	1.5	4.0	33.1	1.6	17.1	0.9	2.7	45.0	81.8	0.0	69.5	3.7	78.1	54.4	27.1	24.0	1.5	0.1	26.8	0.8	1.0	32.8	10.6	0.0	0.3	5.5	67.3	8.0	49.8	8.0	84.9	7.8	0.4	0.0	0.1	17.6	3.8	0.1	5.7	17.9	126.0	0.1	0.0	0.8	205.9	58.5	2.1	0.4	12.3	12.6	0.3	48.5	5.3	0.3	57.1	0.1	31.8	0.1	0.3	4.8	1.0	0.1	18.7	0.0	1.4	11.9	10.0	1.8	0.4	3.2	2.1	0.5	3.8	1.9	4.7	0.1	3.4	2.1	42.0	0.7	0.5	0.5	1.0	4.0	0.8	0.9	0.5	0.8	0.5	0.8	1.7	2.2	1.4	1.0	0.9	0.8	0.3	9.6	3.7	0.0	0.9	109.9	17.8	4.5	10.8	0.5	10.5	6.3	0.3	32.9	12.7	31.3	0.0	5.4	0.2	124.7	1.9	28.0	0.0	40.9	5.1	1.2	13.1	2.5	0.2	15.0	7.9	2.9	74.5	74.7	2.5	1.0	1.1	9.6	0.9	0.0	1.4	50.8	4.1	1.9	3.8	0.0	0.0	2.1	1.8	1.0	2.6	0.0	0.0	0.0	0.0	44.7	86.1	0.0	0.1	34.1	62.9	19.3	25.0	2.0	0.0	0.4	2.8	0.9	1.3	37.0	168.4	2.1	2.1	0.1	50.7	116.0
FAM110B	"C8orf72, MGC39325"	ENSG00000169122	"Family with sequence similarity 110 member B"	Q8TC76	8	57994509-58204279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Inhibitory neurons: 195.6;Oligodendrocyte precursor cells: 253.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 13.4;intermediate monocyte: 3.5;non-classical monocyte: 6.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 13.4;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008318, HPA011781"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Mitochondria, Cytosol"		"HPA008318: AB_1853892, HPA011781: AB_1853891"	"unprognostic (2.07e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.88e-8)"	"unprognostic (4.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (1.06e-2)"	"prognostic favorable (4.31e-8)"	"unprognostic (2.23e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.15e-4)"	6.6	1.3	14.1	1.9	11.5	2.2	5.2	18.1	12.0	7.9	8.1	6.6	0.8	5.7	2.2	1.3	5.0	2.7	15.7	15.2	18.1	5.6	5.6	3.8	0.7	11.7	11.2	5.3	1.6	10.9	3.8	2.7	14.0	5.3	1.4	4.0	5.8	6.7	12.0	2.8	3.2	6.0	8.2	20.5	4.6	6.1	11.9	0.7	6.1	6.0	0.7	6.3	4.9	7.4	0.0	1.1	3.9	0.1	1.7	0.6	1.5	7.5	8.6	5.1	2.3	0.0	0.1	0.0	1.4	5.3	4.6	0.0	3.5	0.0	3.9	0.0	3.6	0.7	1.1	4.5	5.8	1.0	0.2	6.1	1.4	0.2	3.2	0.6	0.0	1.7	0.0	0.1	3.9	0.1	0.0	2.7	3.7	5.3	1.6	0.0	4.3	0.0	12.8	0.8	3.7	4.1	0.0	0.5	0.2	4.5	3.4	0.4	0.0	3.6	2.3	0.0	2.6	1.6	0.0	0.0	1.7	0.0	4.3	0.0	1.4	13.4	0.0	3.5	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.0	6.8	0.0	0.1	0.7	14.1	11.5	18.1	12.0	15.2	18.1	11.7	11.2	14.0	8.2	11.9	7.4	4.2	0.0	5.5	39.2	0.5	9.8	22.8	0.2	3.4	10.6	8.9	6.6	27.7	1.5	0.9	23.9	2.1	1.7	0.1	0.1	7.9	8.7	5.8	1.0	10.9	7.5	7.2	0.0	37.5	2.9	21.9	28.1	9.2	2.5	4.5	5.4	14.6	8.0	4.9	6.7	195.6	0.2	4.1	8.7	10.2	2.2	9.9	6.6	16.0	43.1	1.3	20.1	0.0	253.8	9.2	1.7	0.1	14.7	0.2	17.4	0.0	8.8	0.7	6.6	32.9	38.1	19.8	1.2	2.5	1.0	4.1	1.5	1.0	0.5	0.0	6.7
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193369-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 162.5"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 466.3;Langerhans cells: 571.0;Macrophages: 430.3;monocytes: 463.1;Skeletal myocytes: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	45	"classical monocyte: 256.5;eosinophil: 226.3;intermediate monocyte: 380.6;myeloid DC: 160.0;neutrophil: 294.7;non-classical monocyte: 379.8"	"Group enriched"	"Detected in all"	59	"dendritic cells: 160.0;granulocytes: 294.7;monocytes: 380.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;LHCN-M2: 2.9;NB-4: 2.9;RPTEC TERT1: 5.0;THP-1: 2.1;U-937: 5.0;WM-115: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	7800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	48.5	24.4	3.3	89.4	2.7	5.8	35.1	5.3	3.5	17.2	6.1	44.9	43.7	17.8	7.6	38.5	22.1	45.4	21.6	2.4	5.4	44.9	43.5	32.7	56.5	7.7	5.9	10.9	8.3	5.2	7.9	21.6	6.7	10.5	57.2	0.8	14.8	11.7	8.8	13.9	69.8	45.7	6.2	162.5	23.5	6.2	3.9	30.1	18.8	24.6	27.5	73.3	7.1	9.8	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.2	0.3	5.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.0	5.7	2.8	256.5	226.3	3.9	380.6	1.2	4.3	2.5	3.4	160.0	2.0	1.8	3.0	294.7	2.5	379.8	6.2	4.7	174.0	3.3	2.7	5.3	3.5	2.4	5.4	7.7	5.9	6.7	6.2	3.9	9.8	102.0	6.4	12.1	0.0	26.2	38.1	1.1	0.1	3.4	1.1	1.4	3.0	4.4	0.0	5.0	88.3	10.4	1.3	60.3	17.3	5.9	1.9	7.5	2.6	0.7	50.6	0.0	7.0	0.3	0.0	1.4	102.8	2.0	5.0	10.1	0.6	45.3	5.2	36.2	1.7	0.4	0.3	0.0	466.3	571.0	9.4	27.7	430.3	49.8	33.7	463.1	13.6	39.1	0.0	0.9	0.1	10.9	19.5	82.6	1.1	42.5	5.9	2.2	7.4	0.0	166.2	8.2	0.4	0.4	2.1	31.3	3.7	24.1	0.2	0.8	1.5
FOLR1	"FOLR, FRα"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 480.2;fallopian tube: 187.2;lung: 193.5;salivary gland: 219.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 444.2;RPTEC TERT1: 476.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA	448000	140000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.1	1.7	2.7	0.2	1.8	0.1	28.3	11.8	1.8	123.5	480.2	0.5	0.3	1.9	7.6	3.4	187.2	2.4	0.6	14.1	4.1	153.0	0.2	193.5	0.0	5.7	7.8	0.7	7.1	17.5	8.1	36.2	3.8	1.5	0.4	0.5	219.5	15.2	0.1	2.5	0.4	0.2	3.2	0.2	33.0	0.2	7.7	0.2	45.9	0.0	0.4	0.1	0.1	2.7	0.2	0.2	0.0	0.2	0.0	0.0	64.7	0.1	0.1	0.1	0.1	44.5	46.0	0.0	45.5	0.8	0.0	0.9	2.4	2.1	0.2	0.1	1.4	1.0	444.2	1.3	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.5	0.1	0.1	2.2	0.7	0.0	0.5	15.1	0.0	476.5	0.0	0.1	3.0	1.4	7.1	0.1	38.5	65.7	0.5	0.0	0.0	8.4	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.8	11.8	1.8	14.1	4.1	5.7	7.8	3.8	3.2	7.7	2.7	1.0	496.8	213.3	0.0	1.3	0.9	7.9	80.3	0.0	0.0	211.3	62.9	0.2	34.3	276.3	318.2	0.0	462.2	1.1	0.0	133.1	14.3	0.1	33.6	2.3	3.4	1.8	0.0	0.0	1.4	110.9	4.3	9.7	33.7	5.1	0.0	0.0	0.0	29.5	0.0	0.0	0.1	87.5	0.0	0.4	0.0	0.6	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.3	0.0	366.0	149.1	0.1	0.0	0.1	6.3	0.0	0.5	3.2	0.1	259.0	2.2	0.3	0.3	10.4
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 3645.4"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8"	"Group enriched"	"Detected in some"	25	"MOLT-4: 2255.4;RPTEC TERT1: 4711.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"spinal cord: 27.7"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	2.0	0.9	0.7	1.4	0.6	3.3	1.2	1.4	1.7	1.0	0.0	2.1	1.4	1.5	1.2	0.8	1.8	353.1	1.2	0.8	0.0	3645.4	23.8	4.4	8.9	0.0	0.1	2.4	612.6	0.2	1.6	0.8	0.0	1.7	0.8	1.1	835.6	0.7	0.3	1.0	1.6	2.2	0.0	3.1	2.8	0.6	0.0	74.8	1.0	0.6	4.5	1.8	0.9	0.4	0.0	118.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	3.5	0.0	0.2	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.2	83.6	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.9	140.3	0.0	0.0	0.2	0.3	2255.4	0.0	1.2	0.0	0.0	0.6	0.0	4.6	4711.9	0.0	1.9	0.0	0.0	2.9	0.2	0.2	0.8	0.3	0.8	0.0	1.3	0.5	0.0	1.0	0.3	0.2	0.1	0.2	0.0	0.0	1.2	0.0	1.0	0.0	1.0	0.2	1.8	14.8	0.2	0.3	5.1	4.3	0.0	9.6	0.0	3.8	1.7	2.1	0.7	0.6	1.4	1.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.0	33.6	1.1	0.1	0.8	0.6	0.2	0.1	0.5	1.2	1595.6	0.1	435.9	0.0	0.1	0.7	0.0	2952.4	892.8	21.8	1.6	4.1	2.2	15.1	2.7	0.0	10.0	0.1	3.5	0.5	41.3	0.0	0.6	4.2	3.9	3.6	0.0	0.0	0.3	16.2	4.5	4.1	25.9	9.3	24.8	0.0	0.0	8.8	0.5	1.0	0.0	0.0	23.2	0.0	7.5	0.4	0.2	0.0	3423.7	0.1	3.3	6.6	1.6	3.8	0.3	0.3	0.2	0.9	0.3	27.7	1.2	0.1	0.0
FXYD6-FXYD2		ENSG00000255245	"FXYD6-FXYD2 readthrough"		11	117820163-117876667	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.5;salivary gland: 4.5"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MOLT-4: 6.5;RPTEC TERT1: 7.3"									"HPA068838, HPA075209"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane, Vesicles"		"HPA068838: AB_2686047, HPA075209: AB_2732285"																		0.3	0.2	0.4	0.0	0.4	0.0	0.2	0.5	0.5	0.4	0.2	0.9	0.1	1.0	0.8	0.1	0.6	0.9	0.6	0.4	0.4	7.5	0.2	0.4	0.0	0.3	0.3	1.3	1.9	0.0	0.3	0.2	0.3	0.3	0.0	0.0	4.5	0.1	0.2	0.1	0.3	0.3	0.3	0.9	0.3	0.3	0.3	0.4	0.3	0.2	0.1	0.4	0.2	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.5	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	11.0	0.0	0.0	0.0	0.0	97.8	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	2.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	15.8	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		27000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	3.9	1.0	10.6	5.9	0.8	2.0	4.5	1.3	3.6	0.3	0.5	0.3	0.3	11.8	1.2	2.2	0.3	2.9	3.2	41.3	1.3	0.6	2.2	1.7	6.7	0.1	3.1	4.0	5.9	0.0	0.8	1.6	0.1	0.6	1.2	0.0	0.1	2.1	3.3	0.7	1.8	2.4	0.5	2.5	10.9	0.4	0.9	0.4	4.8	2.3	1.3	3.3	23.6	28.6	0.0	0.0	0.0	0.0	0.0	7.9	4.1	4.9	0.6	0.0	0.0	22.1	7.8	0.4	0.0	0.0	1.0	1.0	0.8	0.6	2.8	12.1	0.0	0.0	0.0	18.2	0.0	0.1	4.5	0.0	17.0	0.2	0.0	0.6	0.0	19.0	0.0	10.7	0.1	0.0	12.6	0.0	0.0	15.5	0.0	32.3	41.3	35.3	24.4	18.3	0.0	0.0	0.1	4.4	0.1	0.0	0.0	0.0	19.6	0.0	0.5	1.9	6.2	0.1	0.0	11.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.9	10.6	2.0	4.5	2.9	3.2	1.7	6.7	0.8	1.8	10.9	3.3	2.2	0.0	0.0	1.0	1.4	2.8	4.1	5.3	21.6	0.3	0.6	2.4	1.1	0.0	6.2	9.2	0.0	0.0	0.0	0.3	13.7	2.9	5.7	0.0	0.1	1.2	0.0	0.0	29.1	0.4	0.0	1.1	0.5	0.4	0.0	0.0	8.2	0.2	0.1	0.0	79.2	0.9	2.0	0.6	0.3	12.0	0.0	0.4	0.0	2.8	0.0	0.2	0.0	4.0	8.7	2.6	0.0	0.0	3.1	14.2	21.9	45.5	1.1	0.4	6.6	0.4	2.2	3.4	6.9	9.2	0.9	0.0	0.4	0.2	1.8	5.1
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 20.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	4.3	1.6	5.1	2.1	5.5	0.2	1.9	4.9	4.6	7.8	20.5	2.0	0.7	3.3	2.8	0.5	8.7	6.5	2.9	5.4	10.8	7.8	3.3	3.8	1.1	24.2	18.0	6.6	9.7	2.4	2.4	1.4	11.4	3.3	2.1	1.3	3.1	8.2	1.3	0.8	1.5	2.1	13.7	2.0	1.8	2.8	6.5	0.2	18.6	0.8	0.7	4.0	2.4	13.2	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	5.1	5.5	4.9	4.6	5.4	10.8	24.2	18.0	11.4	13.7	6.5	13.2	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95822726	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 777.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 723.9;Extravillous trophoblasts: 751.2;Proximal enterocytes: 968.3;Proximal tubular cells: 1165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 569.0;RPTEC TERT1: 462.1;U-87 MG: 441.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008634, HPA046431, CAB069419"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		6300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	82.1	101.4	32.5	80.0	34.9	173.7	37.2	46.3	52.4	28.2	29.0	57.2	194.7	12.7	10.1	13.6	17.2	50.8	102.7	47.3	37.1	247.4	143.6	71.9	61.5	52.0	42.1	10.9	10.9	82.4	23.7	102.0	39.8	28.5	47.4	6.9	59.2	25.6	777.4	38.3	170.3	25.7	34.3	64.9	40.2	4.9	43.6	75.6	18.9	55.9	80.4	53.1	20.9	37.9	22.2	97.1	8.4	18.0	211.3	310.4	1.6	326.5	569.0	35.9	62.9	31.2	10.2	86.2	45.7	99.0	83.0	9.7	12.9	156.4	100.5	75.7	24.1	62.8	63.5	248.1	386.6	67.2	182.8	184.4	23.2	219.7	21.3	81.1	75.3	179.3	8.2	51.3	262.3	7.9	121.4	133.0	22.2	3.3	111.6	186.1	66.8	107.9	462.1	16.8	23.6	12.5	85.3	47.8	39.4	22.0	13.0	66.0	78.0	91.9	101.9	74.6	14.4	37.1	202.0	70.4	441.3	170.6	19.7	48.9	727.2	901.6	222.9	483.8	313.6	142.9	205.0	166.7	459.8	107.8	201.4	186.1	783.8	113.4	411.2	166.6	457.7	781.7	32.5	34.9	46.3	52.4	47.3	37.1	52.0	42.1	39.8	34.3	43.6	37.9	77.5	22.4	28.4	3.6	74.1	17.2	62.9	330.5	8.6	2.2	57.9	31.5	154.9	65.8	183.6	93.8	0.0	47.4	130.0	173.8	723.9	60.4	0.3	83.4	49.0	47.1	31.7	63.1	8.7	96.0	751.2	63.1	35.7	118.0	31.6	3.5	46.4	206.9	271.5	0.0	8.0	89.9	65.1	304.9	276.1	2.3	19.0	232.3	69.4	12.2	340.0	7.8	302.8	2.0	2.4	113.5	291.3	13.9	200.2	89.5	968.3	1165.9	124.1	3.9	19.7	22.1	67.0	0.6	1.6	4.1	20.6	285.3	97.7	11.7	85.4	214.6
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277042	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 48.4;liver: 90.5;salivary gland: 55.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 59.3;Hepatocytes: 119.3;Intestinal goblet cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 107.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	11.9	9.0	5.5	8.7	7.4	15.5	15.8	8.9	6.5	11.3	7.9	34.0	4.3	10.3	3.5	11.6	9.1	7.4	7.7	5.5	7.3	10.0	90.5	6.8	7.3	7.7	7.3	14.8	10.2	6.1	4.8	14.2	8.9	15.3	48.4	8.0	55.3	7.2	7.9	3.8	7.6	11.7	6.6	6.2	4.6	4.8	7.1	6.2	6.9	15.3	9.5	14.2	7.5	10.5	9.9	44.4	20.1	17.1	22.5	22.4	29.9	13.5	17.9	19.5	25.1	10.5	32.6	13.5	14.2	24.2	50.5	3.9	15.3	4.6	21.8	25.1	1.4	11.0	26.0	15.2	15.4	0.2	31.2	14.4	4.6	32.0	30.6	14.3	8.4	20.7	14.4	27.3	19.3	1.8	19.1	6.3	11.8	6.7	23.7	15.5	16.3	3.8	107.7	19.4	16.7	15.2	13.7	5.3	12.6	7.1	4.8	12.0	12.2	12.7	12.9	15.5	12.2	11.7	26.0	7.0	17.0	9.8	18.2	0.2	0.5	0.2	0.7	0.6	0.5	0.6	0.9	0.8	0.4	0.9	1.0	1.2	0.3	0.7	0.8	0.6	0.4	0.6	5.5	7.4	8.9	6.5	5.5	7.3	7.7	7.3	8.9	6.6	7.1	10.5	9.7	9.6	10.0	9.4	7.1	1.9	3.1	6.7	1.8	8.4	8.2	7.5	6.7	10.0	16.9	9.2	6.2	8.6	4.3	59.3	1.9	10.4	3.4	7.2	12.1	6.3	11.5	7.8	12.8	6.0	9.5	8.3	2.6	10.6	10.1	9.1	7.1	119.3	2.9	11.8	15.6	88.1	16.2	7.8	4.4	2.4	10.8	5.4	1.8	5.6	6.1	1.9	2.1	32.2	28.2	5.3	20.3	6.4	7.9	6.9	2.9	2.2	18.8	6.9	13.1	10.0	6.3	1.8	2.7	1.2	1.6	19.8	5.7	2.3	26.8	13.4
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415489	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		190000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	9.6	9.8	5.9	4.9	6.4	0.1	5.6	5.0	5.8	12.0	4.6	22.5	10.6	10.8	16.4	7.4	11.2	9.0	7.9	6.3	7.5	20.6	1.8	17.4	2.5	7.2	6.9	12.3	10.8	5.6	16.6	29.0	6.0	8.0	10.9	1.2	13.0	11.4	24.3	3.8	10.8	17.7	6.6	5.7	16.9	7.8	4.9	8.4	5.9	20.0	2.0	10.3	5.2	8.5	0.0	0.0	209.7	8.3	8.9	1.3	26.0	1.6	0.0	0.0	0.0	0.1	0.5	0.3	71.7	1.2	0.0	0.1	121.8	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	37.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	6.0	0.1	0.1	110.3	0.0	3.2	0.6	19.2	0.0	276.6	8.4	0.1	1.5	0.8	0.1	0.1	242.0	3.2	3.2	0.0	21.3	24.8	0.0	13.6	0.0	0.0	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.4	5.0	5.8	6.3	7.5	7.2	6.9	6.0	6.6	4.9	8.5	1.7	51.3	29.2	54.5	0.2	1.5	3.7	14.7	14.2	0.0	2.9	2.0	4.4	5.7	8.7	23.9	0.0	0.5	0.2	2.5	3.9	7.0	0.6	5.9	1.7	1.2	2.4	0.0	4.7	12.7	36.2	14.4	6.6	10.0	0.0	30.6	0.0	0.0	2.5	0.0	1.4	11.1	4.1	0.6	3.9	2.1	2.1	2.0	1.8	14.0	1.1	1.0	0.0	4.5	4.3	16.5	4.3	0.4	0.1	1.4	4.6	30.3	12.8	0.1	0.0	6.3	13.6	2.4	23.6	2.3	0.4	3.1	1.0	1.4	11.3	0.6
GSG1	MGC3146	ENSG00000111305	"Germ cell associated 1"	Q2KHT4	12	13083532-13103683	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 429.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 10812.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 12.3;U-2 OS: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.50e-1)"	"unprognostic (2.21e-2)"		"unprognostic (6.33e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.23e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.32e-3)"	0.1	0.0	0.6	0.2	0.9	0.8	0.4	1.7	1.4	0.1	1.3	0.1	1.4	0.1	0.6	0.1	0.0	0.2	0.1	0.7	0.5	0.5	0.1	0.1	0.3	0.0	0.0	0.1	4.8	0.0	0.2	0.2	0.0	0.4	0.2	30.4	0.1	0.0	0.3	0.2	0.7	0.0	0.0	0.2	0.1	429.9	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.4	0.3	0.1	2.0	1.2	0.4	0.2	0.4	0.3	0.4	0.2	0.1	0.2	0.1	8.8	0.6	0.1	0.1	0.0	0.8	0.2	0.0	0.2	0.6	0.3	0.0	0.2	0.1	0.8	0.0	1.6	0.1	0.1	0.0	0.1	0.1	1.6	9.8	0.2	0.1	1.0	2.1	0.1	0.2	0.1	3.5	0.1	12.3	0.2	0.6	0.2	0.3	0.0	0.1	0.3	0.0	1.4	0.1	0.5	5.9	0.3	0.3	0.5	0.3	0.1	2.5	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.9	1.7	1.4	0.7	0.5	0.0	0.0	0.0	0.0	0.1	1.4	0.1	3.2	1.1	0.3	0.0	0.1	0.1	0.0	0.0	134.9	0.1	0.0	0.3	1.5	0.0	0.0	6.2	0.1	0.0	0.0	1.9	0.6	2248.2	0.1	0.2	2.8	27.5	2.7	1.8	0.0	0.1	0.7	0.0	0.1	0.0	0.0	1.4	0.0	0.6	1.7	0.8	2.0	2.0	0.3	0.0	10812.1	53.4	2.9	0.0	1.0	0.1	6.7	0.0	0.0	0.1	0.0	1.2	39.9	0.0	0.1	0.1	0.0	0.0	16.1	6.6	0.4	0.1	57.0	27.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120510-45284893	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	10.9	16.6	12.4	11.0	13.2	18.3	12.9	12.4	14.9	13.5	18.1	18.3	10.4	11.6	15.4	16.5	10.0	8.4	20.0	13.1	13.2	15.0	11.3	9.6	13.4	12.3	13.0	12.1	10.7	14.1	12.9	11.0	12.4	10.7	14.2	9.9	12.2	13.0	25.0	24.9	10.0	12.9	13.5	10.2	11.3	13.3	13.0	14.8	11.4	15.8	14.4	15.5	14.8	15.6	43.2	15.9	29.3	21.8	17.6	25.8	24.3	46.2	30.2	46.1	44.9	26.8	65.7	42.9	25.4	33.9	44.8	46.9	44.3	37.1	66.7	32.6	38.4	50.8	20.7	35.2	28.1	57.0	27.9	21.8	55.9	34.4	57.8	52.0	29.9	32.9	36.6	15.8	125.6	24.2	42.0	65.2	34.8	68.6	38.3	39.0	22.2	24.8	101.4	15.0	15.6	26.0	23.5	22.9	39.8	27.5	18.6	45.9	23.7	38.6	33.1	30.8	79.9	10.0	14.6	42.7	44.9	36.1	41.2	16.2	15.9	29.9	10.3	16.7	12.4	17.3	12.1	12.4	18.8	17.8	13.5	13.5	22.5	18.9	18.9	14.7	14.7	10.1	12.4	13.2	12.4	14.9	13.1	13.2	12.3	13.0	12.4	13.5	13.0	15.6	21.6	41.7	32.1	41.1	36.0	75.1	82.8	80.2	35.9	19.2	27.3	30.2	79.4	10.0	41.6	11.0	4.2	33.0	25.7	29.0	49.0	49.7	93.0	34.9	37.5	27.6	28.2	32.6	23.7	33.6	49.4	28.9	13.7	56.8	39.3	25.6	18.2	21.4	49.1	8.4	35.1	26.4	50.8	27.1	38.2	82.3	24.2	32.0	76.5	36.5	38.2	36.8	27.8	57.8	48.9	48.5	30.3	31.6	30.4	88.3	22.6	42.7	29.4	21.5	6.6	35.6	32.3	68.6	83.9	34.5	72.7	33.8	28.8	33.5	40.7	75.1
GTF2H2	"BTF2, BTF2P44, p44, T-BTF2P44, TFIIH"	ENSG00000145736	"General transcription factor IIH subunit 2"	Q13888	5	71032670-71067689	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.5;RPTEC TERT1: 19.1"									HPA047001			Supported	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA047001: AB_2679899"	"unprognostic (7.40e-3)"	"unprognostic (4.71e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.62e-1)"	3.1	2.9	0.6	1.1	0.7	1.1	2.8	1.1	1.7	3.9	0.4	4.6	0.2	3.8	2.0	2.6	3.4	1.2	2.7	0.6	0.9	3.6	3.4	2.8	4.8	0.8	0.9	3.4	4.3	1.1	2.6	0.9	1.0	2.3	1.0	1.7	2.8	0.6	3.5	1.9	2.9	5.1	0.6	2.8	2.9	3.7	0.9	1.4	3.5	0.0	0.3	2.6	3.0	1.2	4.8	0.0	4.2	0.0	11.0	12.8	13.9	0.5	0.2	0.3	0.7	12.0	0.4	18.5	8.4	10.2	6.1	3.1	0.6	0.1	0.3	15.0	14.0	8.7	0.2	0.9	12.3	0.4	0.0	0.0	2.7	0.4	0.0	2.4	0.0	0.1	0.2	3.3	0.0	7.3	5.6	6.0	0.1	0.1	0.0	6.6	2.6	11.1	19.1	0.0	0.4	4.6	12.1	1.4	11.5	0.3	7.7	8.0	4.2	5.3	1.1	0.7	8.7	0.2	0.8	4.7	0.1	0.8	10.1	0.2	0.5	0.2	0.6	0.3	0.2	0.5	0.7	0.5	0.3	0.8	0.7	0.5	2.1	0.3	0.3	0.3	0.0	0.3	0.6	0.7	1.1	1.7	0.6	0.9	0.8	0.9	1.0	0.6	0.9	1.2	6.9	16.0	27.0	6.8	17.6	16.6	23.5	17.5	7.4	23.3	14.9	8.1	16.7	28.6	18.7	12.9	39.6	37.3	9.6	8.4	46.9	19.1	5.4	17.0	17.7	12.6	12.0	15.2	10.0	20.5	17.5	14.6	7.1	17.7	6.3	25.5	14.6	12.5	15.0	25.2	10.2	5.9	14.2	15.0	9.9	7.0	24.2	11.0	14.2	4.7	7.9	10.6	9.2	9.0	11.0	16.7	7.5	13.2	14.6	23.7	8.9	22.5	22.7	39.7	26.3	14.1	12.5	60.3	55.9	6.9	12.5	9.6	15.3	15.5	9.1	18.7
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"retina: 296.7"	"Cell type enriched"	"Detected in some"	4	"Cone photoreceptor cells: 125.1"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	85	"RPTEC TERT1: 14.0"									HPA041597	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Focal adhesion sites"		"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	1.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	41.5	0.0	0.4	0.0	0.1	0.0	0.0	296.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.3	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	1.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	14.5	0.0	0.0	0.0	125.1	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.7	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	1.0	0.0	9.7	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.6	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	17.5	0.0	0.0
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 23.9"	"Lineage enriched"	"Detected in many"	13	"monocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	13.8	7.1	23.6	15.6	30.0	2.2	10.0	5.3	36.6	12.6	0.0	28.9	5.8	16.4	6.0	8.1	13.7	13.3	18.7	30.1	28.2	13.2	7.7	16.5	10.4	9.8	13.9	5.8	10.9	50.3	6.0	43.6	22.8	13.6	8.7	34.7	5.5	12.2	5.9	3.5	11.1	25.0	6.4	11.0	13.8	2.4	14.8	7.2	7.3	14.9	7.3	10.0	11.1	17.0	0.0	0.5	6.5	0.0	2.2	11.4	0.0	2.0	3.6	0.2	0.1	0.0	0.0	0.0	3.0	1.1	5.0	0.1	13.6	0.3	0.8	0.0	4.6	46.0	0.0	0.0	1.2	0.0	0.0	5.1	0.4	0.0	0.2	4.2	0.1	10.2	0.0	23.7	3.0	2.1	29.9	0.1	0.4	0.0	3.2	3.5	0.9	0.7	42.9	4.4	0.7	7.8	0.0	0.2	0.0	6.4	0.0	0.0	0.0	7.3	1.6	12.4	9.5	0.3	0.0	0.0	15.6	0.0	0.0	1.4	0.5	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.5	1.3	23.9	1.6	0.0	5.8	23.6	30.0	5.3	36.6	30.1	28.2	9.8	13.9	22.8	6.4	14.8	17.0	20.2	6.4	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	9.2	0.0	1.1	1.1	0.0	5.9	22.9	0.0	3.7	4.3	3.4	0.0	0.0	0.0	4.2	0.2	5.4	0.0	15.5	1.3	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.0
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827157	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 378.7;Proximal tubular cells: 501.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favorable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favorable (5.19e-4)"	41.2	109.0	81.5	20.2	84.2	82.1	35.1	82.7	103.9	22.8	78.9	53.7	45.3	24.6	31.1	29.0	28.5	21.9	138.6	89.9	83.8	100.1	236.2	39.2	24.6	82.8	80.2	22.0	63.5	54.0	72.7	23.1	83.7	33.5	23.3	32.2	32.5	37.7	198.8	31.2	44.8	24.7	80.1	35.2	52.9	91.7	84.0	35.8	35.1	156.2	18.4	34.8	24.6	87.6	31.1	46.1	40.9	46.5	35.1	13.8	37.0	38.1	35.2	57.7	46.1	23.7	26.5	6.4	76.5	32.9	39.6	33.2	39.1	38.2	17.2	64.5	63.4	12.0	47.9	69.3	50.2	15.7	62.6	16.9	80.6	28.8	19.6	50.6	50.1	79.8	16.1	56.3	18.3	51.2	41.1	34.0	15.7	32.0	42.3	34.2	25.8	73.6	74.5	13.8	54.7	47.4	41.8	52.9	84.9	30.8	38.7	52.0	38.7	17.5	21.5	36.9	44.6	63.3	64.7	19.8	29.8	14.5	28.5	37.3	33.3	64.9	26.0	59.1	19.0	31.3	34.0	27.3	30.7	30.4	32.0	27.4	29.7	25.5	88.2	64.8	42.8	30.3	81.5	84.2	82.7	103.9	89.9	83.8	82.8	80.2	83.7	80.1	84.0	87.6	46.2	9.6	39.0	11.8	33.7	23.8	45.1	59.7	12.0	117.1	39.5	31.1	84.2	65.8	39.7	46.0	64.6	52.4	43.2	60.9	158.5	45.6	193.1	75.0	12.1	35.3	39.6	378.7	24.6	38.3	38.5	25.6	23.9	35.5	30.4	36.0	41.0	186.9	76.2	138.0	22.2	41.2	93.6	49.0	41.6	60.1	46.9	47.6	55.2	12.2	50.1	95.2	64.9	7.1	19.7	49.7	68.8	54.9	50.4	48.3	168.9	501.7	70.2	117.0	72.3	33.3	61.1	245.2	68.3	29.1	45.6	68.7	44.1	45.3	39.9	49.9
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42782908-42804490	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 638.8;Distal tubular cells: 632.0;Paneth cells: 610.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 509.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	121.3	130.0	134.6	75.3	140.6	53.8	81.4	151.4	198.8	90.2	135.4	295.2	162.2	65.9	95.2	162.8	62.6	79.3	323.1	139.4	155.1	198.9	343.5	66.5	50.9	148.1	148.8	39.4	60.8	111.4	90.5	64.6	153.5	101.5	300.1	152.7	75.1	96.3	174.2	68.8	134.8	96.2	156.1	48.9	145.9	63.7	145.6	52.8	115.5	316.7	80.0	99.5	120.1	174.0	159.9	67.0	182.9	165.2	420.3	244.3	195.2	205.1	151.0	168.4	165.8	132.8	166.7	95.8	120.5	161.8	114.0	92.9	143.0	203.0	225.6	135.5	145.9	301.0	127.6	257.4	191.8	180.4	131.4	274.0	233.7	129.0	181.4	94.7	159.8	135.1	299.7	110.3	247.3	51.1	96.1	61.1	162.7	133.7	176.5	80.9	138.0	72.1	454.1	361.1	82.7	108.2	187.6	142.0	207.0	182.9	145.0	130.0	166.1	127.4	105.2	341.1	219.1	89.7	184.1	207.2	165.2	185.7	100.6	115.7	66.2	130.5	72.9	115.4	65.8	56.6	71.5	73.6	77.2	43.6	60.3	70.5	70.0	65.6	143.2	509.4	99.4	171.5	134.6	140.6	151.4	198.8	139.4	155.1	148.1	148.8	153.5	156.1	145.6	174.0	50.1	54.5	82.4	32.3	39.7	131.2	153.1	244.8	59.2	35.7	86.4	62.0	351.5	80.1	133.0	138.0	10.4	114.1	99.5	638.8	632.0	113.3	8.4	87.3	41.2	50.8	82.0	126.8	32.8	145.0	202.7	98.1	100.9	63.6	93.3	49.7	59.6	197.9	77.1	28.6	27.3	193.5	343.8	46.9	113.3	13.0	30.7	63.4	176.1	21.5	82.7	232.5	43.3	14.1	32.9	279.4	610.7	52.3	65.5	193.5	122.4	296.4	106.0	41.2	78.9	28.8	119.8	186.1	78.7	94.2	204.6	299.9	50.7	101.5	168.0	254.2
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686431-37745105	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.1;pancreas: 33.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 139.3"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in single"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.9	6.9	1.5	7.5	0.0	5.7	15.1	0.0	0.0	0.1	61.1	12.9	6.8	0.0	0.0	0.0	0.0	33.0	3.5	0.0	0.0	0.0	2.3	7.1	0.0	0.0	4.4	0.0	0.0	8.6	0.1	0.0	0.0	8.2	3.9	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	2.2	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	139.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	14.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	78.6	1.9	57.0	0.0	0.0	0.0	15.4	45.0	42.0	32.3	18.5	3.6	0.4	14.4	0.0	0.2	25.4	0.0	0.2	13.7	41.7	5.7	0.0	0.0	5.1	0.1	0.0	0.2	13.5	0.0	0.3	0.0	11.6	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.1	31.7	11.4	0.0	0.0	2.6	14.3	38.2	3.7	0.0	0.0	0.0	0.3	3.0	2.5	0.0	0.0	0.0	0.6	0.0	20.4	2.7
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408222-101414133	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 302.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	60.1	70.3	53.5	63.0	57.7	78.0	72.3	53.6	69.6	59.2	58.4	57.2	60.1	61.6	66.1	55.5	55.2	48.7	59.1	57.4	56.8	79.0	77.7	57.4	58.3	56.1	55.5	53.0	42.7	124.0	52.8	71.8	55.6	63.1	60.9	79.4	45.6	72.7	90.4	63.8	59.7	68.7	55.7	59.5	49.0	25.6	55.0	73.0	63.1	77.8	73.2	71.9	47.2	59.8	105.0	72.1	137.8	83.2	119.4	104.0	66.0	87.3	123.5	82.0	166.6	62.1	91.9	107.9	86.6	125.5	112.3	93.8	160.6	122.5	111.9	104.9	78.0	80.1	173.7	84.8	102.2	100.4	74.7	106.1	111.0	80.8	79.3	98.5	113.5	58.1	82.9	150.6	126.8	136.9	83.3	88.7	86.6	171.7	69.7	76.9	146.2	105.1	177.8	140.7	63.1	114.6	130.0	61.3	104.5	97.3	78.9	94.7	122.0	45.0	81.4	129.7	36.2	49.8	76.9	75.0	93.2	114.6	57.5	138.8	104.6	165.1	59.2	112.3	62.9	56.7	56.6	59.3	99.4	54.5	58.7	61.3	247.6	79.5	114.5	41.9	57.4	92.2	53.5	57.7	53.6	69.6	57.4	56.8	56.1	55.5	55.6	55.7	55.0	59.8	46.3	28.9	61.2	0.0	47.7	70.9	94.1	119.0	21.1	40.5	42.6	24.9	48.1	45.8	88.5	90.1	12.5	137.7	37.5	52.0	99.7	99.1	3.2	41.4	35.6	56.1	60.6	41.0	0.0	73.4	65.0	49.0	28.1	44.6	82.4	26.2	52.1	85.3	84.3	16.8	0.0	45.7	83.4	75.4	75.8	6.1	55.3	66.0	69.4	0.0	97.8	44.1	55.6	0.0	0.0	64.5	65.8	59.0	24.6	45.3	58.4	146.2	75.0	34.1	78.9	57.2	64.6	17.6	33.1	28.2	72.0	302.5	42.0	44.3	46.0	64.5
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.8;liver: 54.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 35.8;Distal tubular cells: 29.4;Hepatocytes: 43.3;Late spermatids: 18.4;Proximal tubular cells: 98.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;EFO-21: 9.7;Hep G2: 26.1;RPTEC TERT1: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039466	Approved					NA	NA		16000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039466: AB_2676522"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	4.1	8.3	5.8	0.2	7.4	0.4	1.9	9.3	5.0	0.7	11.4	0.2	0.3	1.1	3.7	1.0	2.0	2.5	21.1	4.4	6.5	51.8	54.8	1.4	0.3	8.2	9.2	0.2	15.3	5.7	3.6	0.1	8.3	1.1	0.1	0.8	1.7	2.1	3.4	1.5	0.3	0.5	7.3	0.4	0.2	0.9	7.9	0.3	1.8	12.1	0.2	0.4	0.9	10.3	0.3	3.7	0.1	7.8	1.5	0.3	0.1	0.1	0.2	0.0	0.0	3.0	0.2	0.3	9.7	0.2	0.5	2.6	0.0	0.2	0.1	0.1	4.0	0.1	1.4	26.1	1.1	0.2	0.1	0.3	0.7	0.1	0.1	1.9	0.4	0.1	0.0	0.4	0.6	1.6	0.1	0.1	0.2	0.2	0.0	0.1	0.6	0.4	31.5	0.6	0.6	1.0	0.1	1.3	0.5	0.2	2.8	0.0	0.2	0.8	0.2	0.3	0.2	0.5	0.9	0.1	2.0	0.1	0.1	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.2	0.2	1.0	0.2	0.2	0.3	0.2	0.1	5.8	7.4	9.3	5.0	4.4	6.5	8.2	9.2	8.3	7.3	7.9	10.3	0.0	0.0	0.0	7.2	1.5	0.1	0.7	0.5	1.8	0.4	0.1	0.4	6.0	35.8	0.2	9.2	0.0	0.1	0.0	0.1	29.4	5.9	3.8	1.8	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.0	0.5	0.0	0.1	0.4	43.3	0.1	1.7	1.2	0.0	0.0	1.3	0.0	18.4	0.0	0.8	1.8	1.0	0.0	2.0	0.0	1.5	12.3	0.5	0.1	0.0	0.0	0.1	0.0	98.0	3.2	0.3	0.0	4.5	0.9	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.2
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 29.1;Distal tubular cells: 131.0;Early spermatids: 29.4;Proximal tubular cells: 53.4;Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"medulla oblongata: 4.6;pons: 2.1;spinal cord: 8.2;white matter: 5.1"	"Immune cell enriched"	"Detected in single"	6	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 36.9;RPTEC TERT1: 45.4;SCLC-21H: 36.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.3"	"Region enriched"	"Detected in some"	6	"spinal cord: 21.4"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	8.2	17.8	0.0	5.9	0.0	0.3	9.4	0.0	0.1	4.2	0.0	13.8	0.2	5.8	17.8	2.8	15.5	0.1	0.0	0.0	0.0	20.1	0.0	2.7	2.1	4.6	0.1	0.8	0.2	0.2	0.0	0.3	2.1	4.9	8.9	0.0	0.0	6.7	16.5	12.0	8.6	3.8	8.2	1.7	3.9	2.4	0.1	2.9	0.5	0.1	0.4	7.3	5.2	5.1	13.6	4.6	0.0	14.1	0.0	0.0	0.8	4.7	8.0	9.6	11.0	7.0	5.1	9.2	12.8	3.7	0.3	9.1	36.9	0.0	5.8	0.0	23.2	0.6	4.8	0.2	0.9	0.8	0.5	7.5	0.4	1.1	12.9	0.0	18.5	15.7	0.0	0.0	3.7	2.4	0.0	2.2	0.5	9.6	1.4	4.8	8.5	0.0	45.4	9.1	36.3	0.1	25.6	0.0	0.1	2.5	0.4	3.7	1.6	0.0	8.6	26.0	4.6	0.0	0.2	0.2	0.0	17.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.1	2.1	8.2	0.1	5.1	11.0	0.0	0.0	0.0	0.6	9.1	7.2	0.1	12.0	0.0	18.7	29.1	0.4	0.0	0.1	12.9	0.0	1.1	1.3	10.3	131.0	0.0	29.4	0.2	2.1	5.9	16.2	5.5	0.0	0.0	3.9	5.8	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	12.5	0.0	0.0	1.9	7.2	0.6	0.6	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.8	0.0	1.7	5.2	2.3	53.4	0.1	0.0	0.0	10.8	16.1	27.4	4.1	8.6	12.4	0.3	1.0	1.2	16.1	5.3
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 70.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.6;Collecting duct cells: 99.3;Early spermatids: 37.9;Endometrial ciliated cells: 25.6;Glandular and luminal cells: 35.0;Hepatic stellate cells: 25.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"medulla oblongata: 28.3;pons: 13.0;spinal cord: 24.5;white matter: 13.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;HEK 293: 47.4;RPTEC TERT1: 35.0;U-251 MG: 38.2"	"Region enriched"	"Detected in single"	39	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	22	"medulla oblongata: 10.1;pons: 3.9;spinal cord: 12.2"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.45e-6)"	22.7	11.3	0.2	7.8	0.1	1.8	19.3	0.2	0.2	23.3	0.3	43.6	6.5	13.6	70.5	13.5	38.5	7.6	5.2	0.3	0.1	38.7	4.1	12.6	4.8	28.3	1.0	1.6	4.8	20.0	0.2	4.2	13.0	9.3	11.8	0.0	0.6	25.4	10.6	7.7	27.5	9.4	24.5	15.7	17.7	10.3	0.4	1.3	4.8	8.2	1.2	11.3	10.2	13.6	6.6	13.9	10.1	4.6	8.7	12.1	2.5	0.2	0.0	0.2	0.2	6.2	43.9	3.5	34.0	30.1	4.4	0.3	2.0	0.7	0.1	10.6	47.4	10.9	7.0	0.0	13.4	0.0	27.3	12.3	0.0	13.3	0.7	6.5	13.8	13.2	14.8	0.4	8.4	0.2	0.7	0.3	0.2	14.3	1.3	0.0	7.0	1.4	35.0	6.7	0.0	0.1	1.5	0.0	7.8	7.5	13.9	3.0	15.1	4.5	13.6	2.5	38.2	3.5	4.5	0.4	9.5	0.0	8.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.6	0.2	0.1	0.2	0.1	0.2	0.2	0.3	0.1	28.3	1.0	13.0	24.5	0.4	13.6	26.6	0.0	1.9	0.0	0.5	2.5	3.0	0.0	11.4	0.0	5.9	2.7	1.8	1.5	0.7	99.3	0.0	3.2	2.0	11.4	7.9	0.2	37.9	25.6	4.3	13.6	2.4	0.8	0.0	0.0	0.8	8.1	0.0	35.0	8.8	0.0	25.0	0.4	0.7	0.0	0.0	7.5	0.0	1.6	4.2	12.9	0.3	0.8	5.4	0.0	0.3	0.0	6.2	0.0	0.0	0.4	7.7	0.4	0.4	3.2	7.6	0.9	0.0	0.0	0.0	4.8	6.2	6.1	11.7	13.9	1.4	0.4	2.0	0.0	9.5	7.0
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593779	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;kidney: 32.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 25.4;Endometrial ciliated cells: 48.8;Glandular and luminal cells: 46.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enhanced"	"Detected in many"		"medulla oblongata: 39.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8;HeLa: 8.7;RPTEC TERT1: 21.7"	"Region enriched"	"Detected in single"	230	"pons and medulla: 22.9"	"Group enriched"	"Detected in some"	9	"medulla oblongata: 19.3;spinal cord: 14.3"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (8.59e-5)"	4.8	3.9	0.1	2.5	0.0	0.1	1.8	0.0	0.1	6.2	0.0	16.6	1.7	2.3	18.4	0.2	7.4	0.2	0.1	0.1	0.0	32.5	0.6	5.9	0.1	39.1	0.3	0.2	0.7	1.0	0.0	1.2	10.9	1.1	4.9	0.0	0.0	6.9	0.4	0.8	12.2	1.9	24.8	2.6	4.9	0.8	0.0	0.0	0.5	0.2	0.0	2.8	1.5	9.0	2.6	6.5	0.0	3.2	3.2	3.5	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.0	6.5	3.7	0.7	0.0	0.3	0.0	0.0	0.0	28.8	1.3	8.7	0.0	5.5	0.0	1.4	1.8	0.0	3.9	0.0	1.1	2.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	0.0	3.6	2.3	0.0	1.2	0.0	21.7	2.2	0.0	0.0	0.2	0.0	3.3	0.1	0.6	0.0	6.5	0.9	2.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	39.1	0.3	10.9	24.8	0.0	9.0	4.9	0.0	1.1	0.0	0.0	0.9	0.2	0.0	1.2	0.0	0.3	0.3	0.4	0.0	0.0	53.3	0.0	0.0	0.1	13.5	25.4	0.0	0.9	48.8	4.1	6.6	4.2	2.7	0.0	0.0	0.0	3.8	1.1	46.0	0.0	0.0	8.2	0.0	0.7	0.0	0.0	11.4	0.0	4.2	0.8	0.5	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.4	0.0	0.1	7.0	0.5	0.0	0.0	0.0	0.2	4.9	8.6	11.0	0.3	0.3	0.0	0.6	0.0	11.3	0.1
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 40.3;kidney: 60.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 12.9;spinal cord: 22.6;white matter: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1"	"Region enriched"	"Detected in single"	102	"pons and medulla: 10.1"	"Group enriched"	"Detected in some"	168	"medulla oblongata: 8.1;spinal cord: 25.4"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	10.2	7.4	0.2	4.4	0.1	0.2	4.6	0.3	0.2	18.3	0.0	16.1	1.0	4.3	40.3	0.3	13.4	0.3	0.7	0.1	0.0	60.2	0.8	6.2	0.4	12.9	0.0	0.3	1.2	1.3	0.1	2.6	0.8	2.0	6.1	0.0	0.2	21.1	1.7	1.2	14.0	2.3	22.6	3.0	9.3	1.1	0.1	0.0	0.7	0.5	0.0	3.8	2.2	6.3	5.2	11.9	0.0	6.2	5.3	5.5	0.1	0.0	0.0	0.0	0.0	6.5	7.7	0.0	28.2	14.2	2.0	0.1	1.4	0.4	0.0	0.2	80.3	7.1	23.8	0.0	7.9	0.6	18.0	6.9	0.2	11.4	0.2	4.3	5.4	0.5	4.7	0.1	15.7	0.3	0.0	0.3	0.0	20.0	4.7	0.0	13.1	0.7	53.2	2.6	0.0	0.0	4.4	0.0	8.2	0.1	2.1	2.5	30.1	1.0	6.0	5.0	22.2	0.0	0.0	0.1	0.9	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	12.9	0.0	0.8	22.6	0.1	6.3	10.6	0.0	0.0	0.0	0.4	0.8	0.5	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	136.1	0.0	0.2	0.0	18.1	113.5	0.1	1.0	80.7	5.5	10.6	7.7	0.4	0.0	2.0	2.9	3.0	0.0	56.4	0.0	0.0	4.2	0.0	1.7	0.0	0.0	9.0	0.0	18.6	3.1	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.8	0.0	0.0	0.6	9.5	2.8	0.0	0.0	0.0	0.9	6.4	4.8	6.2	0.0	1.1	0.3	1.2	0.0	11.0	1.2
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607232-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 135.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.7"	"Region enriched"	"Detected in some"	7	"spinal cord: 22.2"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	13.2	11.0	0.1	3.9	0.1	0.2	12.4	0.0	0.3	21.8	0.1	16.9	1.1	5.2	135.1	0.4	8.7	0.7	0.3	0.1	0.1	30.4	0.4	2.2	2.7	5.6	0.1	0.5	0.8	5.5	0.1	5.8	1.1	2.4	15.9	0.0	0.2	16.9	1.7	3.3	18.1	6.7	13.3	3.0	5.9	1.9	0.3	0.2	0.4	0.2	0.9	7.7	5.5	7.5	48.1	20.6	0.0	0.5	14.2	21.1	0.0	0.0	0.0	0.2	0.8	31.9	0.9	0.9	81.9	19.9	23.9	6.9	0.1	0.0	0.0	22.3	15.1	7.4	15.4	0.0	11.7	0.0	14.8	13.8	6.3	14.2	0.0	3.5	43.8	14.7	8.0	0.3	46.0	12.5	1.0	0.4	0.0	74.7	0.1	0.0	39.2	5.5	66.5	15.8	0.0	0.1	16.0	0.0	84.3	1.1	3.8	4.7	38.1	0.0	24.8	20.5	36.9	2.6	6.3	0.1	0.4	0.0	58.6	0.0	0.0	0.0	1.5	0.0	0.8	0.7	0.2	0.8	0.0	1.4	0.0	0.5	0.0	1.0	0.0	0.7	2.1	0.2	0.1	0.1	0.0	0.3	0.1	0.1	5.6	0.1	1.1	13.3	0.3	7.5	55.4	0.0	0.0	0.0	2.0	5.5	0.9	0.0	0.6	0.0	0.9	1.0	0.3	0.0	0.0	86.5	0.0	6.8	1.6	131.3	148.7	0.1	0.3	82.9	6.3	20.3	36.5	1.3	0.0	1.3	19.3	6.4	0.0	73.1	5.1	0.0	1.4	0.2	11.5	0.0	0.0	77.6	0.0	10.6	5.4	0.2	0.6	2.8	24.9	0.0	1.7	0.0	2.1	0.0	0.0	0.3	67.8	0.0	5.1	0.6	140.3	31.6	0.0	0.0	0.0	3.5	8.9	1.7	20.9	0.2	2.0	1.8	2.6	0.1	63.1	3.5
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48615292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.1;epididymis: 48.1;kidney: 37.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enhanced"	"Detected in many"		"spinal cord: 114.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3"	"Region enriched"	"Detected in single"	65	"pons and medulla: 6.5"	"Region enriched"	"Detected in all"	5	"spinal cord: 51.2"	HPA075905			Supported	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	7.2	7.2	0.1	1.5	0.0	0.0	2.7	0.0	0.0	10.7	0.0	4.7	0.0	2.8	48.1	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.4	0.0	36.4	0.0	0.1	0.1	0.8	0.1	0.3	1.8	1.0	1.2	0.0	0.0	20.8	0.4	0.5	7.1	1.5	114.1	0.1	6.6	1.0	0.0	0.0	0.1	0.0	0.0	3.7	0.7	20.8	2.1	5.3	0.0	0.8	0.7	1.0	0.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	34.0	5.3	0.6	0.0	0.1	0.0	0.0	17.2	36.9	1.0	0.1	0.0	0.3	0.0	5.5	1.1	0.0	0.1	0.0	0.7	2.1	0.2	11.6	0.0	17.3	0.0	0.0	0.4	0.0	11.3	0.0	0.0	3.6	0.1	35.3	1.0	0.0	0.1	0.6	0.0	5.4	0.1	0.4	0.0	8.8	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	1.8	114.1	0.0	20.8	4.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	88.3	0.0	0.0	0.1	1.8	72.4	0.0	0.3	21.3	2.1	2.6	44.1	0.0	0.0	0.0	0.8	0.3	0.0	26.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.2	2.7	8.9	0.0	0.0	0.0	0.1	0.8	2.3	9.2	0.0	0.0	0.0	0.3	0.0	5.0	0.0
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188668-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.9;epididymis: 7.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 18.5;Distal enterocytes: 20.3;Distal tubular cells: 25.4;Endothelial cells: 18.8;Intestinal goblet cells: 20.6;Oligodendrocytes: 28.0;Proximal enterocytes: 22.0;Undifferentiated cells: 28.6"	"Cancer enriched"	"Detected in many"	5	"ovarian cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;Hep G2: 7.2;RPTEC TERT1: 21.3;RT4: 16.9;SCLC-21H: 5.7"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.1"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.0	0.2	1.7	0.5	5.2	0.0	1.6	6.1	5.0	0.3	0.8	2.9	0.3	0.4	7.5	0.5	4.8	0.7	0.1	1.6	3.3	6.5	0.0	3.2	0.4	19.9	5.8	0.4	0.2	0.0	0.0	0.0	8.2	1.0	2.0	0.0	0.2	2.6	0.1	0.6	3.3	0.3	6.5	1.1	0.4	1.7	5.3	0.1	0.1	0.3	0.1	2.2	0.4	10.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	6.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	21.3	16.9	5.7	1.0	0.0	0.0	1.2	0.8	0.0	0.0	3.9	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.2	6.1	5.0	1.6	3.3	19.9	5.8	8.2	6.5	5.3	10.1	14.2	3.2	18.5	0.0	0.1	4.2	0.2	0.0	0.0	0.0	0.9	1.3	0.1	0.0	2.5	7.3	0.0	0.0	0.1	20.3	25.4	0.0	0.1	0.2	0.2	18.8	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	5.6	0.4	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	28.0	0.1	13.2	0.4	0.9	0.7	22.0	3.2	0.0	0.0	0.0	0.6	1.1	3.4	9.5	0.3	2.6	0.0	0.5	0.5	28.6	2.7
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119937	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.6;endometrium 1: 35.9;vagina: 25.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.0;Collecting duct cells: 14.7;Distal enterocytes: 10.6;Distal tubular cells: 15.6;Endometrial stromal cells: 25.3;Endothelial cells: 13.5;Enteroendocrine cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HEK 293: 40.3;RPTEC TERT1: 32.3;SCLC-21H: 11.8;SiHa: 18.4;U-251 MG: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	66	"spinal cord: 6.6"	HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		No	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	2.0	0.1	0.0	0.5	0.0	0.0	2.6	0.0	0.0	20.6	0.0	18.7	0.0	35.9	0.5	0.5	4.1	0.1	0.0	0.0	0.0	19.9	0.0	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	16.8	5.8	0.0	0.1	6.7	0.1	1.5	0.1	18.1	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.2	2.2	25.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.2	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.1	12.0	0.0	0.0	0.5	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	32.3	0.0	11.8	3.1	18.4	0.0	0.1	2.2	0.0	0.0	2.7	0.0	2.1	1.0	14.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.0	0.0	0.0	0.9	6.2	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	14.7	0.0	0.0	0.1	10.6	15.6	0.0	0.0	1.2	25.3	13.5	24.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.8	0.2	1.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	1.1	0.0	0.2	0.0	4.4	2.9
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 42.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.6;Collecting duct cells: 9.2;Distal tubular cells: 15.6;Early spermatids: 14.4;Endothelial cells: 6.5;Theca cells: 4.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in many"	8	"medulla oblongata: 8.9;pons: 5.7;spinal cord: 5.7;white matter: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HSkMC: 11.2;RPTEC TERT1: 12.0;SCLC-21H: 14.5;SH-SY5Y: 10.1"	"Region enriched"	"Detected in single"	35	"pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 4.1;pons: 1.1;spinal cord: 3.0"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"		No	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	3.2	2.3	0.2	0.8	0.4	0.0	2.8	0.4	0.3	3.2	0.1	1.0	0.3	6.9	42.1	0.7	6.8	0.6	0.2	0.2	0.4	7.9	0.0	0.2	0.8	8.9	0.8	5.5	0.2	0.1	0.0	0.1	5.7	1.7	0.6	0.0	0.5	7.1	0.7	0.9	0.8	4.1	5.7	0.7	0.3	1.7	0.4	0.2	0.4	0.0	0.2	1.0	2.0	4.9	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.7	0.2	0.0	0.4	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.9	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	12.0	0.9	14.5	10.1	0.2	0.1	4.6	0.2	0.0	0.0	1.0	0.2	0.2	1.5	0.8	0.0	0.2	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.3	0.2	0.4	8.9	0.8	5.7	5.7	0.4	4.9	6.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.3	15.6	0.0	14.4	0.1	2.1	6.5	1.2	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	3.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.3	4.5	0.0	0.1	0.3	2.9	0.0	0.0	0.0	1.3	1.1	0.8	0.5	0.0	1.3	0.0	0.1	4.7	0.6	0.1
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151550-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 24.4;epididymis: 28.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Collecting duct cells: 16.5;Early spermatids: 3.7;Endothelial cells: 3.6;Leydig cells: 4.7;Proximal tubular cells: 6.5;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Group enriched"	"Detected in many"	21	"medulla oblongata: 10.6;pons: 5.6;spinal cord: 8.1;white matter: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;HEK 293: 39.7;RPTEC TERT1: 29.6;SK-MEL-30: 11.0"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.5"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 6.0;spinal cord: 7.8"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	6.9	8.3	0.0	1.6	0.0	0.0	7.4	0.0	0.1	7.1	0.0	7.3	1.0	24.4	28.0	1.1	14.3	1.5	0.6	0.0	0.0	18.5	0.0	0.4	1.7	10.6	0.3	15.1	0.6	0.1	0.0	0.4	5.6	2.9	2.0	0.0	0.7	11.1	2.8	2.4	6.2	9.7	8.1	7.2	1.0	3.0	0.0	0.2	1.2	0.5	0.4	2.7	4.0	7.3	0.5	0.3	0.0	0.0	2.0	3.0	0.0	0.2	0.9	0.1	1.1	0.9	0.0	0.0	16.6	3.4	0.7	0.2	2.6	0.0	0.4	0.0	39.7	0.5	0.0	0.0	0.5	0.0	0.1	9.3	2.6	0.0	0.5	0.2	6.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	29.6	4.1	2.5	4.2	0.6	0.0	11.0	0.6	0.0	0.0	5.0	0.5	0.2	2.9	2.1	0.0	0.1	0.0	2.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.3	5.6	8.1	0.0	7.3	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	3.7	0.1	1.1	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	2.6	4.7	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	3.0	0.0	0.1	0.3	6.5	0.0	0.0	6.6	0.6	0.9	0.3	0.4	0.0	0.6	0.0	0.1	3.0	1.3	0.0
HOXD8	"HOX4, HOX4E"	ENSG00000175879	"Homeobox D8"	P13378	2	176129694-176132695	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 99.6;kidney: 76.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.8;Collecting duct cells: 60.7;Distal tubular cells: 213.2;Early spermatids: 124.6;Leydig cells: 51.3;Peritubular cells: 53.8;Spermatocytes: 82.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"medulla oblongata: 1.5;spinal cord: 4.0;white matter: 5.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 45.4;RPTEC TERT1: 74.8;TIME: 32.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	70	"spinal cord: 34.6"							NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.22e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.80e-2)"	16.4	20.6	0.0	4.8	0.0	0.0	18.8	0.0	0.0	13.3	0.0	10.8	1.2	19.5	99.6	2.7	17.2	3.1	0.9	0.0	0.0	76.2	0.3	0.9	4.9	1.5	0.0	34.2	1.4	1.1	0.0	0.7	0.8	6.0	4.9	0.0	1.7	24.0	7.8	4.8	8.6	13.1	4.0	10.5	1.6	20.1	0.0	1.0	3.5	1.5	1.3	6.5	9.2	5.8	13.7	2.1	0.0	0.0	8.8	14.1	0.3	1.7	7.2	2.2	0.2	0.1	0.1	0.0	16.7	10.8	1.7	0.1	4.7	0.5	5.4	0.0	6.4	2.3	0.8	0.0	2.9	1.3	0.8	24.7	45.4	0.3	6.7	0.0	22.9	4.4	0.2	0.1	3.7	0.1	0.1	0.4	0.2	0.0	2.6	0.0	4.9	0.2	74.8	9.6	14.2	26.4	4.3	0.0	28.4	1.2	0.0	0.1	32.5	1.1	8.9	15.4	9.1	0.0	0.0	0.0	21.1	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	4.0	0.0	5.8	51.8	0.0	1.1	0.0	0.5	2.7	2.1	0.0	0.6	0.0	0.7	0.6	2.3	0.0	0.0	60.7	0.0	0.0	0.2	2.7	213.2	0.0	124.6	0.7	9.4	36.4	4.8	0.0	0.0	0.0	0.0	14.9	0.0	0.3	0.0	0.0	2.5	0.0	0.1	0.0	0.0	1.8	0.0	0.0	3.4	29.9	51.3	0.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	53.8	0.0	1.3	0.5	25.1	0.7	0.0	32.9	14.1	9.8	82.1	20.4	0.2	2.8	0.1	1.0	31.9	3.4	1.1
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122719-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 42.2;endometrium 1: 57.8;kidney: 52.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	80	"spinal cord: 8.0"	HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	11.6	6.4	0.0	1.3	0.0	0.0	13.9	0.0	0.0	42.2	0.0	29.3	0.1	57.8	14.8	3.5	16.1	0.9	0.2	0.0	0.0	52.1	0.1	0.7	2.4	0.5	0.0	11.1	0.3	0.3	0.0	0.5	0.1	32.3	2.9	0.0	1.2	8.0	1.6	5.8	3.0	15.2	0.5	2.4	0.5	5.6	0.1	0.5	1.4	0.2	0.8	6.1	35.3	0.8	0.1	0.0	0.0	0.0	0.5	0.4	0.2	1.6	1.1	1.3	1.1	0.0	0.0	0.0	11.3	1.6	0.8	7.6	0.1	0.0	0.9	0.0	16.1	0.0	0.8	0.0	0.1	0.0	0.0	3.6	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	19.0	7.1	4.3	21.7	5.5	0.0	13.2	1.1	0.0	0.0	16.9	0.0	3.6	5.3	6.0	0.0	0.0	0.0	1.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.1	0.8	38.4	0.0	0.0	0.0	0.4	2.4	1.9	0.0	0.0	0.0	0.8	0.5	0.7	0.0	0.0	23.9	0.0	0.0	1.0	8.5	37.2	0.0	0.2	0.8	10.9	39.2	7.8	0.0	0.0	0.0	0.2	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	3.0	1.3	34.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	26.7	0.0	1.1	0.0	3.0	0.0	0.0	39.5	1.9	3.3	2.2	1.4	0.1	1.8	0.0	1.1	13.9	3.8	0.8
HSPA12A	"FLJ13874, KIAA0417"	ENSG00000165868	"Heat shock protein family A (Hsp70) member 12A"	O43301	10	116671192-116850251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0"	"Group enriched"	"Detected in many"	14	"B-cells: 1.7;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011273, HPA073244"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA011273: AB_1851190, HPA073244: AB_2686586"	"unprognostic (7.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.31e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (2.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.55e-4)"	15.8	21.9	10.9	1.5	13.5	0.0	8.8	11.2	28.2	13.7	7.9	12.4	0.7	9.2	12.5	3.9	10.3	2.3	9.6	16.6	11.1	17.4	1.6	3.0	2.7	17.3	12.2	20.5	2.7	20.0	7.9	0.8	16.4	5.6	1.9	11.0	2.6	5.5	4.9	5.7	4.1	4.6	2.7	3.8	4.7	6.2	27.3	2.1	9.4	3.4	2.8	7.9	10.0	14.7	8.0	10.0	0.1	7.1	6.6	4.4	0.1	5.5	10.1	1.9	1.0	10.0	2.8	0.0	4.1	7.6	5.2	6.1	8.4	0.7	4.9	0.0	3.2	0.0	0.8	5.5	1.9	0.0	1.0	1.7	6.6	7.3	0.9	13.9	0.0	3.3	0.0	0.0	2.1	4.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	1.2	22.1	1.8	5.3	12.7	4.0	2.9	3.0	2.4	3.2	0.0	0.0	1.4	5.5	12.3	10.2	0.1	3.2	0.0	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.9	13.5	11.2	28.2	16.6	11.1	17.3	12.2	16.4	2.7	27.3	14.7	2.1	6.4	3.6	27.7	1.0	11.1	1.6	0.5	2.8	35.8	5.2	6.9	7.8	2.8	2.0	12.9	22.9	0.1	0.1	1.6	15.6	4.2	4.4	12.5	16.1	3.1	0.0	0.0	205.0	3.5	0.1	17.8	0.0	4.4	0.0	2.4	2.9	0.4	0.1	30.3	186.4	0.3	0.0	0.0	5.2	9.7	63.3	0.5	26.6	9.4	0.0	35.8	0.0	27.6	54.8	2.4	0.0	68.4	0.1	2.1	0.0	25.4	11.3	10.2	13.1	14.7	14.9	1.0	5.2	0.5	5.1	0.3	0.8	82.0	0.3	0.7
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN axonemal central pair apparatus protein"	Q4G0P3	16	70802084-71230722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.9;choroid plexus: 23.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 150.6;Excitatory neurons: 49.2;Respiratory ciliated cells: 153.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;RPTEC TERT1: 2.8;SiHa: 5.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA067155: AB_2685792, HPA074129: AB_2686665"	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.3	0.3	2.2	0.3	3.2	0.5	0.5	1.2	1.4	1.2	23.9	0.6	0.2	0.9	2.0	0.1	5.3	0.5	0.5	3.4	3.5	1.3	0.5	1.4	0.3	8.9	9.9	1.1	0.7	2.5	4.4	0.1	5.8	0.8	0.1	6.4	0.3	0.3	0.1	0.5	0.2	0.1	8.0	0.4	0.2	4.7	4.3	0.0	1.9	0.0	0.0	0.5	0.4	4.4	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.1	1.8	0.3	0.1	0.1	0.6	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.1	0.2	0.0	0.0	0.0	0.4	0.4	0.7	0.0	0.4	0.1	0.1	0.4	2.8	0.4	1.1	0.2	5.3	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.4	0.0	0.1	0.9	0.0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.7	0.1	0.3	0.2	0.1	0.0	2.2	3.2	1.2	1.4	3.4	3.5	8.9	9.9	5.8	8.0	4.3	4.4	0.1	3.2	2.6	35.3	0.0	0.0	0.2	2.6	0.0	17.0	1.5	1.1	2.5	0.0	18.3	9.2	52.1	0.0	0.4	0.0	1.9	2.5	35.4	150.6	6.5	0.7	3.5	0.0	49.2	0.6	0.0	1.4	0.0	4.0	0.0	5.0	0.0	0.0	0.1	0.0	25.9	0.1	4.1	0.0	0.0	31.5	2.5	0.3	3.6	3.7	0.0	9.3	0.0	26.2	21.8	0.3	0.1	4.5	0.1	0.6	0.0	1.8	153.2	30.5	0.0	2.0	1.7	17.7	7.5	0.0	0.0	0.0	0.5	1.6	0.1	0.2
IER3	"DIF-2, IEX-1, IEX-1L, PRG1"	ENSG00000137331	"Immediate early response 3"	P46695	6	30743199-30744548	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 2626.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A-431: 155.9;EFO-21: 55.6;HBEC3-KT: 189.9;RPTEC TERT1: 203.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043847	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA043847: AB_2678699"	"unprognostic (2.83e-3)"	"unprognostic (9.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (5.57e-4)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.77e-2)"	153.6	102.5	0.0	14.4	0.0	0.0	48.2	0.0	0.4	176.4	0.0	81.3	0.0	40.5	3.4	257.9	56.5	0.0	167.9	0.0	0.0	257.1	101.1	158.3	0.0	0.0	0.0	32.5	98.5	0.0	32.3	0.0	0.0	59.4	0.0	1.1	90.2	0.0	12.9	88.8	40.8	0.0	0.0	67.4	157.7	6.3	0.0	0.0	32.3	0.0	1.0	50.9	199.7	0.0	155.9	0.0	0.0	18.0	4.4	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	55.6	9.9	16.2	0.0	0.0	189.9	0.0	0.6	7.1	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	203.4	24.3	0.0	0.5	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	1.3	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.4	208.3	142.4	2.6	47.9	457.7	865.5	557.8	905.5	1.8	735.2	929.2	8.5	175.8	321.4	101.2	0.0	40.3	179.1	634.3	82.2	1141.6	1.4	889.8	539.8	400.7	147.9	3.6	2.9	710.7	58.1	824.8	431.2	2626.8	124.9	5.8	69.7	19.6	329.5	3.3	2.0	656.2	105.8	110.1	711.5	3.6	9.9	914.8	236.5	35.6	295.3	16.0	10.3	1.0	0.6	802.4	671.0	6.8	52.7	658.9	85.3	18.4	85.0	3.3	26.3	331.4	552.5	0.3	2.2	1251.9	329.2	83.0	92.2	35.5	434.9	644.5
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452193-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 33.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 283.9;Endometrial ciliated cells: 82.6;Late spermatids: 157.5;Respiratory ciliated cells: 88.2;Spermatocytes: 116.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nucleoplasm,Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	"Nucleoplasm, Intermediate filaments, Cytosol"	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.1	0.6	0.2	0.0	0.4	0.0	0.5	1.7	0.9	0.8	3.9	0.1	0.0	0.7	1.1	0.0	5.0	0.8	0.1	0.2	0.5	3.0	0.0	0.8	0.0	1.8	2.0	0.2	0.3	1.7	1.0	0.1	1.3	0.5	0.0	1.1	0.2	0.6	0.1	0.1	0.0	0.2	1.0	0.0	0.1	33.4	0.6	0.0	3.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.7	0.9	0.2	0.5	1.8	2.0	1.3	1.0	0.6	0.4	1.1	6.4	0.5	19.6	0.0	0.5	0.7	3.8	0.0	2.5	1.9	1.8	1.8	0.0	11.4	18.4	4.2	0.4	0.1	0.1	1.9	1.1	283.9	82.6	3.2	0.9	1.8	0.0	12.0	0.4	0.3	1.1	0.0	1.7	1.3	0.3	0.7	0.0	0.1	3.3	8.6	0.2	8.2	0.0	0.3	157.5	2.5	0.4	0.0	4.7	0.3	1.8	0.0	5.0	2.6	0.2	0.0	3.0	0.0	0.5	0.0	5.7	88.2	9.0	6.6	0.7	2.7	116.2	6.0	0.2	0.1	0.7	0.3	2.9	0.0	0.3
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55324203-55330756	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.8;heart muscle: 9.8;skin 1: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.5;Collecting duct cells: 5.5;Hofbauer cells: 4.7;Late spermatids: 5.1;Melanocytes: 3.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HEK 293: 1.9;RPTEC TERT1: 7.1;SK-MEL-30: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	9.8	0.1	0.2	0.0	0.6	0.0	4.8	1.1	0.3	2.3	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.1	9.8	0.0	1.1	2.7	0.0	1.8	0.1	0.5	0.8	0.2	0.1	1.7	0.2	0.1	0.6	0.2	0.0	1.6	1.9	0.0	2.8	8.9	0.3	0.1	0.2	1.3	0.0	0.4	0.6	2.2	0.6	1.3	1.1	0.0	0.5	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.1	0.0	1.1	4.8	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.1	0.3	0.0	1.1	0.5	0.8	0.6	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.5	0.0	7.5	0.4	0.6	1.3	0.0	1.2	5.5	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.8	0.0	0.6	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.7	5.1	0.0	0.1	3.6	0.0	0.6	1.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.3	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3;skeletal muscle: 80.0;tongue: 64.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.2	0.0	0.0	2.7	0.0	8.0	8.4	5.4	1.7	14.2	3.4	14.8	0.6	0.0	0.0	68.3	0.1	45.3	0.0	0.0	0.0	0.0	3.3	32.2	1.8	5.5	0.0	5.1	7.4	0.0	3.9	8.9	80.0	2.6	6.3	0.3	0.0	0.0	18.7	0.1	0.0	0.0	4.7	64.5	3.0	44.9	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48232612-48270357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Amyloidosis, Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4375.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 4375.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 731.2;RPTEC TERT1: 1718.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		5800000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	510.2	367.4	286.9	172.5	301.0	125.6	323.8	328.6	489.0	416.1	406.6	260.1	289.2	388.8	1171.8	399.9	305.4	257.5	381.0	320.1	339.2	1306.3	391.2	376.1	236.7	334.9	308.0	507.2	179.6	233.7	290.5	573.8	304.4	312.5	191.4	174.4	408.7	386.2	164.7	399.6	287.4	232.5	373.6	435.2	312.8	121.4	308.8	188.3	386.1	206.2	187.4	305.1	402.2	394.8	67.6	51.8	73.1	116.3	348.5	254.5	119.2	215.0	202.2	87.5	100.6	29.1	248.3	16.6	168.8	121.6	48.5	214.1	61.3	107.0	107.4	69.9	147.3	137.9	29.0	99.0	138.5	140.6	731.2	113.4	149.1	45.1	62.0	375.7	131.2	78.3	24.5	90.9	174.8	29.6	200.4	310.1	266.0	116.5	103.6	100.1	100.5	73.6	1718.9	268.6	26.2	119.5	154.5	110.2	111.0	306.0	74.0	119.4	180.5	62.9	73.8	95.7	85.4	72.9	59.6	2.5	78.0	75.3	155.3	3091.4	864.5	2737.9	387.4	661.3	512.5	235.3	523.1	476.4	428.9	245.3	551.3	466.8	4375.2	356.5	692.7	196.2	563.4	1723.5	286.9	301.0	328.6	489.0	320.1	339.2	334.9	308.0	304.4	373.6	308.8	394.8	1380.0	695.5	300.4	174.6	408.6	862.4	1661.1	2606.2	1006.2	653.1	460.1	573.5	384.8	722.0	1121.9	1991.8	187.7	1164.3	448.2	754.2	545.9	910.2	23.6	751.8	802.2	1166.2	283.3	307.0	114.2	682.9	2362.8	1334.0	302.8	1177.2	578.0	421.2	1319.7	557.3	2117.8	353.3	142.6	503.2	1129.1	1569.8	900.6	76.7	1867.0	1381.5	681.3	252.0	1415.7	1634.9	425.3	174.4	237.9	515.7	788.3	2011.6	445.4	922.5	1259.3	2748.9	795.6	219.4	1222.7	602.4	1022.9	143.6	256.4	1384.6	1149.6	1471.5	723.2	665.5	440.9	1613.4
IVNS1ABP	"ARA3, HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP"	ENSG00000116679	"Influenza virus NS1A binding protein"	Q9Y6Y0	1	185296388-185317273	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 452.5"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 309.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 250.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003405	Approved		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003405: AB_1079141"	"unprognostic (4.11e-3)"	"unprognostic (9.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.18e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.28e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	43.9	17.8	16.7	46.6	26.5	452.5	50.5	21.1	20.8	24.9	26.9	40.2	38.4	22.4	18.1	27.0	19.6	36.4	28.9	15.2	19.7	94.1	23.0	27.7	26.4	20.9	18.3	28.4	25.5	32.4	17.3	26.0	22.3	22.2	51.1	15.0	55.2	26.4	23.1	33.5	34.8	16.9	18.3	27.3	42.2	15.9	20.0	24.9	34.3	21.6	24.1	37.7	29.8	35.0	24.6	22.1	79.2	31.6	27.1	9.0	68.4	46.6	15.3	30.1	27.5	26.2	39.7	36.8	36.8	24.0	13.4	32.9	29.0	31.8	32.1	24.9	21.6	36.8	39.1	22.6	10.9	26.2	13.9	6.7	35.7	23.1	73.2	67.6	39.6	38.6	23.6	21.2	54.6	18.0	44.6	18.1	48.7	61.8	5.6	24.7	20.2	21.0	250.7	31.4	52.5	44.5	40.6	35.4	31.4	103.4	16.2	13.3	27.2	41.9	24.5	10.4	34.9	28.0	23.8	22.8	32.1	26.0	19.4	7.9	10.9	10.5	10.5	7.1	9.6	6.1	8.0	7.7	12.6	3.7	8.5	8.3	33.0	10.4	10.3	3.4	8.9	12.1	16.7	26.5	21.1	20.8	15.2	19.7	20.9	18.3	22.3	18.3	20.0	35.0	159.1	44.8	59.0	13.7	61.3	188.9	90.4	40.9	163.4	14.5	74.0	51.3	56.0	22.8	57.4	128.8	52.1	17.3	102.0	288.3	164.4	41.6	34.4	93.2	36.7	85.8	60.4	52.8	18.2	41.5	67.5	50.3	90.7	159.7	41.1	309.2	26.4	23.3	34.8	21.9	26.2	109.6	36.7	107.2	242.3	34.9	5.9	141.5	101.4	33.7	41.3	11.3	63.8	37.7	72.9	24.0	56.4	2.6	62.7	60.9	103.2	86.3	45.8	32.7	6.6	51.4	52.6	33.2	19.8	108.9	181.6	18.3	120.0	54.2	102.7	91.7
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539030-49558337	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 39.4;pituitary gland: 25.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 11.4;Excitatory neurons: 58.2;Inhibitory neurons: 19.2;Late spermatids: 10.6;Respiratory ciliated cells: 10.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Group enriched"	"Detected in many"	21	"amygdala: 29.6;basal ganglia: 25.6;cerebral cortex: 39.4;hippocampal formation: 30.6;white matter: 24.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.8;AN3-CA: 3.5;HMC-1: 3.4;RPTEC TERT1: 9.1;U-2 OS: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.3	2.9	29.6	0.0	25.6	0.2	0.6	0.0	39.4	0.8	0.0	0.2	0.1	0.6	0.1	0.1	5.8	0.3	0.8	30.6	1.3	3.4	0.3	1.0	0.5	0.0	0.2	0.3	1.3	2.6	25.7	0.0	0.6	0.7	0.0	0.0	0.3	0.3	0.1	0.3	0.3	0.0	0.0	1.4	0.3	2.8	1.4	0.2	1.3	0.0	0.2	0.1	0.3	24.8	0.4	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.2	1.7	0.6	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	9.1	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	29.6	25.6	0.0	39.4	30.6	1.3	0.0	0.2	0.6	0.0	1.4	24.8	0.1	0.0	0.5	4.9	0.0	0.1	0.2	0.5	0.0	0.1	0.1	2.0	1.0	5.7	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.2	6.0	11.4	0.4	0.1	2.4	0.0	58.2	0.0	0.1	0.6	0.0	0.5	0.0	2.4	0.7	0.0	0.0	1.7	19.2	0.0	0.0	0.6	0.5	10.6	0.3	0.6	0.0	1.0	0.7	0.4	2.1	6.0	2.6	0.1	0.1	1.2	0.1	0.0	0.0	0.2	10.9	0.3	0.0	0.4	0.3	1.1	3.4	0.0	0.3	0.0	0.7	0.0	0.2	0.0
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;choroid plexus: 15.1;epididymis: 21.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 57.8;Horizontal cells: 50.5;Inhibitory neurons: 221.4;Microglial cells: 167.7;Oligodendrocyte precursor cells: 196.1"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"RPTEC TERT1: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	0.5	4.2	23.5	0.5	26.5	0.0	1.0	19.4	28.3	2.7	15.1	0.7	0.2	1.6	21.6	0.3	1.7	1.8	0.4	21.8	32.6	3.8	0.1	1.0	0.5	24.3	26.6	0.3	1.4	1.3	1.0	1.2	24.7	1.5	0.5	5.8	0.4	5.6	0.1	0.4	0.3	1.1	28.7	1.5	0.4	2.7	32.7	0.1	0.7	0.2	0.4	0.5	0.6	19.6	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.5	19.4	28.3	21.8	32.6	24.3	26.6	24.7	28.7	32.7	19.6	0.0	0.0	0.0	57.8	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	2.0	1.2	0.0	0.0	18.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	50.5	221.4	0.0	0.0	0.0	0.6	0.7	5.0	0.1	0.0	167.7	0.0	0.2	0.0	196.1	2.8	0.0	0.0	11.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297327-95386077	"Predicted intracellular proteins, Transporters"	"Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport"	"Ion channel, Potassium channel, Repressor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.0;Leydig cells: 25.4;Oligodendrocyte precursor cells: 54.8;Peritubular cells: 42.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.8;BJ hTERT+: 18.0;hTERT-RPE1: 23.2;RPTEC TERT1: 35.2;U-138 MG: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	6.7	1.5	21.8	0.8	20.0	0.0	5.4	15.2	31.2	10.7	12.2	9.8	1.2	10.6	3.6	2.4	10.1	1.5	6.0	22.1	16.8	8.4	2.0	2.4	0.4	15.4	17.2	10.1	2.4	27.0	6.4	5.3	15.2	9.3	0.9	0.5	5.6	14.7	1.5	6.0	3.7	5.1	15.3	2.6	5.5	12.2	18.0	24.4	19.7	1.8	0.5	9.0	10.6	19.3	13.8	0.0	0.8	6.1	5.3	4.2	0.0	6.3	18.0	10.1	9.3	0.0	0.0	0.0	0.6	8.3	5.5	0.2	4.0	1.1	4.3	0.0	1.4	0.0	1.8	0.0	2.2	0.0	0.0	2.9	3.6	2.2	10.0	23.2	0.0	1.0	0.0	0.0	0.8	8.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	35.2	0.0	0.7	0.2	0.3	0.3	6.8	0.0	0.3	0.1	0.3	16.3	3.8	0.0	4.9	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	20.0	15.2	31.2	22.1	16.8	15.4	17.2	15.2	15.3	18.0	19.3	0.4	0.0	1.1	13.4	0.5	0.4	0.8	0.0	1.2	8.1	1.0	1.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.2	7.9	0.2	0.6	0.3	3.7	1.0	4.2	0.0	39.0	0.0	0.1	3.5	0.0	0.3	0.0	7.5	0.0	0.5	0.1	0.0	5.1	0.1	0.0	0.0	0.4	1.3	25.4	0.1	7.2	1.9	0.6	0.5	0.0	54.8	3.0	0.2	0.0	42.9	0.0	0.5	1.0	1.5	0.0	0.0	0.0	8.3	3.7	0.1	0.9	0.2	0.9	0.0	0.0	1.5	0.3	0.1
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728606-21948772	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.5;retina: 18.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9816.7;Inhibitory neurons: 1982.4;Oligodendrocyte precursor cells: 5175.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	0.6	2.2	11.9	1.3	16.4	0.0	0.6	13.8	24.5	11.0	0.0	6.9	1.2	6.2	0.6	4.0	2.5	1.1	0.5	17.8	12.8	8.2	0.2	0.5	0.0	7.0	7.9	1.3	0.5	0.0	4.2	1.0	13.7	0.5	4.1	18.1	0.5	0.3	0.3	0.5	3.8	6.0	4.3	0.3	0.8	0.4	9.0	0.0	6.4	0.0	0.0	1.0	1.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	16.4	13.8	24.5	17.8	12.8	7.0	7.9	13.7	4.3	9.0	10.6	0.0	0.0	0.0	148.2	0.1	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.5	0.0	0.0	14.7	0.0	0.1	0.0	0.3	62.6	0.1	9.8	0.2	2.1	1.6	0.0	0.0	9816.7	0.0	0.0	3.1	0.0	0.2	0.0	12.3	1.1	0.2	0.2	0.0	1982.4	0.6	0.0	0.0	0.0	4.2	0.0	0.5	3.6	119.9	0.6	45.9	0.0	5175.8	91.4	0.0	7.8	0.0	0.0	0.0	0.4	15.2	0.0	12.6	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.1	0.1	14.5	0.7	0.1
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	117	"kidney: 198.0"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 195.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	39	"RPTEC TERT1: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.2	0.1	1.0	0.1	1.6	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.5	0.1	198.0	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.1	0.3	0.5	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.6	0.0	0.0	0.1	0.0	195.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 196.1;parathyroid gland: 269.2;thyroid gland: 139.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 279.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.3	0.4	10.0	0.4	14.0	0.6	3.8	22.7	11.6	0.1	2.3	0.6	0.7	0.5	15.9	0.3	5.1	18.8	0.6	6.8	39.5	196.1	1.3	0.9	0.8	39.7	37.6	0.2	44.2	269.2	1.0	0.9	25.7	0.2	0.2	1.2	11.8	21.7	0.3	0.8	2.5	0.0	29.9	1.5	23.4	1.7	27.3	0.2	139.4	0.0	0.1	0.0	0.0	20.8	0.1	0.4	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.8	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	12.7	0.0	0.0	279.8	0.2	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.2	0.2	1.6	0.3	0.0	0.1	0.3	0.1	10.0	14.0	22.7	11.6	6.8	39.5	39.7	37.6	25.7	29.9	27.3	20.8	0.1	0.0	0.0	12.1	0.0	0.0	0.0	2.7	0.0	0.0	2.3	1.1	0.4	54.3	2.6	244.6	0.0	0.0	0.0	0.0	41.1	12.4	0.0	2.8	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.3	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	54.8	0.1	6.0	0.0	0.0	0.0	0.0	1.0	95.2	9.8	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 13.7;Breast myoepithelial cells: 12.8;Exocrine glandular cells: 17.1;Gastric mucus-secreting cells: 14.3;Intestinal goblet cells: 20.8;Prostatic glandular cells: 14.3;Proximal tubular cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.1;Hep G2: 29.0;RPTEC TERT1: 45.9;U-2 OS: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	3.4	23.1	2.0	1.6	2.0	0.1	20.4	5.1	2.9	10.4	3.2	8.1	4.9	3.4	14.3	1.5	11.7	6.7	0.6	2.1	2.1	11.5	10.3	8.2	0.3	1.9	2.3	0.8	27.2	8.3	2.5	1.3	2.2	7.0	11.9	1.6	28.7	19.1	0.2	1.9	5.2	2.1	1.6	0.6	20.8	0.6	2.5	1.3	15.9	0.6	0.5	2.3	1.4	1.7	0.0	3.5	0.6	0.5	1.3	0.8	3.5	1.8	1.6	3.4	8.4	13.5	8.8	0.1	9.3	1.1	0.4	1.0	0.6	26.1	8.9	0.5	13.2	0.0	3.0	29.0	4.9	0.2	0.1	4.0	0.7	13.9	11.0	2.5	1.0	0.2	0.3	0.1	1.4	0.2	0.3	0.8	6.5	0.5	0.5	0.4	0.0	0.0	45.9	3.5	2.3	0.2	0.0	0.2	4.5	0.8	1.4	1.1	0.8	0.2	20.2	0.7	0.4	0.3	0.2	0.2	0.2	0.2	3.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.0	2.0	2.0	5.1	2.9	2.1	2.1	1.9	2.3	2.2	1.6	2.5	1.7	0.6	3.2	10.8	0.0	0.2	0.4	12.2	2.0	2.8	0.4	13.7	12.8	0.0	1.5	4.1	5.5	0.0	0.6	0.3	5.2	3.9	2.6	0.3	2.7	2.0	0.9	4.8	0.0	0.0	17.1	1.3	1.1	14.3	3.7	1.3	0.5	0.0	4.8	0.2	0.0	0.0	20.8	0.0	0.0	0.0	0.0	3.4	0.4	1.8	0.0	0.1	2.1	0.0	0.0	0.0	10.5	6.6	5.3	0.0	14.3	2.2	15.1	0.1	0.0	0.0	0.0	1.8	0.2	0.3	0.7	0.1	0.7	0.3	0.7	8.5	7.4
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 162.3;pancreas: 85.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 105.8;Collecting duct cells: 90.1;Distal tubular cells: 80.3;Ductal cells: 43.3;Enteroendocrine cells: 64.1;Proximal enterocytes: 60.3;Proximal tubular cells: 79.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;OE19: 17.2;RPTEC TERT1: 44.8;SCLC-21H: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020192, HPA024127"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Plasma membrane"		"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	2.2	1.1	2.1	0.0	25.3	0.4	3.6	11.4	2.8	7.8	25.5	4.2	1.0	0.2	8.0	24.7	0.2	2.0	0.9	162.3	27.7	1.6	0.5	0.6	1.1	0.7	85.4	0.8	0.6	1.1	1.0	7.0	4.2	0.1	3.6	4.8	0.0	1.4	16.1	0.4	0.4	0.2	11.0	2.4	1.3	1.3	31.8	0.0	0.1	0.2	0.3	0.8	0.0	4.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.6	0.2	0.0	5.2	0.0	0.6	0.0	0.2	0.1	0.2	0.0	0.9	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0	0.0	0.4	0.1	17.2	0.6	0.0	0.0	0.1	44.8	0.2	6.6	0.1	0.0	0.9	0.0	0.2	4.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	0.4	3.6	2.0	0.9	0.6	1.1	1.0	0.4	1.3	0.8	0.1	0.0	4.4	0.0	1.3	0.0	0.9	0.6	0.0	0.0	20.3	10.8	0.4	105.8	0.0	90.1	0.0	0.1	0.0	7.9	80.3	43.3	7.0	8.3	1.5	0.3	64.1	0.0	0.7	11.8	9.3	0.4	14.8	15.6	0.0	0.0	0.0	10.2	0.3	0.0	0.3	22.0	0.0	0.3	0.0	14.7	0.6	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.7	21.3	0.0	0.0	2.2	60.3	79.1	0.0	0.0	0.0	0.0	0.3	3.2	7.9	0.0	0.0	0.5	0.9	0.3	28.9	0.5
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Inhibitory neurons: 29.3;Microglial cells: 30.9;Oligodendrocyte precursor cells: 102.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.3;plasmacytoid DC: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.8;HeLa: 57.3;RH-30: 37.2;RPTEC TERT1: 106.0;SH-SY5Y: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.7	7.3	4.6	2.6	11.1	0.4	24.6	2.7	4.8	20.5	5.5	5.4	3.1	31.4	7.3	5.9	10.7	5.6	7.8	3.2	5.9	16.0	4.7	1.4	0.6	5.9	10.3	7.4	4.6	3.4	2.2	0.8	6.4	6.2	3.9	4.2	2.2	12.3	3.6	1.1	4.8	29.3	4.0	1.6	3.2	3.6	5.9	5.0	0.8	5.6	1.2	7.5	5.0	3.8	1.1	0.4	6.9	14.5	0.1	0.0	0.2	0.5	0.0	0.4	0.0	9.1	0.1	0.0	16.5	0.0	0.7	16.9	33.8	5.6	0.0	0.0	12.9	0.4	57.3	0.1	0.8	1.1	2.2	1.8	2.3	0.2	0.7	6.9	25.8	0.0	0.0	0.0	0.0	1.4	5.9	1.6	13.4	0.0	9.6	0.0	37.2	0.1	106.0	4.0	0.0	94.3	0.5	1.2	0.9	2.7	20.9	0.2	0.7	2.4	2.9	2.0	8.6	0.4	0.0	0.2	10.2	0.0	4.1	2.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.6	0.0	1.1	0.0	4.1	0.2	0.3	4.6	11.1	2.7	4.8	3.2	5.9	5.9	10.3	6.4	4.0	5.9	3.8	0.7	0.0	0.0	13.7	0.0	0.8	6.8	5.4	12.0	6.2	2.4	19.9	10.5	0.0	4.8	1.8	0.0	0.2	0.1	1.2	29.4	1.1	0.3	8.0	22.7	1.9	1.2	1.3	8.0	3.4	0.1	8.7	0.0	1.3	0.0	10.0	8.6	1.3	0.6	0.0	29.3	2.1	0.0	0.0	1.2	0.9	6.2	1.0	1.8	30.9	0.2	7.2	0.0	102.5	12.3	0.7	3.4	1.9	0.1	2.7	2.9	12.7	22.3	1.2	6.6	18.1	5.3	1.8	10.6	4.8	0.4	0.0	0.6	6.4	4.1	3.6
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 31.5;liver: 91.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.8;Hepatocytes: 46.9;Langerhans cells: 49.4;Macrophages: 33.0;Proximal tubular cells: 63.2;Syncytiotrophoblasts: 180.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 1.6;liver cancer: 3.3;renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	79	"classical monocyte: 11.0;intermediate monocyte: 32.3;memory B-cell: 36.1;myeloid DC: 11.3;naive B-cell: 42.0;non-classical monocyte: 33.8;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	97	"B-cells: 42.0;dendritic cells: 24.3;monocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.2;RPMI-8226: 9.1;RPTEC TERT1: 21.9;SK-BR-3: 10.9;U-698: 9.4"	"Region enriched"	"Detected in single"	4	"thalamus: 1.1"	"Low region specificity"	"Detected in many"			"HPA031115, HPA056942"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 57: B-cells - Immune response"			"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	1.4	0.8	0.1	5.1	0.2	1.4	5.3	0.1	1.0	0.6	0.5	0.9	0.6	5.4	0.2	0.2	0.2	1.6	0.4	0.3	0.0	31.5	91.7	5.0	8.8	0.0	0.0	0.2	0.1	0.1	0.2	6.8	0.1	0.3	1.1	0.2	0.3	0.2	0.1	0.2	1.2	0.7	0.0	8.4	1.2	1.3	0.8	1.6	0.2	0.0	11.2	5.6	0.1	0.3	0.2	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.2	0.4	0.0	0.2	6.2	0.4	0.0	0.2	2.5	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.2	0.7	0.1	0.2	0.5	0.0	0.4	0.1	0.9	0.0	0.2	0.0	2.4	1.0	0.9	0.4	1.6	0.1	9.1	21.9	4.5	0.3	0.1	0.0	10.9	0.1	2.1	4.3	2.1	0.0	0.0	0.1	0.1	1.6	0.4	0.6	9.4	0.2	2.7	1.8	0.1	11.0	0.2	0.0	32.3	0.0	36.1	0.0	0.0	11.3	42.0	0.0	0.1	0.3	0.0	33.8	24.3	0.0	6.1	0.1	0.2	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.1	0.0	0.5	0.0	33.8	1.0	0.1	13.3	2.2	0.0	1.8	0.8	0.4	2.8	11.1	0.0	0.0	3.6	5.5	0.1	5.9	4.8	4.9	9.5	1.5	0.3	0.0	5.2	6.6	0.2	2.3	0.4	2.0	26.6	0.0	0.1	0.7	46.9	7.0	0.0	30.0	0.0	4.1	22.7	49.4	1.8	0.0	33.0	0.0	0.0	5.5	0.0	1.0	1.0	0.6	1.5	0.0	0.0	11.7	0.2	0.2	63.2	2.3	0.0	0.0	0.1	1.3	1.6	0.3	3.1	1.4	180.1	1.6	0.1	0.0	0.1
KRT222	"KA21, KRT222P, MGC45562"	ENSG00000213424	"Keratin 222"	Q8N1A0	17	40654665-40665181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;retina: 8.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 53.9;Excitatory neurons: 25.9;Horizontal cells: 28.6;Inhibitory neurons: 24.4;Muller glia cells: 46.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 9.7"									"HPA054586, HPA068724, HPA069774"	Enhanced		Approved	"Vesicles,Lipid droplets"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Lipid droplets"		"HPA054586: AB_2682532, HPA068724: , HPA069774: AB_2686195"	"unprognostic (2.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.41e-2)"	1.2	2.7	4.8	0.1	5.5	0.0	0.3	6.1	9.7	0.4	0.0	0.5	0.4	0.5	5.0	0.3	0.3	3.3	0.3	5.0	4.0	0.5	2.8	0.2	0.1	3.8	3.5	0.1	0.5	0.7	1.8	0.0	3.9	1.1	0.5	8.0	0.2	1.4	0.0	0.1	0.9	0.5	1.8	1.8	0.3	0.3	4.1	0.4	0.7	0.1	0.1	0.3	0.4	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.5	6.1	9.7	5.0	4.0	3.8	3.5	3.9	1.8	4.1	5.1	1.5	0.0	0.5	1.3	0.0	0.1	0.8	0.0	1.8	53.9	1.0	0.6	0.5	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.4	0.0	0.1	4.3	0.0	0.0	25.9	0.2	0.2	2.5	0.0	0.0	2.5	0.0	2.2	3.5	0.0	28.6	24.4	0.2	0.0	0.3	0.3	0.6	6.5	0.0	0.0	2.8	0.0	46.7	0.0	1.5	2.1	0.1	0.0	0.7	0.0	0.1	1.2	2.7	0.0	8.9	0.0	0.0	0.2	0.2	1.2	0.9	0.0	0.1	0.1	0.0	0.1	0.1
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755331	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"skin 1: 112.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.8;Late spermatids: 9.2;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPTEC TERT1: 1.3"	"Region enriched"	"Detected in some"	7	"cerebellum: 8.6"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 7.3;hippocampal formation: 4.8"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			2.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.3	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	19.3	22.5	8.3	16.0	9.3	13.4	29.8	10.0	12.2	18.0	12.3	19.9	22.6	21.3	21.7	26.5	18.3	20.0	11.3	9.4	9.5	30.5	27.4	15.4	22.1	8.5	9.5	25.7	30.0	33.4	15.2	22.7	9.2	21.1	21.7	11.0	20.5	22.1	10.6	18.8	17.4	15.7	8.7	17.6	22.7	9.9	8.7	21.6	26.2	10.0	23.7	24.6	14.9	8.9	55.1	11.1	52.2	18.0	19.1	51.2	46.4	31.7	57.2	39.8	49.4	15.6	18.9	35.6	23.8	23.8	27.3	15.7	15.6	25.6	57.7	22.7	21.3	32.4	9.8	26.8	61.8	45.6	8.5	44.9	25.2	29.0	50.1	26.8	37.0	41.0	41.5	19.0	37.9	17.8	48.0	21.6	31.0	42.5	10.3	49.3	36.2	19.2	87.0	49.2	38.9	45.6	44.4	60.0	29.1	31.8	33.3	13.9	27.7	17.5	11.4	55.5	23.1	23.7	13.6	23.6	8.4	19.5	14.7	8.3	12.1	7.5	8.0	7.7	11.1	8.6	10.6	9.5	16.3	8.9	10.6	9.3	8.8	11.3	10.2	5.9	16.3	8.3	8.3	9.3	10.0	12.2	9.4	9.5	8.5	9.5	9.2	8.7	8.7	8.9	10.6	12.8	11.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	13.7	0.0	0.0	8.1	12.9	0.0	70.7	13.1	0.0	25.4	34.4	0.0	12.7	14.1	4.6	0.0	0.0	0.0	38.2	39.9	10.1	0.0	14.3	5.1	17.5	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	1.8	0.0	0.0	35.6	3.6	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	83.5	7.6	43.3	0.0	0.0
LAMTOR3	"MAP2K1IP1, MAPBP, MAPKSP1, MP1, Ragulator3"	ENSG00000109270	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3"	Q9UHA4	4	99878336-99894428	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026858	Supported					NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026858: AB_1853523"	"unprognostic (7.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.75e-9)"	"unprognostic (5.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-2)"	16.9	25.7	14.6	16.4	15.4	32.5	24.9	17.3	26.7	20.8	14.5	24.9	23.5	23.3	39.5	30.1	19.2	19.4	24.3	15.4	15.8	38.1	21.7	17.5	20.4	15.2	16.4	24.3	17.3	36.4	18.9	22.5	15.5	28.3	26.2	23.3	24.6	17.1	21.0	23.8	23.8	19.1	13.6	16.6	21.3	15.6	15.7	20.1	33.9	20.2	21.0	23.8	21.6	14.8	19.9	6.4	26.1	17.5	36.2	35.1	20.2	18.9	18.6	18.3	15.0	15.0	39.0	17.3	18.6	19.5	17.8	9.3	26.1	23.9	25.4	20.5	14.0	12.0	13.1	28.3	35.0	36.1	34.1	23.1	48.9	13.8	15.4	26.9	20.7	12.9	30.4	21.1	35.2	20.4	30.5	35.4	16.1	42.8	10.7	20.2	14.9	19.5	55.2	22.9	20.2	25.2	12.2	40.6	41.0	26.3	20.9	29.3	20.5	14.2	16.7	24.0	14.8	26.5	30.6	33.8	30.0	20.6	20.5	43.5	17.6	38.5	9.8	26.8	12.9	11.4	12.1	11.1	19.0	9.3	14.0	14.1	58.6	18.8	28.4	13.3	13.5	13.8	14.6	15.4	17.3	26.7	15.4	15.8	15.2	16.4	15.5	13.6	15.7	14.8	38.8	57.7	33.7	8.8	35.6	49.6	60.7	77.8	68.3	28.0	53.9	46.1	35.9	24.3	44.2	35.0	12.5	48.8	30.3	95.7	135.0	50.9	12.0	38.3	29.8	27.6	36.1	46.7	15.2	32.6	55.8	37.4	43.8	61.3	41.8	23.9	22.9	25.2	77.8	18.5	13.7	48.9	52.9	41.5	89.8	9.4	40.0	56.9	37.4	3.7	60.7	50.7	38.1	8.5	12.7	43.9	102.5	42.5	30.7	63.9	53.9	130.2	30.3	26.3	19.7	30.9	30.9	72.6	40.2	86.6	64.6	78.4	32.6	22.8	43.3	78.8
LAPTM4B	LC27	ENSG00000104341	"Lysosomal protein transmembrane 4 beta"	Q86VI4	8	97775057-97853013	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 380.1"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 348.5;Rod photoreceptor cells: 575.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HEL: 611.7;RPTEC TERT1: 549.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020782, HPA068830"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB020782: , HPA068830: AB_2686044"	"prognostic unfavorable (5.63e-4)"	"unprognostic (1.91e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (9.25e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	24.2	43.2	30.2	18.0	29.7	5.3	42.9	37.3	29.6	50.1	78.2	34.0	79.7	71.0	29.3	33.7	67.5	46.3	220.9	23.6	35.3	67.3	25.3	39.6	13.7	42.1	36.1	45.1	28.8	185.5	20.3	28.2	39.5	29.2	32.9	380.1	32.8	44.9	153.7	43.9	43.0	47.8	45.2	38.3	32.2	62.5	44.2	8.6	43.0	117.0	20.2	41.0	28.5	50.1	219.2	170.8	171.9	350.3	80.2	61.0	108.1	98.0	50.1	222.9	188.6	103.1	168.0	1.0	378.0	73.5	75.2	241.2	208.8	94.8	242.9	1.5	282.4	611.7	130.6	169.0	66.1	0.3	101.5	83.8	71.0	130.8	66.0	75.1	29.1	69.5	375.7	0.8	92.4	164.1	54.5	34.1	318.8	116.5	106.5	0.6	90.5	0.7	549.4	100.9	172.8	287.1	133.6	63.8	159.4	188.0	154.3	83.7	8.1	47.7	92.0	99.0	70.7	22.4	68.8	2.2	60.8	0.5	144.9	3.3	0.1	0.0	0.5	0.0	1.4	0.3	0.4	0.3	0.1	0.1	0.8	0.9	0.1	0.3	0.0	0.1	0.2	0.2	30.2	29.7	37.3	29.6	23.6	35.3	42.1	36.1	39.5	45.2	44.2	50.1	60.5	102.5	56.1	8.5	4.9	55.2	68.1	63.9	89.4	195.9	59.8	55.6	208.1	82.9	30.9	106.7	223.1	26.6	3.9	17.9	39.2	244.5	7.1	70.6	59.6	77.4	35.4	36.6	15.0	123.6	33.2	72.2	19.4	105.6	12.7	348.5	132.8	32.6	8.6	134.6	36.6	29.6	59.0	3.7	10.1	8.6	23.9	6.6	42.7	4.7	2.8	135.0	1.0	19.1	20.1	72.1	34.4	30.9	1.7	77.0	95.9	62.1	10.5	575.3	59.2	62.6	75.4	7.4	35.8	45.1	44.3	14.1	10.2	119.9	52.1	86.4
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1947.7;kidney: 1726.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 2502.3;Cytotrophoblasts: 1693.0;Distal tubular cells: 3306.5;Proximal tubular cells: 3483.9;Syncytiotrophoblasts: 1639.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 6021.8"									"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		560000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	549.9	424.8	509.1	259.2	528.2	352.8	321.1	593.7	617.0	238.6	549.8	320.2	84.4	273.1	169.0	166.6	252.9	232.9	1947.7	484.1	581.9	1726.6	70.5	220.4	425.8	564.4	575.4	472.4	370.3	447.3	161.3	298.2	556.2	240.9	277.0	290.0	162.3	287.2	309.4	81.4	171.3	309.7	537.8	182.0	459.1	119.5	582.5	534.5	348.5	950.4	449.4	417.9	171.2	517.8	647.2	1697.3	1457.5	966.0	1021.7	1126.6	1689.4	879.8	873.0	1201.5	1179.4	2712.9	3.6	2268.6	561.5	597.3	1170.1	315.8	2031.4	1631.4	1518.4	586.5	1413.1	2339.5	1619.0	3.0	975.0	2212.8	967.9	1300.5	572.1	1056.8	1423.4	1416.9	1395.2	1610.8	1304.6	332.6	1342.7	3.2	1895.9	2665.6	4216.4	1051.1	727.7	1681.3	2032.0	1838.7	6021.8	2832.7	467.2	1077.8	403.6	618.1	1586.1	3842.2	5.3	1704.6	548.3	803.7	1048.1	578.5	1684.5	291.0	420.9	2953.4	891.8	1037.5	978.2	540.8	201.9	25.1	346.8	124.7	583.1	349.4	1341.5	723.8	367.2	250.9	1722.4	1124.1	31.7	459.0	95.2	427.7	1405.8	1431.2	509.1	528.2	593.7	617.0	484.1	581.9	564.4	575.4	556.2	537.8	582.5	517.8	89.8	141.1	316.4	68.2	242.2	73.0	439.5	1103.1	221.4	151.5	332.4	325.0	2502.3	298.8	433.9	474.5	68.8	1693.0	208.0	69.6	3306.5	18.4	10.5	224.3	325.0	227.3	92.4	361.2	39.4	314.9	870.1	299.4	222.8	309.4	268.6	412.6	155.7	11.2	612.9	141.3	55.6	152.2	956.2	189.8	104.3	34.3	274.6	174.8	179.7	33.7	197.3	277.6	159.6	47.7	40.3	99.7	84.3	415.2	303.1	310.6	0.2	3483.9	363.0	118.1	236.7	195.2	363.7	21.5	124.3	216.3	64.2	1639.5	398.1	1105.3	257.0	344.9
LEPROT	"FLJ90360, OB-RGRP, OBRGRP, VPS55"	ENSG00000213625	"Leptin receptor overlapping transcript"	O15243	1	65420587-65436007	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 240.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069444			Approved	Centrosome		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"HPA069444: AB_2686137"	"unprognostic (3.64e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	70.5	53.5	23.2	34.9	26.6	66.1	48.8	24.0	23.6	50.3	41.3	43.9	33.9	57.1	33.3	41.3	37.7	49.7	42.8	20.7	25.5	76.6	53.1	56.8	26.7	29.2	25.1	63.5	40.1	55.0	17.0	69.8	28.2	38.0	41.7	14.9	30.3	42.1	27.4	41.8	35.1	50.5	25.4	44.4	42.3	20.1	27.6	17.3	49.0	33.0	22.6	43.1	28.5	25.6	74.0	25.6	25.6	11.5	153.4	109.8	92.4	112.9	95.3	54.7	56.5	22.0	35.9	17.4	67.8	77.1	88.1	41.7	13.0	41.9	68.3	99.8	13.5	80.2	41.7	30.5	43.0	17.8	36.7	167.3	68.8	49.2	40.1	82.8	72.9	12.0	39.6	28.7	100.9	11.3	5.8	13.7	37.9	18.8	22.7	4.1	54.3	17.2	240.9	54.7	21.9	35.1	64.1	37.1	48.5	93.8	41.5	20.1	125.8	66.7	67.9	58.1	37.0	47.7	65.2	9.5	58.7	32.4	46.1	90.8	60.7	53.7	17.8	50.6	18.9	10.8	13.8	13.7	39.4	7.3	15.6	12.5	50.4	21.0	76.0	28.0	13.7	47.7	23.2	26.6	24.0	23.6	20.7	25.5	29.2	25.1	28.2	25.4	27.6	25.6	283.5	166.7	66.6	0.0	26.3	57.6	90.3	189.5	47.3	20.8	79.5	101.0	57.3	98.7	130.4	178.4	22.9	214.1	46.2	71.4	82.2	142.0	6.6	84.3	124.7	181.6	55.8	148.5	0.0	144.3	100.4	170.4	37.2	142.8	62.6	95.4	215.6	82.1	104.7	38.7	0.0	58.8	130.2	126.5	68.5	10.9	198.8	128.6	72.9	0.0	112.3	82.4	43.3	0.0	0.0	163.4	58.0	149.0	25.3	81.2	54.1	186.5	101.0	28.0	190.7	132.3	159.3	15.9	20.6	49.8	66.9	367.8	37.6	209.6	47.2	84.4
LGR4	GPR48	ENSG00000205213	"Leucine rich repeat containing G protein-coupled receptor 4"	Q9BXB1	11	27365961-27472790	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 204.4;Distal enterocytes: 123.3;Glandular and luminal cells: 137.7;Syncytiotrophoblasts: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 83.5;RPTEC TERT1: 100.4;U-2197: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030267, HPA054350"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"		"HPA030267: AB_10610004, HPA054350: "	"unprognostic (5.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.00e-7)"	"unprognostic (5.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.76e-1)"	16.4	16.8	10.2	8.1	10.2	2.4	16.1	13.0	9.2	7.5	10.2	36.8	22.6	10.2	13.3	13.7	10.2	9.0	19.4	7.8	10.5	51.5	55.7	3.2	1.5	14.1	10.4	22.9	59.7	6.4	6.8	34.4	12.8	15.4	36.8	44.4	18.1	16.1	14.4	18.3	24.7	13.2	13.4	11.7	31.0	13.9	10.1	4.4	15.2	8.2	3.0	10.1	11.7	18.0	28.3	50.7	49.5	5.7	4.5	3.1	56.0	15.7	14.8	13.8	11.8	7.6	0.5	0.1	10.1	21.2	23.2	45.8	83.5	31.1	23.5	0.2	37.0	15.3	28.4	36.1	1.4	1.6	0.1	4.1	19.5	9.5	21.0	57.0	7.0	0.0	4.5	0.1	5.7	9.0	0.1	2.7	47.9	76.3	20.4	0.2	33.8	3.3	100.4	12.1	0.7	6.0	7.7	45.7	4.6	37.6	15.1	23.4	22.6	10.2	8.2	82.6	14.6	18.9	15.2	0.0	17.3	0.0	6.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	10.2	13.0	9.2	7.8	10.5	14.1	10.4	12.8	13.4	10.1	18.0	1.7	3.2	0.5	204.4	1.4	30.3	13.5	33.1	38.7	18.6	17.2	14.1	26.6	24.3	15.4	44.1	25.0	55.1	0.4	123.3	3.9	21.4	7.1	75.4	11.5	3.9	16.8	3.4	35.6	50.7	29.2	14.5	43.3	137.7	0.0	78.6	3.6	60.7	8.1	25.2	51.6	47.1	20.3	5.3	5.7	2.2	5.0	1.6	7.2	15.0	2.1	109.8	0.0	36.7	62.1	31.4	48.8	17.0	0.6	11.7	37.9	19.4	14.5	14.8	6.6	6.9	13.0	1.3	1.4	36.8	21.9	128.6	1.8	6.3	55.5	19.7
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 32.4;retina: 42.6"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 289.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Group enriched"	"Detected in some"	13	"RPTEC TERT1: 53.5;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	0.0	0.3	24.0	0.2	22.3	0.3	0.0	24.7	16.2	0.0	7.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	26.6	30.7	3.1	0.0	0.0	0.5	31.1	32.4	0.0	0.0	0.0	1.5	0.4	24.7	1.5	0.3	42.6	0.0	5.8	0.0	0.1	0.2	0.2	32.2	0.1	0.4	0.1	26.1	0.0	4.6	0.0	0.0	0.0	0.0	29.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.0	22.3	24.7	16.2	26.6	30.7	31.1	32.4	24.7	32.2	26.1	29.1	0.0	0.0	0.0	21.2	1.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.7	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.3	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	289.4	0.0	0.5	1.4	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LONP2	"LONP, LONPL, MGC4840"	ENSG00000102910	"Lon peptidase 2, peroxisomal"	Q86WA8	16	48244300-48363122	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008862	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"			"HPA008862: AB_2137156"	"unprognostic (8.08e-3)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.59e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.71e-7)"	"unprognostic (6.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	21.8	19.2	20.4	14.8	22.8	13.5	46.0	23.0	24.7	19.5	27.9	16.7	20.3	19.3	25.9	16.8	22.2	14.8	22.4	23.0	21.2	20.1	86.9	14.6	15.6	20.5	19.8	24.4	22.1	38.2	25.3	13.9	21.8	29.6	18.7	39.0	20.9	22.2	23.7	17.9	18.4	20.9	21.3	17.3	20.0	9.1	20.4	17.1	32.6	22.5	16.4	19.3	16.0	23.5	24.3	33.1	18.3	25.5	42.1	34.6	30.9	30.4	23.1	28.0	12.8	17.3	12.4	11.0	29.2	30.9	14.1	29.8	33.4	33.6	38.7	18.0	21.7	16.1	20.1	38.2	25.8	27.5	20.7	32.2	36.6	26.2	24.4	33.8	21.1	20.7	27.6	12.6	29.2	22.4	26.5	13.6	13.7	22.8	32.5	34.0	33.1	35.1	31.7	16.1	28.6	17.7	34.6	38.1	31.6	22.8	17.6	20.5	28.3	28.7	16.9	25.2	23.7	25.6	22.8	18.0	33.7	18.5	21.3	6.8	11.6	8.0	10.6	12.0	11.7	10.5	12.9	11.2	11.4	11.7	12.3	11.4	4.4	8.4	12.7	8.5	10.7	10.7	20.4	22.8	23.0	24.7	23.0	21.2	20.5	19.8	21.8	21.3	20.4	23.5	33.0	57.7	66.3	70.8	44.6	34.9	43.1	38.3	40.5	104.5	51.0	39.1	62.7	75.8	52.0	27.6	85.5	40.1	37.9	31.9	13.7	35.0	30.8	43.7	48.2	34.2	49.7	23.4	97.2	30.7	29.0	43.3	39.8	53.6	30.4	65.2	42.5	194.6	30.5	85.8	95.4	36.8	38.7	53.8	42.7	10.1	59.0	38.3	39.2	60.0	45.1	63.9	32.0	73.9	87.6	31.3	38.9	54.5	41.5	52.3	40.9	30.0	56.3	141.7	39.5	67.2	42.5	22.0	17.0	36.7	36.8	64.0	39.8	41.4	41.2	45.8
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
LRRC6	"CILD19, LRTP, tilB, TSLRP"	ENSG00000129295	"Leucine rich repeat containing 6"	Q86X45	8	132570416-132675592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 23.2;testis: 26.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 228.5;Endometrial ciliated cells: 101.5;Excitatory neurons: 85.8;Inhibitory neurons: 67.1;Late spermatids: 62.1;Respiratory ciliated cells: 152.7;Spermatocytes: 102.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.5;RPTEC TERT1: 15.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028058	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028058: AB_1853337"	"unprognostic (1.53e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.98e-4)"	"unprognostic (4.17e-2)"	3.1	4.3	9.4	1.9	12.2	3.5	2.7	5.6	14.1	4.9	23.2	2.4	0.9	3.1	5.6	1.2	19.5	3.6	2.3	9.7	8.3	11.5	1.5	4.1	0.9	12.8	12.8	3.5	2.8	5.6	8.3	1.7	9.1	2.3	1.5	13.8	2.0	2.2	0.4	1.3	2.6	1.8	10.6	4.0	1.3	26.2	9.1	0.8	7.7	0.6	0.7	2.1	2.2	10.4	0.4	2.2	3.5	0.0	2.9	4.8	7.5	0.3	0.5	1.7	1.5	0.4	8.5	0.0	2.5	3.1	2.4	0.0	0.6	1.1	1.7	0.3	0.0	0.0	0.6	0.1	1.2	0.0	3.8	4.2	2.1	3.9	0.1	4.0	0.8	3.6	0.3	0.0	2.2	2.8	0.0	0.1	5.6	2.6	2.1	0.0	0.1	1.2	15.7	0.0	1.8	2.6	0.3	0.0	0.4	5.4	0.9	0.5	0.0	2.0	7.2	6.3	0.7	0.0	1.0	0.2	5.3	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.3	0.0	0.3	9.4	12.2	5.6	14.1	9.7	8.3	12.8	12.8	9.1	10.6	9.1	10.4	2.2	6.4	0.5	24.5	0.5	1.3	3.7	7.7	1.8	2.5	3.3	3.7	2.8	1.5	18.0	9.2	8.4	0.0	0.2	1.7	21.5	6.4	228.5	101.5	7.3	3.1	1.2	0.8	85.8	1.8	0.2	4.4	0.0	7.3	0.0	2.9	4.2	0.5	2.1	1.7	67.1	0.7	8.2	0.8	1.4	62.1	3.7	2.8	0.0	11.2	0.6	7.2	1.0	6.6	5.3	0.7	1.4	4.5	0.0	1.2	2.6	34.7	152.7	13.7	0.0	1.3	4.5	102.6	10.5	1.2	1.1	0.0	0.5	6.0	1.7	1.9
LRRIQ1	"FLJ12303, KIAA1801"	ENSG00000133640	"Leucine rich repeats and IQ motif containing 1"	Q96JM4	12	85036314-85264457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.1;choroid plexus: 18.1;fallopian tube: 13.7;retina: 8.8;testis: 15.5"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 185.6;Early spermatids: 423.8;Endometrial ciliated cells: 287.5;Late spermatids: 248.1;Respiratory ciliated cells: 381.5;Rod photoreceptor cells: 257.6;Spermatocytes: 190.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.1;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046162	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA046162: AB_10963055"	"unprognostic (3.55e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.69e-2)"		"unprognostic (4.81e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.64e-1)"	0.1	0.7	2.8	0.1	3.2	0.0	1.0	1.9	2.5	1.6	18.1	0.1	0.0	1.4	2.4	0.0	13.7	0.4	0.2	2.9	3.8	2.0	0.0	2.6	0.0	11.1	8.5	0.4	0.3	3.0	1.4	0.0	6.5	1.4	0.0	8.8	0.4	0.7	0.0	0.0	0.0	0.6	6.7	0.1	0.2	15.5	3.7	0.1	2.4	0.0	0.0	0.1	0.1	4.3	0.0	0.3	2.0	0.0	0.5	1.3	0.2	0.3	0.2	0.8	0.2	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.6	0.8	0.2	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.5	1.8	0.8	0.9	1.5	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.4	0.0	3.1	0.0	1.6	2.5	0.1	0.0	0.2	0.4	0.9	0.1	0.1	1.8	0.5	0.7	0.1	0.0	0.5	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.2	1.9	2.5	2.9	3.8	11.1	8.5	6.5	6.7	3.7	4.3	0.2	3.2	4.8	22.2	0.0	0.4	1.6	12.0	0.0	11.1	2.9	3.2	1.3	4.3	49.2	16.5	185.6	0.1	0.0	0.2	9.8	11.3	423.8	287.5	2.1	1.6	11.5	0.0	24.5	1.3	0.0	1.3	0.0	7.1	1.3	3.9	0.0	0.0	0.1	0.0	4.8	0.3	14.2	0.0	0.3	248.1	4.4	1.2	3.6	2.8	0.0	16.7	0.0	1.5	1.8	1.6	0.1	4.1	0.1	3.1	0.0	6.1	381.5	257.6	13.1	2.4	3.3	190.8	46.3	0.0	0.0	0.1	0.3	0.7	0.2	0.3
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lung: 52.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	4.8	3.1	1.1	10.1	1.9	9.0	2.6	0.9	2.1	5.1	1.2	4.3	0.6	4.8	1.9	7.0	4.1	6.2	3.9	1.3	1.1	10.9	5.6	52.4	6.8	1.7	1.1	5.4	3.6	8.4	2.1	1.2	1.4	2.6	1.8	1.5	3.5	2.0	5.5	2.1	3.6	4.0	1.1	10.8	2.1	0.8	1.2	2.5	2.9	7.9	5.4	4.5	5.5	1.9	0.0	4.6	0.0	0.0	2.3	5.6	0.0	1.3	3.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.4	0.0	2.1	0.4	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.3	0.0	0.5	2.7	0.1	3.1	1.5	1.0	0.4	0.5	0.6	0.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	7.2	2.2	0.0	5.2	0.0	1.8	0.0	0.0	2.1	1.7	0.0	0.0	58.2	0.0	6.9	0.3	0.0	1.3	1.1	1.9	0.9	2.1	1.3	1.1	1.7	1.1	1.4	1.1	1.2	1.9	7.4	32.1	502.2	17.3	29.9	2.4	1.8	0.4	2.8	8.6	1.3	1.4	7.8	5.7	17.3	27.6	0.0	0.0	1.9	0.0	1.9	1.3	0.5	0.4	2.6	7.0	0.0	2.1	92.0	2.7	0.1	16.1	0.5	0.4	13.9	2.7	13.2	8.2	4.6	47.1	28.0	0.0	0.0	55.8	8.7	1.2	19.0	52.2	12.4	73.1	133.1	8.6	3.1	256.9	3.1	0.8	1.1	12.0	2.8	0.6	0.0	22.5	3.4	1.0	0.0	22.5	4.8	0.3	1.0	12.6	3.1	0.4	3.4	11.2	0.0	0.7
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040546-6054060	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.3;lung: 9.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 3.9;Collecting duct cells: 1.8;Ductal cells: 3.8;Proximal tubular cells: 2.4"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"RPTEC TERT1: 79.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA075974			Uncertain	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		73000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA075974: AB_2686770"	"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	8.3	0.0	0.3	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.2	0.6	2.2	0.1	9.7	0.0	0.2	0.2	0.4	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	1.4	0.0	3.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	79.6	0.0	0.3	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	1.0	0.2	0.6	0.2	0.2	0.0	0.1	0.7	0.0	0.0	9.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Early spermatids: 140.9;Late spermatids: 335.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 5.4;RPTEC TERT1: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	2.1	3.5	2.4	0.9	6.5	1.7	2.1	5.7	5.7	4.5	2.5	3.1	0.8	3.2	2.2	2.0	3.3	1.7	5.4	3.1	4.7	5.3	0.4	1.6	0.5	9.7	5.4	3.9	0.3	9.5	2.1	0.9	7.3	4.6	1.0	1.3	2.6	4.8	1.1	2.0	1.3	2.7	4.0	1.6	2.7	8.9	6.2	1.2	10.5	1.0	0.8	3.8	4.0	13.6	0.1	0.1	2.1	0.1	2.8	3.8	2.1	1.5	3.8	2.0	2.3	0.1	0.1	0.2	0.1	3.6	0.7	0.2	2.2	4.8	1.6	0.4	1.0	0.2	0.5	0.2	0.8	0.1	0.1	1.8	3.0	4.0	1.8	5.4	3.0	0.5	1.9	0.3	1.1	0.2	0.2	0.2	0.8	0.0	0.3	0.7	1.0	0.0	5.3	0.0	0.3	0.8	0.0	0.1	3.4	0.8	1.1	0.2	0.2	1.2	1.5	1.0	0.3	0.1	0.1	0.2	1.2	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.3	0.3	0.2	0.8	0.3	0.1	0.2	0.0	0.1	2.4	6.5	5.7	5.7	3.1	4.7	9.7	5.4	7.3	4.0	6.2	13.6	2.2	0.0	0.0	6.8	0.0	5.0	15.6	4.5	8.0	0.2	2.7	4.1	3.1	0.0	1.3	11.0	0.0	4.1	0.1	0.2	15.6	0.1	140.9	1.3	1.6	2.9	1.2	0.0	10.0	0.4	2.3	4.0	0.0	1.3	0.0	2.5	3.3	0.1	4.4	0.0	5.5	0.3	0.0	0.3	3.3	335.2	9.3	1.2	14.2	5.6	0.7	2.0	1.0	1.0	25.3	0.0	0.1	9.8	0.0	8.6	0.1	5.3	3.3	0.2	6.6	2.6	4.7	36.3	2.2	2.7	3.4	7.7	0.2	2.7	0.1	5.5
LYG1	SALW1939	ENSG00000144214	"Lysozyme g1"	Q8N1E2	2	99284238-99304742	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.5"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 161.4"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 31.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted in other tissues"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.53e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.76e-4)"	"unprognostic (6.94e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-3)"	1.9	1.6	3.1	1.2	3.3	0.9	2.1	6.0	4.3	3.6	1.8	2.3	1.2	2.3	1.8	1.3	2.3	0.8	2.0	3.0	2.6	23.5	5.8	1.9	1.6	3.2	2.8	2.4	1.6	0.2	2.0	0.7	3.2	3.3	1.1	2.6	1.7	0.7	2.1	1.7	2.8	0.9	2.6	4.7	1.7	5.5	3.1	2.4	2.6	0.4	1.3	2.5	2.3	4.1	0.3	2.3	1.7	2.8	3.9	2.2	1.9	0.9	1.0	0.9	1.5	0.4	2.0	0.5	1.5	0.4	0.2	1.0	2.3	0.3	1.1	1.6	1.4	1.3	2.0	0.7	0.7	0.4	3.1	1.8	2.4	1.4	0.6	2.0	0.5	3.0	0.7	1.5	1.0	0.5	1.2	4.0	0.4	1.2	2.1	2.9	1.0	0.8	3.9	0.9	1.0	0.6	0.3	0.7	0.6	2.0	0.3	0.4	1.3	1.2	1.4	2.0	1.0	1.7	1.0	0.3	0.3	2.4	0.5	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	3.1	3.3	6.0	4.3	3.0	2.6	3.2	2.8	3.2	2.6	3.1	4.1	0.6	0.0	0.0	3.6	1.5	0.0	0.2	0.6	0.0	1.0	0.8	0.8	0.5	1.5	1.5	1.8	2.1	0.3	0.5	0.5	21.5	0.7	10.8	0.2	0.3	0.5	0.0	0.0	4.6	0.2	0.2	0.4	0.0	0.2	4.5	0.8	1.1	0.5	0.3	0.0	4.2	0.3	0.0	0.3	0.3	4.8	0.3	1.4	0.0	2.8	0.8	0.2	0.0	2.0	5.6	0.6	0.1	0.4	0.0	0.6	0.2	161.4	0.2	0.6	0.0	0.1	0.5	2.4	1.1	0.0	0.0	0.5	0.6	0.3	0.4	0.2
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MAL	"MVP17, VIP17"	ENSG00000172005	"Mal, T cell differentiation protein"	P21145	2	95025677-95053992	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2817.9;vagina: 863.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 373.3;Distal tubular cells: 236.7;Muller glia cells: 91.5;Oligodendrocytes: 168.1;Skeletal myocytes: 82.3;Squamous epithelial cells: 90.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 101.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 217.6;naive CD4 T-cell: 293.3;naive CD8 T-cell: 138.1;T-reg: 233.6"	"Lineage enriched"	"Detected in many"	38	"T-cells: 293.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 516.4;MOLT-4: 722.0;RPMI-8226: 256.7;RPTEC TERT1: 2531.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065691			Approved	"Golgi apparatus,Centrosome"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	Centrosome	"HPA065691: AB_2685533"	"unprognostic (1.57e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (5.18e-6)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.89e-2)"	"prognostic favorable (3.96e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.57e-1)"	5.3	1.8	251.3	10.8	333.9	12.7	4.4	264.8	400.2	450.7	177.4	50.8	2.2	2.6	8.3	2817.9	8.9	2.9	17.9	260.8	256.7	400.4	1.7	25.3	25.1	281.3	282.1	3.2	3.0	0.4	3.9	3.4	272.9	21.8	6.3	10.1	544.0	11.1	2.8	12.6	17.0	2.4	264.0	9.4	52.7	1.1	303.2	261.2	21.3	4.3	352.8	15.0	863.2	449.3	51.3	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	12.0	0.0	0.3	2.4	0.2	0.0	0.5	516.4	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.4	0.1	0.1	0.0	722.0	0.2	0.2	0.0	0.0	0.7	0.0	256.7	2531.4	65.3	0.6	0.0	0.1	9.4	1.6	2.1	0.3	0.9	0.8	0.0	0.2	0.1	0.5	0.4	0.3	0.3	0.3	0.4	0.1	0.7	0.6	0.1	4.7	0.3	2.1	3.1	217.6	38.4	0.5	3.5	293.3	138.1	2.6	7.7	0.6	1.2	233.6	71.0	251.3	333.9	264.8	400.2	260.8	256.7	281.3	282.1	272.9	264.0	303.2	449.3	0.9	0.0	0.0	12.1	3.1	1.1	0.2	0.0	1.8	1.5	1.2	0.9	11.3	0.0	1.3	373.3	4.2	0.2	0.9	0.0	236.7	0.1	5.3	4.3	0.6	0.5	0.0	46.1	0.5	0.0	0.0	4.7	24.5	8.2	1.3	3.2	2.5	0.0	0.1	5.0	0.5	0.0	14.2	0.0	1.3	19.5	0.9	1.0	17.8	1.9	2.5	91.5	4.1	6.6	168.1	0.1	0.0	0.0	8.9	0.2	0.0	3.2	0.0	2.7	6.6	82.3	5.3	0.0	0.6	90.9	1.0	0.3	35.8	0.0	0.1	0.8
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671465-58754477	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	7.1	2.5	2.9	11.2	2.8	10.5	6.3	4.8	3.6	7.7	4.2	5.1	3.6	5.4	4.2	12.5	5.1	5.8	5.4	3.1	4.1	6.7	6.9	7.3	21.1	3.2	2.6	5.3	4.0	5.3	4.7	4.0	3.0	11.5	5.5	8.7	5.8	3.8	8.3	9.4	7.7	4.2	3.0	11.5	4.6	8.2	4.1	15.6	5.3	2.8	23.1	7.1	9.6	3.6	11.4	16.0	16.8	5.2	3.1	6.7	9.2	19.7	12.1	15.7	12.6	13.8	13.5	27.0	10.3	24.0	11.1	12.0	10.8	7.6	20.8	17.0	6.8	9.7	9.0	21.8	4.0	20.1	11.4	4.0	12.2	11.8	10.4	6.6	3.4	7.7	15.3	42.3	9.6	3.3	4.7	9.7	6.3	4.1	7.1	14.8	11.5	19.7	88.9	2.8	2.5	4.5	11.7	6.0	9.3	12.0	5.1	12.2	5.7	22.6	9.1	7.1	20.8	38.5	54.4	16.3	10.6	15.6	9.9	0.3	0.5	0.2	0.7	0.7	0.6	1.1	1.4	0.8	0.7	2.1	1.0	0.8	0.3	0.5	0.5	1.3	0.8	0.4	2.9	2.8	4.8	3.6	3.1	4.1	3.2	2.6	3.0	3.0	4.1	3.6	35.0	22.4	19.2	24.2	67.8	33.0	32.3	4.8	26.2	14.7	13.6	11.0	14.4	10.0	7.0	11.0	85.5	6.2	53.2	11.1	3.9	16.6	12.7	10.4	17.5	31.1	6.7	0.8	61.3	8.5	6.0	15.7	13.7	24.7	31.7	28.1	10.4	11.1	11.8	55.5	42.9	8.6	8.2	21.0	96.5	8.0	10.2	55.9	12.4	34.7	79.5	26.2	20.6	52.3	11.9	16.2	21.9	7.2	42.2	46.6	8.0	30.7	5.8	18.1	19.7	16.1	12.9	40.1	35.6	25.4	24.7	9.0	55.2	5.7	10.7	38.1
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765328	"Metabolic proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.7;fallopian tube: 22.5;testis: 24.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 186.0;Endometrial ciliated cells: 50.1;Late spermatids: 33.7;Respiratory ciliated cells: 100.5;Spermatocytes: 114.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.6;SCLC-21H: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA073761: AB_2732241"	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.4	1.5	2.2	0.2	2.5	0.1	1.2	1.9	2.4	1.7	15.7	1.2	0.0	1.7	1.7	0.5	22.5	0.8	1.3	2.4	2.8	3.1	0.3	2.0	0.3	4.2	5.3	1.0	0.9	4.2	9.3	0.0	3.9	0.9	0.5	8.5	1.0	1.3	0.4	0.4	0.3	0.8	3.5	0.2	0.7	24.5	2.8	0.5	4.8	0.5	0.2	0.5	0.4	3.0	0.3	1.2	0.9	2.5	0.1	1.1	0.3	0.0	0.4	0.5	0.3	0.1	0.8	0.5	0.5	0.1	1.1	0.6	0.0	0.7	0.5	0.0	0.0	0.2	0.2	0.8	0.5	0.4	1.2	0.7	0.2	0.0	0.1	0.5	0.7	1.1	0.0	0.7	0.3	1.5	0.8	0.3	1.6	0.1	1.4	1.6	0.9	0.0	3.6	0.2	3.5	0.7	1.1	0.5	0.3	0.5	1.1	0.0	0.0	0.6	0.6	0.1	0.3	0.3	1.6	0.2	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.5	1.9	2.4	2.4	2.8	4.2	5.3	3.9	3.5	2.8	3.0	0.2	6.4	1.5	6.8	0.0	0.8	1.4	3.9	1.8	3.0	2.1	2.4	1.3	2.8	6.4	0.0	0.0	0.1	0.0	0.0	13.7	1.3	186.0	50.1	1.2	0.6	1.2	0.0	8.9	0.0	0.1	1.3	1.5	1.6	0.0	1.1	0.0	0.0	0.1	3.3	6.3	0.0	10.2	0.0	0.2	33.7	1.8	0.5	1.8	1.9	0.0	9.6	0.0	1.0	1.3	0.1	0.0	3.0	0.0	0.4	0.0	6.0	100.5	10.2	0.0	0.5	1.7	114.9	5.1	0.5	0.3	0.0	0.2	1.6	0.1	0.9
MEGF11	"DKFZp434L121, KIAA1781"	ENSG00000157890	"Multiple EGF like domains 11"	A6BM72	15	65895079-66253747	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;fallopian tube: 7.8;kidney: 8.4;retina: 14.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 175.8;Horizontal cells: 126.2;Late spermatids: 177.8;Oligodendrocyte precursor cells: 460.4"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.7;glioma: 2.3;renal cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;HEK 293: 2.7;RPTEC TERT1: 9.2;SCLC-21H: 7.2;U-698: 2.0"	"Region enriched"	"Detected in all"	4	"cerebellum: 35.0"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.8"							NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.84e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.81e-3)"	"unprognostic (5.71e-5)"	"unprognostic (7.94e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.89e-2)"	0.0	0.1	8.3	0.2	5.3	0.3	0.1	23.0	7.0	0.1	0.4	0.1	0.0	0.1	0.8	0.1	7.8	0.0	0.1	10.5	7.5	8.4	0.0	0.5	0.1	6.6	8.8	0.3	0.2	0.0	3.0	0.0	7.0	0.1	0.0	14.2	0.1	0.1	0.1	1.3	0.1	0.0	4.5	0.2	0.3	3.9	8.0	0.1	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.1	0.3	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.2	0.0	0.1	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	0.0	0.0	9.2	0.2	7.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	5.3	23.0	7.0	10.5	7.5	6.6	8.8	7.0	4.5	8.0	7.4	0.2	0.0	3.7	5.2	0.4	2.2	0.7	1.0	0.6	5.3	0.8	0.0	1.4	0.0	0.3	3.7	8.4	0.3	0.4	0.0	0.0	0.1	175.8	0.3	0.3	1.5	0.0	0.4	9.5	0.2	0.1	0.7	2.6	0.8	0.0	0.2	2.9	0.0	0.1	126.2	18.4	0.0	0.0	0.3	3.5	177.8	2.5	0.4	0.0	1.0	0.0	4.4	0.0	460.4	1.7	0.1	0.1	1.5	1.3	0.6	0.0	2.2	0.8	25.7	0.0	1.0	0.5	2.9	1.9	0.6	3.8	0.5	0.9	0.1	0.0	0.5
METTL25	"C12orf26, FLJ22789"	ENSG00000127720	"Methyltransferase like 25"	Q8N6Q8	12	82358528-82479239	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 68.2;Excitatory neurons: 63.2;Inhibitory neurons: 58.4;Microglial cells: 45.9;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039534, HPA041207"	Enhanced		Uncertain	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Mitochondria, Cytosol"		"HPA039534: AB_10794749, HPA041207: AB_10794406"	"unprognostic (1.60e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.00e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.44e-2)"	3.1	3.1	2.5	3.0	3.2	3.1	5.7	2.7	23.5	3.9	3.3	4.1	4.1	3.7	4.5	3.5	3.6	2.8	4.7	3.2	4.4	4.5	2.5	3.5	4.8	14.0	1.9	5.4	2.6	4.1	2.6	3.5	10.5	3.2	4.7	6.0	4.2	2.9	4.5	3.6	3.1	3.4	1.0	3.7	2.8	5.9	6.8	4.3	4.7	3.7	4.0	3.6	3.1	14.0	1.2	2.8	3.8	0.9	4.0	4.6	3.6	5.6	3.3	2.9	2.2	3.1	3.0	7.3	1.2	4.3	0.7	1.2	7.5	1.0	1.9	6.3	5.6	3.7	1.4	3.4	2.3	6.4	4.1	3.5	3.4	1.0	0.0	5.8	6.2	2.6	2.3	3.1	3.1	4.1	2.7	5.5	5.6	3.2	1.0	1.7	2.2	3.9	9.2	3.9	2.7	2.1	2.2	3.5	3.7	3.0	2.9	6.0	2.5	1.4	1.4	2.3	3.3	3.9	2.4	2.9	2.2	3.9	3.0	19.0	6.5	3.9	4.3	6.0	6.1	5.3	4.6	3.7	4.9	7.2	6.0	4.9	12.2	10.0	5.5	11.1	4.3	3.6	2.5	3.2	2.7	23.5	3.2	4.4	14.0	1.9	10.5	1.0	6.8	14.0	7.9	9.6	9.6	68.2	7.6	4.6	7.3	12.4	4.6	7.0	8.1	8.5	12.7	8.6	8.4	3.7	6.2	11.8	11.5	5.5	7.9	5.5	4.9	5.6	6.6	7.0	7.3	1.7	63.2	3.2	5.4	7.4	8.2	5.9	3.8	7.1	10.8	4.5	5.6	3.3	58.4	4.1	12.2	3.8	5.2	1.7	4.7	6.4	5.4	45.9	14.7	4.2	4.1	89.0	98.9	4.3	5.6	10.5	11.6	3.4	6.3	8.4	12.7	11.5	0.0	12.3	7.2	12.9	9.5	10.6	6.1	7.8	6.4	8.7	6.0	4.4
MICOS10	"C1orf151, FLJ36999, Mic10, MINOS1, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial contact site and cristae organizing system subunit 10"	Q5TGZ0	1	19484403-19629821	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 453.9;Cytotrophoblasts: 283.4;Extravillous trophoblasts: 279.7;Hofbauer cells: 531.0;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059930	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA059930: AB_2684167"	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.11e-4)"	4.9	5.0	11.5	3.1	11.6	2.6	6.0	11.9	13.6	8.6	11.0	9.3	5.1	7.0	6.2	7.2	7.3	4.1	12.6	11.5	13.1	9.7	4.0	4.6	4.3	12.9	11.7	6.4	5.2	11.1	9.5	4.0	13.1	8.5	8.8	5.9	5.1	8.3	14.3	4.8	6.0	7.0	11.3	3.6	6.7	3.4	13.8	4.0	6.5	16.8	5.9	7.0	6.2	11.1	10.0	13.3	7.3	8.4	13.7	13.6	4.5	8.3	9.6	9.5	10.1	9.3	8.7	8.1	6.8	11.0	7.7	6.9	12.8	10.9	15.2	12.7	9.1	7.1	21.2	13.0	6.0	11.6	5.1	10.7	17.5	9.5	11.6	7.4	14.1	6.0	15.8	5.9	14.4	17.2	5.8	15.0	6.2	12.5	16.7	5.7	9.3	10.8	23.3	5.9	15.4	6.7	9.6	7.4	7.1	5.7	7.1	6.7	9.3	7.4	5.7	9.5	8.3	3.8	6.8	8.4	5.8	21.3	7.1	3.8	4.8	5.7	3.6	6.6	3.3	4.3	4.9	4.1	5.1	4.1	6.3	4.5	3.2	2.3	7.0	5.0	4.9	5.9	11.5	11.6	11.9	13.6	11.5	13.1	12.9	11.7	13.1	11.3	13.8	11.1	63.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.9	0.0	0.0	0.0	0.0	283.4	25.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	279.7	52.8	0.0	0.0	0.0	0.0	0.0	0.0	531.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	183.5	5.3	0.0	0.0	0.0
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	30.9	55.3	34.4	21.2	37.2	34.2	26.4	51.4	47.1	28.8	27.8	30.1	37.4	36.5	23.8	20.7	34.6	32.3	43.9	37.8	32.2	105.3	116.7	29.6	20.1	32.2	30.7	41.6	20.0	43.3	24.4	23.6	33.7	24.8	32.9	31.5	20.8	22.3	72.2	29.0	32.7	38.4	29.0	27.0	43.3	20.2	30.4	26.1	22.9	76.9	21.6	30.8	21.7	34.1	42.2	71.8	45.4	53.3	70.8	66.6	20.6	45.8	101.6	65.7	89.8	42.2	77.2	56.8	37.3	63.5	54.0	49.1	57.7	40.7	76.9	51.9	46.6	38.3	37.1	61.2	56.4	53.3	40.1	66.6	36.2	72.4	66.5	90.4	57.7	53.4	60.0	64.5	77.6	37.9	46.7	49.9	19.0	45.0	17.3	50.5	60.9	37.4	80.8	31.0	34.8	49.8	54.2	65.9	42.0	45.2	39.3	50.5	36.2	32.6	50.1	65.7	38.4	33.9	62.6	39.2	65.1	69.6	22.5	21.5	60.0	110.8	16.8	49.8	14.7	15.1	14.7	15.5	26.0	17.5	14.4	12.0	48.8	15.2	54.5	16.5	15.3	35.4	34.4	37.2	51.4	47.1	37.8	32.2	32.2	30.7	33.7	29.0	30.4	34.1	30.4	54.5	36.0	47.7	23.4	9.9	16.0	22.6	14.2	31.9	25.3	19.6	35.8	25.8	38.3	35.0	20.9	20.7	16.9	25.9	80.3	35.6	10.7	42.0	43.0	22.7	14.4	25.0	185.5	26.7	18.8	31.1	45.9	48.2	18.3	31.5	23.9	60.4	34.8	16.8	205.9	24.4	16.2	36.9	13.4	12.5	26.8	40.1	12.4	64.6	38.0	51.3	10.3	146.8	97.5	51.4	24.9	25.9	25.0	10.7	29.3	110.7	34.0	33.8	6.6	29.0	27.2	54.5	40.0	14.2	14.2	21.5	19.0	73.4	23.6	14.2
MORN2	MOPT	ENSG00000188010	"MORN repeat containing 2"	Q502X0	2	38875962-38929072	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 174.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1976.5;Endometrial ciliated cells: 783.4;Late spermatids: 3753.7;Respiratory ciliated cells: 848.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057815			Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA057815: AB_2683537"	"unprognostic (7.28e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.80e-2)"	13.5	30.5	41.9	6.2	44.6	9.7	20.6	42.8	55.9	30.5	62.8	14.5	6.6	16.6	73.3	13.7	96.3	16.0	26.2	42.4	44.9	69.3	17.6	18.0	5.5	45.0	46.4	19.4	20.2	79.5	56.8	8.0	45.7	18.0	13.5	37.6	21.3	18.8	20.0	10.2	8.1	11.3	43.7	6.6	15.2	174.2	43.6	8.2	46.0	17.3	5.7	14.5	13.2	44.3	60.9	30.5	37.2	46.0	40.4	60.5	21.0	27.7	42.9	42.5	40.2	18.3	33.5	3.8	21.8	40.9	42.4	15.9	16.5	34.9	63.4	25.3	32.8	12.9	32.6	46.1	34.8	21.2	9.2	35.6	42.8	51.5	18.9	54.0	39.9	11.7	22.7	8.9	35.8	58.6	9.3	40.5	27.6	40.0	31.7	5.2	38.8	13.3	83.0	33.4	37.1	49.4	41.3	27.0	59.6	21.7	36.5	28.5	26.5	30.2	29.8	48.0	44.1	16.6	26.4	2.3	68.8	6.0	54.4	1.5	8.3	1.2	1.6	6.7	3.1	2.5	1.9	2.4	5.9	2.7	3.2	3.3	0.7	2.7	5.5	3.0	4.0	3.8	41.9	44.6	42.8	55.9	42.4	44.9	45.0	46.4	45.7	43.7	43.6	44.3	14.1	16.0	25.3	2.6	7.9	9.7	25.5	103.9	10.2	16.7	29.5	45.7	40.5	35.8	90.9	60.7	10.4	15.9	4.2	19.5	270.1	61.4	1976.5	783.4	34.1	16.0	22.9	7.4	2.5	44.4	22.9	28.8	18.8	43.6	9.5	35.2	12.8	24.5	23.6	16.8	2.3	18.1	73.2	9.0	6.7	3753.7	53.4	15.1	23.2	0.0	10.2	106.7	3.1	1.5	1.8	41.0	34.3	51.6	5.5	22.4	7.4	396.6	848.6	35.1	26.3	21.3	40.5	530.7	92.0	15.7	10.5	7.7	6.1	51.8	22.0	30.0
MPC2	"BRP44, DKFZP564B167, SLC54A2"	ENSG00000143158	"Mitochondrial pyruvate carrier 2"	O95563	1	167916675-167937072	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2288.1;Late spermatids: 5134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056091	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA056091: AB_2683035"	"unprognostic (3.25e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.79e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.67e-1)"	53.6	89.9	32.3	15.8	37.1	63.3	50.7	34.2	39.0	34.3	35.0	80.3	47.8	30.6	15.8	38.8	34.5	19.6	174.0	36.8	35.6	148.1	266.6	35.1	14.0	31.8	33.4	35.3	52.4	35.6	73.5	13.8	31.6	89.3	33.7	28.4	55.3	16.0	162.1	42.5	65.8	14.8	31.5	28.9	140.4	240.4	34.9	20.1	32.3	66.3	15.0	43.0	35.4	34.4	40.7	43.2	14.6	32.3	31.5	26.2	4.1	70.2	26.9	23.7	27.2	92.3	19.6	75.0	49.4	29.1	21.4	31.4	17.0	28.1	20.3	98.3	34.5	33.2	34.1	60.7	22.4	38.1	21.9	19.6	23.6	41.8	21.8	20.0	20.3	52.5	39.6	34.9	38.7	18.1	52.4	31.4	26.2	73.7	45.2	27.8	31.3	54.7	155.0	30.5	25.8	28.4	41.6	39.1	34.3	29.2	73.9	38.9	30.4	27.8	24.8	45.3	29.9	61.2	65.9	74.5	73.5	28.6	14.6	95.0	33.1	92.5	44.1	30.5	45.7	50.2	51.6	45.8	58.7	41.3	48.6	46.7	61.4	55.6	38.5	40.2	81.3	84.2	32.3	37.1	34.2	39.0	36.8	35.6	31.8	33.4	31.6	31.5	34.9	34.4	81.6	35.3	43.7	14.4	75.0	126.1	157.7	213.8	52.9	54.5	167.2	166.9	428.0	513.3	119.2	130.6	22.9	468.6	78.2	267.5	1025.2	206.1	2288.1	153.3	38.5	75.0	331.5	388.3	23.5	145.5	55.3	119.3	112.1	98.3	88.2	332.1	55.3	679.5	159.6	45.4	19.9	326.4	146.5	77.1	113.3	5134.8	106.2	93.9	120.9	15.9	272.9	123.8	76.2	13.0	16.8	100.5	237.2	112.8	84.7	245.6	516.2	974.3	175.3	69.7	65.7	90.3	147.1	788.0	170.5	75.3	114.4	343.1	94.9	705.0	415.5	173.9
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046805: AB_2679816, HPA056622: AB_2683195"	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	31.3	30.1	21.8	18.9	27.4	13.9	28.6	26.5	23.5	29.1	14.8	27.8	23.7	21.7	25.2	25.0	18.1	20.7	35.0	18.8	26.7	56.0	63.7	17.8	20.3	23.4	24.4	17.4	23.6	45.2	12.2	25.7	25.4	21.6	30.9	19.3	24.1	25.1	66.4	23.9	19.9	29.0	26.8	16.9	18.4	16.5	24.9	24.3	36.9	44.8	25.1	24.5	15.1	32.5	100.7	57.5	53.3	48.3	57.0	68.1	75.6	63.4	57.0	78.5	62.2	88.5	40.6	56.5	62.1	69.2	73.8	69.5	83.7	95.8	117.8	63.2	72.4	77.4	44.4	114.3	61.0	82.9	44.5	45.6	72.4	79.7	72.3	49.6	84.1	60.8	86.4	32.3	78.5	61.9	76.1	64.9	69.9	102.9	65.2	94.5	116.5	74.5	134.1	61.9	58.8	50.2	62.2	71.2	72.4	53.3	61.1	32.8	57.0	68.3	75.4	61.2	94.6	33.3	53.8	47.1	53.9	81.0	61.1	17.7	20.2	14.2	22.1	26.8	25.1	26.8	22.7	23.8	29.7	22.7	19.9	24.6	1.4	24.4	24.9	35.0	26.5	17.2	21.8	27.4	26.5	23.5	18.8	26.7	23.4	24.4	25.4	26.8	24.9	32.5	31.8	19.2	29.6	10.7	27.4	29.1	28.6	77.8	21.1	38.3	32.4	29.5	40.2	25.8	49.4	49.7	52.1	90.3	26.3	24.0	125.2	88.7	27.6	42.7	48.4	27.7	27.6	32.8	13.9	61.1	87.3	33.7	36.7	50.3	19.0	35.8	27.1	67.6	47.3	48.8	14.3	36.5	44.7	14.6	17.0	11.2	35.4	23.7	33.8	12.2	35.0	39.6	34.0	15.1	20.0	53.6	27.7	36.5	36.5	36.1	36.5	167.7	32.8	50.9	19.7	31.4	38.1	55.5	17.6	44.3	28.3	57.7	25.3	62.2	50.7	35.6
MRPL33	"C2orf1, RPL33L"	ENSG00000243147	"Mitochondrial ribosomal protein L33"	O75394	2	27771717-27988087	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1318.9;Distal tubular cells: 710.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066872	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA066872: AB_2685739"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.68e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.20e-2)"	157.7	642.9	142.0	66.7	146.7	98.2	131.4	145.2	215.2	127.7	146.4	233.3	76.8	145.7	151.2	94.1	140.8	81.8	555.1	142.2	146.0	297.4	135.6	131.6	79.8	143.2	141.5	132.5	120.0	161.0	189.2	74.2	142.9	151.1	98.0	135.8	114.8	120.7	716.4	79.0	114.8	121.2	142.6	122.9	166.7	108.6	143.0	110.5	112.8	650.0	81.9	162.7	110.1	148.5	378.2	168.6	302.0	124.0	186.5	209.7	141.3	233.7	294.8	230.7	300.9	151.0	288.2	108.1	286.5	246.9	347.4	112.8	171.6	186.1	328.9	169.6	325.9	211.0	161.8	272.2	282.7	213.4	120.5	270.6	162.2	209.1	364.8	370.9	297.2	163.5	167.6	178.4	307.1	126.0	147.6	231.8	170.4	384.0	241.9	73.8	341.1	152.1	711.5	150.6	172.8	248.4	161.7	205.2	268.1	277.6	92.0	216.5	253.1	145.8	314.7	143.3	375.0	205.5	347.2	325.7	200.8	346.6	137.1	502.5	203.4	211.2	126.7	160.5	136.8	128.3	143.8	135.6	284.0	112.3	121.5	147.2	154.2	125.9	160.6	183.3	175.0	125.4	142.0	146.7	145.2	215.2	142.2	146.0	143.2	141.5	142.9	142.6	143.0	148.5	213.3	179.5	144.5	10.4	104.3	56.0	107.2	283.5	66.0	48.6	171.2	190.4	1318.9	165.8	205.6	321.8	25.0	138.1	103.8	132.3	710.2	202.8	97.0	249.6	143.3	207.1	153.2	66.3	16.3	349.6	131.4	131.1	81.1	229.1	190.4	91.7	165.0	259.2	150.2	42.1	17.2	186.8	207.5	161.3	120.2	53.2	170.6	119.3	154.7	6.5	200.7	134.4	141.1	12.1	16.8	239.3	151.3	197.8	84.7	134.7	134.9	386.1	191.5	64.9	164.3	134.3	184.0	214.9	152.4	71.4	57.1	104.0	113.0	101.8	173.9	129.9
MRPS6	"C21orf101, MRP-S6, RPMS6"	ENSG00000243927	"Mitochondrial ribosomal protein S6"	P82932	21	34073224-34143034	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 281.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 747.4;Prostatic glandular cells: 568.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007861, HPA008163, HPA049676"	Supported		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846"	"unprognostic (2.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.16e-3)"	"unprognostic (4.01e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.06e-5)"	67.6	72.5	53.9	33.8	56.1	15.6	46.1	53.0	118.1	42.7	85.9	81.6	22.7	37.1	50.7	31.3	37.9	24.8	57.3	55.4	60.8	281.0	50.6	37.8	46.7	54.7	56.5	41.7	22.2	24.2	39.4	51.8	55.6	33.1	36.5	25.6	26.2	41.6	96.1	53.5	39.0	36.7	58.9	28.6	51.3	44.8	63.3	38.3	97.5	76.8	49.8	50.6	33.7	57.8	70.8	56.6	211.0	77.2	74.1	72.9	71.4	79.5	185.4	68.7	70.0	181.8	134.9	105.6	51.7	104.0	92.8	28.7	124.6	106.0	73.4	193.5	65.4	89.6	34.3	47.8	35.4	45.2	31.7	35.0	107.8	127.2	116.5	104.2	47.4	45.2	116.5	28.0	140.7	66.0	73.4	104.1	136.9	135.4	122.1	99.6	37.4	101.5	307.4	60.4	187.5	50.0	84.5	46.2	103.6	112.6	87.3	58.7	24.3	62.8	36.6	115.4	46.3	132.5	125.8	96.3	204.2	118.4	62.8	67.0	53.8	60.4	90.3	53.7	66.6	74.9	67.0	81.4	56.1	48.4	83.8	87.3	46.8	115.7	57.5	101.4	74.0	79.6	53.9	56.1	53.0	118.1	55.4	60.8	54.7	56.5	55.6	58.9	63.3	57.8	45.1	22.4	40.9	32.3	83.9	266.8	229.8	226.6	126.9	40.5	78.9	125.9	59.8	28.6	75.8	252.0	10.4	195.2	103.0	56.3	747.4	41.1	83.1	85.2	88.6	58.0	91.5	45.4	25.7	36.7	237.0	111.7	32.6	58.6	137.7	184.5	25.7	95.7	126.5	8.4	57.9	211.0	75.3	36.4	207.6	73.1	28.0	104.8	101.4	32.8	164.0	37.9	108.1	45.2	6.2	52.8	138.5	102.7	102.0	568.4	61.0	159.2	66.0	26.5	118.3	26.9	104.8	90.4	136.5	71.0	331.0	182.4	124.2	49.8	99.9	335.6
MT1E	"MT1, MTD"	ENSG00000169715	"Metallothionein 1E"	P04732	16	56625475-56627112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1787.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 4001.6;Paneth cells: 4625.0;Proximal enterocytes: 5720.1;Proximal tubular cells: 8933.3;Undifferentiated cells: 2966.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.8;T-cells: 20.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 1095.1;LHCN-M2: 827.5;RPTEC TERT1: 946.2;U-2 OS: 527.7"									HPA041152	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041152: AB_2732490"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.86e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.78e-2)"	927.5	339.2	364.4	52.2	378.0	2.8	264.0	393.5	510.1	109.2	317.9	261.4	105.1	60.3	12.6	135.4	299.6	40.9	128.8	354.1	378.2	497.9	1787.5	230.3	11.7	376.7	390.6	72.4	537.3	16.3	53.3	19.1	394.6	240.3	189.3	36.8	94.7	20.6	323.0	192.4	357.7	85.5	366.2	30.3	584.7	11.5	400.8	4.0	382.6	92.5	8.0	89.1	140.9	355.9	102.2	0.0	0.0	0.0	154.5	177.0	1.6	263.8	278.6	70.7	82.1	0.9	133.0	0.0	20.3	91.6	10.7	216.7	241.2	1095.1	96.8	102.7	0.0	4.1	139.4	17.5	69.2	0.6	0.6	122.7	362.4	185.5	211.6	426.7	43.5	0.1	0.2	0.7	827.5	0.2	0.4	67.3	94.3	0.0	1.1	0.3	0.0	2.9	946.2	0.0	14.2	0.7	0.7	0.2	1.0	17.4	0.5	124.1	108.6	0.4	527.7	82.5	51.5	0.5	1.9	2.8	296.9	170.2	0.9	0.0	2.9	0.0	14.7	2.1	5.0	0.5	8.2	20.3	5.8	0.0	3.7	14.7	0.1	0.2	1.8	0.3	20.6	3.8	364.4	378.0	393.5	510.1	354.1	378.2	376.7	390.6	394.6	366.2	400.8	355.9	1237.9	394.2	158.2	83.9	59.6	178.6	240.1	86.9	306.2	0.0	214.2	311.0	106.8	589.0	168.4	496.6	0.0	18.4	32.7	2403.7	1402.9	392.8	1.8	710.8	161.7	210.0	241.9	186.9	0.2	193.7	908.6	522.8	880.2	1646.2	28.5	184.3	222.8	4001.6	34.9	0.0	0.2	2467.0	22.4	110.6	29.0	4.6	149.5	121.0	110.3	8.4	61.9	0.0	1.0	7.5	2.0	314.3	4625.0	51.1	20.6	998.6	5720.1	8933.3	137.6	0.0	216.9	818.8	513.7	3.2	3.7	286.4	148.0	79.8	96.0	14.7	2966.9	84.3
MT1F	MT1	ENSG00000198417	"Metallothionein 1F"	P04733	16	56657731-56660698	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 585.6;kidney: 573.8;liver: 562.0;thyroid gland: 1183.2"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 10399.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 55.6;classical monocyte: 30.2;gdT-cell: 47.0;MAIT T-cell: 41.8;memory B-cell: 25.7;memory CD4 T-cell: 48.9;memory CD8 T-cell: 80.3;naive CD4 T-cell: 49.4;naive CD8 T-cell: 85.5;T-reg: 89.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 143.4;NB-4: 238.9;NTERA-2: 137.1;RPTEC TERT1: 754.6;THP-1: 131.9;U-937: 126.2"															NA	NA		160000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.15e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (2.78e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.85e-1)"	45.7	60.4	375.3	29.9	386.7	10.2	16.5	415.0	585.6	8.1	339.9	158.4	82.2	8.6	2.7	10.6	19.8	19.1	7.9	359.9	376.2	573.8	562.0	11.5	23.4	417.6	407.6	2.8	312.3	5.0	23.2	4.0	396.9	70.5	123.0	52.5	18.4	14.0	2.8	8.5	222.2	16.5	379.1	20.5	88.3	4.5	406.8	6.3	1183.2	1.8	14.5	14.8	6.0	361.3	4.9	7.4	0.0	0.2	0.4	0.3	10.0	6.1	15.6	5.6	9.5	2.0	29.5	0.1	19.3	1.3	8.8	26.5	51.5	6.0	5.8	143.4	7.1	8.9	1.4	2.6	3.7	0.2	100.9	1.5	1.7	6.1	1.7	2.5	0.8	2.1	0.4	0.1	0.3	14.7	0.4	238.9	137.1	1.2	12.9	0.0	0.6	4.4	754.6	5.3	75.1	8.3	6.1	2.4	2.6	19.8	3.5	131.9	0.0	0.0	1.7	0.9	0.7	0.4	0.0	0.0	87.5	126.2	1.1	55.6	30.2	8.9	47.0	2.8	41.8	25.7	48.9	80.3	8.2	10.7	49.4	85.5	4.8	8.1	1.4	3.3	89.2	64.1	375.3	386.7	415.0	585.6	359.9	376.2	417.6	407.6	396.9	379.1	406.8	361.3	25.9	0.0	9.3	18.6	55.4	8.5	28.1	18.6	18.2	0.0	42.0	77.1	9.5	181.6	15.1	327.4	0.0	6.7	27.5	652.8	1119.2	194.4	0.6	376.6	79.5	16.8	170.9	95.6	0.1	123.2	379.6	22.5	57.1	946.3	11.4	77.8	48.9	1365.5	29.6	0.0	0.0	631.0	4.1	70.3	9.4	1.9	31.4	115.6	92.5	2.8	53.4	0.0	27.8	1.0	0.3	126.5	1252.2	5.3	65.9	107.0	2028.8	10399.1	22.6	0.0	6.6	26.4	41.6	3.2	1.5	3.9	8.0	19.4	68.6	6.9	851.3	19.2
MT1M	"MT1, MT1K"	ENSG00000205364	"Metallothionein 1M"	Q8N339	16	56632659-56633981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 398.9;liver: 562.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1333.5;Distal enterocytes: 906.4;Glandular and luminal cells: 1180.5;Hepatocytes: 1549.5;Paneth cells: 1204.8;Proximal enterocytes: 933.2;Smooth muscle cells: 680.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 181.8"															NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.83e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.19e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (4.67e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.71e-2)"	398.9	27.7	214.3	32.8	233.5	0.1	145.6	240.4	316.0	31.2	183.0	134.0	21.2	14.8	4.1	83.4	95.4	42.6	36.6	207.3	219.5	47.6	562.4	116.5	4.5	225.3	226.8	16.1	145.8	2.6	10.4	2.7	232.6	57.5	140.9	24.7	31.5	6.7	48.2	44.6	113.6	37.3	217.6	7.7	98.5	3.9	246.4	5.2	64.3	4.0	2.5	33.4	26.1	213.6	0.0	0.0	0.0	0.0	39.1	27.3	0.5	1.2	9.9	1.2	2.4	0.4	0.6	0.0	7.9	6.3	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.2	0.1	3.1	0.0	14.8	0.0	23.7	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.2	13.4	0.0	1.3	0.0	0.1	0.2	181.8	0.0	0.2	0.5	0.0	0.0	0.0	1.7	0.0	2.7	5.5	0.1	0.0	1.8	0.0	0.1	0.0	0.2	4.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	214.3	233.5	240.4	316.0	207.3	219.5	225.3	226.8	232.6	217.6	246.4	213.6	1333.5	12.8	7.2	49.6	9.3	27.5	19.0	3.1	27.9	0.0	13.7	52.7	7.9	121.5	6.0	14.7	0.0	0.3	4.9	906.4	37.2	58.9	0.1	413.6	114.7	141.3	32.7	131.0	0.1	117.0	70.5	308.1	25.5	1180.5	15.9	11.9	82.8	1549.5	1.7	0.0	0.1	397.5	0.0	65.9	39.9	1.5	47.8	35.2	88.9	5.6	24.3	0.0	0.0	6.0	0.3	64.1	1204.8	12.0	29.4	152.4	933.2	258.6	5.2	0.0	78.9	587.1	680.1	0.0	0.5	4.7	20.2	1.0	15.5	1.2	559.6	7.9
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Oligodendrocytes: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	18.6	9.5	29.3	10.7	46.9	18.7	10.3	49.4	33.3	11.2	24.8	9.9	12.8	9.4	9.4	20.9	7.5	9.6	12.7	28.0	36.3	30.6	24.2	13.6	12.0	57.6	48.5	11.5	12.4	21.3	1.9	25.9	56.5	11.0	10.3	12.1	14.9	11.4	29.4	11.2	11.6	10.0	45.3	15.1	13.0	8.5	40.8	16.7	14.2	24.0	10.6	10.1	5.4	63.3	8.1	9.0	8.2	5.2	17.7	9.6	7.2	11.9	23.9	9.4	9.4	5.9	3.5	3.9	15.5	15.5	9.1	11.5	6.5	7.0	8.9	12.5	2.1	5.5	6.2	10.4	10.3	8.9	12.2	13.2	5.4	6.1	6.7	10.8	23.7	10.9	4.9	9.2	8.9	2.3	9.3	5.6	4.7	9.7	4.3	6.7	6.7	19.5	35.6	12.7	3.0	7.8	5.4	6.3	2.4	10.4	4.2	16.4	10.9	10.6	8.0	5.6	6.8	9.4	7.8	9.0	6.7	4.7	13.4	3.7	3.2	3.1	0.7	4.0	0.8	1.9	0.8	0.6	3.1	2.8	1.2	1.2	13.5	1.4	7.4	3.7	1.2	1.7	29.3	46.9	49.4	33.3	28.0	36.3	57.6	48.5	56.5	45.3	40.8	63.3	15.8	25.6	15.2	86.2	11.3	8.9	4.3	3.3	8.0	0.0	6.7	4.6	24.1	10.0	7.0	33.1	0.0	19.3	12.9	12.7	1.9	3.4	13.6	10.1	9.6	16.8	6.0	5.2	15.4	3.8	3.1	8.6	13.3	19.7	17.1	9.4	11.4	33.9	11.8	0.0	13.6	7.7	2.0	24.9	16.2	24.9	10.5	19.0	8.8	55.3	13.8	0.0	3.1	25.6	149.3	5.6	9.2	7.5	8.0	6.7	14.4	18.6	4.7	0.0	0.0	10.6	8.9	11.1	8.9	33.6	11.1	38.4	6.8	6.7	8.2	8.7
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 201.5;Spermatocytes: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	20.4	37.4	31.8	15.2	33.6	9.2	27.0	32.8	46.7	22.1	35.9	31.2	22.8	18.7	39.3	38.1	28.9	14.5	49.8	33.3	34.4	46.4	30.8	15.6	14.2	33.9	32.0	21.1	26.3	48.1	29.5	25.8	33.2	26.4	35.5	47.3	20.4	22.6	74.4	23.4	20.2	25.7	34.0	15.6	24.4	64.3	33.5	18.2	20.4	70.9	20.8	25.1	24.7	35.6	52.2	31.0	60.8	37.8	40.0	45.9	58.3	54.5	52.0	49.8	58.3	53.1	55.8	66.4	91.4	49.1	79.9	34.5	67.1	67.6	67.9	66.6	49.4	63.9	39.1	94.9	62.7	98.9	20.7	51.1	83.5	52.2	89.1	60.3	72.0	64.3	86.8	50.2	59.6	47.4	34.9	102.9	58.3	101.8	45.5	0.0	44.0	60.8	142.4	93.3	87.0	74.4	45.7	60.9	120.7	116.4	33.7	64.0	63.5	49.2	43.5	52.1	57.9	55.4	62.1	79.8	61.1	49.7	60.8	8.0	9.3	4.1	9.6	15.8	13.1	18.9	12.4	11.1	14.8	13.7	14.9	15.4	0.0	19.6	14.4	12.1	16.9	9.9	31.8	33.6	32.8	46.7	33.3	34.4	33.9	32.0	33.2	34.0	33.5	35.6	34.4	19.2	22.6	50.6	20.8	31.1	36.2	130.9	37.5	0.0	38.2	43.8	69.2	31.5	63.6	57.0	0.0	78.8	11.1	38.8	201.5	51.8	22.3	60.9	25.7	31.4	41.5	19.5	106.0	39.5	63.3	30.2	28.1	33.9	43.1	25.7	16.4	33.7	47.8	0.0	106.3	47.7	103.7	21.7	15.7	18.8	35.4	19.6	35.6	43.1	26.1	0.0	12.3	93.5	180.2	49.8	26.1	32.7	23.1	48.2	39.6	106.3	63.8	0.0	39.5	24.9	52.4	247.8	127.1	56.5	41.9	65.0	18.8	55.8	52.6	53.7
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46835111-46882172	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 9155.0;skeletal muscle: 5135.3;tongue: 2074.2"	"Cell type enriched"	"Detected in some"	53	"Cardiomyocytes: 3626.2"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		7300000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	5.8	4.1	11.3	0.9	11.1	1.5	8.9	11.4	14.8	6.7	8.4	2.5	1.6	3.3	3.4	157.0	4.2	3.6	9155.0	11.0	12.8	50.3	4.1	5.7	3.3	15.2	13.0	5.2	2.7	1.3	1.7	4.7	12.1	25.1	0.8	1.9	19.6	1.5	5135.3	4.0	2.3	2.0	13.2	7.9	2.1	2.3	12.6	0.7	2.4	2074.2	0.5	2.4	4.7	13.2	0.5	0.7	0.4	0.3	4.4	1.5	3.6	0.7	0.4	0.4	0.6	8.6	0.8	1.6	1.4	0.1	0.2	0.5	0.4	0.1	0.7	0.3	0.1	0.8	2.6	0.3	0.7	0.9	0.8	8.7	0.2	0.3	0.1	0.2	0.1	0.5	0.4	1.2	0.2	1.2	0.3	0.5	1.0	0.4	0.4	0.9	0.3	0.1	34.2	1.3	0.6	0.4	0.3	0.7	0.1	0.7	0.3	0.5	0.2	1.0	0.8	0.6	0.3	0.5	0.4	0.7	0.3	0.8	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.3	0.0	0.1	0.4	0.0	0.0	11.3	11.1	11.4	14.8	11.0	12.8	15.2	13.0	12.1	13.2	12.6	13.2	0.7	0.0	0.0	1.0	0.0	0.8	0.2	0.0	0.0	0.2	2.3	0.1	3626.2	0.0	0.0	1.8	0.0	0.4	0.0	0.0	54.8	0.0	2.4	0.1	2.2	32.8	0.0	0.0	0.1	0.0	16.4	23.7	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	12.8	1.2	0.7	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	68.1	0.0	0.4	6.6	27.9	20.4	0.2	0.5	0.0	0.4	0.8	0.4	0.1	0.0	0.0
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 406.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 33.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 24.7;monocytes: 33.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 72.1;RPTEC TERT1: 71.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: AB_2686745"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	57.5	12.0	2.8	44.4	5.2	406.0	31.7	4.7	6.0	13.4	19.1	24.5	52.6	36.3	3.7	26.9	64.8	51.3	23.6	3.4	4.8	29.2	52.4	48.2	27.2	6.7	4.2	19.1	27.0	3.6	12.5	22.3	5.5	26.6	30.6	8.0	80.8	7.4	4.6	45.7	23.2	54.6	6.2	26.9	30.5	3.7	6.8	18.8	24.7	10.2	22.7	71.3	18.3	5.0	6.5	5.2	3.5	4.4	9.7	16.7	5.3	26.2	72.1	11.3	10.7	6.3	7.8	12.2	32.4	7.2	34.8	20.5	2.5	11.4	29.2	35.9	2.3	11.7	10.2	3.4	14.7	0.8	0.7	11.6	17.3	30.5	13.7	27.8	8.4	0.3	2.0	24.6	16.2	8.1	0.2	6.9	6.0	2.3	15.3	1.5	15.7	1.5	71.0	42.7	1.5	1.9	4.4	5.3	29.6	7.4	6.3	4.8	10.6	18.1	18.0	6.9	8.6	20.4	7.8	8.1	32.9	2.2	2.5	11.7	5.9	1.7	1.4	13.1	1.7	2.9	2.1	1.6	3.8	4.6	6.0	4.2	24.7	0.8	33.9	6.0	1.3	2.3	2.8	5.2	4.7	6.0	3.4	4.8	6.7	4.2	5.5	6.2	6.8	5.0	199.5	86.6	266.6	10.7	91.3	281.7	61.2	123.0	103.0	9.0	108.7	105.8	20.6	84.4	143.0	66.2	2.1	19.3	98.6	157.8	0.0	213.0	4.6	116.1	221.4	135.3	73.6	21.0	23.7	132.1	41.0	214.2	277.8	291.9	381.8	17.9	82.1	65.2	56.5	10.1	20.2	69.7	59.0	150.6	291.5	1.3	20.2	318.4	71.2	16.9	79.0	25.7	12.3	17.1	79.3	127.6	115.8	0.7	128.5	88.8	91.2	5.6	117.3	8.9	19.7	218.4	131.1	0.6	2.6	136.4	251.7	25.6	134.0	19.2	111.7	70.5
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375200-17735994	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 264.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;RPTEC TERT1: 19.2;RT4: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: AB_2686789"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	3.2	4.1	2.9	1.3	2.4	0.4	2.8	0.0	4.2	6.1	6.8	4.1	0.8	4.8	2.8	1.8	2.7	1.6	0.9	1.8	2.5	5.1	0.2	1.1	0.5	3.3	2.8	3.5	0.5	0.3	2.8	2.6	3.0	3.4	1.6	7.8	2.0	2.7	0.4	2.3	1.5	2.5	1.7	1.0	2.2	2.5	3.8	2.2	2.6	0.7	0.5	4.0	3.7	0.9	7.9	3.1	5.5	0.0	0.1	0.2	8.7	3.5	2.4	1.5	0.8	0.3	1.5	0.5	12.7	2.4	7.5	6.8	3.5	4.4	2.2	0.1	1.1	0.0	5.4	0.0	0.0	0.0	0.0	0.7	3.1	0.1	6.8	6.7	0.0	0.0	0.0	0.0	0.8	3.8	0.0	0.0	6.7	3.6	2.0	0.0	0.0	0.3	19.2	12.0	1.4	2.8	9.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	8.0	0.1	8.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	2.9	2.4	0.0	4.2	1.8	2.5	3.3	2.8	3.0	1.7	3.8	0.9	0.6	3.2	0.0	22.5	0.0	8.3	10.6	4.6	8.6	11.4	2.0	2.4	1.7	0.0	14.7	1.8	22.9	6.0	0.1	1.3	5.9	0.8	0.9	12.4	20.1	3.5	4.2	0.0	40.1	2.2	5.4	6.1	3.6	25.0	0.0	0.2	0.7	0.0	1.4	3.3	264.4	1.9	2.0	4.6	2.6	2.3	16.8	2.4	3.6	40.3	5.0	11.9	0.0	14.1	8.1	6.8	2.4	31.2	0.0	7.0	0.9	7.8	8.2	18.9	6.6	2.0	11.9	0.3	0.6	5.1	3.8	2.6	0.9	4.5	4.3	12.8
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334739-100361635	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.4"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 705.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		1700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	5.1	3.9	1.3	1.4	2.4	3.5	6.8	1.4	1.9	3.4	1.7	3.8	2.7	4.1	5.5	4.4	4.1	3.4	5.2	1.6	1.3	18.5	26.4	3.2	2.4	0.7	0.8	3.3	3.7	3.9	2.7	2.4	0.9	3.6	3.4	3.6	3.8	4.9	10.1	5.0	2.8	3.0	0.9	2.2	4.1	1.2	1.2	2.5	5.9	7.6	3.7	5.2	3.6	1.4	12.3	12.1	1.4	6.2	10.3	14.1	7.4	4.9	7.3	11.5	10.9	10.4	13.7	12.3	7.4	7.2	4.9	9.1	5.4	13.2	13.7	3.8	2.8	9.0	4.1	5.3	12.6	5.9	5.8	8.8	19.9	6.1	10.1	6.0	7.4	6.9	4.2	9.8	14.2	11.9	3.9	5.3	5.4	15.3	18.0	4.3	5.0	12.0	19.4	7.7	8.2	3.8	6.8	11.6	7.3	3.7	8.6	5.4	5.5	7.2	2.9	3.5	4.4	5.9	7.0	10.6	11.4	9.9	9.3	0.2	0.7	0.4	1.0	0.7	1.4	1.5	1.0	0.8	2.0	1.5	1.2	1.1	0.4	1.1	0.5	0.6	1.2	0.3	1.3	2.4	1.4	1.9	1.6	1.3	0.7	0.8	0.9	0.9	1.2	1.4	22.3	12.8	17.2	8.5	31.5	32.6	51.7	92.0	37.0	12.8	43.7	56.1	56.4	45.8	53.5	58.8	16.7	92.5	26.1	14.6	187.9	73.6	3.1	53.6	47.2	16.7	24.0	17.0	12.0	52.7	73.7	38.0	29.6	42.3	21.0	55.3	15.0	183.6	63.5	13.5	8.8	22.0	65.1	23.5	39.9	4.1	44.1	26.9	49.8	4.7	89.9	15.4	22.6	12.1	8.0	62.1	20.6	37.6	20.8	54.3	24.1	705.6	60.5	24.9	39.5	23.9	51.6	2.7	17.5	53.7	41.6	59.2	27.7	118.1	36.7	53.0
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115175-138139443	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 37.2;testis: 53.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.4	6.5	9.7	0.5	10.5	0.0	4.5	9.2	11.7	8.6	18.6	2.1	0.2	4.9	23.1	1.0	37.2	8.7	3.6	10.5	9.2	20.5	0.5	4.5	0.4	10.5	12.3	5.3	4.4	24.3	8.9	0.1	12.1	5.0	1.1	12.9	3.7	4.5	0.4	0.3	0.6	3.1	9.6	0.2	2.8	53.3	11.0	0.7	12.4	0.6	0.2	2.1	0.6	8.9	0.0	0.0	3.9	4.3	0.0	0.0	0.0	0.7	0.4	0.7	0.3	0.1	1.8	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	2.1	0.0	0.9	0.0	3.8	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	29.9	0.0	6.7	2.5	0.0	0.8	4.9	1.7	0.5	1.6	0.0	0.7	0.0	0.0	0.9	0.4	0.8	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.5	9.2	11.7	10.5	9.2	10.5	12.3	12.1	9.6	11.0	8.9	1.0	6.4	7.5	26.8	0.3	0.6	8.5	41.1	0.0	11.7	9.0	7.9	4.3	8.6	38.1	33.1	14.6	0.5	0.1	0.3	86.1	23.8	704.9	205.8	9.2	3.5	5.4	0.0	57.9	4.0	0.0	4.2	2.6	12.7	0.0	7.7	3.6	0.6	0.1	6.7	42.2	3.3	44.7	0.0	0.3	256.5	9.0	1.4	10.6	3.7	0.6	19.1	0.0	11.1	8.1	4.2	0.3	13.9	0.0	4.8	0.2	92.3	431.9	25.8	0.0	0.5	12.6	326.8	24.7	0.0	0.3	0.0	0.8	10.9	1.7	5.9
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 388.9"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 3913.2;Skeletal myocytes: 1639.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 204.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		410000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	130.9	11.4	1.0	25.2	1.1	0.9	91.9	1.4	1.5	36.0	1.9	37.1	1.5	31.0	2.8	15.4	55.0	43.1	35.5	1.3	1.4	24.1	388.9	64.6	9.6	3.9	1.6	21.3	11.4	1.6	10.6	23.8	2.2	31.9	8.7	0.3	21.1	3.1	73.1	49.3	32.2	30.1	1.7	36.7	30.1	2.2	1.2	2.7	33.0	5.3	8.8	48.6	33.9	3.1	0.2	17.6	0.3	18.6	92.0	118.3	0.1	21.2	58.7	35.2	69.2	0.0	17.5	0.2	58.1	45.1	4.2	0.2	0.0	8.0	34.1	0.2	0.0	0.2	16.7	0.0	123.3	0.2	0.0	255.3	89.4	24.1	37.3	29.8	50.1	0.1	0.3	0.2	144.1	0.1	0.1	0.2	0.1	0.0	0.5	0.2	79.0	0.0	479.6	0.1	0.2	0.2	97.7	0.1	0.3	5.3	0.0	0.2	37.4	18.3	34.3	23.8	3.1	0.3	0.3	0.4	6.4	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.1	1.4	1.5	1.3	1.4	3.9	1.6	2.2	1.7	1.2	3.1	411.8	44.8	411.3	1.0	11.2	103.6	13.2	16.5	2.2	1.9	38.5	73.9	4.7	75.8	13.3	80.9	0.0	1.0	1.6	0.0	9.8	238.3	0.3	19.0	89.9	190.0	5.3	147.2	1.3	157.0	2.5	452.2	5.1	80.5	13.9	0.5	195.2	3913.2	28.4	0.0	1.6	0.0	0.0	126.8	142.1	1.6	74.3	9.2	96.0	1.9	5.7	0.0	0.0	0.0	0.2	323.1	0.0	13.2	1.5	10.8	0.0	99.2	11.9	0.2	0.0	1639.1	154.3	0.3	0.8	1.9	92.1	2.2	20.1	0.0	0.0	3.1
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564414	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.1;liver: 120.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 92.9;Hepatocytes: 105.1;Proximal enterocytes: 331.0;Proximal tubular cells: 153.8"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"Hep G2: 28.3;HHSteC: 14.1;RPTEC TERT1: 44.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA047699: AB_10965320"			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.2	22.6	0.1	1.4	0.1	0.4	1.0	0.5	0.4	0.2	1.8	8.3	29.6	0.1	0.1	0.2	0.2	12.6	0.4	0.2	0.1	28.2	120.6	0.4	0.3	0.1	0.1	14.0	3.1	0.0	1.4	0.0	0.1	0.3	1.6	0.3	0.3	0.0	0.3	0.5	39.1	0.8	0.0	0.4	0.5	0.7	0.2	0.1	0.3	0.1	0.2	6.5	0.1	0.5	0.0	0.9	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	28.3	14.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	44.9	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	92.9	0.0	22.0	0.0	0.0	0.0	8.0	43.0	11.5	0.7	0.0	0.0	0.3	0.0	2.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.6	8.9	105.1	0.0	0.0	1.6	17.0	0.0	3.5	0.0	2.0	0.9	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	19.9	0.0	0.0	0.0	331.0	153.8	0.0	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.0	0.0	0.9	1.1	30.4	3.7
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822539-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.1;ovary: 32.5;placenta: 24.2"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	11	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.6"	HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	0.8	16.1	0.0	0.9	0.0	0.0	0.7	7.0	0.3	1.8	0.0	1.4	0.1	1.7	4.6	0.6	0.9	10.1	3.5	0.0	0.1	6.2	0.1	0.2	0.0	0.1	0.6	32.5	0.4	0.1	0.3	24.2	0.5	4.9	0.3	0.1	1.1	0.9	0.2	0.1	0.3	1.7	0.1	0.0	0.5	3.3	0.0	0.1	0.2	3.3	0.0	1.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.6	0.0	0.1	0.0	3.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.8	0.0	34.8	0.7	0.0	0.2	0.0	1.8	0.0	40.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.1	0.1	0.6	0.5	0.1	0.0	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	1.2	1.0	4.8	0.0	0.0	0.0	0.0	79.4	0.0	0.2	19.6	0.2	1.3	0.0	3.2	0.7	0.0	0.0	0.9	0.0	10.1	8.9	0.0	0.0	0.0	2.1	0.0	0.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	2.6	113.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.6	1.7	0.1	0.0	67.9	0.0	70.2	0.2	0.1
NTPCR	"C1orf57, HCR-NTPase, MGC13186, THEP1"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	3.0	4.0	8.9	2.0	9.3	0.8	3.6	8.3	9.6	5.0	10.9	4.5	2.0	4.2	3.8	3.2	4.7	3.2	4.5	9.0	10.3	3.6	2.8	3.4	2.9	11.4	9.3	5.3	5.9	5.3	4.2	2.5	12.0	4.1	4.3	8.0	3.3	4.0	13.5	4.3	3.9	4.1	9.8	3.4	3.0	2.2	10.0	3.6	4.4	11.8	2.7	3.8	4.2	9.1	2.0	4.9	5.4	2.7	4.0	5.2	0.1	1.3	4.3	4.0	5.5	3.5	2.3	3.1	2.9	2.7	2.2	2.6	3.7	5.0	4.4	2.3	6.9	0.9	3.4	4.5	4.1	1.7	1.8	6.9	9.4	3.9	3.9	4.0	3.3	5.8	2.8	4.6	4.8	1.5	4.4	4.4	5.4	4.0	5.7	2.9	3.5	4.6	5.9	2.4	4.7	7.8	1.9	1.6	1.9	4.0	4.0	3.8	2.5	3.3	2.7	3.6	3.7	5.2	4.6	3.5	3.9	4.1	4.9	0.3	0.5	0.2	0.6	0.6	0.7	0.5	0.9	0.3	0.4	0.6	1.2	1.0	0.9	0.5	0.5	0.1	1.1	0.4	8.9	9.3	8.3	9.6	9.0	10.3	11.4	9.3	12.0	9.8	10.0	9.1	45.5	19.2	21.1	24.8	16.9	19.4	37.3	85.3	24.5	15.8	31.5	34.8	63.9	38.6	36.3	25.8	27.1	68.9	16.1	37.3	93.9	62.2	47.7	27.3	29.4	29.1	25.8	15.8	16.1	64.5	59.1	33.1	16.3	27.7	16.5	44.9	23.9	34.3	42.3	10.1	16.1	50.0	75.3	22.8	17.3	27.3	20.2	21.2	23.2	15.0	30.1	41.0	47.4	16.1	20.8	46.5	31.2	30.5	12.2	40.1	66.0	82.0	27.2	21.8	13.1	21.3	27.7	86.5	40.4	40.1	23.9	28.0	16.5	67.9	66.5	41.6
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302063-205321745	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.7;vagina: 45.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 46.9;Endometrial ciliated cells: 45.3;Glandular and luminal cells: 52.4;Intestinal goblet cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 120.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.1;RPMI-8226: 36.1;RPTEC TERT1: 40.9;SuSa: 45.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	2.1	3.7	1.3	7.7	1.9	11.4	0.9	4.6	1.7	31.0	3.2	8.0	16.5	1.6	1.3	56.7	4.0	1.7	1.2	1.2	1.3	28.2	5.1	10.3	11.5	2.1	1.8	1.3	16.0	0.8	3.0	4.4	2.0	1.9	8.8	0.5	15.1	1.6	0.7	22.4	12.5	1.2	1.4	13.1	2.5	3.7	2.2	3.9	16.1	1.1	8.0	3.1	45.3	4.1	4.3	23.1	13.7	0.6	0.3	0.6	44.1	5.5	5.7	14.7	5.9	24.4	0.8	7.0	3.2	1.5	24.1	8.3	3.2	8.3	6.3	0.0	0.4	0.0	1.4	4.2	9.3	0.0	0.1	2.6	6.1	8.6	5.0	3.3	0.7	0.0	0.9	1.7	2.8	1.0	0.0	0.1	8.9	3.1	0.7	0.0	1.0	36.1	40.9	0.1	2.1	0.2	1.6	6.5	0.7	45.6	6.6	0.1	1.7	5.3	2.5	0.6	8.7	12.1	2.0	4.4	0.8	0.0	2.1	11.2	16.5	40.1	10.3	11.8	7.6	37.9	12.7	12.3	10.4	39.3	27.9	21.9	120.4	17.5	13.1	4.1	8.1	17.4	1.3	1.9	4.6	1.7	1.2	1.3	2.1	1.8	2.0	1.4	2.2	4.1	2.0	6.4	6.8	0.3	28.0	1.1	3.2	3.7	13.1	1.1	1.9	2.2	2.7	20.0	2.9	33.1	0.0	9.2	7.1	34.9	5.9	46.9	2.0	45.3	7.5	5.9	10.8	2.7	0.1	1.8	29.1	3.7	7.7	52.4	0.0	2.4	0.7	2.6	4.7	0.0	0.4	43.0	18.3	12.3	11.1	2.1	0.0	8.9	7.2	3.7	38.5	1.3	18.6	0.5	3.5	6.9	7.8	0.0	18.5	2.5	18.3	17.2	7.7	0.5	6.6	2.4	5.5	0.9	1.1	21.5	5.4	4.1	5.7	0.5	22.0	0.5
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422573-87459455	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 160.7"	"Low region specificity"	"Detected in all"							"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9900	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	23.6	36.1	20.8	16.2	21.4	6.7	19.7	25.5	38.5	27.6	39.1	27.0	42.6	24.8	32.2	19.6	24.9	16.2	28.8	21.9	24.7	40.4	46.6	23.0	13.7	21.0	20.5	26.7	67.6	55.3	29.1	19.9	21.9	30.4	27.1	20.1	28.1	23.8	42.1	16.6	40.3	23.8	19.6	14.7	22.3	22.5	22.1	13.4	28.8	45.0	14.8	22.4	24.3	26.0	30.8	25.6	34.0	19.8	67.6	39.6	26.0	59.8	35.6	21.3	21.1	17.1	53.1	47.6	58.9	47.6	41.0	21.1	32.1	38.1	33.2	34.5	24.0	13.4	34.5	31.8	42.4	25.6	21.2	41.5	52.4	25.6	22.6	45.5	41.6	13.7	40.3	30.0	38.7	33.4	39.1	23.2	29.1	68.5	12.0	45.0	31.8	27.0	160.7	24.2	41.3	28.7	37.6	63.0	30.8	44.5	36.8	38.2	43.7	34.7	34.3	25.8	27.8	21.5	18.7	37.9	51.3	21.9	48.2	1.6	17.9	5.9	19.1	21.2	18.2	22.2	18.5	19.5	21.4	18.8	22.5	26.0	1.8	15.6	24.0	20.6	19.0	16.0	20.8	21.4	25.5	38.5	21.9	24.7	21.0	20.5	21.9	19.6	22.1	26.0	32.6	67.3	44.8	20.2	14.9	9.9	40.4	45.0	9.6	15.3	11.3	13.1	40.9	30.0	55.0	23.9	27.1	33.2	13.1	21.0	41.1	44.7	28.6	26.0	26.2	25.8	16.8	6.7	21.7	36.5	32.5	29.4	8.6	27.0	20.8	23.3	18.2	47.5	33.2	6.7	24.0	18.0	40.7	12.7	11.0	11.5	25.4	14.7	10.6	20.6	16.4	26.8	8.2	18.6	24.8	29.4	37.0	26.7	15.8	32.9	55.7	56.2	41.0	18.6	26.3	36.9	23.7	44.5	23.6	15.7	9.5	37.6	12.1	29.8	24.9	27.3
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88534033-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 7.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	6.5	0.7	4.3	1.2	3.4	4.2	2.8	6.0	5.5	4.0	1.8	0.5	0.9	2.0	1.3	0.4	4.3	1.0	0.7	3.4	3.4	2.3	4.5	0.7	0.9	0.7	1.2	1.1	0.4	0.3	0.1	0.6	1.4	0.9	0.4	4.8	1.6	0.7	1.3	1.5	0.9	0.4	0.4	1.1	0.8	1.3	3.6	0.5	1.3	0.1	0.5	0.4	0.3	5.1	1.5	2.6	1.0	1.0	0.1	0.7	0.7	2.6	0.7	0.3	0.5	0.6	1.0	0.6	1.1	0.3	0.7	1.3	0.4	0.1	0.9	0.4	0.8	1.3	4.0	1.0	0.4	0.7	1.1	0.5	0.2	0.3	0.2	0.4	0.0	0.9	0.9	2.7	0.7	0.7	0.7	1.2	1.4	0.5	0.7	0.5	0.5	0.9	10.4	0.8	0.6	0.4	1.6	0.8	0.5	0.7	1.2	0.6	0.9	0.9	1.9	1.5	0.6	0.9	0.8	0.7	0.7	0.9	0.7	2.1	0.3	0.8	0.6	0.1	0.6	0.2	0.3	0.7	0.0	0.3	0.6	0.7	0.8	0.5	0.1	0.3	0.6	0.3	4.3	3.4	6.0	5.5	3.4	3.4	0.7	1.2	1.4	0.4	3.6	5.1	0.2	0.0	0.0	1.3	0.1	0.0	1.9	0.7	1.2	0.2	7.5	3.2	0.3	4.3	0.1	1.8	0.0	0.2	0.0	0.0	1.9	0.8	11.4	39.1	4.3	0.8	0.0	0.0	1.2	0.2	1.3	0.8	0.0	13.9	0.0	13.2	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	4.4	0.9	0.2	0.0	0.0	0.0	0.5	0.0	1.0	0.7	0.2	0.0	2.2	0.1	0.4	0.0	18.6	0.2	0.8	0.0	0.3	1.3	0.4	1.6	0.0	0.1	1.1	0.3	12.7	0.0	2.2
OCIAD1	"Asrij, FLJ20455, OCIA, TPA018"	ENSG00000109180	"OCIA domain containing 1"	Q9NX40	4	48805212-48861817	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044803	Approved		Approved	Mitochondria		NA	NA		21000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA044803: AB_10961287"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.82e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.10e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.34e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	129.5	184.0	161.1	99.4	170.6	107.7	153.9	154.6	212.9	150.3	173.5	161.1	155.8	138.0	192.2	118.1	167.2	124.6	219.3	177.3	177.0	238.1	326.5	124.1	127.3	161.1	153.1	159.1	156.1	248.7	109.9	118.4	157.6	145.9	159.9	143.7	161.9	148.1	255.0	107.1	134.6	133.3	163.1	105.1	141.3	91.0	165.8	133.6	239.4	255.9	133.9	136.3	72.3	172.6	165.2	118.2	231.7	162.8	230.8	283.0	178.6	253.1	393.8	261.1	311.3	110.6	473.2	190.4	241.5	238.0	311.4	141.7	229.4	250.4	296.2	149.4	152.7	293.4	105.7	88.1	336.5	309.1	300.9	292.0	353.5	208.3	258.4	315.4	270.0	173.9	339.8	104.1	300.0	107.7	261.4	287.6	195.2	211.7	110.4	169.6	216.9	203.1	502.9	154.5	139.8	261.0	120.4	101.1	306.5	179.8	212.8	271.5	196.9	176.1	200.7	120.7	333.1	256.3	380.4	283.1	223.2	251.0	220.2	47.8	60.2	76.5	62.6	68.0	90.8	74.1	73.1	79.2	75.4	64.9	90.2	80.5	48.3	95.4	86.5	85.2	68.5	73.5	161.1	170.6	154.6	212.9	177.3	177.0	161.1	153.1	157.6	163.1	165.8	172.6	176.7	160.3	124.5	85.8	107.1	79.7	111.3	243.3	102.4	126.6	96.7	119.6	152.3	102.9	169.4	121.4	66.7	170.5	103.1	140.0	137.0	140.0	34.3	147.3	120.5	120.2	130.1	89.8	125.1	128.3	168.8	124.4	84.1	110.5	141.8	102.6	118.9	167.3	152.7	89.2	137.2	131.3	124.1	94.0	77.2	35.5	132.3	106.1	87.2	76.8	107.2	206.1	121.5	106.1	158.1	130.7	122.5	139.2	115.3	104.2	164.1	178.9	151.2	111.6	124.9	121.3	112.7	188.3	88.3	94.1	75.9	164.7	109.8	197.2	142.7	100.4
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase L"	Q9ULD0	10	49734641-49762379	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 98.5;kidney: 121.8;liver: 80.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 30.4;Collecting duct cells: 29.5;Cone photoreceptor cells: 31.3;Distal tubular cells: 92.0;Hepatocytes: 55.3;Horizontal cells: 30.3;Proximal tubular cells: 84.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.7;renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.3;RPTEC TERT1: 43.4;SH-SY5Y: 16.3;SK-BR-3: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favorable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.2	11.6	23.1	0.3	23.4	0.0	0.0	23.7	41.1	0.7	98.5	1.4	1.0	2.2	0.5	0.1	1.0	0.4	5.8	24.4	36.9	121.8	80.0	0.0	0.2	38.4	25.6	1.6	4.3	50.5	29.3	0.1	38.9	1.6	0.3	18.7	17.1	6.3	0.1	0.1	1.1	0.7	15.4	0.3	1.0	2.3	33.8	0.5	23.0	0.8	0.6	0.5	0.5	24.3	0.0	0.0	4.7	21.3	0.0	0.0	2.7	0.1	0.1	1.1	0.2	10.5	2.3	0.0	11.4	0.0	3.4	0.4	7.4	0.2	0.4	0.0	0.4	0.0	0.2	5.3	0.2	0.0	1.6	0.3	0.0	0.0	0.0	0.6	0.0	5.4	0.5	0.0	0.0	3.2	8.2	7.3	2.0	0.8	1.0	0.0	0.0	0.0	43.4	0.7	12.0	16.3	0.1	16.2	1.1	6.1	4.5	2.9	0.0	0.0	10.6	0.0	0.7	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	23.4	23.7	41.1	24.4	36.9	38.4	25.6	38.9	15.4	33.8	24.3	0.0	0.0	0.0	20.2	0.8	0.0	0.9	0.4	0.0	30.4	0.1	0.1	4.4	2.8	0.1	29.5	31.3	0.0	0.0	0.4	92.0	1.1	0.2	0.9	0.2	0.3	4.8	0.0	16.8	0.0	0.1	0.3	0.0	1.6	0.0	0.7	1.4	55.3	0.1	30.3	21.4	0.5	2.0	1.3	0.0	0.5	0.0	0.5	0.0	1.0	0.0	5.4	0.0	3.5	1.8	0.1	1.1	0.0	0.0	0.3	0.0	84.7	0.0	18.1	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.1	0.6	0.4	0.3	0.3
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657912-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 440.2;Late spermatids: 1206.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 93.3;RPTEC TERT1: 118.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.85e-4)"	8.3	2.6	3.1	7.8	3.0	1.2	6.0	0.1	3.6	10.2	6.5	6.5	3.7	8.4	6.6	13.0	5.9	11.4	2.9	4.8	2.7	13.3	2.2	5.8	12.9	1.2	4.9	3.1	1.6	1.6	6.7	22.3	3.0	11.8	7.8	5.5	6.8	20.9	1.6	4.9	6.7	11.1	0.3	9.5	6.1	25.0	1.3	2.8	3.5	2.2	17.8	20.3	5.9	2.6	19.3	10.6	2.0	39.3	4.2	7.4	63.1	5.2	6.1	4.9	6.8	27.0	14.3	45.6	48.8	1.1	17.0	11.5	8.9	45.1	6.0	0.3	8.2	0.1	26.4	18.3	2.7	0.1	0.2	7.7	39.7	7.8	93.3	18.2	23.4	0.2	0.1	0.2	22.7	16.0	0.2	0.1	24.9	64.9	26.5	0.5	0.8	0.9	118.3	7.8	3.0	0.5	8.9	17.0	5.4	36.9	11.1	0.2	15.2	6.1	61.7	0.5	26.2	4.1	3.0	42.6	8.6	0.1	39.3	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.1	3.0	0.1	3.6	4.8	2.7	1.2	4.9	3.0	0.3	1.3	2.6	20.5	9.6	3.9	2.9	50.6	10.8	7.5	10.1	4.6	7.3	13.8	6.6	2.3	4.3	7.3	7.3	0.0	15.3	2.4	7.9	9.8	1.8	440.2	11.0	26.5	21.1	15.0	5.7	70.5	4.9	25.9	10.4	6.1	26.4	0.0	1.3	18.2	0.6	2.5	0.0	129.9	4.6	6.1	0.9	6.3	1206.2	11.1	2.2	8.8	17.8	1.7	45.7	1.0	12.1	2.3	16.2	9.0	4.1	21.0	18.3	6.1	24.8	6.9	2.3	19.7	4.8	15.6	7.0	4.1	14.4	12.4	30.2	3.5	1.0	8.8	16.3
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 58.0;testis: 76.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 453.5;Endometrial ciliated cells: 88.6;Respiratory ciliated cells: 199.1;Spermatocytes: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	6.8	8.2	9.7	2.4	10.4	2.0	9.4	7.4	10.5	9.5	31.3	7.3	2.9	10.0	22.0	5.0	58.0	8.8	7.9	11.1	13.0	19.1	2.8	11.0	1.9	11.3	14.7	9.1	8.2	30.2	23.1	5.6	10.9	9.9	3.9	23.1	8.7	8.9	4.9	6.8	2.7	7.9	9.9	1.4	6.3	76.1	13.5	3.6	17.9	5.2	1.5	5.9	4.8	8.3	6.7	6.3	7.6	8.9	8.9	8.6	1.4	4.0	9.7	9.7	6.6	0.1	5.8	1.5	7.3	7.3	7.1	5.1	0.2	7.5	6.2	1.1	5.9	0.1	3.9	0.7	10.9	0.8	1.2	9.8	12.0	13.7	5.9	14.1	6.7	6.3	0.1	1.7	7.7	4.8	3.6	2.5	7.8	2.6	2.6	3.8	3.1	1.2	16.0	2.3	20.4	9.0	7.5	3.5	5.4	7.2	7.6	1.1	5.8	7.0	2.6	12.7	6.9	2.8	3.1	0.8	13.4	0.2	4.7	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	0.2	0.6	0.2	0.6	1.0	0.1	0.1	0.0	1.2	0.7	0.2	9.7	10.4	7.4	10.5	11.1	13.0	11.3	14.7	10.9	9.9	13.5	8.3	3.0	9.6	10.9	4.6	0.4	1.5	5.5	21.3	3.4	5.4	7.9	7.5	5.5	5.7	21.3	12.9	16.7	12.2	0.0	2.0	23.5	15.1	453.5	88.6	5.8	3.3	4.9	1.7	8.1	9.3	3.4	6.4	6.1	7.7	0.0	4.8	2.2	2.3	4.2	5.0	6.9	2.3	32.6	0.8	1.2	66.8	12.5	1.4	3.6	1.0	0.1	12.9	0.0	5.0	2.6	7.2	4.0	9.1	0.4	3.5	0.5	26.1	199.1	21.3	0.0	4.7	7.7	163.7	20.6	3.6	3.1	20.1	0.7	13.9	2.3	5.2
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 455.4;Inhibitory neurons: 147.0;Microglial cells: 193.0;Oligodendrocyte precursor cells: 367.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 9.6"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		21000	"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavorable (4.41e-4)"	13.1	15.9	19.6	4.8	17.0	0.5	21.5	10.9	12.4	25.9	16.0	30.4	10.6	20.7	12.2	47.8	20.6	14.9	14.6	17.8	20.6	25.1	22.1	15.2	2.6	15.7	22.1	38.5	34.2	20.7	7.3	21.7	15.9	17.0	21.7	13.6	20.1	23.9	40.5	52.1	13.4	21.8	16.0	4.2	17.7	14.0	24.0	13.5	15.2	30.9	12.4	21.3	30.8	13.9	50.6	121.1	40.1	28.6	28.5	24.2	59.1	22.2	25.4	37.3	40.0	44.3	43.3	0.3	31.4	44.6	30.4	35.8	34.7	56.7	46.1	0.4	26.8	0.0	14.9	44.1	36.2	5.7	0.1	28.7	54.9	50.9	38.1	35.9	23.3	32.4	34.7	14.9	44.8	35.4	59.3	4.2	18.0	32.7	41.4	44.9	39.0	21.9	80.9	38.4	20.1	20.9	26.8	37.3	42.9	49.6	21.1	6.7	28.4	18.7	56.1	35.5	24.2	13.2	17.1	0.1	21.0	0.2	22.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	19.6	17.0	10.9	12.4	17.8	20.6	15.7	22.1	15.9	16.0	24.0	13.9	6.4	35.3	35.3	455.4	0.2	34.0	42.3	19.8	19.9	8.7	17.1	24.9	39.0	21.5	24.3	14.7	29.2	24.9	0.2	25.6	0.0	34.1	19.9	22.3	29.9	9.4	24.0	2.7	5.4	36.4	25.0	22.3	13.3	33.4	1.3	33.1	8.9	24.8	3.4	11.8	147.0	30.1	14.2	0.6	4.7	20.3	30.4	7.7	5.4	193.0	0.8	28.8	1.0	367.9	13.9	38.8	23.8	38.4	1.4	31.4	13.7	25.6	29.3	19.7	26.3	23.4	26.1	6.2	27.6	40.4	61.5	40.1	1.5	32.1	22.0	47.2
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 267.9;thyroid gland: 565.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.0	1.4	0.6	0.9	0.5	1.7	0.1	1.1	14.5	1.7	1.8	0.6	8.8	32.9	2.2	37.5	3.6	2.1	1.0	1.9	267.9	1.2	1.6	1.7	5.2	1.3	1.7	1.0	1.4	1.4	1.9	3.0	1.1	0.9	1.5	1.9	26.1	0.5	1.8	2.4	0.8	3.7	0.8	1.4	2.4	2.3	0.5	565.5	0.3	1.0	2.1	1.0	1.9	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.4	0.9	0.1	1.1	1.0	1.9	5.2	1.3	3.0	3.7	2.3	1.9	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase subunit alpha"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		290000	"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	35.4	56.3	29.0	12.4	29.8	6.2	25.8	55.5	34.6	22.3	44.4	37.5	13.2	14.9	218.2	19.4	17.4	11.6	35.4	28.6	26.3	111.7	104.3	12.0	8.0	28.9	27.4	19.9	27.6	25.7	12.3	21.3	31.1	25.9	27.6	25.2	26.9	16.9	17.6	18.6	18.0	13.7	30.3	17.2	40.9	9.2	33.9	11.4	20.4	27.2	6.4	21.3	17.5	38.7	10.6	18.5	29.8	9.9	27.9	24.2	16.6	10.2	15.4	9.5	9.0	23.0	13.9	0.8	15.2	10.1	12.0	11.8	9.1	14.1	15.6	17.5	10.1	24.6	12.7	49.7	15.4	1.2	11.3	22.4	15.2	8.8	14.6	23.0	19.6	13.0	9.8	13.4	17.1	11.6	2.6	54.8	18.6	37.2	8.1	21.4	12.9	17.3	167.0	20.5	91.1	10.9	7.0	38.4	17.9	31.9	27.9	43.1	14.3	9.6	8.0	6.7	7.3	13.1	12.9	0.4	18.4	131.6	6.9	1.6	9.1	1.7	4.5	11.2	5.9	3.6	2.8	4.2	13.5	2.3	3.9	4.9	1.1	8.7	12.3	1.1	6.5	5.2	29.0	29.8	55.5	34.6	28.6	26.3	28.9	27.4	31.1	30.3	33.9	38.7	11.3	3.2	8.7	152.8	6.6	1.9	29.1	12.7	8.6	15.5	13.5	8.8	10.5	52.9	14.8	20.2	29.2	25.7	4.3	20.7	99.7	19.7	17.6	76.5	22.4	12.0	3.6	3.4	152.8	8.4	6.9	12.9	12.2	72.9	14.0	20.7	12.1	48.8	11.8	28.6	166.5	12.4	12.2	14.2	2.2	12.0	8.7	8.2	5.4	217.4	6.0	11.5	10.3	200.6	182.5	5.8	17.5	13.5	9.4	11.2	13.2	86.9	13.2	31.7	13.1	12.3	10.1	7.2	6.2	10.6	3.8	30.2	6.4	17.6	27.6	19.2
PCDH20	"FLJ22218, PCDH13"	ENSG00000280165	"Protocadherin 20"	Q8N6Y1	13	61409685-61415522	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;smooth muscle: 9.0"	"Cell type enhanced"	"Detected in some"		"Club cells: 6.2;Excitatory neurons: 8.2;Inhibitory neurons: 7.9;Intestinal goblet cells: 5.3;Ionocytes: 6.1;Oligodendrocyte precursor cells: 32.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"RPTEC TERT1: 51.3"									HPA062669			Approved	"Vesicles,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles	"Cytokinetic bridge"	"HPA062669: AB_2732687"	"unprognostic (2.40e-1)"		"unprognostic (1.80e-1)"		"unprognostic (2.45e-1)"		"unprognostic (7.83e-2)"	"unprognostic (6.79e-4)"			"unprognostic (2.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.34e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.12e-1)"		0.5	1.1	3.0	0.3	4.4	0.0	0.9	1.0	11.2	2.3	0.0	3.1	0.9	3.1	2.6	0.7	0.5	0.6	3.5	18.0	3.7	0.8	1.3	3.3	0.0	1.5	4.6	0.3	0.1	0.0	0.5	0.4	1.3	1.0	1.7	0.0	0.7	1.0	0.4	1.0	1.0	9.0	2.3	1.2	1.0	0.1	2.8	0.8	0.2	0.7	0.0	0.6	0.5	2.3	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	51.3	0.0	0.7	1.9	0.0	3.6	0.5	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	4.4	1.0	11.2	18.0	3.7	1.5	4.6	1.3	2.3	2.8	2.3	0.0	3.2	0.5	2.3	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	5.3	6.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	32.6	1.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.2
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1047.0"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	20.9	8.2	0.6	24.6	0.8	43.2	36.4	0.4	1.2	29.9	0.7	44.4	21.6	10.7	2.9	205.9	25.7	197.6	1.4	0.5	0.7	1047.0	6.8	29.5	0.4	0.4	0.5	0.7	99.9	0.0	1.1	3.9	0.7	12.1	30.9	0.0	203.4	8.6	1.6	153.1	66.4	3.1	0.4	3.7	63.4	1.4	0.9	1.9	1.5	0.6	60.2	20.0	66.6	0.4	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.8	0.4	1.2	0.5	0.7	0.4	0.5	0.7	0.4	0.9	0.4	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 160.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 91.0;Proximal enterocytes: 49.5;Proximal tubular cells: 79.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.3;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes		"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	25.4	5.4	2.7	2.9	3.1	7.1	10.2	3.8	2.9	4.5	6.0	8.7	26.0	3.3	4.1	3.1	8.1	9.7	2.4	2.7	2.8	33.9	160.2	6.4	3.9	3.2	3.1	4.1	4.8	7.2	3.2	1.0	3.3	5.0	7.5	2.2	5.6	3.4	6.8	4.2	20.1	3.2	2.6	3.0	3.9	0.5	3.0	3.4	16.1	5.2	3.8	2.3	2.3	3.7	6.0	6.6	2.6	0.1	15.7	5.7	3.1	1.4	3.3	3.7	6.3	7.6	17.1	0.1	11.9	3.5	9.2	1.4	7.5	8.7	6.5	9.5	7.7	7.8	3.6	38.3	15.7	2.0	5.1	5.0	6.1	3.9	5.5	5.6	3.8	4.6	3.3	8.6	8.2	4.4	2.4	2.2	4.8	0.1	4.9	5.3	5.0	0.9	35.9	1.0	3.6	5.2	3.6	7.4	15.6	6.2	8.6	6.5	0.0	2.4	2.5	6.0	4.3	9.8	8.9	3.1	5.3	2.8	5.6	1.2	4.2	1.5	6.5	1.6	7.7	4.3	8.8	7.5	1.5	5.7	9.2	6.1	4.5	9.9	2.3	0.2	16.6	4.1	2.7	3.1	3.8	2.9	2.7	2.8	3.2	3.1	3.3	2.6	3.0	3.7	4.3	6.4	13.6	6.5	7.0	3.7	4.7	4.0	3.4	10.8	2.4	2.9	3.7	35.8	3.4	29.5	14.6	3.9	5.9	11.5	13.7	13.2	0.1	10.1	2.7	3.9	7.2	9.4	15.4	3.8	7.3	5.0	7.7	6.3	1.3	2.0	6.8	91.0	9.6	3.3	18.4	8.0	6.1	4.7	3.7	0.3	5.6	5.5	10.6	8.4	27.4	10.1	9.2	8.5	10.6	5.0	17.7	8.2	5.9	2.0	49.5	79.1	13.1	6.4	0.0	6.6	4.4	0.1	1.6	4.9	2.8	1.6	11.4	1.9	14.6	2.7
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.2	14.8	4.6	2.0	4.8	3.8	11.9	6.0	5.2	6.8	5.1	7.9	5.3	4.2	17.2	7.3	8.7	4.5	11.7	4.2	4.2	15.6	9.1	4.9	3.2	4.3	4.4	5.0	26.9	17.1	6.0	4.1	4.5	10.4	8.4	6.9	10.6	6.4	10.7	11.2	4.7	3.3	4.4	3.3	15.6	10.0	4.7	3.7	11.0	9.8	3.3	5.4	6.7	5.5	4.4	4.3	4.4	6.2	6.6	9.8	2.4	6.1	8.9	7.5	7.4	4.9	6.0	1.5	11.3	8.3	8.5	5.3	3.3	13.8	9.8	5.7	7.5	6.4	4.3	0.9	13.9	8.1	5.3	9.6	13.1	5.4	7.9	8.7	5.4	12.0	13.0	5.2	10.6	13.4	3.5	7.9	5.0	13.9	8.3	4.8	3.4	5.7	17.4	6.4	8.3	10.6	6.5	9.0	8.4	4.9	5.8	7.7	2.5	4.8	1.7	7.3	5.3	6.9	5.1	0.0	4.2	6.4	4.9	2.9	1.3	2.2	0.7	1.0	0.7	1.5	1.3	1.6	2.3	1.0	2.4	1.5	0.9	1.6	1.9	1.8	2.3	0.9	4.6	4.8	6.0	5.2	4.2	4.2	4.3	4.4	4.5	4.4	4.7	5.5	4.9	3.2	9.4	10.7	6.3	12.1	14.9	16.5	9.1	9.1	19.5	13.8	18.7	11.5	14.7	11.0	8.4	19.6	2.3	11.6	60.7	16.5	12.5	18.7	6.4	5.6	10.3	15.8	12.4	22.7	21.0	6.8	10.2	11.1	14.0	7.9	6.1	7.0	12.4	0.0	14.7	21.8	30.5	5.7	6.2	10.2	9.0	6.4	14.2	5.6	11.9	20.8	4.1	17.6	19.9	16.7	13.2	9.8	3.7	16.0	15.0	38.3	16.1	9.9	6.6	5.7	8.2	30.6	16.7	15.4	18.2	17.1	6.6	24.3	17.2	17.4
PHYHD1	MGC16638	ENSG00000175287	"Phytanoyl-CoA dioxygenase domain containing 1"	Q5SRE7	9	128920966-128942041	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Muller glia cells: 139.3;Proximal tubular cells: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 13.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 13.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 32.7;BEWO: 50.6;HSkMC: 28.3;RPTEC TERT1: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012115			Approved	"Nuclear speckles"		NA	NA		36000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA012115: AB_1859448"	"unprognostic (1.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.38e-10)"	"unprognostic (1.10e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.83e-3)"	28.2	25.7	41.9	3.2	39.9	8.4	34.6	37.9	40.8	39.8	41.7	24.4	2.3	33.8	38.3	25.6	28.5	13.2	35.1	36.3	46.9	49.9	78.7	23.1	4.5	48.1	51.9	39.1	70.2	15.6	15.5	9.6	46.5	36.8	3.8	41.8	40.0	30.0	29.3	43.7	12.4	15.4	48.1	14.7	33.4	7.2	47.9	6.8	43.0	12.8	4.6	25.9	25.6	48.7	0.2	0.5	0.4	0.8	46.5	32.7	50.6	3.7	0.0	3.4	6.0	1.8	0.5	0.7	0.4	3.0	0.3	0.7	0.4	0.3	2.9	0.5	5.4	0.1	6.7	18.0	15.1	0.8	0.6	28.3	1.0	0.4	0.2	0.2	0.3	0.3	0.3	1.2	24.3	0.4	0.5	0.7	17.0	0.2	0.2	20.5	9.7	0.3	78.9	0.7	1.1	0.4	0.5	0.3	0.3	11.4	4.7	0.6	1.3	0.7	2.1	0.7	0.5	0.4	0.9	20.7	0.3	0.4	0.7	1.3	0.2	0.2	1.3	0.3	0.3	2.8	0.4	0.5	1.7	0.7	1.8	1.9	0.8	2.2	0.4	13.0	0.3	0.5	41.9	39.9	37.9	40.8	36.3	46.9	48.1	51.9	46.5	48.1	47.9	48.7	8.5	32.1	34.3	51.6	3.7	22.0	63.2	26.8	57.5	9.4	40.0	46.9	19.8	10.0	31.0	33.1	29.2	58.8	3.4	0.7	119.3	11.4	0.4	27.0	26.0	9.5	1.2	12.0	1.2	15.8	30.0	34.5	7.7	53.8	0.0	42.8	31.8	82.2	10.7	3.3	0.8	2.4	4.1	3.2	5.5	4.2	68.6	3.1	12.4	5.6	0.1	139.3	4.1	1.0	0.7	14.2	0.5	66.2	2.6	19.3	0.0	161.5	14.6	67.5	52.6	48.1	17.8	0.9	3.9	32.7	24.3	30.9	2.7	44.6	1.4	35.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1 ciliary IPT domain containing fibrocystin/polyductin"	P08F94	6	51615299-52087613	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 4.7;kidney: 13.6;pancreas: 9.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 60.1;Collecting duct cells: 46.0;Early spermatids: 293.6;Late spermatids: 83.1"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favorable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.1	1.1	0.0	0.0	0.0	13.6	1.5	0.0	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.3	1.4	60.1	0.0	46.0	0.0	0.1	0.0	0.1	1.9	18.2	293.6	0.2	0.0	0.3	0.0	0.0	3.2	0.9	0.1	0.1	2.6	0.4	0.0	0.0	0.0	3.7	0.1	0.0	2.8	0.0	0.0	0.0	0.0	83.1	2.1	0.5	5.4	0.0	0.0	3.1	0.0	0.5	0.7	2.6	0.0	0.4	0.0	0.4	0.0	23.3	0.0	0.1	0.0	0.0	0.1	15.0	1.7	0.0	0.0	0.0	0.3	0.0	0.1	0.8
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.4;intestine: 90.8;parathyroid gland: 63.7;placenta: 60.4"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 542.7;Distal enterocytes: 750.2;Extravillous trophoblasts: 420.5;Langerhans cells: 251.9;Late spermatids: 251.1;Paneth cells: 355.4;Proximal enterocytes: 255.0;Syncytiotrophoblasts: 959.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 70.4"	"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 34.8"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 34.8"	"Cell line enhanced"	"Detected in many"		"AF22: 71.8;MCF7: 84.9;OE19: 91.2;PC-3: 112.5;RPTEC TERT1: 187.1;SCLC-21H: 157.7"	"Region enhanced"	"Detected in all"		"cerebellum: 63.0"	"Region enhanced"	"Detected in all"		"cerebellum: 45.0"	HPA030156	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	2.2	5.8	4.4	9.0	3.9	0.2	23.3	70.4	5.2	4.9	3.4	90.8	15.5	3.4	3.4	5.2	5.5	5.7	0.5	5.9	6.9	2.8	8.2	4.1	2.2	13.9	7.4	0.8	6.3	63.7	22.1	60.4	14.6	6.2	62.4	56.1	8.5	2.4	0.7	9.1	28.3	3.9	3.9	3.2	34.4	4.2	6.8	3.7	1.1	0.6	4.1	5.4	1.2	5.0	0.1	2.8	71.8	0.3	0.6	0.3	62.4	0.0	0.8	0.3	1.2	0.4	3.0	0.0	0.4	0.0	3.8	0.3	0.0	1.5	0.8	0.4	3.7	1.2	3.9	1.7	0.2	0.0	12.3	0.3	1.2	1.2	15.3	34.0	0.3	0.5	22.3	0.4	0.2	84.9	0.3	0.4	29.6	91.2	112.5	0.6	10.8	0.4	187.1	10.6	157.7	0.2	0.0	17.1	2.0	39.4	12.0	1.8	5.7	0.2	47.3	0.2	6.2	0.2	0.3	0.2	46.7	1.5	0.4	0.0	0.6	0.0	0.0	3.2	0.7	0.0	0.0	0.0	34.8	0.1	0.4	0.1	0.1	1.9	0.3	0.5	0.4	0.7	4.4	3.9	70.4	5.2	5.9	6.9	13.9	7.4	14.6	3.9	6.8	5.0	3.0	3.2	3.9	17.0	4.6	19.8	2.3	2.5	2.8	23.6	94.8	53.3	0.3	2.8	10.2	1.8	4.2	542.7	0.9	750.2	19.6	22.6	106.0	5.3	1.6	3.9	98.0	4.0	5.5	35.8	420.5	6.9	52.0	5.5	38.7	0.3	1.1	3.8	53.1	6.7	15.5	94.9	14.2	75.5	251.9	251.1	1.2	51.2	44.4	9.4	25.5	15.2	0.0	6.0	8.5	50.4	355.4	0.4	1.2	13.8	255.0	26.9	58.3	54.8	6.6	0.3	2.7	3.3	5.8	12.4	17.0	959.8	3.5	0.2	92.9	8.3
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917496	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.8;urinary bladder: 128.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.0;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	647000	88000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	57.6	4.8	2.5	41.7	2.7	36.2	17.6	2.7	8.9	9.3	4.4	13.1	11.9	22.0	16.7	14.4	10.3	28.5	23.1	2.4	2.9	103.8	5.0	22.0	14.3	3.8	2.9	2.3	10.1	8.3	2.9	36.5	5.4	9.1	18.2	0.3	17.3	13.7	10.8	25.5	13.7	23.4	3.3	40.6	15.7	3.7	4.7	5.9	17.9	18.9	7.2	128.5	16.2	4.7	171.1	88.9	36.8	1.7	3.1	59.5	2.0	101.9	461.6	40.0	62.2	2.3	856.0	0.1	184.0	14.5	416.9	114.1	0.9	165.8	44.8	9.9	0.0	0.1	4.4	1.7	72.6	15.6	32.3	158.7	20.2	271.4	103.7	447.0	114.7	1.0	1.1	0.9	822.4	0.2	0.2	22.7	10.8	0.3	244.5	0.4	112.6	0.9	3100.7	130.6	0.1	0.2	0.3	4.0	2.4	25.4	1.2	22.9	300.6	3.5	20.3	21.6	869.8	0.2	1.3	1.6	216.0	25.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.1	2.5	2.7	2.7	8.9	2.4	2.9	3.8	2.9	5.4	3.3	4.7	4.7	29.0	3.2	4.6	0.3	1.4	37.3	635.9	237.3	19.9	0.0	3.0	24.4	2.5	0.0	103.6	29.5	0.0	28.0	1.6	0.6	68.4	62.7	0.5	50.7	22.2	46.4	3.5	0.0	0.2	21.3	21.7	69.7	0.0	68.9	31.1	0.1	3.9	0.0	39.8	0.0	0.3	0.1	140.4	4.0	33.1	1.3	2.5	53.4	7.2	4.7	23.8	0.0	0.0	0.5	0.2	613.9	0.3	0.0	0.5	695.0	0.0	1.4	35.4	0.0	6.6	27.6	65.2	0.0	0.2	60.6	29.5	17.5	4.7	0.6	1.7	869.6
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.6;salivary gland: 57.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Region enhanced"	"Detected in all"		"cerebellum: 55.6"	"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	6.3	7.2	8.6	3.4	3.7	0.5	7.0	55.6	6.3	4.6	31.0	20.5	2.6	8.2	24.4	9.0	15.0	5.9	17.9	2.5	10.8	3.0	0.3	5.4	1.7	13.4	17.8	2.1	2.1	0.7	8.2	6.5	12.0	9.7	17.9	15.1	57.4	6.1	2.7	4.6	4.2	9.1	5.3	1.3	14.4	2.4	23.3	4.5	32.7	6.8	2.3	8.2	5.3	6.5	0.0	15.1	7.9	0.0	0.0	0.4	0.1	35.8	9.5	10.9	6.1	3.4	2.6	0.0	0.6	91.4	39.0	0.1	2.3	7.6	14.7	0.0	5.3	3.8	5.7	0.0	1.6	0.0	0.0	2.3	3.0	12.7	45.9	18.7	0.1	0.0	4.3	0.4	77.6	5.0	0.0	0.0	8.8	48.2	10.4	0.0	0.0	0.7	96.9	5.8	25.5	18.4	0.0	23.8	15.1	10.5	19.2	0.2	0.5	11.2	0.9	1.2	14.2	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	8.6	3.7	55.6	6.3	2.5	10.8	13.4	17.8	12.0	5.3	23.3	6.5	37.8	6.4	0.5	60.1	0.3	2.4	3.8	1.5	2.2	82.9	5.7	5.3	72.6	0.0	8.9	5.5	0.0	0.0	4.5	17.9	0.0	0.7	1.4	46.2	4.6	40.4	42.0	0.0	105.9	0.2	0.0	9.0	18.8	53.5	0.0	36.6	1.8	0.0	0.1	164.9	113.8	36.4	14.2	0.0	2.1	1.2	1.5	0.8	7.2	183.6	0.6	2.9	0.0	168.9	2.9	7.1	9.7	20.7	0.2	8.5	2.1	1.2	39.5	6.6	13.1	10.5	36.0	1.5	2.0	0.5	1.0	0.1	1.4	4.8	40.4	2.5
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 203.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	18.0	10.4	21.2	13.9	25.5	4.4	19.6	10.7	42.0	18.6	5.0	21.4	25.9	25.9	20.5	39.4	12.7	24.0	29.2	25.9	14.8	39.1	38.7	36.6	14.9	12.4	14.9	19.2	27.3	27.6	21.8	37.3	13.3	17.9	20.1	19.8	25.2	18.8	31.8	66.5	25.1	23.6	13.2	13.7	21.2	40.7	13.7	15.6	27.3	57.4	18.0	24.9	21.7	36.9	25.9	23.5	23.3	16.1	33.1	37.5	28.0	28.2	49.1	16.8	18.0	20.0	31.8	16.1	13.3	25.6	17.0	55.4	22.3	86.1	15.4	11.4	21.8	0.0	22.6	23.6	21.8	2.9	7.3	20.5	69.7	13.9	58.3	27.5	56.8	33.2	24.3	0.1	15.6	9.9	14.8	2.5	18.1	39.3	15.5	4.0	33.1	3.2	203.2	28.3	31.6	15.5	36.4	26.8	28.9	32.7	14.9	0.3	54.6	14.1	11.5	15.4	14.3	0.1	0.0	5.4	21.6	0.1	8.8	0.3	2.7	2.3	27.1	2.4	17.5	5.1	16.3	21.9	3.2	10.3	25.4	21.9	0.8	21.3	2.9	1.6	11.9	11.6	21.2	25.5	10.7	42.0	25.9	14.8	12.4	14.9	13.3	13.2	13.7	36.9	48.6	144.2	42.0	19.9	28.0	72.8	54.7	51.6	97.9	46.5	25.6	19.2	55.9	55.8	46.0	57.0	75.0	58.4	47.6	39.1	41.1	63.1	202.0	50.2	30.6	70.8	22.3	6.9	133.8	85.3	53.9	34.3	28.1	83.7	5.1	20.8	32.5	45.1	37.2	26.9	92.9	19.6	22.4	23.7	23.6	336.5	44.1	20.4	24.9	35.6	28.5	20.2	147.2	35.2	161.9	71.4	26.9	36.1	7.4	91.4	64.4	118.1	29.1	49.5	26.3	32.2	28.9	119.4	86.1	71.6	84.8	39.7	39.7	14.7	27.5	83.5
POGLUT2	"EP58, KDELC1, MGC5302"	ENSG00000134901	"Protein O-glucosyltransferase 2"	Q6UW63	13	102784281-102798976	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Extravillous trophoblasts: 23.3;Fibroblasts: 3.8;Hofbauer cells: 3.3;Syncytiotrophoblasts: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.9;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020780, HPA043946, HPA064398"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		44000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256"	"unprognostic (1.97e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (4.81e-4)"	"unprognostic (4.34e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.60e-3)"	4.6	2.3	1.5	3.1	2.2	1.6	3.3	2.2	2.4	5.6	1.6	3.5	1.3	11.1	4.3	2.6	4.3	8.1	4.8	1.5	1.5	4.6	7.7	3.4	2.4	1.8	1.7	6.5	1.6	2.8	2.1	12.2	1.9	2.7	2.7	3.4	1.8	4.2	0.8	2.3	2.1	12.5	1.7	3.6	2.4	1.5	1.9	1.9	2.9	2.5	1.9	6.0	3.2	2.7	8.1	6.0	36.8	35.5	37.0	28.5	9.0	21.4	16.4	19.5	33.5	17.1	11.5	0.0	16.7	17.6	10.0	13.3	26.6	10.9	19.5	3.4	22.1	9.8	16.3	18.8	32.1	25.4	34.5	27.0	12.3	14.8	14.2	29.1	43.0	12.3	16.3	0.0	10.5	9.0	11.4	20.8	23.5	11.5	17.9	0.0	26.3	9.5	53.7	0.7	5.5	33.7	21.0	5.6	12.3	30.5	16.1	10.9	13.3	12.8	9.3	14.7	21.6	7.4	14.4	0.0	25.2	0.0	22.6	0.0	0.0	0.0	1.4	0.0	2.4	0.2	0.7	1.1	0.6	0.0	0.2	0.7	0.0	3.9	0.0	0.0	0.9	0.2	1.5	2.2	2.2	2.4	1.5	1.5	1.8	1.7	1.9	1.7	1.9	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	23.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0
PPA2	FLJ20459	ENSG00000138777	"Inorganic pyrophosphatase 2"	Q9H2U2	4	105369077-105474067	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	7.4	12.8	23.8	9.0	24.6	22.0	12.0	24.3	53.7	7.4	29.5	17.4	14.2	7.4	12.5	10.8	8.4	8.0	27.5	23.7	26.3	20.7	14.8	7.5	8.3	24.4	24.3	5.8	11.8	11.7	7.7	7.4	24.5	13.3	14.0	13.6	13.8	5.7	27.6	12.2	13.8	6.8	24.0	9.9	12.6	6.3	25.4	7.0	11.5	35.5	8.7	8.1	6.7	26.6	20.6	8.5	18.5	32.3	11.3	9.1	12.9	10.2	15.7	14.6	9.9	22.2	30.4	15.6	14.5	9.7	11.3	9.5	39.2	18.7	17.0	23.6	11.8	13.5	13.7	19.9	9.3	36.7	13.6	9.7	19.6	9.9	7.9	15.4	14.6	28.4	22.3	22.0	12.5	26.2	32.5	26.6	13.9	42.4	28.3	28.2	10.9	17.9	49.7	14.7	17.8	10.7	7.8	48.9	19.0	10.7	24.8	32.1	6.9	9.2	19.2	8.9	20.0	19.0	27.3	18.4	17.5	18.6	14.1	27.0	20.9	15.4	21.0	30.1	18.6	28.5	21.7	23.7	49.9	22.6	21.1	23.9	9.5	36.4	26.4	25.9	23.4	23.5	23.8	24.6	24.3	53.7	23.7	26.3	24.4	24.3	24.5	24.0	25.4	26.6	26.7	9.6	67.3	86.2	37.6	50.0	82.4	205.0	38.1	29.7	64.8	40.9	63.3	45.8	126.2	33.1	16.7	119.0	25.9	73.3	264.1	114.0	113.7	42.3	35.3	36.3	65.7	70.2	138.2	120.1	98.5	31.1	37.2	42.3	45.6	26.4	24.3	64.2	83.5	21.9	134.6	104.6	142.4	42.9	86.1	126.4	27.7	47.1	76.5	74.9	50.5	39.2	30.9	169.9	145.7	65.0	90.4	32.4	41.9	68.1	112.2	285.4	90.7	22.6	39.5	46.3	43.6	50.8	10.8	59.1	57.7	84.7	34.3	72.1	138.0	94.6
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 218.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA		75000	"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	40.2	20.4	41.2	19.5	48.0	44.0	23.9	45.1	61.8	23.0	43.1	28.6	20.3	23.9	30.0	22.5	21.2	21.8	33.3	38.6	42.1	29.0	44.0	21.9	28.7	41.4	44.1	22.9	32.4	35.8	18.9	18.8	42.1	30.6	28.7	49.9	27.0	23.3	129.4	20.5	21.7	22.8	40.2	26.4	23.1	21.4	42.7	36.0	22.8	86.5	27.0	24.7	21.4	50.9	37.1	32.8	41.8	31.2	51.3	23.8	47.6	27.9	32.0	28.2	24.8	43.8	23.3	40.7	42.4	32.4	23.0	19.6	47.6	18.2	41.6	41.7	18.4	42.9	19.9	30.8	41.4	38.6	34.1	23.0	31.5	22.5	37.9	22.2	23.5	18.4	31.7	41.5	25.7	30.6	38.6	61.5	52.4	33.4	11.0	40.5	46.6	27.1	66.3	36.9	33.7	42.5	25.3	37.4	33.5	62.3	20.2	26.7	21.6	24.7	35.5	20.6	27.8	36.2	25.5	37.7	13.4	63.2	18.3	6.9	2.2	8.1	4.6	3.0	3.9	4.2	4.3	3.9	3.7	4.5	5.8	4.0	6.1	3.2	3.6	3.6	4.3	1.1	41.2	48.0	45.1	61.8	38.6	42.1	41.4	44.1	42.1	40.2	42.7	50.9	17.4	19.2	20.8	78.4	49.3	60.5	40.3	14.4	35.3	51.9	31.8	19.9	55.4	38.6	24.0	40.5	64.6	31.5	68.6	64.5	46.9	42.5	68.5	44.1	33.3	22.0	40.2	32.8	95.9	46.4	29.7	33.7	35.2	62.4	26.6	27.4	20.3	55.0	26.8	107.7	91.8	31.5	30.5	55.2	63.0	43.0	35.8	45.0	56.9	38.4	46.7	57.5	51.5	112.6	218.0	44.7	46.6	33.8	51.9	71.2	26.8	41.0	16.9	147.5	26.3	33.5	32.4	48.5	27.7	36.6	62.4	64.6	63.8	29.5	37.3	88.7
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 259.7;skeletal muscle: 831.6;tongue: 271.1"	"Cell type enriched"	"Detected in many"	4	"Distal tubular cells: 1348.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.8;NTERA-2: 29.4;RPTEC TERT1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007811, HPA041542"	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	241.3	2.6	37.1	1.1	73.6	0.3	169.8	26.1	45.7	1.6	20.4	29.6	3.0	2.2	0.7	10.3	3.8	1.5	110.9	38.9	36.9	259.7	138.1	1.0	0.5	29.0	32.0	7.7	14.2	20.8	1.8	0.0	26.0	7.9	1.8	14.6	9.7	3.2	831.6	7.6	13.2	3.3	25.5	0.5	27.8	2.2	31.6	0.2	2.6	271.1	0.5	5.4	1.5	34.1	0.0	0.0	3.9	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.4	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	0.0	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	73.6	26.1	45.7	38.9	36.9	29.0	32.0	26.0	25.5	31.6	34.1	7.9	0.0	0.0	3.3	3.4	0.1	0.0	0.0	0.0	2.2	23.7	40.6	300.7	5.7	0.0	18.4	0.0	0.0	0.5	0.0	1348.0	3.5	1.6	10.4	0.5	4.6	2.4	2.7	3.1	0.4	0.1	24.5	0.0	13.8	0.0	21.0	6.4	218.4	0.6	112.7	1.8	2.1	0.0	3.8	0.0	1.9	1.2	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.5	2.5	0.1	1.2	0.0	0.3	0.5	156.8	0.0	2.8	0.0	19.2	21.6	0.2	5.9	0.0	0.3	0.0	0.9	4.2	2.0	0.2
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167720-119178812	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1060.4;Proximal tubular cells: 937.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	165.7	335.3	92.4	96.0	92.6	82.3	138.3	101.3	116.0	103.4	139.2	133.3	137.8	87.0	120.8	83.3	116.7	88.0	278.2	95.2	104.5	385.7	571.2	74.9	108.4	97.2	97.1	74.9	96.2	223.8	60.0	126.3	99.0	126.7	139.8	52.5	132.1	131.7	376.0	38.0	132.1	130.0	100.4	76.3	97.5	48.3	98.6	98.3	176.7	402.7	104.0	112.8	65.1	102.7	350.6	392.2	234.1	267.3	241.7	259.8	145.9	244.8	414.8	364.5	380.7	303.4	339.9	407.2	208.8	290.8	173.4	155.5	391.5	296.1	408.8	401.5	411.4	183.7	149.7	542.4	252.5	347.8	212.7	306.8	186.4	292.1	269.7	261.2	268.6	245.2	230.0	82.5	338.7	140.2	265.1	292.7	218.9	264.0	229.3	276.5	339.7	281.5	623.8	164.6	103.0	149.2	259.8	346.1	332.2	201.0	179.6	411.5	190.5	118.3	178.1	170.9	323.1	128.0	200.7	327.0	185.7	507.4	107.3	144.4	429.1	246.9	110.5	369.5	142.7	179.9	145.6	134.6	382.1	149.8	149.5	134.0	239.9	132.8	333.9	214.8	205.7	510.2	92.4	92.6	101.3	116.0	95.2	104.5	97.2	97.1	99.0	100.4	98.6	102.7	61.4	48.1	74.5	14.4	65.1	69.8	117.8	274.0	81.4	27.5	145.2	105.2	236.5	131.5	119.0	147.1	10.4	328.4	50.6	84.5	1060.4	124.5	5.0	105.1	76.0	78.3	110.9	132.8	15.4	75.1	212.0	100.8	116.7	77.3	52.6	131.0	73.2	390.0	247.6	40.4	15.4	132.5	221.8	164.2	96.0	10.5	77.3	127.9	133.4	10.3	158.4	76.9	39.1	12.5	18.8	63.8	99.3	101.2	153.7	95.1	176.1	937.8	163.4	24.8	72.3	63.1	105.3	11.2	23.2	146.4	52.6	155.0	56.1	440.0	207.0	119.6
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645314-56715335	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;skeletal muscle: 38.7;tongue: 36.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	1.4	1.4	2.0	0.5	3.5	0.0	3.3	3.0	3.5	1.4	4.1	5.0	0.5	1.8	1.1	4.7	2.7	1.9	40.8	3.9	2.1	13.6	0.7	1.4	0.1	0.9	1.3	1.5	1.8	8.3	1.3	0.5	0.9	3.8	1.4	13.5	4.3	2.6	38.7	0.7	1.3	3.1	0.3	1.3	2.2	1.1	1.3	0.4	3.3	36.4	0.1	1.8	1.3	1.5	0.0	3.8	2.1	0.0	0.7	0.5	2.3	1.9	1.5	2.5	4.3	3.9	4.9	0.0	0.6	0.6	7.5	0.1	8.0	0.0	7.1	0.0	8.8	0.0	7.0	5.5	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.8	0.8	2.0	0.0	0.0	1.1	0.1	0.0	0.0	5.6	0.0	5.5	0.0	0.0	0.0	14.1	1.3	2.0	5.5	6.0	0.1	0.0	6.0	3.3	0.0	0.0	1.5	2.3	2.8	6.6	0.0	0.0	0.0	4.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.5	3.0	3.5	3.9	2.1	0.9	1.3	0.9	0.3	1.3	1.5	1.1	9.6	4.8	30.7	2.0	0.9	8.0	6.7	2.2	42.0	19.4	9.5	328.5	24.3	14.3	49.7	50.1	1.0	0.2	6.1	54.8	9.5	3.9	14.4	2.9	10.3	14.4	0.0	109.4	4.8	0.4	15.3	5.1	17.4	2.5	11.7	9.7	8.1	0.1	26.9	119.0	6.3	8.2	0.0	1.6	4.8	6.8	1.4	5.4	18.7	0.0	18.6	0.0	84.9	20.4	6.2	3.0	29.3	0.0	21.2	0.2	82.4	10.7	115.5	6.6	24.5	17.2	7.2	3.7	17.7	0.4	0.4	1.2	5.3	6.1	13.4
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 272.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 581.7;Respiratory ciliated cells: 144.8;Rod photoreceptor cells: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.2;CACO-2: 70.6;CAPAN-2: 28.9;EFO-21: 62.2;NTERA-2: 97.4;RPTEC TERT1: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004922, CAB011525, HPA031053"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.3	0.3	4.1	6.2	3.0	4.0	27.7	2.7	3.5	44.9	2.0	30.7	12.4	6.0	4.3	5.1	5.4	30.9	6.7	3.3	2.8	20.9	1.8	3.1	0.0	3.8	4.3	0.1	14.4	0.0	0.1	30.1	3.6	2.8	16.7	272.9	57.9	7.1	1.0	0.9	22.9	3.5	2.8	0.2	24.8	8.0	5.0	0.1	4.8	0.0	0.1	4.2	0.2	3.1	0.0	0.0	37.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	70.6	28.9	0.6	62.2	0.0	0.0	0.1	7.3	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	97.4	0.0	0.0	1.4	0.1	0.0	91.1	0.1	12.0	3.6	0.0	2.4	1.9	3.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.0	2.7	3.5	3.3	2.8	3.8	4.3	3.6	2.8	5.0	3.1	0.2	3.2	4.8	1.3	0.3	0.0	0.1	7.2	0.0	14.8	38.2	30.0	8.6	31.5	29.9	82.8	581.7	0.6	1.0	39.3	0.0	64.1	31.4	71.1	1.7	5.1	44.4	2.1	0.9	15.5	0.1	4.4	31.6	14.8	0.0	3.8	0.7	0.1	0.1	10.1	5.4	15.0	34.6	0.0	0.0	44.3	3.1	0.7	0.0	27.2	0.6	47.5	0.0	45.8	1.2	38.2	28.3	6.4	0.4	1.5	18.8	3.6	144.8	311.3	0.0	0.8	3.1	2.1	1.0	0.7	0.0	0.1	0.7	0.3	26.0	4.1
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349309-37457292	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.4"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: AB_2686878"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favorable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	8.6	3.7	12.3	2.1	24.9	0.2	5.2	21.6	19.7	4.4	4.7	4.0	2.9	4.3	1.5	4.1	2.6	8.8	6.4	12.9	15.9	10.5	7.9	5.5	1.7	26.7	21.3	4.2	1.6	1.2	1.4	8.1	25.3	3.4	4.1	1.5	2.9	7.8	15.9	2.2	3.0	5.4	18.4	2.9	2.4	1.5	18.4	1.5	8.3	7.8	1.0	5.6	3.8	39.4	32.3	7.2	5.6	5.6	18.7	15.4	2.4	14.1	17.6	4.7	8.2	17.1	20.2	0.0	21.8	10.4	8.9	10.7	15.6	10.0	8.3	0.1	5.2	5.2	7.7	5.7	22.6	0.0	7.2	23.2	8.1	9.1	7.7	9.4	24.8	0.0	2.6	0.1	16.5	2.4	0.1	0.1	6.8	5.1	13.4	0.0	13.1	0.0	79.2	1.7	0.0	0.1	9.7	15.6	6.1	15.3	0.1	3.5	17.6	7.5	4.2	14.2	4.1	0.0	0.1	0.0	7.3	0.0	7.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.3	24.9	21.6	19.7	12.9	15.9	26.7	21.3	25.3	18.4	18.4	39.4	29.7	6.4	4.2	15.7	0.0	11.3	4.8	7.6	5.2	2.2	5.3	5.3	8.1	15.7	2.7	33.1	0.0	7.0	0.2	7.6	7.9	6.8	0.7	3.3	12.9	18.4	3.0	0.0	23.3	3.1	14.9	9.6	4.6	9.2	1.3	3.9	17.9	16.3	4.8	18.5	10.8	5.7	14.2	4.1	5.3	0.4	4.7	1.4	3.6	31.9	0.8	2.2	0.0	12.5	229.8	18.7	7.5	2.6	0.0	9.1	4.3	9.4	2.9	0.5	6.6	8.3	8.4	2.5	4.2	5.2	6.3	10.4	0.4	3.5	4.8	8.1
PSENEN	PEN2	ENSG00000205155	"Presenilin enhancer, gamma-secretase subunit"	Q9NZ42	19	35745600-35747519	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 573.3;Respiratory ciliated cells: 954.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047435	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047435: AB_2680047"	"unprognostic (1.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.41e-3)"	50.4	65.7	87.8	39.0	86.9	35.6	54.2	91.0	89.6	59.4	127.3	57.3	42.0	46.5	134.6	69.5	228.0	37.8	55.2	88.5	96.1	76.5	78.4	54.9	41.2	95.5	103.8	37.5	63.0	75.1	60.0	36.4	100.2	46.7	63.4	38.5	55.6	53.3	51.9	45.4	43.1	47.7	96.0	57.6	52.2	148.9	89.3	54.0	58.4	46.7	61.7	59.3	44.6	97.5	94.2	187.8	75.1	87.2	136.5	85.3	43.2	49.8	108.9	111.0	117.7	52.3	173.7	48.9	116.0	99.4	76.2	54.6	65.3	86.1	105.0	81.8	55.1	34.5	44.1	50.6	118.9	53.7	60.5	88.8	153.4	129.7	106.2	95.8	112.2	94.1	53.7	116.5	127.8	108.5	62.8	63.7	55.9	214.9	49.7	58.8	30.2	89.9	226.4	46.7	62.1	94.5	65.6	144.3	45.6	98.8	92.0	119.7	46.4	88.4	52.9	60.3	81.1	88.0	107.6	62.1	152.0	50.3	72.1	140.8	208.3	202.0	131.3	232.9	123.9	109.3	95.8	114.0	154.8	100.4	73.1	92.9	539.2	91.4	191.1	337.1	107.4	245.3	87.8	86.9	91.0	89.6	88.5	96.1	95.5	103.8	100.2	96.0	89.3	97.5	58.4	38.5	38.2	4.2	53.5	38.7	59.3	192.5	39.3	13.2	55.6	36.7	29.7	51.5	137.6	128.8	14.6	92.5	73.2	132.8	60.7	146.8	199.1	573.3	42.7	52.4	70.2	36.6	1.9	151.0	135.9	50.5	34.1	75.6	57.7	22.5	42.1	49.7	164.4	6.7	2.1	66.1	185.1	51.2	90.9	126.5	54.7	69.8	71.2	1.9	85.9	58.6	86.5	2.0	6.3	171.4	152.5	40.6	83.1	44.2	122.4	194.4	954.0	19.7	52.6	33.9	147.7	344.8	35.8	48.4	48.4	104.1	53.3	56.3	67.3	74.0
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 190.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 6.9;basal ganglia: 16.5;cerebral cortex: 8.7;hippocampal formation: 14.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	6.8	5.5	6.9	5.6	16.5	2.3	10.3	1.0	8.7	5.9	0.0	8.3	12.7	4.9	4.4	4.5	5.1	5.3	7.1	14.1	1.3	31.5	14.0	6.0	7.9	0.0	0.0	2.0	7.5	9.2	1.3	5.6	0.0	7.1	8.0	11.8	8.3	4.6	9.2	5.4	10.0	3.3	0.0	6.9	14.1	1.1	0.8	7.3	10.6	10.0	7.9	9.0	3.7	0.0	26.9	11.7	0.1	4.8	7.0	13.0	14.7	6.9	0.7	2.6	3.5	10.7	20.9	25.0	5.9	4.5	1.2	11.4	8.3	4.3	4.3	30.2	9.9	24.9	6.1	5.6	7.2	8.2	8.0	8.2	17.0	8.0	1.3	0.1	1.5	22.9	17.5	8.4	4.1	7.8	17.8	9.5	5.7	15.9	2.5	13.7	2.4	13.1	43.2	6.4	22.7	1.4	12.5	3.7	23.3	5.2	8.6	30.4	3.4	0.2	6.3	5.5	0.1	6.3	7.6	25.2	3.3	14.7	8.7	3.4	7.2	4.7	7.5	11.6	8.1	9.2	8.8	8.1	7.6	5.8	6.8	7.1	2.2	5.6	10.3	6.7	14.2	5.9	6.9	16.5	1.0	8.7	14.1	1.3	0.0	0.0	0.0	0.0	0.8	0.0	12.1	28.9	26.3	2.9	13.5	11.0	14.7	7.7	9.6	0.9	13.6	9.4	29.5	15.7	20.6	29.5	0.0	19.6	10.2	19.5	52.8	22.5	0.3	10.7	5.5	8.3	11.5	9.4	0.5	34.4	18.7	10.2	41.8	17.8	24.1	5.1	11.4	24.3	15.6	0.0	0.2	13.1	18.3	17.1	6.5	0.3	0.9	12.3	8.8	10.3	14.6	13.9	33.0	0.0	0.2	26.8	26.7	0.0	8.1	11.4	19.8	190.5	14.4	9.9	6.6	7.7	16.0	1.1	6.5	7.6	12.4	12.0	13.2	3.0	19.2	22.2
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877721-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 586.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Extravillous trophoblasts: 60.8;Proximal tubular cells: 324.8;Sertoli cells: 138.1"	"Group enriched"	"Detected in many"	4	"renal cancer: 18.8;testis cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075879	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA075879: "	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	32.5	72.2	45.0	1.1	43.8	0.0	20.2	45.7	60.8	43.8	38.0	10.3	1.2	19.1	2.7	3.7	20.3	3.5	33.0	42.6	43.5	586.8	84.6	25.6	2.4	46.5	44.9	22.2	7.6	1.2	5.9	16.0	46.7	12.4	0.6	0.7	2.7	3.5	7.7	9.8	9.6	2.6	44.5	54.4	7.6	10.3	46.2	0.4	6.5	2.2	0.4	12.3	20.3	43.3	0.0	0.2	0.2	0.2	15.9	1.9	0.2	0.4	0.2	0.3	0.2	0.4	0.0	0.0	1.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	15.5	0.0	0.1	0.0	0.2	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.3	2.1	0.0	0.1	0.1	5.3	0.0	116.9	0.0	0.2	0.7	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	43.8	45.7	60.8	42.6	43.5	46.5	44.9	46.7	44.5	46.2	43.3	4.6	0.0	0.0	17.3	2.5	1.3	0.1	0.0	0.6	1.5	2.9	0.4	5.0	2.8	0.0	33.1	0.0	0.6	0.1	0.0	95.9	0.0	11.6	0.6	20.5	4.1	0.0	8.0	1.6	0.5	60.8	9.6	0.0	0.6	0.0	0.1	17.2	0.7	2.0	1.7	2.8	0.0	0.0	1.3	2.8	32.5	5.9	2.1	0.0	1.9	0.0	3.2	0.0	1.0	0.3	0.3	0.0	2.2	0.0	0.0	0.0	324.8	0.0	1.7	138.1	6.5	21.7	0.9	2.7	0.0	0.9	0.8	2.0	0.3	0.0	0.1
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 63.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 48.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 26.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 29.4;RPTEC TERT1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved					NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavorable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	4.0	2.2	7.1	1.7	1.0	0.1	7.5	0.0	2.6	6.6	8.5	9.5	12.4	2.2	17.7	13.2	10.1	2.7	21.1	3.2	5.2	23.0	29.5	5.7	1.1	0.3	14.7	0.6	14.8	10.7	2.9	7.3	1.6	5.9	10.1	2.5	8.5	5.1	63.5	30.1	12.9	1.4	0.4	0.3	9.7	3.2	26.7	3.6	10.1	46.9	4.4	4.2	7.2	0.4	11.1	13.5	0.5	3.5	0.0	0.0	21.1	2.3	0.0	2.9	3.2	7.2	17.7	0.0	2.4	0.1	7.3	25.8	3.7	15.2	2.9	6.2	8.2	0.0	6.2	7.5	0.1	0.0	0.1	0.2	16.0	3.6	7.7	1.2	0.0	4.5	0.0	0.1	0.2	14.0	19.3	3.3	1.6	29.4	10.0	0.1	4.4	0.3	34.0	21.1	8.6	1.8	5.9	21.8	0.0	7.1	12.5	1.8	0.1	1.0	8.2	1.4	0.0	10.4	18.2	0.0	11.2	0.0	7.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	7.1	1.0	0.0	2.6	3.2	5.2	0.3	14.7	1.6	0.4	26.7	0.4	0.4	16.0	28.4	0.7	0.5	11.9	25.9	19.3	4.0	13.4	7.8	8.6	48.6	24.3	24.7	31.3	0.0	23.6	0.1	30.0	17.6	14.5	21.5	27.6	3.1	3.3	13.1	0.0	16.1	19.2	23.7	1.8	15.8	38.4	1.3	0.9	4.6	36.3	2.6	0.0	5.2	18.7	8.2	0.0	1.8	18.5	1.2	0.8	3.6	1.0	0.7	0.3	1.0	0.5	0.6	29.1	24.0	1.9	0.2	26.1	27.9	19.2	28.4	2.2	6.6	3.2	6.0	1.6	10.4	7.0	20.6	10.8	0.8	0.4	18.4	29.0
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 167.5;Microglial cells: 189.3;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.5;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"	NA	NA		670000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	6.0	3.2	10.2	20.5	13.8	29.5	6.1	6.9	14.9	6.2	18.5	10.2	9.4	2.4	7.8	1.9	4.1	7.1	2.7	10.0	12.7	13.9	11.9	10.0	15.5	9.7	11.7	1.6	6.1	15.8	10.1	7.6	12.4	7.9	8.7	8.1	10.1	7.0	2.4	4.2	14.5	5.9	6.0	23.3	14.6	2.3	18.5	7.0	19.6	2.7	11.0	6.9	2.1	14.7	7.6	28.3	12.1	7.0	1.9	4.1	4.2	7.5	5.5	12.9	9.2	2.0	40.8	6.9	51.8	19.1	19.6	6.0	19.0	2.0	14.9	46.6	5.4	1.9	34.9	2.8	12.1	2.7	41.5	3.2	0.6	3.8	1.0	31.7	7.8	0.5	2.6	4.4	4.7	17.0	0.1	17.3	9.7	25.7	4.4	1.6	1.6	4.0	52.6	11.1	7.9	2.5	20.2	12.0	19.4	8.9	13.0	20.3	25.7	9.9	10.8	20.5	23.4	1.1	1.7	11.4	11.7	8.0	37.3	0.7	1.1	2.8	1.6	2.0	1.0	0.8	0.9	1.2	0.8	0.5	0.7	0.9	9.5	1.0	4.7	1.5	1.0	0.8	10.2	13.8	6.9	14.9	10.0	12.7	9.7	11.7	12.4	6.0	18.5	14.7	1.5	9.6	16.7	43.1	11.3	0.3	9.8	0.8	0.6	13.6	8.3	4.1	3.7	17.2	13.0	38.6	6.2	1.9	32.7	35.5	0.0	7.4	5.5	13.5	2.2	4.5	12.6	3.2	81.0	5.0	0.6	4.0	22.4	22.9	13.9	2.5	5.0	15.6	30.0	10.1	167.5	10.1	2.0	74.2	5.7	8.2	0.3	40.2	1.8	189.3	36.0	10.3	21.6	239.8	167.7	11.8	28.0	0.4	12.9	25.3	37.6	13.5	4.9	1.3	0.0	3.3	4.9	0.2	4.8	0.5	0.3	1.9	22.0	2.3	7.6	8.2
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947097-19985175	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	35.7	27.3	39.2	27.0	39.9	41.4	33.2	42.1	49.5	30.5	36.6	29.7	29.6	22.7	42.4	42.3	21.1	32.2	36.3	38.6	43.1	33.6	42.8	29.5	24.3	42.7	42.5	19.9	27.2	53.8	20.5	49.2	42.2	30.7	30.5	35.4	35.8	28.8	29.1	36.0	28.2	28.0	44.0	24.2	32.6	18.0	41.1	28.9	41.1	30.3	29.1	35.4	29.7	46.1	29.8	26.8	38.5	26.4	65.8	57.8	38.9	51.3	59.7	47.8	55.0	31.9	45.7	21.8	30.3	56.7	27.6	18.4	29.0	38.2	55.7	37.9	24.1	31.9	24.9	31.1	82.2	45.0	38.1	53.6	71.0	56.1	81.9	59.9	61.6	28.5	37.1	34.1	57.9	46.2	34.8	31.9	48.4	40.8	42.6	25.8	27.2	32.2	98.9	38.8	12.0	39.6	36.9	45.3	60.3	57.0	35.4	35.8	61.6	34.5	30.1	44.4	44.2	42.0	73.5	28.6	55.0	40.4	57.1	28.7	18.0	31.3	7.9	19.6	10.6	7.9	9.3	9.6	18.1	5.8	8.5	8.1	36.0	20.3	26.3	11.8	10.9	11.5	39.2	39.9	42.1	49.5	38.6	43.1	42.7	42.5	42.2	44.0	41.1	46.1	114.8	60.9	45.1	33.0	43.6	170.0	129.5	48.8	62.0	34.0	57.0	35.9	57.0	27.1	52.6	42.3	31.3	74.7	44.2	68.7	103.7	52.2	21.2	45.9	44.4	72.4	62.0	55.3	33.7	45.3	67.2	65.2	66.3	72.0	85.0	39.1	41.7	39.3	54.2	15.2	31.4	59.4	65.1	44.4	158.8	15.9	36.7	60.9	83.6	28.1	43.1	86.1	41.2	65.9	44.1	65.2	55.9	35.3	50.7	109.7	49.4	62.3	48.1	36.8	52.6	86.5	72.4	24.6	27.1	65.0	188.0	164.3	60.6	37.1	41.5	151.0
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781379-27890681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 79.0;Proximal tubular cells: 110.9;Respiratory ciliated cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.8;RPTEC TERT1: 40.8;U-266/84: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		11000	"Cluster 22: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	5.8	24.8	3.9	2.0	4.3	1.8	3.9	5.2	5.1	3.5	5.0	6.1	25.2	2.8	10.9	3.1	15.5	2.7	5.2	4.1	4.4	27.5	46.5	3.1	1.7	4.4	4.6	8.1	4.6	9.3	11.0	1.8	4.3	2.4	5.2	13.8	2.1	3.4	8.2	1.5	25.6	2.2	3.9	1.7	2.8	9.2	3.9	3.1	9.8	5.9	2.2	2.2	2.3	4.4	6.4	4.9	0.5	0.6	0.4	1.7	3.9	1.3	1.7	1.5	1.1	9.3	2.9	2.4	17.8	3.6	3.0	2.3	0.6	2.7	2.1	0.9	0.3	0.1	0.7	8.2	2.7	1.7	0.2	2.4	3.3	5.8	7.8	1.5	1.2	3.8	0.5	4.0	3.6	8.2	1.5	4.6	0.8	4.6	4.3	1.8	0.3	1.4	40.8	0.5	1.7	2.5	6.1	7.7	2.8	2.3	3.9	9.3	0.2	1.2	0.9	4.3	2.7	13.6	18.2	3.8	3.6	5.6	0.2	1.6	2.5	1.4	1.9	0.9	4.2	4.4	2.7	4.8	3.5	3.7	3.1	2.3	1.0	4.5	0.2	0.4	4.2	2.3	3.9	4.3	5.2	5.1	4.1	4.4	4.4	4.6	4.3	3.9	3.9	4.4	9.9	6.4	5.0	14.7	24.0	2.0	3.1	11.7	26.7	10.7	5.1	7.1	7.1	5.7	9.7	18.4	4.2	4.2	10.5	12.2	46.9	12.6	36.9	35.2	2.4	7.8	3.6	3.0	13.9	12.3	1.3	10.9	8.6	7.4	2.5	4.6	2.9	29.5	6.5	8.4	18.3	4.7	6.1	4.4	3.4	26.4	1.5	50.8	1.8	2.8	2.4	15.5	3.1	15.6	10.3	7.0	14.9	2.6	21.2	1.0	79.0	110.9	59.0	25.6	0.0	3.3	11.2	23.8	20.0	5.2	1.6	1.5	19.6	9.5	10.7	1.9
RFK	"FLJ11149, RIFK"	ENSG00000135002	"Riboflavin kinase"	Q969G6	9	76385526-76394517	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 352.0;Pancreatic endocrine cells: 220.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023259, CAB033887, HPA057163"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357"	"unprognostic (1.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	11.6	20.6	18.0	14.6	18.4	25.0	11.7	12.6	21.1	11.7	12.5	30.8	33.1	12.8	18.2	12.9	13.6	19.9	16.3	20.6	27.2	27.0	29.2	12.4	11.6	16.9	18.4	11.7	16.4	23.8	12.0	13.2	27.0	13.0	22.9	14.7	11.0	9.9	14.9	5.1	28.2	11.9	14.2	10.2	29.0	16.7	21.6	12.0	19.7	18.7	11.2	13.9	5.9	13.5	21.9	23.2	13.9	18.1	20.5	20.3	41.8	25.2	18.6	17.8	13.9	8.2	13.3	35.3	28.7	18.2	32.3	22.9	19.3	16.5	35.3	10.4	18.0	11.2	30.4	26.2	36.7	37.9	25.6	13.5	29.3	21.4	23.2	19.9	58.3	30.4	30.6	28.7	36.1	20.8	49.3	13.3	18.1	51.2	22.7	26.7	18.3	8.9	82.0	10.6	35.0	12.7	26.9	37.2	22.9	18.1	9.4	20.2	35.9	18.5	33.3	40.1	35.6	30.7	32.3	12.4	30.7	33.3	25.9	5.2	9.8	3.6	5.0	19.9	7.5	5.8	7.3	6.0	11.8	4.4	7.0	6.7	1.4	8.5	21.1	4.3	7.4	9.8	18.0	18.4	12.6	21.1	20.6	27.2	16.9	18.4	27.0	14.2	21.6	13.5	27.3	16.0	9.2	5.9	22.9	45.4	23.8	15.3	22.2	50.4	24.5	20.6	37.9	34.3	20.1	42.3	20.9	54.1	18.4	158.8	60.7	64.9	191.7	37.8	18.5	46.2	28.2	48.8	18.0	189.3	352.0	33.5	33.1	42.3	12.0	18.0	124.2	40.9	33.2	11.8	19.3	23.1	40.7	57.6	26.6	118.1	22.1	29.9	30.2	10.3	25.2	44.7	9.2	7.1	6.5	220.6	68.3	65.1	12.7	33.6	79.9	142.8	27.7	28.7	0.0	23.0	21.7	91.8	64.1	18.8	40.5	123.5	23.1	18.8	33.7	22.6
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: AB_2732299"	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	6.5	13.3	11.5	26.6	9.9	47.4	5.5	21.6	12.0	14.3	10.6	24.3	31.8	13.2	21.8	11.7	10.0	9.8	15.0	10.4	11.0	16.2	3.9	20.6	41.0	13.0	12.2	8.9	6.1	7.7	5.1	5.7	13.4	9.2	19.3	9.9	11.5	9.8	11.8	9.2	32.3	11.5	8.7	33.3	28.2	9.0	10.6	25.6	14.6	2.8	31.4	9.1	7.3	11.7	58.3	69.2	12.4	15.3	4.4	6.4	5.6	5.3	5.2	2.5	4.4	28.8	129.0	6.3	42.6	6.0	1.4	8.6	23.2	33.7	2.2	177.1	8.0	37.9	47.5	27.7	10.1	38.6	25.8	9.0	7.5	5.4	2.9	23.8	17.6	44.7	5.6	9.9	1.4	41.7	50.7	56.7	10.4	13.6	147.3	26.5	0.7	10.8	127.9	4.9	9.9	9.4	38.5	4.5	2.6	5.6	19.9	15.0	21.4	4.0	40.1	12.5	1.5	12.3	7.6	20.0	5.0	42.9	2.6	23.8	10.9	41.5	97.0	36.5	92.7	55.5	77.2	82.5	31.0	45.2	59.5	73.2	24.4	61.4	69.8	74.3	90.2	43.3	11.5	9.9	21.6	12.0	10.4	11.0	13.0	12.2	13.4	8.7	10.6	11.7	3.1	38.5	10.7	1.0	54.1	8.7	1.9	5.5	3.4	8.1	9.3	3.8	1.5	15.7	11.3	23.9	0.0	2.7	111.8	273.9	41.1	34.0	20.2	16.5	5.6	3.5	6.7	12.2	5.3	55.3	3.9	5.3	50.4	37.1	20.8	13.1	10.0	4.0	14.4	0.0	3.9	28.6	2.0	10.9	224.9	53.8	4.1	40.3	21.4	3.7	241.2	4.7	103.0	1.0	1.2	191.7	279.6	2.2	39.4	3.8	121.6	15.1	13.5	9.7	6.6	2.6	4.5	17.7	2.9	2.5	13.2	5.5	99.2	23.4	17.3	44.3
RHPN2		ENSG00000131941	"Rhophilin Rho GTPase binding protein 2"	Q8IUC4	19	32978592-33064888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.0;Endometrial ciliated cells: 90.2;Gastric mucus-secreting cells: 94.8;Glandular and luminal cells: 108.8;Muller glia cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 52.4;OE19: 50.7;RPTEC TERT1: 52.9;SK-BR-3: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051749	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA051749: AB_2681589"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.32e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (1.22e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	3.0	0.8	5.5	4.4	5.9	0.0	12.7	5.8	6.6	8.4	7.8	23.6	21.7	5.4	2.4	1.2	15.0	13.6	1.5	5.2	5.8	14.5	19.6	4.1	1.3	6.3	6.9	1.7	12.4	16.9	4.8	8.2	6.1	27.1	19.0	20.2	19.4	2.2	0.3	10.5	17.8	1.8	5.1	0.9	35.2	0.7	7.2	1.9	5.4	0.9	2.6	11.5	1.1	6.4	28.6	52.4	4.9	8.6	1.0	0.1	24.5	6.6	5.0	10.0	10.5	45.9	28.6	0.0	41.1	3.7	8.8	13.5	15.9	5.8	12.4	13.2	9.7	3.2	5.9	17.9	6.6	0.0	4.1	1.2	11.5	8.4	4.7	7.6	1.3	1.2	7.2	0.0	3.0	24.4	0.1	2.9	10.5	50.7	8.4	0.0	6.0	5.6	52.9	14.0	11.0	5.8	11.2	54.5	13.4	13.9	15.2	1.4	0.7	0.1	12.7	3.6	11.2	6.3	4.6	2.1	1.6	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.9	5.8	6.6	5.2	5.8	6.3	6.9	6.1	5.1	7.2	6.4	0.3	22.4	1.1	20.2	3.9	1.3	6.3	6.2	7.4	1.9	30.4	15.4	0.9	17.2	14.7	12.9	12.5	18.2	2.1	61.0	3.9	31.0	0.4	90.2	11.1	1.1	4.8	0.0	1.3	13.1	6.8	6.4	94.8	108.8	1.3	0.2	3.3	13.0	1.9	0.0	1.4	22.2	18.3	3.0	0.0	0.3	2.1	1.6	1.8	4.7	0.0	76.8	0.0	9.5	1.6	33.8	52.6	1.2	6.1	23.5	11.7	19.8	51.9	10.1	0.0	0.6	3.7	0.0	1.4	3.8	1.8	3.4	1.1	0.0	23.3	36.1
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 365.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 653.2;Inhibitory neurons: 572.7;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in many"	16	"cerebellum: 365.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;EFO-21: 8.8;LHCN-M2: 10.0;RPTEC TERT1: 15.0;SH-SY5Y: 10.7;TIME: 5.4;U-138 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 352.9"	HPA076565	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.2	1.2	5.5	0.8	14.1	0.0	0.5	365.0	22.5	0.3	0.0	0.3	0.7	0.2	0.0	2.1	0.0	3.9	0.1	16.3	8.4	0.0	0.0	0.2	0.0	0.3	9.0	0.0	0.4	1.6	2.4	0.0	20.8	3.0	0.1	7.4	1.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	1.4	4.1	5.4	0.0	0.0	0.9	0.0	0.1	0.0	13.2	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.2	1.4	0.0	0.2	0.0	0.0	5.2	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	1.6	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	15.0	0.0	0.4	10.7	0.0	0.0	0.0	0.3	0.7	0.0	5.4	5.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	14.1	365.0	22.5	16.3	8.4	0.3	9.0	20.8	0.0	5.4	13.2	0.2	0.0	0.5	120.2	0.0	0.0	0.2	2.1	0.0	69.1	3.0	3.2	1.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.2	0.0	0.9	2.5	0.0	0.0	653.2	0.8	0.0	1.8	0.0	0.0	1.3	0.3	3.6	0.0	0.0	62.2	572.7	0.0	2.0	0.0	0.0	10.2	0.3	0.3	3.6	16.9	0.0	109.7	0.0	323.2	76.5	0.5	0.0	1.5	0.0	1.0	0.0	0.4	3.6	9.9	0.0	1.3	2.7	21.3	13.6	0.0	0.1	0.0	0.1	0.3	0.0	0.5
RP1	"DCDC4A, ORP1"	ENSG00000104237	"RP1 axonemal microtubule associated"	P56715	8	54509422-54871720	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"retina: 236.4"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 333.6;Rod photoreceptor cells: 1115.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;HDLM-2: 5.2;hTERT-RPE1: 2.0;RPTEC TERT1: 10.2;U-2197: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.3"	HPA042257	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA042257: AB_10797385"	"unprognostic (3.19e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.16e-3)"		"unprognostic (6.24e-2)"		"unprognostic (4.56e-2)"	"unprognostic (4.13e-5)"	"unprognostic (2.48e-1)"	"unprognostic (2.16e-5)"	"unprognostic (8.92e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.96e-2)"	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.7	0.1	3.5	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	236.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.6	0.0	0.1	0.0	0.7	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.1	0.1	0.5	16.0	4.8	0.0	0.0	0.0	0.0	1.2	0.0	72.5	3.0	1.4	0.4	0.0	31.1	5.5	333.6	0.0	0.0	0.0	3.9	0.0	0.3	81.9	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	32.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	130.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	149.0	1115.8	0.0	0.0	0.4	3.2	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
RPL17-C18orf32		ENSG00000215472	"RPL17-C18orf32 readthrough"		18	49481681-49492479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 153.8;Alveolar cells type 2: 154.3;Club cells: 96.6;granulocytes: 65.6;Respiratory ciliated cells: 117.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043724, HPA046385"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-2)"			"unprognostic (1.70e-3)"	"unprognostic (3.83e-4)"		"unprognostic (1.95e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"		"unprognostic (2.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"		"unprognostic (5.42e-2)"		41.7	77.7	109.4	35.7	111.6	49.1	49.6	117.5	159.2	36.5	113.7	43.7	51.3	32.2	70.3	25.7	31.1	38.6	63.6	106.0	119.4	96.0	85.0	42.2	35.1	116.3	112.8	34.4	51.8	84.3	9.4	35.3	116.2	48.7	41.6	104.7	54.5	34.4	30.1	22.2	48.3	26.7	116.2	35.9	55.7	30.5	112.3	32.8	53.4	38.2	27.2	38.1	5.2	126.1	29.4	25.0	57.3	47.1	55.7	42.3	42.7	34.6	36.6	27.9	32.9	7.7	33.8	21.8	74.0	33.5	30.5	29.6	26.2	29.7	31.1	67.7	20.2	28.0	15.7	28.3	56.6	46.3	59.2	50.5	65.0	22.5	42.3	61.4	35.2	48.6	19.2	60.9	79.2	16.8	41.4	26.8	20.1	28.0	13.0	26.2	21.2	59.4	115.2	34.7	64.5	120.0	22.0	36.8	76.1	41.4	50.3	45.4	33.0	37.4	25.7	23.4	36.8	106.2	60.1	24.9	42.0	26.0	42.7	92.6	30.2	71.3	23.0	41.1	33.4	28.3	27.1	26.5	27.9	20.3	23.3	31.2	85.1	22.3	48.5	38.4	30.9	49.2	109.4	111.6	117.5	159.2	106.0	119.4	116.3	112.8	116.2	116.2	112.3	126.1	0.5	153.8	154.3	0.3	0.4	0.3	0.7	0.3	0.6	0.4	0.5	0.5	0.0	0.0	96.6	0.0	0.0	0.1	0.2	0.2	0.0	0.2	2.8	0.3	0.7	17.8	0.0	0.0	0.1	0.2	0.1	18.5	0.5	0.4	65.6	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.6	0.0	4.3	0.0	20.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.3	117.3	0.3	0.0	0.2	0.4	1.0	0.5	1.0	0.1	0.3	9.1	0.5	0.1	0.5
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 4751.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5473.4;Extravillous trophoblasts: 6093.0;Pancreatic endocrine cells: 6926.5;Urothelial cells: 6250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 17820.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA		7900000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	656.7	214.3	92.6	487.2	92.8	415.2	574.7	99.1	222.3	1070.5	106.8	303.0	181.6	297.7	675.4	4751.5	611.1	437.8	354.1	92.3	104.4	882.5	127.6	776.0	206.7	118.1	108.6	152.0	264.1	905.1	210.7	723.2	118.0	536.4	328.7	8.4	1247.1	544.1	91.0	894.7	239.5	468.3	110.2	713.7	482.6	68.9	124.1	303.5	325.3	150.9	959.9	1527.7	1771.1	126.8	1889.0	1483.7	70.5	542.1	1960.9	2451.3	1172.4	1796.3	2626.0	1439.7	1464.8	697.6	2066.0	2.5	1571.4	2355.4	1142.4	2595.4	73.7	3254.0	814.0	913.6	149.2	162.6	830.1	409.1	1511.3	149.6	1098.4	1867.2	3255.1	1577.8	1974.9	826.9	1116.1	0.3	340.9	352.1	2137.7	3058.8	19.8	694.0	513.9	4043.1	1491.9	2.5	757.1	1426.0	4361.1	3196.5	2.5	115.8	1367.7	1797.9	1255.3	1727.2	1378.9	1612.5	1584.8	757.0	533.1	1188.8	975.7	2.5	17.0	8.2	1713.0	490.9	915.2	7956.3	4682.6	7210.4	713.6	4560.1	939.4	354.9	1346.4	845.1	3020.5	252.7	391.5	437.0	17820.3	740.5	4871.8	1042.8	1269.9	5289.9	92.6	92.8	99.1	222.3	92.3	104.4	118.1	108.6	118.0	110.2	124.1	126.8	718.5	137.8	189.4	1.3	136.6	2210.3	3924.9	5473.4	1027.8	0.7	686.8	823.8	30.8	546.2	2673.9	2284.2	0.0	3257.0	384.0	421.7	1019.3	4344.5	277.6	1738.8	561.2	617.8	277.7	52.6	0.0	4330.2	6093.0	890.7	676.4	1503.0	437.6	251.1	372.6	11.6	3806.0	0.0	0.0	479.6	1485.2	1216.7	2054.0	634.0	320.9	1971.8	1243.3	15.9	2265.2	0.8	371.8	0.0	0.0	6926.5	690.2	258.4	153.8	4365.0	343.9	925.4	2674.2	2.4	210.4	536.2	1054.9	14.5	34.8	4207.9	2822.4	3753.1	470.4	334.8	500.2	6250.2
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 3084.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 28.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.9;NK-cells: 28.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 811.3;SuSa: 896.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		36000	"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	275.3	137.3	237.4	47.7	247.3	4.4	222.4	241.0	347.5	133.7	214.6	198.9	30.6	111.8	72.1	91.7	129.8	103.9	310.1	233.1	240.8	262.2	66.2	138.0	48.8	252.9	245.5	138.2	75.7	317.4	73.9	70.1	249.4	100.9	59.8	25.8	156.1	64.6	250.6	114.0	116.5	68.9	245.8	111.7	94.4	41.2	251.6	21.2	318.7	220.6	49.6	121.2	122.7	258.6	188.7	153.7	174.5	111.4	150.7	437.5	62.7	254.7	400.0	150.6	172.2	150.4	203.7	4.9	471.6	435.5	22.3	174.7	73.5	158.7	132.7	0.8	68.1	12.0	178.0	129.6	99.8	5.9	39.2	355.3	59.4	135.3	145.0	441.9	346.5	1.3	61.4	0.3	475.2	663.4	0.4	3.4	141.0	161.1	460.2	30.0	180.4	1.4	811.3	141.9	53.4	2.0	544.7	277.2	576.7	896.9	226.4	6.8	495.0	103.3	57.9	139.5	312.0	2.0	5.3	9.3	185.5	3.2	62.1	4.1	2.0	0.2	0.4	0.9	0.9	4.1	0.4	0.3	7.0	2.0	0.6	0.5	0.3	28.3	1.4	11.9	1.4	1.1	237.4	247.3	241.0	347.5	233.1	240.8	252.9	245.5	249.4	245.8	251.6	258.6	331.0	28.9	106.1	29.7	9.3	110.5	177.4	105.0	103.0	2.1	311.2	345.6	141.9	164.5	104.0	465.3	0.0	132.4	15.3	148.7	248.4	323.3	8.4	399.3	449.1	251.9	124.7	17.3	1.2	323.6	202.1	450.0	58.6	573.8	23.5	185.5	372.3	51.8	162.3	0.0	0.5	167.5	61.1	31.7	107.7	36.3	771.7	37.1	238.3	13.1	14.8	308.1	1.0	0.0	8.8	488.4	164.7	314.1	6.3	240.0	128.7	521.7	77.1	6.9	0.0	234.2	132.5	12.8	23.4	80.3	75.7	74.7	20.5	3084.7	100.6	244.3
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;kidney: 36.4;liver: 36.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 52.6"	"Low region specificity"	"Detected in all"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.3	0.0	18.0	0.6	29.2	0.1	0.3	29.7	21.3	19.6	2.1	2.6	1.0	17.4	0.0	0.3	11.0	0.4	0.8	17.9	21.7	36.4	36.5	0.0	0.0	41.0	32.2	4.5	1.0	6.5	6.5	3.9	36.6	0.8	2.6	4.6	0.2	1.6	0.0	0.2	1.3	8.4	31.1	0.0	2.5	1.7	26.6	0.1	23.7	0.2	0.0	2.8	7.2	40.2	0.0	1.7	29.5	0.2	0.8	0.6	0.0	10.0	25.3	0.6	1.4	0.0	0.0	0.0	11.2	14.1	8.8	0.0	18.6	0.0	0.9	0.0	11.3	0.0	0.0	18.5	0.7	0.0	8.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.8	1.9	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	46.2	0.0	10.0	0.2	0.6	0.5	0.1	0.4	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.3	0.4	0.2	0.3	18.0	29.2	29.7	21.3	17.9	21.7	41.0	32.2	36.6	31.1	26.6	40.2	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	1.4	10.0	0.0	9.2	25.0	0.0	0.0	0.0	11.7	0.5	0.7	8.9	17.5	0.9	0.0	2.7	0.2	0.0	0.0	1.6	0.0	14.3	0.0	0.0	0.7	30.1	0.1	0.0	8.2	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	26.2	0.0	0.5	0.0	5.0	47.6	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.0	0.0	0.0	0.5	0.2	2.3	0.0	0.1	0.0	0.3	0.6	0.0	0.1
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064543-73124088	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 36.5;Collecting duct cells: 42.3;Muller glia cells: 48.5;Peritubular cells: 26.7;Smooth muscle cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 7.5;pons: 6.3;spinal cord: 7.7;white matter: 16.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 9.5;RPTEC TERT1: 16.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA029595: AB_10600763"	"prognostic favorable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.4	3.0	0.4	1.4	0.5	0.3	3.4	1.2	0.6	5.2	0.6	4.7	0.9	4.4	4.5	9.5	8.2	1.3	2.3	0.8	0.8	8.3	0.6	3.9	1.5	7.5	0.9	3.3	1.2	0.1	1.6	9.4	6.3	15.1	1.1	9.0	4.6	10.8	0.6	1.9	2.5	8.9	7.7	1.1	9.6	2.6	0.4	0.2	2.5	1.4	0.2	17.9	4.7	16.7	0.2	0.2	0.4	0.5	0.0	0.0	1.3	9.5	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.3	0.9	0.5	0.2	0.2	0.1	0.0	16.9	0.1	0.5	0.5	1.0	0.4	0.1	3.1	0.2	0.1	0.5	0.1	1.5	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.5	1.2	0.6	0.8	0.8	7.5	0.9	6.3	7.7	0.4	16.7	0.6	9.6	0.0	1.0	0.2	1.3	6.9	0.0	36.5	2.4	5.8	11.6	3.8	4.3	0.0	42.3	2.1	0.2	1.0	0.5	1.9	1.3	10.3	7.2	1.4	1.7	0.0	0.0	0.5	0.0	0.4	13.2	10.7	14.9	0.0	0.2	1.4	0.2	0.4	0.0	0.4	0.2	0.0	0.0	0.4	3.2	12.2	0.4	3.6	0.0	0.0	48.5	0.0	1.0	0.2	0.6	0.0	26.7	0.0	1.8	0.0	3.6	0.0	2.2	6.6	0.9	28.7	11.4	4.4	0.6	1.3	0.4	0.5	0.2	0.1	0.5
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724409-246768137	"Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 159.5"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1380.7;Spermatocytes: 822.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	20	"basophil: 872.9"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 872.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	26.6	53.7	35.1	14.4	45.5	35.7	23.6	51.5	43.2	22.6	40.8	27.2	34.4	26.2	17.6	9.3	31.6	21.6	32.8	35.3	45.4	49.8	158.2	21.0	13.5	64.0	45.2	22.4	18.8	36.5	24.3	23.8	64.3	39.4	26.8	31.7	15.3	26.0	60.7	24.1	34.6	24.0	57.0	11.5	28.0	159.5	47.3	20.1	33.5	54.7	10.6	81.5	12.0	86.8	55.3	53.2	37.7	22.8	44.5	55.7	0.5	42.3	58.8	70.1	58.3	32.7	150.6	29.3	53.8	49.0	38.9	17.7	32.4	12.6	71.6	40.8	11.9	49.6	46.9	65.9	41.6	97.1	40.7	37.6	5.9	47.4	4.8	65.7	76.4	60.0	62.9	0.1	70.9	13.5	101.6	122.6	56.5	29.6	41.7	83.8	48.5	0.3	216.6	128.2	42.7	48.0	57.3	2.5	39.0	20.2	42.1	99.6	49.8	32.1	28.5	78.7	110.5	138.0	51.1	17.4	54.7	130.2	43.3	872.9	24.3	44.1	18.1	22.2	22.4	11.2	5.4	15.7	10.7	9.4	7.1	22.0	6.4	34.1	15.4	18.2	4.0	17.1	35.1	45.5	51.5	43.2	35.3	45.4	64.0	45.2	64.3	57.0	47.3	86.8	25.0	6.4	11.5	25.8	8.0	30.1	40.6	54.6	1.8	31.2	42.4	17.5	38.0	55.8	40.5	152.6	18.8	41.4	14.6	42.4	31.3	67.2	1380.7	72.7	39.4	23.6	44.9	54.7	23.7	69.0	17.4	35.7	32.6	111.9	57.2	49.2	22.5	187.8	89.4	6.7	20.5	27.4	52.9	45.7	13.7	245.6	47.5	29.7	48.0	10.3	20.3	67.4	18.6	27.2	37.3	75.2	27.8	47.4	8.3	49.2	138.4	69.7	79.4	39.2	19.7	36.7	39.4	822.3	76.2	5.6	68.5	84.6	17.0	42.8	55.0	201.9
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798796	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.7;brain: 353.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 248.4;Oligodendrocyte precursor cells: 892.7;Oligodendrocytes: 513.6"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 69.2;RPTEC TERT1: 90.1"					"Low region specificity"	"Detected in all"			HPA042380	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	6.8	156.7	226.1	3.7	283.7	2.9	5.7	302.5	260.4	10.6	85.2	12.9	4.5	12.5	97.6	5.8	18.7	9.3	8.1	212.6	277.4	33.1	2.5	15.0	3.0	353.6	272.7	93.7	40.9	18.7	31.4	7.5	291.0	12.7	4.0	70.2	18.0	24.3	1.3	8.2	6.0	12.0	314.1	4.5	10.6	33.3	255.6	10.6	35.5	4.2	4.4	7.7	8.7	316.2	11.2	7.1	36.0	18.6	19.7	12.5	0.6	69.2	33.9	29.7	22.8	0.5	1.7	22.5	23.5	14.5	8.0	19.9	10.6	7.6	37.0	4.4	4.7	1.0	8.1	0.7	2.9	10.0	6.9	10.0	30.6	5.9	5.2	30.5	48.4	25.8	1.3	2.2	15.6	4.4	42.6	2.1	2.6	0.2	5.0	35.6	21.5	17.9	90.1	11.2	20.1	11.5	11.4	0.5	6.8	3.5	1.3	5.0	59.5	31.5	18.1	11.9	18.9	6.0	2.5	2.2	15.3	10.5	9.0	1.9	0.6	0.1	3.9	0.2	2.5	0.2	0.8	2.3	0.3	0.4	0.7	2.6	0.7	1.1	0.4	0.7	0.2	1.2	226.1	283.7	302.5	260.4	212.6	277.4	353.6	272.7	291.0	314.1	255.6	316.2	1.4	44.8	3.9	248.4	0.8	10.7	16.5	16.3	5.7	101.4	6.8	4.8	2.9	27.1	25.7	27.6	25.0	1.9	3.9	0.4	13.7	79.7	115.0	13.5	9.3	7.7	7.7	0.0	84.3	46.9	0.2	16.8	2.6	14.8	0.0	10.5	10.4	0.2	1.1	101.0	107.0	0.3	10.2	1.3	3.3	100.3	55.0	1.8	3.6	23.4	1.9	145.3	4.1	892.7	513.6	8.9	0.0	58.3	0.7	11.3	0.2	20.4	13.0	14.6	6.6	3.6	11.5	2.9	3.7	2.7	7.2	0.1	3.2	137.4	2.0	9.3
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 385.5;skin 1: 302.7"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	3.1	0.1	0.0	0.1	0.1	0.1	19.5	0.1	0.1	69.9	0.0	1.1	0.0	0.1	0.1	385.5	0.3	0.1	0.1	0.0	0.0	0.4	0.1	59.8	0.0	0.1	0.2	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	57.8	0.0	1.5	302.7	0.1	0.0	0.1	0.0	0.6	2.3	0.1	0.5	2.2	0.0	76.8	0.1	121.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	44.8	66.8	81.8	27.7	84.5	14.7	69.4	87.4	114.6	42.6	72.0	43.9	45.4	48.0	79.5	54.1	44.7	39.7	103.6	85.1	109.1	101.6	74.3	35.9	29.7	91.3	96.8	42.6	51.3	94.1	43.2	48.3	103.1	59.9	49.8	74.5	49.2	47.1	40.8	29.9	37.1	50.9	91.4	27.9	53.7	33.8	95.2	29.3	67.4	59.3	32.8	38.9	19.4	105.6	53.9	38.1	92.6	49.9	80.6	109.3	67.4	85.5	78.0	64.6	71.8	24.4	81.0	22.0	75.5	83.9	60.6	22.6	57.3	113.6	95.7	79.1	40.4	33.5	18.8	59.7	70.1	70.2	40.5	72.5	155.9	59.0	63.1	124.1	87.1	63.8	53.0	60.0	116.3	36.5	94.7	42.5	30.2	47.6	57.1	54.0	39.1	32.1	197.1	52.9	68.4	70.4	57.0	84.5	97.0	81.7	63.4	41.9	68.0	104.4	60.5	86.9	83.1	94.4	193.4	64.9	118.2	32.2	102.3	47.8	16.5	23.0	27.5	23.0	35.1	36.8	32.3	27.3	21.4	30.3	46.8	36.4	9.7	36.9	23.1	26.7	33.2	37.0	81.8	84.5	87.4	114.6	85.1	109.1	91.3	96.8	103.1	91.4	95.2	105.6	63.2	48.1	47.2	15.3	34.4	61.1	69.7	74.1	78.6	135.0	84.9	96.0	140.3	62.9	51.8	126.9	22.9	139.9	31.3	63.4	320.8	99.2	537.1	67.5	52.4	54.4	37.8	34.7	33.8	112.8	82.2	58.3	66.8	58.4	36.8	32.0	51.4	65.0	47.6	171.6	37.1	42.7	114.0	23.0	27.9	91.2	60.0	34.5	138.7	17.8	36.7	205.6	22.6	20.6	42.9	92.9	37.0	66.2	30.8	91.7	46.8	311.1	54.9	71.0	46.0	40.8	64.5	60.7	56.1	83.8	56.7	88.9	36.3	39.6	46.1	56.0
SEC14L6		ENSG00000214491	"SEC14 like lipid binding 6"	B5MCN3	22	30522799-30546682	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"epididymis: 21.2;parathyroid gland: 30.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.5;Cholangiocytes: 11.5;Collecting duct cells: 12.9;Ductal cells: 6.6;Muller glia cells: 18.6"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 12.3;RPTEC TERT1: 21.8;SiHa: 6.6"									HPA067695			Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA067695: AB_2685889"	"unprognostic (3.49e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.25e-2)"	"unprognostic (8.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.02e-2)"	1.4	1.4	5.3	0.3	4.6	2.1	3.9	4.5	4.7	3.5	5.9	0.5	0.6	3.2	21.2	0.3	1.7	4.5	0.3	4.4	5.0	8.4	0.4	11.9	0.4	8.6	6.2	2.4	5.5	30.5	2.5	0.5	8.8	1.7	0.3	5.0	0.4	2.6	0.2	10.0	0.5	2.2	5.2	0.4	1.2	5.4	8.7	0.3	0.3	0.8	0.6	0.4	0.4	4.9	0.2	0.1	0.9	0.3	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.2	0.5	0.3	1.1	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	3.0	0.3	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.7	0.0	0.1	12.3	0.2	0.0	0.5	0.1	0.4	0.5	0.0	0.1	0.2	0.0	0.1	21.8	0.2	0.2	0.1	6.6	0.1	0.0	0.2	1.8	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.1	0.1	0.5	0.0	5.3	4.6	4.5	4.7	4.4	5.0	8.6	6.2	8.8	5.2	8.7	4.9	0.0	12.8	10.5	0.3	0.2	0.1	0.5	0.0	0.0	0.2	0.4	0.5	0.3	11.5	3.7	12.9	0.0	0.0	0.0	0.0	1.9	6.6	0.0	0.3	0.4	1.0	0.0	0.0	0.7	0.8	0.0	0.2	0.0	1.5	1.3	0.2	0.7	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.6	18.6	0.0	1.5	0.6	1.8	0.0	0.7	0.0	0.1	0.0	2.9	0.0	0.5	0.0	2.7	0.1	0.9	0.4	0.0	0.0	0.1	0.9	0.0	0.0	0.2
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1007.1"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 1238.4;Proximal enterocytes: 789.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6"	"Group enriched"	"Detected in all"	8	"granulocytes: 170.2;monocytes: 43.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	147.5	121.5	35.8	47.4	57.3	68.9	83.2	40.0	51.4	61.1	96.9	68.4	51.4	37.0	9.5	108.4	36.5	170.0	35.8	41.2	42.7	105.2	99.3	81.8	33.6	64.5	44.9	125.8	177.1	1007.1	12.0	70.6	49.6	47.6	39.0	14.1	70.8	60.3	50.2	75.7	282.5	48.4	35.8	21.5	104.2	30.4	53.6	39.7	56.7	33.9	78.1	141.3	96.7	94.0	4.1	6.9	4.2	0.4	51.7	12.9	5.9	76.7	159.4	98.4	79.8	12.2	10.6	13.1	11.3	79.8	48.0	2.5	6.8	12.2	72.0	0.5	3.1	0.6	175.7	9.2	298.1	0.7	6.8	77.3	75.4	96.7	124.3	39.3	167.1	2.3	25.6	192.8	35.6	0.6	1.1	3.0	4.8	20.3	8.3	2.4	8.9	1.5	469.5	1.4	2.2	18.6	241.7	0.7	319.7	43.2	0.5	2.1	373.9	28.8	12.3	176.9	17.1	36.2	358.5	40.3	26.7	12.0	39.5	2.2	43.4	170.2	0.7	24.4	1.6	1.9	1.3	0.8	14.1	1.4	1.6	2.0	91.6	3.6	14.5	0.9	2.5	12.6	35.8	57.3	40.0	51.4	41.2	42.7	64.5	44.9	49.6	35.8	53.6	94.0	346.2	38.5	177.8	34.0	68.0	183.3	133.7	277.3	329.0	12.0	87.1	112.0	28.4	88.6	168.6	68.0	35.5	41.0	27.0	132.2	21.5	81.3	9.6	145.8	73.1	232.1	10.7	14.7	68.2	171.2	33.6	88.8	206.4	483.4	271.8	33.9	353.4	21.9	284.2	0.0	225.7	65.1	91.6	181.3	1238.4	7.7	15.2	492.5	268.6	58.1	29.6	4.6	2.1	270.9	377.7	36.2	123.9	15.8	92.4	51.0	789.1	124.3	61.5	29.3	13.1	43.5	102.9	38.1	10.2	348.1	116.2	579.8	46.9	48.9	36.3	123.8
SGPP2	"FLJ39004, SPP2"	ENSG00000163082	"Sphingosine-1-phosphate phosphatase 2"	Q8IWX5	2	222424543-222562621	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.0;Excitatory neurons: 43.5;Glandular and luminal cells: 54.2;Microglial cells: 48.7;Urothelial cells: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.2;EFO-21: 13.0;hTCEpi: 52.6;RPTEC TERT1: 59.0;SCLC-21H: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.69e-2)"	2.8	6.1	11.1	4.0	12.8	1.4	5.3	15.0	15.3	13.3	2.1	17.3	17.3	2.7	3.8	21.4	13.2	11.5	5.2	11.0	13.7	16.4	0.4	8.0	3.9	17.9	10.9	0.5	3.1	26.8	5.9	0.1	17.6	1.5	18.1	3.6	7.9	7.6	0.8	22.4	18.2	1.4	9.7	1.0	25.1	1.6	15.2	5.3	21.2	0.0	15.2	22.3	10.0	9.8	1.4	1.1	0.4	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	16.2	0.6	13.0	0.0	0.2	0.3	0.2	0.1	0.0	0.3	4.6	1.0	0.4	0.0	0.0	1.7	0.8	0.0	52.6	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.8	0.4	1.2	0.5	10.6	0.4	0.7	0.4	0.6	59.0	3.7	16.5	0.6	0.0	1.9	0.1	0.8	0.2	0.1	0.0	0.2	0.5	0.6	0.5	0.5	0.4	1.0	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	11.1	12.8	15.0	15.3	11.0	13.7	17.9	10.9	17.6	9.7	15.2	9.8	0.1	3.2	11.5	1.3	2.2	3.7	4.4	29.1	4.6	5.3	1.6	1.5	6.9	7.2	26.2	12.9	6.2	0.1	0.6	20.2	1.9	14.5	9.7	33.0	4.8	1.5	1.2	0.0	43.5	1.8	0.3	1.4	25.5	54.2	0.0	0.4	0.0	0.1	0.2	1.7	15.8	5.5	14.2	0.0	1.1	3.7	0.6	0.8	0.0	48.7	0.1	0.7	1.0	2.5	1.1	9.3	16.3	0.4	2.3	7.5	13.1	0.5	20.4	5.9	0.0	2.1	1.7	3.1	1.0	26.3	14.3	2.5	2.5	0.3	9.9	39.4
SHISAL2B	FAM159B	ENSG00000145642	"Shisa like 2B"	A6NKW6	5	64690442-64718190	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 3.0;pancreas: 4.9;stomach 1: 2.8"	"Group enriched"	"Detected in some"	13	"Breast glandular cells: 1.8;Pancreatic endocrine cells: 1.0"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 3.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 9.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA011778	Enhanced					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA011778: AB_1848382"	"unprognostic (5.83e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.01e-2)"		"unprognostic (1.49e-1)"		"unprognostic (9.12e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.36e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.60e-1)"	"unprognostic (6.99e-2)"	0.2	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	4.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	9.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	3.0	1.4	0.2	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"SIM bHLH transcription factor 2"	Q14190	21	36699115-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 31.1;kidney: 61.3"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.3	0.3	1.8	0.0	1.1	0.0	0.4	0.7	1.4	2.3	0.4	0.5	0.0	0.5	0.8	31.1	0.6	0.0	0.2	1.5	2.5	61.3	0.4	0.2	0.0	0.7	1.4	0.2	0.3	1.8	1.6	0.0	0.5	6.6	0.0	0.0	0.6	0.0	10.6	0.5	0.3	0.0	0.5	0.3	9.5	0.4	2.4	0.0	0.4	0.0	3.5	0.7	0.7	0.7	6.4	9.6	0.0	0.3	0.0	0.0	9.4	0.0	0.0	0.9	0.0	5.0	14.7	0.0	8.6	0.2	17.0	3.2	4.8	0.0	0.5	7.8	15.0	0.0	14.3	0.3	0.0	0.0	0.0	1.6	1.4	0.0	2.6	24.9	0.0	0.0	0.0	0.0	16.0	3.7	0.0	0.0	0.0	6.4	43.0	0.0	0.0	0.0	54.3	33.5	0.4	0.0	15.7	0.0	0.9	1.6	4.1	0.0	0.6	0.0	2.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	0.7	1.4	1.5	2.5	0.7	1.4	0.5	0.5	2.4	0.7	0.2	0.0	0.0	0.0	0.0	0.3	19.1	0.0	100.7	0.2	0.1	0.1	2.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	9.8	0.1	2.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.8	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	7.1	1.1	0.0	0.0	0.0	1.3	9.5	0.1	0.2	0.0	0.5	0.0	1.5	0.9	0.5	0.2	68.3	0.4	0.0	0.4	0.0	0.2	4.0
SIRPA	"BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2"	ENSG00000198053	"Signal regulatory protein alpha"	P78324	20	1894167-1940592	"CD markers, Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 157.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 138.1;Excitatory neurons: 87.4;Hofbauer cells: 100.8;Macrophages: 82.5;monocytes: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 24.1;eosinophil: 48.7;myeloid DC: 13.9;neutrophil: 50.8"	"Group enriched"	"Detected in many"	150	"dendritic cells: 13.9;granulocytes: 50.8;monocytes: 24.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 142.7;RPTEC TERT1: 100.3;SK-MEL-30: 120.2"									"CAB002776, CAB015122, HPA054437, HPA058511"	Enhanced					NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"			"CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738"	"unprognostic (9.78e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.19e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.84e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.24e-2)"	49.7	40.4	145.5	49.2	146.6	44.1	41.2	98.9	157.3	27.2	56.0	16.6	27.0	15.0	19.9	13.1	23.3	27.3	30.3	155.1	105.0	27.3	53.4	42.3	22.5	101.0	123.4	19.5	12.6	4.8	15.9	26.3	94.9	15.6	14.8	39.8	29.9	15.3	17.4	29.8	22.3	21.6	99.9	28.1	11.8	6.9	135.2	7.1	12.2	9.0	16.9	35.4	21.9	126.6	11.8	25.2	12.5	23.2	29.4	27.5	1.8	60.5	51.1	16.2	4.9	16.2	0.3	0.0	14.3	142.7	43.6	11.6	10.0	70.6	6.7	0.1	7.1	0.0	2.8	9.0	35.4	24.4	28.5	24.9	32.5	13.8	16.6	46.1	50.8	0.2	1.4	15.4	22.0	0.7	0.0	33.9	13.9	0.0	11.2	0.1	22.2	16.1	100.3	0.0	1.7	3.7	8.2	0.0	120.2	4.5	4.0	76.9	76.6	71.1	36.7	46.4	30.5	0.1	0.1	0.2	22.2	77.3	8.2	0.3	24.1	48.7	0.0	6.0	0.0	0.1	0.0	0.0	13.9	0.0	0.0	0.0	50.8	0.0	2.2	0.9	0.1	10.0	145.5	146.6	98.9	157.3	155.1	105.0	101.0	123.4	94.9	99.9	135.2	126.6	60.6	3.2	6.5	138.1	4.3	14.3	12.8	28.3	6.2	13.2	18.8	27.7	12.7	34.3	10.1	9.2	14.6	20.2	0.6	2.8	1.9	26.8	0.5	1.5	2.2	13.7	9.6	4.4	87.4	2.1	2.1	23.7	1.1	4.8	17.7	1.6	20.3	29.3	100.8	15.2	44.2	3.5	2.0	57.2	54.3	1.2	5.0	82.5	23.2	33.7	85.0	23.7	0.0	40.7	51.1	25.1	9.9	1.9	1.6	9.7	17.7	16.1	5.1	26.8	6.6	3.4	7.8	0.2	8.3	2.8	6.7	36.5	2.1	0.0	2.6	7.7
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	878	"kidney: 705.6"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in single"	4	"renal cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	705.6	0.4	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.4	0.2	0.6	0.5	0.6	0.4	0.2	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	38.6	0.0	0.0	0.0	0.0	209.4	0.0	13.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.2	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782915-25832052	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"kidney: 169.3;liver: 49.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	647	"RPTEC TERT1: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050513			Approved	"Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	169.3	49.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 164.3"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 197.8"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	210	"RPTEC TERT1: 114.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.3	37.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	1.8	0.0	0.0	0.2	0.1	7.9	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	197.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.3;intestine: 31.9;liver: 47.3;pancreas: 22.7"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	20.6	28.7	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	3.7	47.3	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.1	0.2	0.0	26.7	0.0	0.0	0.0	0.0	0.0	31.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490468-4587469	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.0;intestine: 64.7;kidney: 51.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	4.6	1.7	13.2	2.3	15.4	0.1	4.1	9.5	14.8	5.8	12.9	12.4	34.8	3.7	45.0	2.3	2.6	25.5	2.8	16.5	12.6	51.0	41.2	20.9	2.6	10.8	13.0	0.6	2.1	0.3	6.8	8.1	13.6	6.3	10.2	6.0	4.8	3.2	1.4	1.5	64.7	3.2	10.9	0.4	5.2	0.8	13.9	0.4	29.5	1.3	8.2	5.6	1.5	10.1	0.1	2.0	1.6	9.5	24.3	29.1	8.3	10.4	21.4	3.2	3.1	17.2	0.5	13.7	0.6	5.4	3.9	0.0	3.6	5.7	2.9	70.9	4.5	0.0	13.6	0.1	0.8	0.9	0.0	2.0	0.2	12.1	0.0	1.6	32.5	0.2	0.0	0.0	2.2	0.3	0.0	0.3	4.2	10.5	1.8	0.0	0.0	0.2	66.4	6.1	2.2	2.0	0.8	3.8	0.0	7.7	1.4	0.5	17.6	4.9	0.4	9.5	3.0	0.1	0.1	0.0	23.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.2	15.4	9.5	14.8	16.5	12.6	10.8	13.0	13.6	10.9	13.9	10.1	12.2	163.5	3.2	4.2	0.4	0.0	1.1	0.6	4.6	3.9	2.0	0.8	2.3	28.6	6.1	0.0	0.0	0.1	0.0	52.4	3.9	8.1	4.3	10.7	13.3	10.6	0.0	0.0	48.4	0.8	0.0	1.8	2.0	98.7	0.0	0.6	2.5	68.4	0.1	0.0	50.3	10.1	0.0	1.3	0.3	11.2	0.3	1.1	0.0	67.5	0.0	0.8	0.0	161.4	3.5	9.3	10.6	0.0	0.0	2.4	110.6	43.1	3.3	1.1	0.0	0.5	3.1	0.1	0.2	1.0	0.6	0.1	1.4	0.4	8.5	1.8
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291116-100306547	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 419.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Collecting duct cells: 123.2;Endometrial ciliated cells: 136.7;Glandular and luminal cells: 136.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.26e-4)"	28.0	44.6	57.6	5.3	66.1	13.5	34.4	71.1	74.2	46.8	72.2	20.2	8.1	32.1	37.5	36.3	84.4	12.2	30.5	56.9	57.8	124.5	35.9	44.1	8.1	91.8	69.3	49.9	22.2	6.6	62.8	6.6	83.8	69.1	5.3	47.4	45.5	12.6	11.9	42.4	18.5	8.2	68.7	20.5	26.6	44.8	66.8	8.8	419.6	6.0	5.7	26.9	27.0	94.9	11.0	23.2	29.7	39.0	6.8	2.5	17.4	8.2	8.9	16.8	9.9	5.4	6.7	0.0	20.4	2.8	8.6	11.5	12.7	4.2	5.6	4.2	5.4	10.4	35.8	9.9	16.1	6.1	13.0	7.4	12.9	7.7	7.1	25.5	23.3	35.7	3.4	1.2	4.9	34.8	37.9	33.6	14.8	9.7	22.5	49.1	12.4	0.8	55.5	7.7	42.9	52.8	19.3	13.2	15.4	12.5	33.0	10.2	24.5	6.1	11.7	8.6	12.9	2.9	1.3	1.4	6.9	14.9	7.6	1.5	1.1	2.1	0.9	0.2	0.0	0.1	0.4	0.9	1.2	0.5	0.1	0.6	1.2	0.1	0.0	0.5	0.6	0.2	57.6	66.1	71.1	74.2	56.9	57.8	91.8	69.3	83.8	68.7	66.8	94.9	23.5	9.6	26.5	108.7	5.8	6.5	16.3	14.8	22.8	17.9	57.1	38.5	1.4	11.5	23.3	123.2	75.0	6.2	17.8	9.4	17.6	31.4	19.7	136.7	24.8	20.9	20.9	3.8	26.4	11.8	0.7	10.9	12.2	136.0	14.5	22.6	31.8	9.5	7.4	21.9	22.4	8.8	12.2	2.8	30.0	62.4	2.5	11.7	10.6	30.9	8.8	21.0	12.3	42.7	78.5	14.2	17.0	6.0	4.1	39.6	4.6	13.1	45.1	82.7	13.1	7.0	12.6	4.2	5.0	24.5	6.5	18.6	6.4	6.3	14.3	13.8
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.6;skeletal muscle: 86.3;tongue: 63.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 38.8;Hepatocytes: 43.6;Proximal tubular cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA045260: AB_10962505"	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	9.5	9.9	5.2	6.0	6.2	10.5	8.4	5.1	6.0	9.7	8.6	5.6	4.3	9.1	6.8	7.0	6.5	7.5	71.6	4.7	6.5	41.9	32.2	7.7	8.3	5.6	5.4	18.5	5.5	5.1	4.3	4.3	6.0	13.6	6.0	1.6	8.2	12.7	86.3	5.9	4.4	10.1	5.3	11.5	5.1	6.1	5.6	5.1	11.4	63.3	7.9	6.3	6.2	5.4	3.9	8.4	5.0	21.4	24.4	15.5	1.7	18.2	10.5	15.3	9.2	8.8	10.4	0.0	15.5	18.6	11.4	7.4	11.6	18.2	18.1	12.8	9.4	14.6	5.5	23.8	14.4	20.9	18.9	10.1	12.1	22.6	16.7	18.0	26.9	14.3	8.9	0.0	31.3	4.6	7.7	14.6	7.3	4.5	10.7	19.1	8.3	7.8	33.3	3.2	1.0	5.0	10.2	16.1	14.7	8.6	12.0	28.0	10.0	14.2	8.0	16.0	12.6	3.7	8.0	0.3	15.6	19.5	22.3	0.0	1.2	1.9	0.8	1.3	0.6	0.6	0.9	0.9	1.7	0.6	1.0	0.4	0.0	0.7	0.6	2.2	0.3	0.5	5.2	6.2	5.1	6.0	4.7	6.5	5.6	5.4	6.0	5.3	5.6	5.4	6.2	6.4	2.2	4.2	4.5	12.9	2.0	4.2	1.2	1.9	8.6	4.4	38.8	8.6	2.5	14.7	4.2	0.8	5.6	1.6	23.5	3.2	10.1	7.4	3.5	6.0	2.4	3.0	3.6	1.4	0.9	2.6	1.1	7.8	5.1	7.7	9.3	43.6	4.1	0.0	4.2	3.4	6.1	10.0	7.7	7.7	5.0	6.5	5.4	5.6	6.6	0.9	3.1	4.0	0.8	2.2	1.6	6.4	3.9	3.9	2.1	29.5	3.4	1.0	6.6	3.6	3.3	0.3	1.8	3.8	6.1	0.5	6.6	8.6	3.3	1.5
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960758-149993455	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"intestine: 212.0"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 2026.2;Glandular and luminal cells: 684.5;Syncytiotrophoblasts: 808.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 66.1;RPTEC TERT1: 151.7;TIME: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	5.2	30.7	2.2	7.8	2.3	2.5	9.2	9.5	3.8	6.3	4.0	212.0	12.9	9.3	22.8	10.7	5.0	5.5	2.8	2.2	3.5	4.9	1.7	7.3	4.0	3.8	3.4	4.8	3.4	37.7	7.1	34.0	3.5	12.2	189.6	20.8	35.8	18.4	3.9	7.8	16.1	9.3	3.8	3.7	3.3	4.2	3.9	4.2	4.5	3.7	5.9	4.7	3.0	3.4	9.5	8.6	10.5	17.3	12.6	8.8	2.5	8.9	8.0	7.0	8.5	44.7	5.1	7.4	66.1	9.5	16.8	6.8	10.0	20.5	12.4	6.0	6.4	9.3	6.7	5.2	9.4	17.3	15.2	9.8	11.8	11.7	15.2	17.3	16.8	9.0	2.4	7.1	29.6	3.0	6.6	9.1	3.2	3.2	13.5	9.5	16.3	3.9	151.7	41.6	3.2	8.1	15.6	3.6	27.2	8.1	7.3	10.0	80.4	16.0	11.8	14.2	10.7	5.2	7.3	4.3	14.7	20.6	23.5	4.9	0.5	0.3	0.9	0.3	1.1	0.5	0.5	0.8	0.7	0.5	0.8	0.9	0.3	1.1	1.6	0.7	1.1	0.5	2.2	2.3	9.5	3.8	2.2	3.5	3.8	3.4	3.5	3.8	3.9	3.4	47.4	44.8	11.3	3.3	8.5	4.6	13.2	22.9	7.4	17.1	23.8	14.6	7.8	7.2	24.2	33.1	16.7	219.2	11.5	2026.2	1.9	6.1	32.7	237.0	92.3	29.8	21.1	16.6	5.4	9.9	7.7	21.5	5.1	684.5	90.0	29.6	17.2	2.0	30.4	6.7	7.9	52.5	20.3	15.3	11.8	15.7	17.4	17.4	90.7	17.8	19.6	15.2	15.5	16.6	6.0	12.1	177.4	12.4	15.2	15.1	91.7	5.1	26.6	84.5	0.0	18.7	13.9	8.7	11.4	73.9	5.1	808.9	14.0	26.3	208.9	5.5
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046118	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 99.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 31.0;Endometrial ciliated cells: 30.5;Glandular and luminal cells: 93.7;Proximal tubular cells: 36.2;Syncytiotrophoblasts: 85.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.1;RPTEC TERT1: 4.5;WM-115: 3.5"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	1.2	0.4	0.3	0.5	0.6	1.1	1.9	1.0	0.2	0.3	0.5	0.5	0.5	0.3	0.1	0.4	6.7	6.3	0.4	0.3	20.2	0.1	0.2	0.2	0.2	0.0	0.1	99.8	2.2	0.0	4.5	0.1	0.2	0.1	0.5	1.6	2.3	3.8	1.0	0.8	0.1	0.0	0.3	0.3	0.2	0.6	0.0	19.8	0.7	0.1	0.5	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	2.1	0.1	0.1	0.0	0.0	0.3	0.4	0.1	0.4	0.0	0.1	0.3	0.1	0.2	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.3	0.3	4.5	0.1	0.4	0.1	0.3	0.5	0.1	0.7	0.3	0.1	0.2	0.2	0.5	0.2	0.1	0.3	0.2	0.3	0.2	0.2	3.5	0.9	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.4	0.5	1.9	1.0	0.4	0.3	0.2	0.0	0.1	0.0	0.6	0.2	0.2	3.2	3.0	0.0	0.6	0.4	0.7	0.0	0.0	4.5	9.1	0.4	13.9	8.6	0.0	9.2	0.0	31.0	0.1	0.5	5.9	11.5	0.0	30.5	9.7	1.0	0.0	0.0	0.0	21.1	2.8	0.5	0.0	93.7	4.5	0.1	0.0	0.0	3.6	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.9	3.6	0.0	1.0	0.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	3.9	36.2	0.0	2.3	6.6	2.1	1.0	0.2	0.4	0.0	0.9	85.1	0.9	0.1	1.1	0.7
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC35B3	"C6orf196, CGI-19, dJ453H5.1, PAPST2"	ENSG00000124786	"Solute carrier family 35 member B3"	Q9H1N7	6	8411435-8435561	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054661, HPA057801"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA054661: AB_2682561, HPA057801: AB_2683532"	"unprognostic (2.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.88e-3)"	11.3	9.7	6.0	10.2	7.6	4.6	12.9	6.3	10.6	12.2	7.2	24.2	14.8	9.4	43.0	10.3	9.6	15.1	10.3	6.3	6.2	16.4	23.4	10.6	12.2	7.2	6.6	8.1	18.4	14.6	12.0	14.7	7.1	12.1	24.9	5.2	15.0	17.4	5.7	10.7	16.9	9.4	6.4	13.4	17.9	8.8	6.6	9.9	18.2	4.5	11.8	12.3	10.9	9.4	14.8	7.7	10.4	14.1	23.4	35.7	8.5	37.9	31.4	13.5	17.3	24.7	13.9	12.5	20.9	27.7	19.5	10.6	11.5	10.3	22.6	18.0	8.4	6.1	6.1	15.0	24.5	9.1	13.2	24.4	14.3	14.3	15.5	17.5	18.5	7.4	13.2	5.1	30.5	10.2	6.9	13.7	8.2	20.6	9.2	6.2	9.7	12.6	36.7	13.2	9.9	8.4	9.8	8.6	17.9	29.6	6.5	18.4	15.9	22.3	6.4	15.9	17.2	12.8	23.9	6.3	12.8	10.0	29.6	5.4	4.5	4.8	6.2	3.5	6.9	4.2	6.2	6.6	4.0	5.8	7.0	5.5	5.2	10.8	5.8	2.7	7.0	4.3	6.0	7.6	6.3	10.6	6.3	6.2	7.2	6.6	7.1	6.4	6.6	9.4	13.3	6.4	10.6	21.9	14.9	13.5	13.0	29.4	10.8	5.7	20.9	10.3	9.1	20.0	27.5	29.5	4.2	21.1	18.5	42.8	7.9	20.5	9.9	28.6	19.4	15.1	14.9	5.5	19.5	24.3	29.1	21.8	28.1	15.5	6.3	11.5	18.5	23.6	19.9	10.1	17.7	47.3	36.7	15.1	10.4	7.6	15.5	11.3	21.4	24.4	16.7	7.1	13.4	30.7	65.7	15.4	33.4	12.0	22.2	22.6	31.1	27.5	46.8	3.7	13.1	9.9	15.7	32.1	14.2	13.7	17.6	16.4	13.1	10.7	33.5	22.9
SLC35F5	FLJ22004	ENSG00000115084	"Solute carrier family 35 member F5"	Q8WV83	2	113705011-113756693	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034828, HPA049229"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA034828: AB_2674350, HPA049229: AB_2680682"	"unprognostic (1.59e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.83e-2)"	9.8	22.8	4.6	6.0	5.9	8.0	14.3	12.0	6.6	9.3	31.5	14.7	13.7	10.3	11.5	11.1	8.0	11.1	11.0	6.1	6.4	18.0	14.6	9.9	9.0	6.7	4.8	12.4	15.1	17.4	5.2	11.1	7.1	11.2	13.6	14.1	9.8	6.9	12.3	20.3	12.9	8.9	5.4	10.1	12.9	7.1	5.2	5.7	23.7	11.2	10.0	8.0	6.3	12.0	9.7	9.6	7.7	4.9	48.6	36.8	14.0	15.9	13.2	7.7	12.9	24.3	18.9	18.5	22.1	21.9	21.3	8.7	12.2	12.5	17.9	5.7	4.9	9.7	9.6	19.7	20.8	12.8	24.0	46.8	17.4	17.9	25.9	22.1	15.2	4.6	7.7	11.2	19.1	8.5	5.6	14.0	3.6	15.0	5.2	6.5	13.1	9.7	52.5	15.8	2.1	6.0	12.9	14.5	11.5	12.8	9.4	12.6	12.7	14.3	6.3	9.2	6.7	9.7	8.7	8.2	16.8	8.9	13.6	2.9	0.7	0.6	0.5	0.8	0.6	0.9	0.5	0.4	0.6	1.2	0.6	0.6	2.1	1.0	1.2	0.9	0.9	0.6	4.6	5.9	12.0	6.6	6.1	6.4	6.7	4.8	7.1	5.4	5.2	12.0	18.9	22.4	19.8	39.5	18.0	25.4	31.1	20.0	31.9	10.3	20.4	9.8	25.4	21.5	30.4	73.5	22.9	46.3	11.6	44.1	11.7	28.7	28.3	32.4	21.9	15.4	14.5	9.9	43.4	28.5	72.0	24.8	28.5	38.6	24.1	14.4	12.5	20.8	28.3	5.0	47.0	25.6	12.2	13.4	17.2	15.6	12.5	14.6	8.8	39.4	15.5	21.0	7.2	65.4	83.2	23.1	29.7	13.9	37.5	35.3	47.9	45.1	26.3	19.6	0.0	14.2	22.7	60.0	20.5	32.7	34.0	66.4	10.8	41.0	24.8	35.1
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 48.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.8;Microglial cells: 362.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	8.2	9.7	7.9	6.3	7.4	4.6	7.1	0.0	21.0	10.8	0.0	4.3	3.9	11.0	3.7	3.6	9.5	8.8	4.3	15.8	0.0	8.7	2.0	7.4	8.3	0.1	0.4	7.9	4.8	5.2	1.1	12.8	1.7	19.1	4.2	5.1	3.7	6.7	1.3	7.0	4.0	7.7	1.4	18.3	5.0	9.3	9.9	10.6	48.4	3.1	7.6	6.3	2.1	5.8	7.3	27.1	46.8	13.0	9.5	21.1	24.3	34.8	16.4	16.1	8.1	38.4	26.4	10.4	51.3	19.6	12.4	10.4	28.6	31.6	19.9	5.4	21.8	11.7	37.1	34.0	10.8	45.4	4.9	12.9	5.1	17.7	20.2	56.9	37.3	10.5	34.9	14.3	26.7	7.3	12.7	14.0	53.8	44.1	18.8	28.9	16.6	27.0	74.8	12.7	17.5	24.7	34.4	65.1	18.7	81.2	11.2	26.5	36.1	28.7	33.6	19.0	18.7	4.6	3.7	6.3	24.5	19.9	29.9	41.5	4.7	3.7	7.5	4.4	6.1	12.3	6.8	6.7	6.4	15.8	6.0	7.8	0.8	21.7	3.3	32.8	7.6	2.6	7.9	7.4	0.0	21.0	15.8	0.0	0.1	0.4	1.7	1.4	9.9	5.8	72.1	3.2	12.8	40.8	42.0	25.6	12.1	51.3	13.1	23.0	16.9	23.1	7.6	5.7	33.2	36.8	8.4	49.3	60.2	4.3	1.9	17.7	28.5	13.2	48.7	75.4	15.6	26.9	170.8	11.3	66.0	35.3	11.2	16.5	13.3	25.7	26.4	2.8	24.5	8.4	78.3	5.9	26.4	20.7	27.1	16.0	19.0	31.8	7.2	362.6	16.2	17.0	20.6	49.3	49.5	24.3	2.8	18.8	21.3	20.1	4.5	14.7	9.5	20.0	13.1	41.9	29.1	61.3	33.6	7.5	20.5	23.4	35.4	30.8	6.2	7.8
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC44A3	"CTL3, MGC45474"	ENSG00000143036	"Solute carrier family 44 member 3"	Q8N4M1	1	94820342-94895246	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"OE19: 35.9;RPTEC TERT1: 101.4;RT4: 69.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in all"			HPA047433	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047433: AB_2680046"	"unprognostic (8.06e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.63e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (9.09e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.31e-3)"	2.2	8.8	15.7	6.2	15.3	0.1	8.1	17.9	16.9	8.8	14.0	31.5	26.1	7.2	6.6	9.4	8.0	10.9	3.9	14.8	17.0	29.3	6.3	10.3	0.8	20.7	16.4	1.7	27.0	5.2	15.0	3.4	16.4	10.8	35.4	4.3	23.4	7.7	0.2	6.0	28.0	2.8	17.6	0.9	29.3	2.5	15.7	4.9	5.2	0.6	2.2	22.1	6.5	18.3	23.4	3.2	0.8	0.0	2.5	3.2	15.9	0.4	3.4	0.8	3.7	21.4	5.8	0.0	15.4	0.4	6.9	7.7	3.5	5.5	1.4	0.0	4.1	0.0	1.2	1.7	1.1	0.0	0.0	9.9	5.1	1.6	0.0	6.3	0.4	0.0	0.0	0.0	1.4	3.4	0.0	0.3	1.0	35.9	0.8	1.8	0.7	1.3	101.4	69.5	10.4	17.0	1.0	10.8	7.8	7.3	6.2	0.7	0.0	0.5	3.5	1.5	0.2	0.0	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	15.3	17.9	16.9	14.8	17.0	20.7	16.4	16.4	17.6	15.7	18.3	0.4	25.6	6.7	26.1	0.6	3.1	27.8	14.6	4.0	0.7	15.6	8.3	5.7	37.1	22.7	12.9	0.0	15.9	0.1	18.2	15.6	33.4	32.5	12.8	3.2	1.3	16.3	0.0	1.4	27.8	0.8	3.8	16.3	22.5	1.3	5.3	0.7	2.1	1.3	0.0	4.6	32.2	20.3	0.3	0.4	5.3	5.0	0.8	5.4	2.8	1.0	17.0	0.0	5.5	2.0	38.3	36.5	10.9	0.0	12.9	22.8	38.6	11.4	0.2	0.0	9.6	3.4	0.1	0.2	10.2	3.8	6.7	0.8	4.1	42.8	30.3
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 76.0;liver: 96.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 53.2;Hepatocytes: 51.3;Proximal enterocytes: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.0;T-47d: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favorable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	13.8	11.7	5.1	10.2	5.7	2.9	10.0	7.7	5.2	14.7	10.0	19.8	46.7	5.6	11.1	4.0	7.5	23.8	12.3	4.7	5.7	18.2	96.0	11.5	16.3	5.9	6.0	3.9	6.7	23.9	10.2	9.5	6.1	6.5	18.8	15.9	9.0	9.9	8.5	4.2	76.0	8.2	6.6	18.2	7.8	11.0	6.6	11.6	12.5	8.6	11.1	7.0	2.2	5.6	0.0	2.8	0.0	7.6	6.0	2.3	0.2	2.7	15.7	3.0	4.4	0.1	6.6	5.2	4.7	4.0	11.5	0.6	3.5	1.4	4.5	3.9	6.2	3.6	0.0	0.0	11.4	0.0	4.3	9.8	2.9	4.5	7.3	3.0	5.6	15.7	3.9	0.0	14.5	3.0	8.6	0.6	0.3	8.0	2.2	3.5	13.3	0.2	27.0	0.9	1.2	0.4	0.0	14.1	5.7	3.1	20.6	4.6	2.0	1.4	2.7	0.4	16.0	4.0	2.0	0.8	0.9	0.0	2.8	33.1	8.9	3.8	10.3	13.1	8.6	7.4	8.0	10.1	11.7	9.7	11.4	10.8	9.8	7.0	19.4	11.0	10.6	8.7	5.1	5.7	7.7	5.2	4.7	5.7	5.9	6.0	6.1	6.6	6.6	5.6	6.2	0.0	5.4	16.0	14.5	1.9	0.1	7.4	1.8	33.7	15.1	3.3	9.6	17.2	15.6	9.2	8.4	0.6	16.4	49.0	1.9	15.5	4.6	2.1	1.7	12.2	3.6	4.6	11.6	5.6	0.3	6.2	0.0	2.1	25.9	53.2	17.5	51.3	10.8	21.9	13.0	6.8	2.0	32.1	36.6	1.8	1.5	22.5	7.2	16.9	9.3	14.2	12.3	14.6	15.6	3.5	5.3	2.2	6.5	0.6	125.0	10.1	15.4	9.8	0.0	2.8	7.2	2.6	0.9	4.9	1.7	0.7	11.4	16.8	13.9	0.2
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073578-34106260	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 96.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 129.1;Collecting duct cells: 138.0;Granulosa cells: 148.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	6.9	5.9	8.6	4.5	9.2	1.9	6.6	5.7	11.4	3.7	96.0	4.5	2.6	6.8	5.2	3.1	4.8	2.5	2.4	10.7	17.0	29.0	5.9	3.9	4.9	9.3	9.9	3.9	1.9	3.2	4.1	10.6	9.2	2.9	5.2	5.6	2.8	3.5	2.5	6.7	3.7	2.9	8.2	2.4	3.9	6.2	20.3	3.9	25.2	2.6	4.8	3.8	3.4	9.2	10.5	9.3	19.0	13.4	15.5	12.7	9.1	11.8	35.7	7.2	10.9	15.5	22.5	16.9	9.3	24.0	13.5	5.3	23.3	6.7	12.2	17.7	6.0	17.5	9.0	5.2	4.1	7.6	7.1	6.1	17.0	19.7	7.8	22.0	4.4	13.7	17.6	3.9	18.7	7.1	8.1	6.1	9.6	4.0	9.0	8.1	3.4	7.7	28.1	14.5	9.9	4.6	24.5	6.4	5.6	11.3	3.9	8.0	4.2	14.0	10.7	27.1	4.8	20.1	18.5	12.4	28.2	10.9	9.6	0.0	0.2	0.0	0.6	0.2	0.5	0.1	0.3	0.4	0.2	0.1	0.4	0.6	0.1	0.2	0.1	0.5	0.1	0.1	8.6	9.2	5.7	11.4	10.7	17.0	9.3	9.9	9.2	8.2	20.3	9.2	18.8	16.0	10.2	0.0	33.3	0.0	46.5	0.0	129.1	33.8	37.4	34.9	11.4	10.0	13.0	138.0	20.9	27.4	43.0	39.1	21.5	4.0	9.0	38.7	59.9	16.4	49.3	17.0	0.0	5.5	19.7	42.3	18.3	42.5	41.3	148.6	5.0	20.7	15.2	37.0	0.0	69.3	0.0	14.4	0.0	7.2	6.5	41.0	0.0	0.0	23.3	6.7	16.5	0.0	0.0	7.6	49.7	20.7	54.1	88.4	16.3	9.4	8.7	20.9	13.1	15.4	33.7	14.8	18.5	39.7	0.0	28.2	48.3	14.0	36.3	69.5
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.2;kidney: 36.0;liver: 81.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Hepatocytes: 22.7;monocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.8;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	50	"classical monocyte: 5.7;intermediate monocyte: 5.7;myeloid DC: 2.4;neutrophil: 3.0;non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 2.4;granulocytes: 3.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;RPTEC TERT1: 13.8;SuSa: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.2	0.4	22.6	1.1	23.3	0.1	0.4	18.0	35.2	0.8	12.4	0.7	4.5	1.1	6.8	0.0	3.4	1.0	0.3	18.5	21.5	36.0	81.5	2.4	0.5	19.8	25.2	0.3	1.6	0.4	0.8	0.5	20.9	0.1	1.8	0.5	0.1	0.0	0.1	0.2	0.8	0.9	16.5	0.5	2.4	1.6	22.4	0.3	6.3	0.0	0.3	0.4	0.3	17.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.8	0.1	0.0	0.4	0.0	0.0	0.1	2.9	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.0	0.0	7.9	0.0	0.0	1.9	22.6	23.3	18.0	35.2	18.5	21.5	19.8	25.2	20.9	16.5	22.4	17.7	0.1	0.0	0.5	4.2	0.6	0.1	0.0	0.0	0.0	0.5	0.9	0.6	0.7	0.0	0.1	46.0	0.0	0.0	0.0	1.6	1.9	0.0	4.6	3.5	1.7	0.2	0.0	0.0	0.4	0.4	0.0	0.6	2.0	8.8	0.0	0.1	0.7	22.7	2.4	0.0	0.3	1.7	0.0	1.9	2.5	6.2	0.6	1.6	0.0	8.4	10.7	5.2	0.0	0.5	9.2	0.0	1.2	0.0	0.0	0.0	0.0	8.0	0.0	0.4	6.6	0.6	0.4	2.3	4.5	0.0	0.4	0.8	0.1	0.1	1.0	0.1
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 153.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	13.4	0.0	16.5	0.1	0.1	11.0	20.1	0.1	13.9	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.6	12.2	11.9	153.1	36.8	0.8	0.0	11.6	12.6	0.2	0.0	0.0	3.0	0.0	11.7	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.1	0.3	0.1	3.1	13.8	0.1	6.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.5	11.0	20.1	12.2	11.9	11.6	12.6	11.7	12.1	13.8	11.7	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 68.5"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 59.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 59.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 66.6;RPTEC TERT1: 111.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.9	25.6	1.7	8.4	6.9	54.7	8.5	5.0	7.7	11.3	0.0	3.9	0.9	10.4	0.0	6.7	6.7	9.4	24.4	3.5	3.8	12.2	1.5	20.5	7.5	9.6	6.6	28.9	2.3	2.5	7.4	7.9	6.7	4.3	2.4	68.5	17.1	7.2	30.9	18.3	17.1	6.9	1.7	15.6	9.4	3.7	11.0	4.5	9.3	8.7	9.1	8.1	6.1	6.8	4.1	18.4	4.6	10.1	11.6	5.7	15.9	4.3	26.4	8.4	6.2	8.8	5.6	12.6	4.5	10.9	11.7	4.3	4.5	10.1	16.5	3.7	9.7	8.8	66.6	24.2	0.0	3.7	22.3	1.9	2.6	7.8	1.6	7.7	14.5	6.2	10.1	3.5	18.6	8.1	9.4	20.3	6.1	7.1	10.8	6.1	7.3	24.9	111.8	28.5	7.2	4.6	3.1	3.2	0.6	36.8	11.5	4.5	15.3	9.7	3.9	5.2	6.2	3.9	6.0	7.1	19.3	6.6	23.2	5.6	9.2	8.6	2.5	7.3	1.3	4.0	2.7	3.0	2.8	2.1	0.5	0.6	59.2	1.8	9.4	1.4	8.7	4.6	1.7	6.9	5.0	7.7	3.5	3.8	9.6	6.6	6.7	1.7	11.0	6.8	42.7	6.4	21.5	1.3	16.4	49.3	17.1	51.5	43.9	126.1	9.5	6.9	4.2	7.2	52.8	20.2	571.3	3.0	14.5	0.5	0.0	12.0	19.6	82.1	23.0	29.4	14.4	9.4	17.4	8.2	15.8	13.5	29.0	126.9	13.3	2.5	11.7	0.6	27.2	10.1	18.5	3.5	46.8	60.1	59.5	16.6	17.4	58.8	17.8	32.8	110.9	30.8	10.3	3.0	23.9	31.1	12.6	17.3	13.3	17.6	51.3	23.3	69.5	547.8	0.0	11.4	8.3	0.4	1.3	15.7	23.9	5.1	25.5	46.8	3.6	16.8
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642503-62685785	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 57.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.8;Extravillous trophoblasts: 239.4;Melanocytes: 60.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 197.2;RPTEC TERT1: 193.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.7"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	32.4	5.6	26.2	1.8	24.0	1.3	23.4	24.2	35.7	11.1	19.6	9.8	1.2	8.7	0.3	16.7	13.1	1.8	48.6	23.9	25.4	35.8	5.0	57.2	2.4	26.5	24.8	6.5	4.9	3.8	2.9	4.7	28.0	5.9	1.8	21.5	8.5	1.0	18.8	25.6	9.2	0.8	25.7	6.6	13.5	2.1	31.6	1.1	8.6	5.6	3.2	12.0	16.8	24.9	14.8	19.1	0.8	10.8	2.5	2.1	26.5	4.7	16.6	14.1	5.4	32.0	14.9	17.8	44.2	0.5	9.6	22.0	16.4	1.0	5.4	2.1	9.6	21.7	22.1	23.8	0.1	16.6	6.7	0.0	6.5	0.3	6.2	4.2	2.5	10.7	17.1	4.6	0.0	14.8	17.2	63.9	5.4	74.1	197.2	30.6	1.1	26.2	193.9	14.2	17.4	25.1	4.1	4.4	15.7	6.5	1.0	7.5	2.8	0.4	10.5	7.0	27.2	9.2	15.9	11.1	38.1	24.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.9	0.7	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.2	26.2	24.0	24.2	35.7	23.9	25.4	26.5	24.8	28.0	25.7	31.6	24.9	61.8	3.2	1.3	1.3	13.1	27.3	1.4	19.8	1.2	14.1	1.2	0.8	4.4	1.5	5.9	25.8	31.3	2.1	3.7	7.5	0.0	5.9	0.3	8.7	3.6	40.3	0.0	2.1	7.9	2.5	239.4	4.3	20.9	35.6	0.0	0.0	14.6	0.6	5.5	0.0	6.6	8.4	2.0	9.7	33.5	0.7	0.3	11.9	60.5	3.7	0.0	6.1	0.0	1.5	0.3	11.8	1.9	0.7	19.1	3.5	0.8	9.6	1.3	43.2	0.0	1.9	2.9	0.2	3.0	1.1	16.1	23.5	5.6	0.1	7.5	11.0
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296284	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5;neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.8	0.2	0.6	0.3	8.6	0.5	0.0	0.4	0.3	0.0	1.0	2.2	0.1	0.2	0.1	0.2	2.3	0.3	0.2	0.0	41.6	7.6	7.8	0.5	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.0	0.8	0.1	2.0	3.6	0.1	0.3	1.5	0.1	0.0	1.3	0.6	0.8	0.3	1.0	1.6	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	1.1	0.0	1.0	0.2	1.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.5	0.0	1.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	1.2	98.8	0.1	0.7	0.5	0.0	0.3	0.0	2.3	0.0	2.4	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	25.8	0.1	9.5	1.0	7.3	3.8	0.0	0.3	0.0	0.6	2.1	0.4	0.1	0.2	1.3	9.8	2.6	0.0	0.2	0.0	1.0	0.2	0.3	0.0	0.4	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.1	6.4	49.7	0.3	0.6	0.0	0.1	1.2	0.0	0.0	1.8	0.3	0.3	1.5	6.4	5.5	0.0	0.0	9.6	1.4	1.9	0.2	21.6	0.0	0.1	0.3	0.0	5.7	9.1	0.8	0.0	0.3	0.0	1.6	5.7	0.0	0.4	11.0	0.2	0.0	6.6	0.1	2.0	0.6	0.3	2.6	0.3	2.4	0.0	1.0	3.2	0.0	26.8	1.5	0.3	0.3	0.1	0.0	1.4	0.0	1.8	32.8	3.1	0.0	0.0	0.1	0.1	2.5	2.4	0.0	0.0	0.0	3.4	0.1	1.1	0.4
SMIM11B		ENSG00000273590	"Small integral membrane protein 11B"	Q8TCY0	21	7744962-7777853	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 5.6;Club cells: 4.3;Distal tubular cells: 3.9;granulocytes: 5.1;Respiratory ciliated cells: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Focal adhesion sites"		"HPA051321: AB_2681440"					"unprognostic (1.99e-1)"					"unprognostic (1.78e-1)"				"unprognostic (1.35e-1)"				14.6	17.0	22.5	1.1	22.6	0.5	15.6	21.7	24.1	17.6	21.7	23.3	2.1	16.8	15.0	9.3	19.2	3.1	30.7	22.3	22.5	24.3	20.6	11.3	4.8	24.7	23.1	20.6	18.6	9.1	21.3	4.2	22.2	17.4	5.7	10.0	15.4	11.2	37.3	9.8	13.9	3.4	19.7	14.0	58.2	6.5	22.4	12.2	19.5	16.3	8.5	18.4	14.3	23.4	23.6	9.6	7.7	17.3	19.0	37.9	0.2	8.8	30.0	11.2	0.8	1.0	1.4	1.1	7.0	14.3	23.8	1.1	17.0	27.7	10.0	34.3	45.9	19.2	1.2	13.8	19.5	3.1	25.9	18.8	26.6	0.4	1.4	7.9	14.5	29.3	31.2	3.6	10.6	11.9	26.6	2.1	0.6	36.3	0.6	1.1	0.4	1.2	34.7	6.2	16.2	1.9	21.6	15.3	17.7	0.6	28.2	0.8	3.1	10.9	4.5	9.2	9.8	19.2	20.6	1.5	0.1	9.9	1.5	1.5	11.0	4.6	11.6	5.8	11.3	19.6	9.1	6.0	11.4	12.2	16.1	9.7	0.9	1.4	5.0	8.4	14.7	6.4	22.5	22.6	21.7	24.1	22.3	22.5	24.7	23.1	22.2	19.7	22.4	23.4	0.1	16.0	5.6	0.0	0.2	0.0	0.6	0.0	0.0	0.8	0.8	0.3	0.0	1.5	4.3	0.0	0.0	0.3	0.3	0.3	3.9	0.5	0.2	0.2	0.1	0.4	0.0	2.7	0.0	0.4	0.3	2.1	0.0	0.1	5.1	0.1	0.4	0.6	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.3	0.3	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.3	0.3	1.9	10.9	0.3	0.0	0.9	0.1	0.3	0.4	0.0	0.0	0.3	0.6	0.1	0.5	0.3
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"	A0A1B0GVY4	4	164754064-164803795	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 7.8;intestine: 24.6;prostate: 11.0"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 93.3;Pancreatic endocrine cells: 139.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted - unknown location"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.1	0.1	0.3	1.4	0.3	1.0	1.0	0.6	0.5	5.0	0.3	15.4	22.0	0.3	0.9	0.1	0.1	7.8	0.1	0.3	0.1	0.1	0.1	0.4	0.3	0.4	0.2	0.1	0.4	0.1	0.0	0.1	0.4	11.0	15.5	0.2	1.2	0.1	0.2	0.2	24.6	0.7	0.1	0.1	0.6	0.1	0.4	0.0	0.1	0.0	0.1	1.7	0.0	0.9	0.1	0.8	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.0	0.3	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.6	0.5	0.3	0.1	0.4	0.2	0.4	0.1	0.4	0.9	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.1	0.0	0.0	9.3	3.7	0.0	0.1	0.0	0.0	0.0	3.8	0.0	2.5	2.2	0.3	0.0	0.0	0.0	93.3	0.0	0.2	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.8	10.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0
SNX25	SBBI31	ENSG00000109762	"Sorting nexin 25"	Q9H3E2	4	185204237-185370185	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 128.9;Astrocytes: 50.6;Excitatory neurons: 57.7;Inhibitory neurons: 60.7;Oligodendrocyte precursor cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036928			Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA036928: AB_10669720"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.89e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.55e-3)"	7.6	8.0	7.0	7.3	8.4	2.0	9.5	17.3	7.9	6.0	23.9	12.3	3.5	6.9	6.3	7.1	9.7	8.5	8.7	7.5	8.9	11.3	9.1	29.1	11.5	9.6	10.0	7.4	10.0	13.3	10.5	11.8	9.7	14.9	6.7	25.5	6.7	8.6	10.2	6.2	7.9	7.0	8.1	9.5	6.2	12.7	8.8	2.9	16.7	8.6	12.9	7.2	5.4	7.3	11.9	6.2	7.8	11.0	20.5	15.0	11.5	35.6	17.1	17.9	14.9	5.3	8.1	33.6	3.8	26.0	12.4	4.6	8.9	7.8	20.0	55.9	14.5	5.7	7.5	12.8	11.9	3.8	8.0	10.4	8.3	15.6	8.6	36.0	15.7	6.3	12.0	33.3	23.9	3.5	1.5	6.9	6.3	1.6	5.9	4.9	9.0	8.6	43.0	4.5	16.5	11.9	7.4	2.0	30.3	10.8	4.2	4.9	30.0	10.2	6.5	9.8	15.7	29.3	12.8	7.1	16.7	2.8	12.9	0.0	0.0	0.0	0.1	0.0	0.3	0.7	0.3	0.4	0.0	1.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	7.0	8.4	17.3	7.9	7.5	8.9	9.6	10.0	9.7	8.1	8.8	7.3	9.5	25.6	128.9	50.6	12.6	4.8	4.2	2.3	4.6	15.9	7.0	3.4	6.8	0.0	7.3	5.5	31.3	4.8	5.5	5.4	0.0	4.8	5.9	11.5	8.1	9.6	0.0	0.0	57.7	2.6	4.9	4.9	5.1	10.3	1.3	3.9	12.5	8.8	2.0	6.7	60.7	4.0	2.0	3.2	2.5	4.8	9.6	2.2	21.4	32.8	0.6	5.6	3.1	55.3	21.4	3.9	1.6	9.8	11.3	9.4	5.6	2.3	6.7	15.7	0.0	4.8	5.7	9.0	16.2	2.3	6.1	5.6	7.0	10.3	3.3	5.5
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 436.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 498.5;Leydig cells: 424.1;Peritubular cells: 365.6;Smooth muscle cells: 428.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.2;BJ: 38.1;PC-3: 55.1;RPTEC TERT1: 231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	510000000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	221.4	20.4	14.3	26.1	20.9	0.0	134.2	15.8	23.8	226.5	436.1	122.7	18.2	151.6	10.4	62.1	177.6	22.4	150.1	47.1	14.1	124.1	16.5	155.0	10.6	22.9	23.4	59.7	86.7	2.6	19.8	39.8	17.5	131.3	13.4	1.9	70.9	23.4	22.0	91.9	65.2	37.1	16.4	24.8	102.1	74.1	19.0	5.8	176.6	22.9	7.0	178.3	170.4	13.6	0.0	0.0	0.0	0.0	66.2	17.3	2.0	38.1	16.7	2.3	1.4	0.5	0.0	0.0	11.8	8.0	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	16.8	0.0	15.8	0.0	17.9	0.1	0.0	1.1	0.0	0.0	0.1	0.3	1.1	8.0	0.0	55.1	0.0	0.0	0.6	231.3	0.8	0.2	0.2	0.0	1.2	0.0	2.1	32.8	0.0	0.0	8.7	1.0	1.6	0.4	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	20.9	15.8	23.8	47.1	14.1	22.9	23.4	17.5	16.4	19.0	13.6	46.1	12.8	18.1	7.2	1.0	90.8	65.5	0.6	10.2	0.4	21.7	22.1	23.0	144.4	7.6	90.1	0.0	211.4	1.8	25.6	15.6	63.6	18.7	81.9	45.8	21.0	34.6	0.0	0.1	1.8	17.0	498.5	5.1	80.3	0.0	0.1	15.4	0.2	17.3	0.0	0.1	51.9	0.0	0.3	115.5	33.9	424.1	3.2	80.0	3.7	0.0	20.7	0.0	0.5	0.7	3.5	89.3	365.6	1.1	80.4	0.0	142.7	0.1	1.4	197.2	6.5	428.9	73.2	4.4	6.1	70.3	190.0	7.6	6.1	51.8	9.6
SORCS3	"KIAA1059, SORCS"	ENSG00000156395	"Sortilin related VPS10 domain containing receptor 3"	Q9UPU3	10	104641290-105265242	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 11.7"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 270.4;Inhibitory neurons: 193.7;Oligodendrocyte precursor cells: 462.9"	"Group enriched"	"Detected in some"	13	"glioma: 1.8;renal cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.39e-2)"			"unprognostic (8.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-1)"		"unprognostic (1.98e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (2.63e-2)"	"unprognostic (1.97e-1)"			0.2	2.0	6.5	0.1	7.7	0.0	0.1	1.8	7.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	7.0	11.7	0.2	0.0	0.0	0.0	3.6	4.1	0.8	0.0	0.0	0.2	0.0	2.2	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.2	1.7	0.0	0.1	1.0	10.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	7.7	1.8	7.5	7.0	11.7	3.6	4.1	2.2	1.7	10.3	4.8	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.1	0.1	0.0	0.0	270.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	462.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 111.3;stomach 1: 60.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 68.5;Distal tubular cells: 29.4;Gastric mucus-secreting cells: 76.5;Horizontal cells: 30.3;Ionocytes: 128.1;Melanocytes: 32.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;EFO-21: 12.7;HEL: 4.8;NTERA-2: 4.9;RPTEC TERT1: 23.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.2;hippocampal formation: 18.4;pons and medulla: 15.1;thalamus: 11.9"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.2	0.5	1.3	0.9	2.7	0.1	17.9	1.7	3.4	2.6	111.3	10.9	11.6	4.7	0.3	3.7	5.0	0.3	3.1	3.7	0.3	22.3	0.0	39.2	0.1	0.7	0.9	1.1	0.6	0.6	2.4	0.0	0.1	1.8	15.0	3.0	15.6	3.5	0.1	16.8	8.6	1.1	0.2	0.1	60.4	1.9	2.2	0.1	8.6	0.9	3.9	1.4	3.5	1.8	0.0	0.0	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	12.7	0.0	0.0	0.3	0.4	0.0	0.0	0.1	2.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.3	0.1	0.0	0.1	0.7	0.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.7	1.7	3.4	3.7	0.3	0.7	0.9	0.1	0.2	2.2	1.8	0.4	0.0	0.0	0.0	0.2	5.6	4.3	2.1	9.1	0.6	68.5	17.8	3.8	0.0	2.0	14.7	0.0	0.0	0.4	1.2	29.4	0.0	19.7	1.0	0.1	2.9	2.4	0.0	0.0	0.0	0.0	3.9	76.5	1.5	0.0	0.0	0.4	0.1	0.0	30.3	0.0	0.2	128.1	0.0	1.2	13.0	7.2	0.4	32.0	0.0	0.0	14.2	0.0	0.0	0.0	0.4	2.2	2.6	0.4	1.1	0.0	21.8	0.0	0.7	0.0	0.1	0.3	3.4	1.2	14.1	7.2	0.0	0.9	0.0	2.3	1.5
SPAG1	"CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS"	ENSG00000104450	"Sperm associated antigen 1"	Q07617	8	100157906-100259278	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Fertilization	Hydrolase	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.0;Endometrial ciliated cells: 190.6;Respiratory ciliated cells: 198.6;Spermatocytes: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023748, HPA053682"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA023748: AB_2671304, HPA053682: AB_2682229"	"unprognostic (9.95e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (9.11e-3)"	"unprognostic (8.83e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.62e-4)"	1.8	1.3	3.0	3.6	3.2	10.1	3.0	4.2	3.0	5.4	14.0	12.9	2.9	2.4	1.5	7.8	10.0	3.7	1.5	3.0	4.6	3.2	4.7	5.0	2.7	7.2	9.0	1.0	2.5	9.0	5.7	1.8	6.2	3.1	18.3	1.9	4.6	3.5	0.4	7.9	2.7	1.8	6.0	2.0	6.3	19.4	4.8	2.1	3.4	0.6	4.4	5.3	3.0	5.4	31.3	8.3	0.5	1.8	1.8	1.5	4.6	5.7	3.4	6.8	7.1	8.3	13.5	1.2	20.0	1.8	10.1	16.1	5.9	11.1	6.3	18.1	6.1	5.2	9.0	3.1	2.4	1.4	4.5	1.3	5.8	8.4	6.6	5.3	5.8	5.7	0.2	16.1	1.0	11.2	3.1	1.4	0.5	15.6	9.1	0.5	1.3	4.7	26.1	14.8	4.8	3.5	7.8	6.4	7.0	2.2	9.2	5.9	5.3	6.8	9.8	3.6	14.9	10.9	8.9	0.9	6.5	5.0	3.4	0.0	0.1	0.6	0.1	0.0	0.0	0.8	0.1	0.1	0.1	0.3	0.0	0.1	0.7	1.0	0.2	0.2	0.0	0.0	3.0	3.2	4.2	3.0	3.0	4.6	7.2	9.0	6.2	6.0	4.8	5.4	7.7	48.1	22.8	18.9	7.7	5.6	9.6	18.1	2.2	2.0	13.3	7.7	5.6	22.8	37.2	18.4	0.0	1.3	19.0	32.9	5.9	19.7	96.0	190.6	7.1	6.9	22.1	0.4	30.1	8.6	8.7	5.0	22.4	39.5	10.1	7.3	4.2	8.0	2.8	8.4	21.6	14.9	6.1	2.2	5.3	32.3	5.0	3.9	1.8	6.5	4.5	11.5	5.2	4.5	4.1	14.9	17.7	3.8	15.9	10.3	2.4	10.0	198.6	2.3	0.0	4.8	6.4	91.9	4.7	2.9	5.4	2.3	12.0	1.3	20.1	23.3
SPAG7	"ACRP, FSA-1, MGC20134"	ENSG00000091640	"Sperm associated antigen 7"	O75391	17	4959226-4967817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 305.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024032, HPA052394"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA024032: AB_1857410, HPA052394: AB_2681810"	"unprognostic (7.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (4.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.72e-2)"	51.1	56.1	55.4	37.5	56.0	46.0	48.3	58.5	63.5	50.5	56.0	67.1	37.1	67.1	41.0	52.0	68.2	38.0	156.7	56.4	57.4	84.0	69.7	46.0	44.7	58.8	56.1	42.9	45.5	69.3	38.4	52.3	59.4	45.8	38.2	47.6	48.0	40.5	305.3	48.0	45.4	50.3	56.6	51.7	56.6	35.6	58.5	47.2	56.1	215.5	41.7	54.0	47.6	58.8	41.8	90.7	116.9	65.4	79.8	115.5	67.5	80.9	91.8	77.8	59.5	53.7	53.3	52.9	116.6	100.5	54.2	58.6	59.3	123.9	35.1	77.5	52.6	57.6	74.5	75.3	111.3	32.1	82.1	127.4	87.9	66.5	123.9	118.6	99.4	66.9	39.0	53.2	96.2	66.9	58.7	71.2	66.8	58.0	29.0	61.4	74.1	38.3	135.7	52.1	32.8	64.6	68.7	27.3	68.2	59.9	59.2	50.2	96.6	52.4	34.0	26.1	67.2	46.5	40.3	32.5	101.4	45.6	69.1	96.0	88.3	82.6	82.3	72.6	89.7	97.2	77.1	77.9	103.9	81.1	95.5	84.0	23.1	67.3	73.7	105.9	95.0	91.0	55.4	56.0	58.5	63.5	56.4	57.4	58.8	56.1	59.4	56.6	58.5	58.8	40.6	57.7	52.6	11.1	54.6	55.3	103.0	252.0	52.3	62.0	62.9	66.3	135.8	77.2	125.4	99.3	45.9	183.5	61.1	82.0	324.8	161.6	23.0	63.1	49.1	64.2	57.2	33.7	7.3	144.1	183.5	66.1	40.8	48.1	73.4	68.3	70.6	72.4	139.3	92.5	8.1	73.5	156.6	64.9	88.9	21.9	46.0	65.6	104.9	2.8	221.0	89.7	97.9	7.1	12.0	128.8	82.8	42.2	39.4	98.7	116.4	239.3	127.4	69.7	72.3	53.5	70.1	55.8	50.6	52.8	50.2	230.8	52.2	89.5	74.6	105.2
SPATA6L	"C9orf68, FLJ10058"	ENSG00000106686	"Spermatogenesis associated 6 like"	Q8N4H0	9	4553386-4666674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.1;Late spermatids: 102.8;Respiratory ciliated cells: 40.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;CAPAN-2: 2.4;HDLM-2: 1.4;HeLa: 1.1;RPTEC TERT1: 1.7;SCLC-21H: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039585	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"			"HPA039585: AB_10674984"	"unprognostic (8.18e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.03e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-3)"	0.8	0.4	1.2	0.2	1.3	0.0	1.2	1.8	1.5	1.1	3.0	0.7	0.9	0.4	0.2	1.0	3.6	1.4	0.5	1.3	1.5	2.2	5.3	1.5	0.2	1.9	2.5	0.5	2.8	0.5	4.4	0.4	1.4	1.2	0.3	0.5	0.7	0.5	0.1	0.9	1.4	0.1	1.3	0.2	1.3	5.4	2.0	0.0	2.3	0.0	0.1	0.9	0.9	1.1	0.5	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	1.4	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.2	1.7	0.0	1.5	0.8	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.3	1.8	1.5	1.3	1.5	1.9	2.5	1.4	1.3	2.0	1.1	4.3	9.6	12.6	21.9	0.1	0.6	2.8	7.8	1.8	2.9	2.5	1.3	2.0	12.8	10.2	3.7	12.5	2.6	0.8	1.3	3.9	6.6	120.1	21.0	0.8	5.4	0.0	0.8	24.6	5.3	0.3	1.2	8.6	3.1	1.3	1.5	3.3	11.8	0.6	0.0	27.6	6.0	12.2	0.0	1.2	102.8	1.8	0.4	0.0	9.4	0.1	1.1	0.0	10.6	10.0	4.2	3.7	2.6	0.3	2.1	6.5	2.9	40.4	0.8	0.0	1.7	1.5	9.7	3.7	2.9	1.1	2.1	1.3	0.9	2.7	2.6
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 478.4;Paneth cells: 467.4;Proximal tubular cells: 568.2;Skeletal myocytes: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 16.8;granulocytes: 48.0;T-cells: 31.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 475.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"		"HPA055427: AB_2682813, HPA066310: AB_2685655"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	47.1	27.0	36.9	37.2	38.4	10.4	31.7	35.2	48.6	77.5	44.2	85.5	82.1	37.5	26.6	65.3	81.6	114.8	117.3	41.4	41.0	70.0	110.3	47.6	24.1	42.1	45.0	66.0	60.6	41.9	40.4	68.8	44.0	50.7	83.2	16.5	166.1	67.8	70.6	33.6	82.8	51.3	43.6	39.1	101.4	28.9	39.9	40.8	42.9	36.3	22.9	81.2	45.7	46.7	174.8	94.6	113.0	13.8	74.0	96.4	43.4	299.6	100.1	193.2	143.8	262.6	190.0	1.0	69.1	197.4	108.5	167.5	35.2	186.9	130.4	109.5	47.2	1.4	80.0	315.2	138.8	28.9	12.3	121.4	182.5	134.3	128.3	138.0	75.4	21.6	41.1	119.0	280.0	55.4	4.4	8.3	28.2	303.4	226.7	0.6	388.2	11.1	475.5	134.2	3.1	31.9	77.0	45.5	127.0	165.3	23.9	39.5	120.9	131.3	129.3	41.4	170.9	34.9	36.3	2.2	104.1	14.1	179.5	48.0	5.2	7.6	5.8	5.9	14.0	2.8	6.3	6.0	16.8	3.3	2.6	3.1	4.2	6.8	4.7	12.8	31.6	2.8	36.9	38.4	35.2	48.6	41.4	41.0	42.1	45.0	44.0	43.6	39.9	46.7	83.4	86.6	26.2	104.5	11.2	91.1	262.5	123.6	67.7	21.4	63.2	51.4	127.8	403.2	70.3	172.9	12.5	19.4	9.5	478.4	111.6	157.7	75.9	129.8	59.4	64.2	55.1	15.1	116.4	147.0	38.2	101.8	151.9	56.9	56.5	51.4	94.2	230.0	82.5	60.6	202.9	246.6	54.9	139.6	98.1	22.4	165.6	56.1	128.1	68.4	18.0	8.7	2.1	79.9	106.5	210.8	467.4	142.1	9.4	284.9	153.2	568.2	167.1	56.4	78.9	470.9	89.3	38.0	82.6	68.4	77.9	9.9	28.2	6.6	78.4	198.8
SPESP1	SP-ESP	ENSG00000258484	"Sperm equatorial segment protein 1"	Q6UW49	15	68818221-68946811	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 400.4;Spermatocytes: 455.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045936, HPA051040"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in male reproductive system"	NA	NA		52000	"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA045936: AB_2679504, HPA051040: AB_2681322"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-2)"	2.3	3.4	1.1	0.8	1.1	0.4	2.2	1.2	1.6	1.2	1.0	1.6	1.2	1.5	6.3	2.6	1.8	3.5	3.1	1.1	1.2	2.0	1.2	1.1	0.8	1.3	1.2	3.4	1.9	4.7	1.2	12.9	1.3	3.5	1.1	2.8	1.8	2.9	1.6	1.0	0.9	1.2	1.3	1.3	1.5	73.2	1.1	0.9	1.9	1.9	0.7	2.4	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	17.8	18.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.7	5.0	0.0	0.0	0.0	0.0	6.3	0.0	13.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	2.9	0.0	0.0	3.3	15.9	0.0	0.0	1.4	0.0	26.8	0.2	19.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	31.6	1.1	1.3	0.4	0.2	1.1	0.5	0.5	0.4	0.3	0.8	0.3	0.3	0.5	0.5	0.2	0.8	0.4	0.4	0.5	1.1	1.1	1.2	1.6	1.1	1.2	1.3	1.2	1.3	1.3	1.1	1.6	5.1	0.0	0.0	0.0	0.2	1.9	3.0	23.7	1.8	1.0	2.7	4.1	4.1	1.5	4.0	7.3	4.2	92.3	0.3	0.2	1.9	2.1	400.4	3.9	3.4	3.6	1.8	0.8	0.0	2.7	7.2	5.5	0.0	2.0	0.0	1.7	2.2	1.8	7.8	0.0	0.0	0.9	6.1	2.1	3.3	90.3	21.1	1.2	5.4	0.0	1.0	5.3	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.3	0.0	3.9	6.3	5.6	46.0	3.4	4.2	455.0	88.7	1.1	2.3	62.1	0.5	11.1	0.2	1.5
SPNS2	SLC62A2	ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498881-4539035	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	17.3	2.6	13.1	5.2	14.0	7.9	14.7	13.1	18.2	14.6	0.1	6.5	12.2	8.6	0.6	51.0	7.8	12.1	10.7	14.1	12.1	28.6	3.8	28.3	4.9	26.4	16.2	1.8	10.0	1.1	2.1	7.9	28.9	5.3	2.1	0.6	16.5	2.0	4.4	24.8	10.8	4.8	13.9	11.4	21.0	1.3	15.5	1.7	8.5	3.9	13.3	6.6	22.6	25.1	9.7	1.2	0.0	0.2	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	8.1	0.5	11.8	0.0	0.1	0.5	0.0	0.7	0.0	0.1	0.2	0.6	0.2	0.0	0.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	4.7	0.0	0.0	0.0	3.8	0.2	17.0	0.1	17.6	0.3	0.8	0.0	0.3	161.7	0.5	5.4	0.2	0.0	76.7	0.0	5.1	2.7	7.5	0.2	0.2	0.7	0.3	0.1	0.3	0.3	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	14.0	13.1	18.2	14.1	12.1	26.4	16.2	28.9	13.9	15.5	25.1	32.7	6.4	10.6	1.6	0.2	1.8	0.4	2.1	0.0	1.2	4.3	3.6	1.2	22.8	16.2	22.0	0.0	1.3	0.2	2.8	1.9	16.7	0.2	0.5	1.0	34.5	0.0	3.2	23.4	3.0	30.5	1.7	26.0	2.8	0.0	0.0	12.5	6.7	1.1	6.7	26.2	12.7	2.0	0.3	1.6	0.2	0.6	1.9	1.8	37.5	0.0	0.4	0.0	3.5	97.8	18.6	0.0	0.4	1.2	11.7	1.9	24.3	16.9	1.1	0.0	1.4	3.1	0.6	0.5	0.6	2.4	1.9	1.6	0.1	1.1	39.8
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 60702.5"	"Group enriched"	"Detected in all"	4	"glioma: 1690.9;renal cancer: 1385.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 24.8"	"Lineage enriched"	"Detected in single"	249	"granulocytes: 24.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 316.8"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	73000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	113.1	24.4	276.0	59.5	490.3	1.0	70.2	652.0	736.4	27.5	265.0	44.9	9.5	131.2	9.8	4.8	52.8	2424.4	37.0	301.6	417.1	3587.6	35.6	18.8	9.1	813.2	645.3	9.9	292.0	19.2	20.6	2791.9	781.8	15.7	7.6	745.5	88.7	22.1	16.0	2.7	14.4	38.3	472.6	9.2	11.0	11.7	633.1	8.4	8.3	0.4	5.7	25.0	6.0	855.0	2.2	144.0	19.1	1.1	0.0	0.2	0.3	5.6	4.4	1.4	9.1	0.6	0.2	0.2	4825.8	2.3	371.5	1.4	0.0	0.0	3.1	11.2	0.0	0.0	1.8	2469.7	0.3	6.8	5.1	0.5	0.3	34.9	0.1	118.8	4.2	0.2	0.1	10.8	1.3	0.2	1.2	21.3	227.5	0.3	0.0	2.4	0.5	1189.8	10348.3	1.8	1.1	0.9	0.3	0.8	339.1	441.9	0.5	5.2	0.3	11.5	27.1	0.4	25.8	0.9	7.9	13.9	436.3	1.1	457.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	276.0	490.3	652.0	736.4	301.6	417.1	813.2	645.3	781.8	472.6	633.1	855.0	35.7	3.2	4.7	5.2	34.0	1.5	5.2	0.1	1.2	46.6	1767.7	22.4	17.9	1584.2	0.3	2183.1	27.1	335.6	6.9	0.0	1003.7	7273.8	0.1	61.2	25.2	367.9	0.0	2.7	1.4	71.7	294.5	48.9	0.0	154.2	0.0	1.7	5.7	5.0	60702.5	785.7	9.9	0.0	0.0	57.4	7.7	1.0	0.9	247.7	1.8	99.3	69.2	3862.9	0.0	4.5	532.1	215.4	0.0	0.0	0.1	0.4	0.0	5594.0	1.6	169.7	0.0	0.9	21.6	0.5	0.2	1.1	1.0	667.8	30.0	0.4	0.0	9.9
STMP1	"C7orf73, Mm47, PL-5283"	ENSG00000243317	"Short transmembrane mitochondrial protein 1"	E0CX11	7	135662496-135693418	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 249.0;Distal tubular cells: 197.6;Extravillous trophoblasts: 261.3;Hofbauer cells: 185.2;Proximal tubular cells: 209.5;Syncytiotrophoblasts: 275.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 431.7;eosinophil: 127.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 431.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065565			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA065565: AB_2685512"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.81e-2)"	15.7	28.5	15.5	17.7	17.3	41.3	22.9	15.8	20.5	21.1	17.9	19.8	18.2	16.1	25.7	46.7	15.9	16.6	25.4	15.2	17.2	27.9	32.0	15.2	21.2	17.6	16.4	12.9	15.1	18.5	19.0	19.8	18.1	20.3	22.5	19.2	21.0	15.0	48.4	21.5	19.2	16.4	16.9	14.7	20.4	23.8	16.6	28.8	32.2	32.8	26.2	20.0	27.4	17.6	41.5	19.4	44.9	42.4	52.6	73.2	27.3	44.8	43.5	36.3	37.8	12.0	45.2	38.3	39.3	68.7	35.6	17.0	43.9	57.0	48.9	48.2	36.1	59.4	20.4	28.8	51.7	61.3	36.8	46.0	63.6	43.6	40.4	54.9	30.5	48.5	65.3	33.0	80.9	54.0	87.6	69.5	88.6	57.4	48.5	43.6	48.0	63.0	102.2	21.5	56.6	54.7	60.8	41.3	43.9	43.1	16.9	66.0	51.1	35.3	29.0	63.5	63.2	38.1	58.5	72.9	109.1	63.1	65.9	431.7	57.3	127.7	23.8	61.2	22.8	24.9	22.5	24.3	61.0	21.0	21.0	24.1	44.6	38.9	68.1	34.5	33.1	50.9	15.5	17.3	15.8	20.5	15.2	17.2	17.6	16.4	18.1	16.9	16.6	17.6	67.4	41.7	47.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	128.9	145.3	0.0	0.0	27.9	97.5	0.0	249.0	57.2	0.0	197.6	164.3	0.0	102.2	97.3	39.4	0.0	0.0	0.0	97.4	261.3	43.9	0.0	90.8	56.8	80.1	0.0	0.0	185.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.7	0.0	0.0	146.8	0.0	0.0	0.0	0.0	131.8	0.0	0.0	6.4	0.0	0.0	209.5	34.2	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	275.4	29.8	65.8	0.0	0.0
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 70.3;stomach 1: 163.3"	"Cell type enriched"	"Detected in many"	7	"Gastric mucus-secreting cells: 553.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 25.4;RT4: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.7	0.0	0.2	0.6	0.2	0.0	0.9	0.2	0.6	2.4	7.5	2.5	29.2	0.5	15.9	0.3	2.0	6.2	1.1	0.5	0.2	70.3	2.8	2.2	1.8	0.3	0.4	0.2	5.3	5.9	2.9	1.3	0.6	0.5	5.2	0.0	1.4	0.9	0.6	0.1	3.3	0.8	0.2	0.5	163.3	0.1	0.7	0.4	19.4	0.6	0.8	0.7	0.5	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.2	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.3	0.0	25.4	7.3	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.5	0.2	0.3	0.4	0.6	0.2	0.7	1.2	7.0	3.2	14.1	0.3	1.0	1.5	1.6	0.0	0.0	0.9	0.3	0.1	2.2	15.7	3.1	20.2	2.1	0.3	0.0	3.9	58.7	7.6	0.1	5.7	0.8	4.8	0.0	0.0	0.4	0.2	0.3	2.6	553.0	5.6	1.3	0.2	3.3	0.9	18.6	1.7	0.2	6.4	12.2	0.3	5.4	0.2	0.0	2.7	0.0	3.7	0.1	0.1	0.0	0.0	0.1	6.2	6.8	0.0	2.0	2.8	9.6	73.4	1.0	1.5	0.0	2.9	1.2	0.7	0.3	0.0	1.8	0.1	1.1	0.1	4.9	1.3
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240302-45286341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.1;gallbladder: 20.8;pituitary gland: 16.8"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 336.8"	"Group enriched"	"Detected in many"	5	"breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.1	4.7	7.0	1.5	12.7	0.0	0.2	1.7	30.1	0.0	0.0	12.2	12.5	0.2	0.0	0.0	0.2	20.8	5.2	18.0	11.5	8.9	0.3	0.5	0.0	5.7	1.2	0.0	7.1	0.4	16.8	0.0	5.4	1.8	12.6	11.3	1.9	0.0	0.1	0.2	12.8	0.8	0.0	0.1	11.0	1.7	9.0	0.3	1.6	0.1	0.0	0.0	0.0	5.2	0.0	19.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	56.8	0.0	15.0	0.7	0.0	0.0	0.1	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	12.7	1.7	30.1	18.0	11.5	5.7	1.2	5.4	0.0	9.0	5.2	0.0	0.0	0.0	4.6	0.1	0.0	0.2	0.0	0.0	3.3	0.1	0.3	15.3	17.2	0.0	3.7	25.0	0.0	0.0	10.2	5.9	1.2	3.1	0.4	0.2	0.1	336.8	0.0	41.6	0.6	0.0	1.7	3.6	2.0	0.0	2.5	0.0	0.0	0.0	1.7	43.8	37.3	4.1	0.0	0.0	9.7	0.3	0.0	0.0	5.6	0.0	0.7	0.0	1.5	3.5	8.2	14.3	0.0	0.0	2.3	13.9	0.5	0.0	2.7	0.0	0.0	0.2	2.0	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.2
TCAIM	"C3orf23, DKFZp313N0621, TOAG-1"	ENSG00000179152	"T cell activation inhibitor, mitochondrial"	Q8N3R3	3	44338119-44409451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.9"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.93e-3)"	"unprognostic (5.07e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (2.19e-7)"	"unprognostic (4.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.81e-4)"	8.6	8.5	7.9	6.7	8.6	4.8	6.6	12.0	10.5	5.9	8.7	9.6	8.2	6.7	8.4	10.1	6.4	9.7	19.4	7.0	8.8	24.2	42.9	9.3	6.9	9.8	9.1	8.1	5.7	11.4	3.5	9.2	9.8	9.9	9.8	10.3	4.7	5.9	22.0	7.7	9.2	8.7	8.7	7.2	9.4	5.6	9.1	8.4	7.4	18.9	7.9	9.9	4.2	10.9	15.5	7.5	8.3	10.6	13.5	10.8	17.3	14.8	17.4	15.7	16.5	7.0	35.6	22.0	10.8	10.0	11.4	7.1	8.0	16.5	17.4	9.2	8.8	15.5	10.4	16.5	23.5	25.9	14.4	12.7	33.0	15.9	17.9	14.9	21.3	22.1	19.2	12.5	16.2	10.8	25.2	13.2	7.8	17.4	17.5	5.0	9.1	16.8	36.6	24.2	8.3	20.3	16.5	22.6	24.1	14.4	17.1	15.3	18.1	9.4	11.2	24.7	22.4	8.4	16.5	16.1	21.2	20.9	16.1	14.8	7.9	10.6	3.6	10.0	4.2	2.3	4.7	3.6	10.3	3.7	3.8	5.5	3.6	3.6	10.1	5.5	9.4	4.0	7.9	8.6	12.0	10.5	7.0	8.8	9.8	9.1	9.8	8.7	9.1	10.9	12.5	9.6	16.1	38.5	7.4	10.3	9.3	12.2	12.0	18.9	11.1	8.3	30.1	24.3	10.5	14.7	12.5	13.6	14.5	12.0	60.7	23.6	3.3	10.3	7.8	11.6	6.0	7.2	55.8	20.9	21.0	7.5	12.2	17.7	21.0	15.1	15.0	47.7	20.0	25.2	90.4	17.1	12.2	18.8	10.1	2.0	8.7	17.6	7.2	20.6	16.0	17.1	9.2	42.7	47.1	25.6	14.7	4.9	7.4	10.8	11.7	46.2	11.4	13.1	13.1	8.1	12.8	6.2	11.0	16.8	9.5	13.4	8.2	14.6	17.3	13.4
TENM4	"KIAA1302, ODZ4, Ten-M4, TEN4"	ENSG00000149256	"Teneurin transmembrane protein 4"	Q6N022	11	78652829-79441030	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;ovary: 16.6;parathyroid gland: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.5;Early spermatids: 96.8;Excitatory neurons: 337.4;Inhibitory neurons: 297.7;Microglial cells: 117.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 9.1;hTERT-RPE1: 9.5;PC-3: 10.8;REH: 10.4;SH-SY5Y: 17.4"	"Low region specificity"	"Detected in all"							"HPA019521, HPA065961"	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019521: AB_2670171, HPA065961: AB_2685588"	"unprognostic (2.81e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.40e-3)"	"unprognostic (5.64e-2)"	"unprognostic (7.07e-2)"	"unprognostic (9.81e-3)"	1.9	1.4	7.5	1.0	13.4	0.0	0.7	0.3	12.6	2.5	0.0	0.5	0.1	1.3	0.2	2.0	2.1	0.4	0.4	9.0	7.5	1.5	0.0	0.4	0.5	10.9	9.2	16.6	0.3	14.0	7.1	0.1	7.9	0.4	0.3	2.6	0.5	0.2	0.4	3.3	0.3	1.0	13.0	0.3	0.5	1.6	11.8	1.9	5.8	1.0	1.2	0.5	1.5	17.8	0.0	0.0	3.4	0.0	3.7	5.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	6.7	0.0	2.1	5.0	5.3	0.0	4.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	9.1	2.3	2.5	4.5	9.5	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.0	1.8	0.3	10.8	10.4	0.0	0.0	6.4	1.1	7.1	17.4	0.0	0.0	0.0	6.2	0.0	0.1	0.5	0.1	1.2	0.1	5.9	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	13.4	0.3	12.6	9.0	7.5	10.9	9.2	7.9	13.0	11.8	17.8	0.1	0.0	0.0	134.5	0.2	0.9	0.8	3.4	17.1	7.5	0.1	0.0	1.9	4.3	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	96.8	1.1	1.7	0.3	0.0	0.0	337.4	0.0	0.2	2.6	0.0	0.8	1.3	0.8	0.0	0.0	0.1	0.0	297.7	0.0	0.0	0.6	0.4	56.6	5.3	0.7	0.0	117.1	0.4	13.9	0.0	58.3	21.3	0.0	0.0	1.9	0.0	0.4	0.0	0.4	7.0	1.0	0.0	25.1	2.8	4.8	1.0	7.3	2.0	0.1	0.1	0.3	0.0	0.6
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.1;salivary gland: 97.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 21.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.9	0.3	0.9	1.7	1.6	0.2	28.7	1.7	1.1	18.1	19.0	19.0	0.6	0.5	8.3	13.3	3.5	2.9	0.2	1.7	0.9	49.1	0.2	5.6	0.2	1.6	2.1	0.1	6.4	2.6	0.8	7.4	1.1	13.6	22.6	0.0	97.5	2.0	2.6	31.9	3.2	0.6	0.7	1.8	16.3	1.1	1.9	0.2	37.6	0.1	1.2	1.8	10.9	0.7	0.0	1.6	0.0	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.7	0.0	0.7	0.4	4.4	4.5	0.0	0.0	3.2	15.7	0.0	0.0	0.0	0.0	0.6	0.0	17.3	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.9	0.1	0.0	0.5	2.1	42.4	31.8	13.3	0.1	1.7	0.1	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.7	1.1	1.7	0.9	1.6	2.1	1.1	0.7	1.9	0.7	0.1	6.4	28.8	3.9	0.3	1.7	38.0	10.3	28.5	0.0	22.1	11.6	2.6	17.2	35.4	79.1	0.0	32.2	0.9	117.9	31.3	2.7	0.1	43.5	5.8	1.0	10.2	0.0	0.2	1.5	2.3	0.8	58.6	83.0	0.0	1.2	0.0	0.4	4.9	0.0	0.3	31.2	262.4	4.6	0.8	0.5	0.3	5.5	7.2	9.4	0.2	0.5	0.0	0.0	0.1	7.4	28.0	0.0	2.1	36.3	0.3	27.7	11.9	0.0	0.0	1.9	1.1	0.1	1.5	41.0	3.3	20.2	1.1	9.5	44.3	40.7
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390142	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"kidney: 110.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.6;Distal tubular cells: 23.5;Proximal enterocytes: 72.5;Proximal tubular cells: 207.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.8"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 1.7;pons: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"RPTEC TERT1: 91.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.0	11.7	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.0	110.4	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.8	0.0	0.0	0.0	0.2	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	1.7	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.3	0.0	0.0	0.0	48.6	23.5	0.0	1.0	0.1	0.0	0.0	9.7	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	72.5	207.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	18.4	0.0
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364608-96513926	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7;heart muscle: 3.6;tongue: 1.9"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 82.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"RPTEC TERT1: 20.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.0	0.1	1.3	0.1	1.5	0.2	0.0	0.6	1.7	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.3	3.6	1.2	1.3	0.0	0.0	0.0	0.1	2.6	1.0	0.1	0.2	0.0	0.4	0.1	2.9	0.1	0.1	0.2	0.2	0.0	0.9	0.0	0.3	0.1	2.2	0.1	0.3	0.1	4.7	0.0	0.1	1.9	0.0	0.0	0.0	2.0	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.1	0.2	0.1	0.2	0.1	0.0	2.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.6	0.1	0.1	0.4	0.0	20.1	0.0	0.7	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.6	1.7	1.2	1.3	2.6	1.0	2.9	2.2	4.7	2.0	0.4	0.0	1.1	0.3	0.7	0.1	0.5	1.9	0.0	0.0	0.0	0.0	5.5	1.5	1.0	0.0	0.0	2.4	0.1	0.0	0.0	0.2	6.9	0.2	0.1	1.4	0.0	0.0	1.9	0.6	0.1	2.4	1.5	0.5	0.0	82.4	0.0	0.0	0.3	0.0	5.6	1.7	2.0	0.3	1.4	5.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	18.6	0.7	0.0	0.0	1.4	0.8	1.0	0.2	0.2	0.0	0.0	0.7	0.4	0.2	2.6	0.0	0.4	3.4	0.3	0.1	0.2	0.6
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TMEM128	MGC13159	ENSG00000132406	"Transmembrane protein 128"	Q5BJH2	4	4235542-4248223	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044809	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA044809: AB_10963539"	"unprognostic (4.97e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	22.5	27.2	21.7	15.4	24.0	8.4	33.0	24.0	34.8	25.3	21.9	23.1	20.7	27.3	47.0	20.4	29.2	16.9	22.9	21.1	23.8	33.5	19.7	25.0	23.3	25.2	23.5	36.6	21.4	44.7	17.8	26.9	24.9	26.8	24.9	16.2	22.0	25.5	14.4	22.5	19.4	16.4	24.6	22.2	23.7	25.3	23.2	23.6	37.2	15.3	23.2	17.9	18.4	29.1	15.7	12.0	43.7	33.3	34.8	29.0	31.1	33.2	37.2	34.8	33.0	13.5	60.9	9.1	17.0	29.6	33.0	13.3	21.1	22.5	33.0	25.0	13.1	17.1	8.8	19.0	48.9	41.4	30.0	40.6	38.7	13.5	27.0	31.1	20.9	29.9	24.7	17.9	40.7	17.1	34.0	55.3	36.3	22.8	23.4	13.2	17.5	19.7	52.9	24.4	24.5	39.6	13.5	12.9	41.2	28.6	44.4	40.5	20.5	32.8	13.8	30.9	35.0	49.8	43.9	30.6	34.2	28.6	40.7	25.7	36.5	42.8	36.3	50.4	45.8	38.1	43.9	36.2	38.1	34.3	59.0	49.9	17.4	45.6	45.0	61.5	36.7	37.9	21.7	24.0	24.0	34.8	21.1	23.8	25.2	23.5	24.9	24.6	23.2	29.1	20.7	12.8	22.7	8.8	13.8	17.8	20.3	63.5	12.0	9.9	25.5	22.0	9.1	24.3	30.5	31.3	2.1	45.3	17.3	24.2	29.4	28.7	25.9	16.3	19.6	18.6	17.3	15.2	11.1	23.7	44.4	23.1	7.1	14.6	15.8	14.3	27.8	18.2	30.2	13.5	12.3	23.2	28.5	23.5	14.0	8.9	40.7	14.9	39.2	10.3	25.2	26.4	23.7	14.1	24.5	18.2	33.9	37.6	5.7	24.0	24.9	38.3	32.6	11.7	46.0	18.9	20.3	76.7	34.4	12.8	25.1	43.8	16.3	17.0	17.7	20.6
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.8;kidney: 32.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.1	2.7	1.9	2.2	6.4	0.0	3.2	6.6	3.2	8.9	2.9	5.7	33.8	1.2	1.3	0.4	6.8	7.2	3.3	1.6	4.1	32.2	9.2	5.1	0.2	10.5	6.9	0.4	8.7	6.8	1.8	5.2	8.9	0.9	4.5	0.8	4.8	3.1	0.1	1.2	19.3	0.4	5.9	0.9	2.5	3.8	5.7	0.0	7.2	0.0	0.1	1.8	0.3	13.9	22.4	1.6	0.3	0.1	0.0	0.0	14.3	0.2	0.0	0.0	0.0	5.2	40.8	0.3	27.9	0.0	1.8	18.5	0.0	9.3	0.0	0.3	0.0	0.0	2.4	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.3	0.0	0.5	0.0	1.5	1.6	1.0	0.0	0.5	1.6	0.4	0.3	0.0	70.5	5.6	0.4	0.1	1.1	25.0	0.2	0.5	68.5	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.6	0.1	1.9	6.4	6.6	3.2	1.6	4.1	10.5	6.9	8.9	5.9	5.7	13.9	0.6	16.0	5.9	0.7	0.2	0.1	2.1	2.8	0.0	0.2	8.2	15.5	2.3	27.1	5.4	51.5	0.0	30.5	0.2	28.9	35.2	49.0	14.8	16.2	1.6	0.7	3.6	0.0	0.0	4.7	5.2	0.4	3.1	17.9	0.0	2.2	1.4	16.2	1.9	0.0	0.2	6.7	0.0	0.6	0.3	13.6	0.0	0.7	5.4	0.0	1.1	7.7	0.0	0.0	5.2	30.6	23.3	0.0	0.0	1.2	90.7	89.1	3.8	0.1	0.0	0.0	0.9	0.1	0.2	0.6	0.0	6.4	0.8	0.7	12.9	1.4
TMEM163	"DKFZP566N034, SV31"	ENSG00000152128	"Transmembrane protein 163"	Q8TC26	2	134455759-134719000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3;pancreas: 27.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 36.9;Excitatory neurons: 62.2;Exocrine glandular cells: 30.8;Oligodendrocyte precursor cells: 219.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.3;RPTEC TERT1: 67.3;SCLC-21H: 30.2;U-937: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007224	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA007224: AB_2667780"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (7.94e-4)"	"unprognostic (9.05e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.75e-3)"	"prognostic favorable (3.15e-4)"	3.4	8.5	13.5	5.1	13.4	0.3	1.4	18.8	13.3	0.2	5.4	1.0	0.6	0.4	0.3	0.1	2.8	9.3	6.7	12.9	15.2	1.6	0.4	14.5	10.4	18.3	20.7	0.9	27.8	0.8	13.9	3.7	15.4	0.2	0.5	4.0	3.0	0.2	0.3	0.1	1.0	0.4	16.5	1.6	7.3	6.5	28.3	2.0	0.9	0.5	16.4	12.2	0.1	23.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.2	20.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	3.5	6.7	0.1	0.1	0.3	0.0	0.6	0.1	0.0	5.2	1.1	2.3	0.0	0.1	0.1	67.3	10.0	30.2	1.1	0.0	0.0	1.6	0.1	0.0	0.0	7.0	0.0	0.4	0.0	1.5	1.6	0.0	0.0	0.0	12.6	1.3	0.0	0.0	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.2	13.5	13.4	18.8	13.3	12.9	15.2	18.3	20.7	15.4	16.5	28.3	23.0	19.3	3.2	36.9	2.6	6.7	0.0	0.0	0.0	0.0	2.7	0.2	5.1	5.4	7.2	0.0	0.0	0.0	0.1	0.9	0.1	0.0	8.5	4.8	0.3	0.2	3.5	0.0	0.4	62.2	30.8	0.4	0.7	20.9	1.0	0.0	0.6	0.4	0.3	5.0	1.7	23.5	0.4	0.0	1.3	0.0	3.8	0.0	2.7	0.0	14.0	2.6	1.0	5.2	219.7	13.0	12.6	0.1	0.4	0.3	0.0	0.0	0.3	0.0	5.7	0.0	0.5	0.4	2.1	1.6	0.0	0.4	0.1	0.7	1.9	0.1	2.5
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;retina: 3.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.4;Cone photoreceptor cells: 22.9;Excitatory neurons: 13.1;Inhibitory neurons: 13.9;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 9.3;Rod photoreceptor cells: 11.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.3;RPTEC TERT1: 12.3;SCLC-21H: 9.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"							"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	0.5	1.0	1.4	1.0	3.0	0.3	0.2	1.5	2.6	0.7	0.0	0.4	0.7	0.3	0.7	0.2	1.0	0.8	0.4	2.3	2.1	1.8	1.7	0.6	1.0	2.6	2.1	0.3	0.3	0.1	0.8	0.1	2.8	0.4	0.3	3.4	0.2	0.3	0.3	0.5	0.6	0.4	1.0	1.0	0.2	0.3	1.7	1.0	2.6	0.3	0.7	0.2	0.1	2.8	0.0	0.3	7.3	0.1	1.0	0.0	0.0	0.3	0.2	0.2	0.8	0.3	2.4	0.0	5.8	0.3	0.4	0.1	0.9	0.0	0.2	1.4	0.3	2.9	0.1	1.4	1.9	0.1	0.5	0.6	0.6	0.5	0.7	1.8	0.0	0.9	0.0	0.3	6.3	0.8	0.2	0.1	4.1	0.0	0.0	1.4	2.0	0.0	12.3	0.0	9.9	14.5	0.3	0.1	5.7	4.0	0.5	1.0	0.0	0.2	0.4	0.0	0.4	1.7	2.2	0.4	1.9	0.2	1.4	0.8	1.0	0.1	1.2	1.0	0.9	1.5	2.0	1.4	0.0	1.4	2.1	0.9	2.3	0.3	3.2	0.1	3.7	0.7	1.4	3.0	1.5	2.6	2.3	2.1	2.6	2.1	2.8	1.0	1.7	2.8	0.3	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	14.4	0.1	0.5	0.8	4.3	0.0	5.5	22.9	0.1	0.3	0.0	0.0	0.6	0.0	0.4	0.4	0.2	4.9	0.0	13.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	1.4	0.8	0.4	0.0	13.9	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.0	3.7	0.2	2.2	3.1	11.1	9.3	0.1	0.6	0.4	0.3	0.1	0.3	2.8	0.1	11.6	0.0	3.6	0.4	0.0	0.7	0.0	0.0	0.0	0.8	0.1	0.2	0.1
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074064-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.3;parathyroid gland: 11.9;tongue: 12.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 175.0;Excitatory neurons: 584.8;Inhibitory neurons: 566.2;Oligodendrocyte precursor cells: 306.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;HDLM-2: 5.7;NTERA-2: 5.1;RPTEC TERT1: 8.2;SCLC-21H: 6.4;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048771	Uncertain		Approved	Nucleoli,Vesicles		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoli	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.3	1.4	3.7	0.6	5.4	0.0	0.5	0.2	7.4	0.3	0.0	0.8	0.0	0.8	0.4	0.7	0.3	0.3	11.3	7.0	5.0	1.3	0.0	0.3	1.4	1.5	5.9	0.1	0.9	11.9	4.2	0.0	5.6	2.3	0.3	5.5	1.2	0.5	4.6	0.2	0.4	1.0	0.6	0.7	0.3	0.5	5.2	1.4	8.5	12.2	3.1	0.5	0.2	1.9	0.0	0.1	0.0	0.0	0.5	0.2	1.5	0.1	2.3	0.7	0.8	0.0	0.0	1.9	2.0	0.1	0.5	0.0	6.0	0.0	1.9	5.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	5.1	0.0	0.0	0.4	0.9	2.6	8.2	2.4	6.4	3.9	0.1	0.2	0.9	1.2	0.8	0.0	0.0	0.1	0.9	2.7	0.0	0.0	0.0	0.0	0.4	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.2	7.4	7.0	5.0	1.5	5.9	5.6	0.6	5.2	1.9	1.3	0.0	0.0	175.0	0.0	0.5	0.7	0.9	0.6	25.5	1.4	0.5	48.7	0.0	1.3	1.8	2.1	0.0	0.0	0.0	1.9	0.1	1.3	0.2	0.1	1.2	0.0	0.0	584.8	0.4	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.1	30.3	566.2	0.0	2.0	0.0	0.0	1.6	0.0	0.1	1.8	24.4	0.0	4.2	0.0	306.1	81.3	0.8	0.0	0.7	0.0	2.2	0.0	3.4	0.2	1.8	0.0	3.9	0.8	1.4	0.7	2.9	0.1	0.3	0.3	0.2	0.1	2.0
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 76.0;salivary gland: 52.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 144.8;Melanocytes: 26.6"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 2.1;neutrophil: 1.1;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054059	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.1	0.5	0.2	0.5	1.1	4.7	0.6	0.7	2.8	0.4	0.1	1.3	0.2	0.6	0.3	0.1	0.2	0.0	0.6	0.1	76.0	0.1	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.4	0.4	0.1	0.3	52.3	1.2	0.1	5.3	0.3	0.1	0.0	0.2	0.4	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	2.1	0.2	0.2	0.3	0.2	0.4	0.2	0.1	0.2	0.1	0.3	0.2	0.1	1.1	2.0	0.2	0.2	0.1	0.1	0.5	0.5	0.6	0.7	0.6	0.1	0.2	0.1	0.4	0.0	0.5	1.0	0.1	3.2	9.9	0.0	0.1	0.0	0.9	3.0	0.0	0.4	14.1	7.9	0.4	0.0	4.4	53.3	0.0	0.0	0.2	0.0	144.8	0.0	0.0	0.9	0.4	0.5	0.0	0.0	0.6	0.2	0.1	0.2	0.0	1.3	1.3	0.1	0.0	0.0	0.1	1.7	0.4	0.0	2.0	0.0	0.8	0.0	0.0	0.1	26.6	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.9	3.5	1.3	0.0	0.5	0.2	0.0	0.2	0.0	0.4	0.0	0.6	0.0	0.2	0.6
TMEM220		ENSG00000187824	"Transmembrane protein 220"	Q6QAJ8	17	10699015-10730023	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 103.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 173.3;Proximal enterocytes: 576.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.84e-4)"	"prognostic favorable (2.23e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.97e-2)"	8.6	10.9	3.3	4.9	3.8	5.8	7.2	3.3	3.3	6.4	5.5	8.2	15.7	6.9	4.5	4.3	6.1	5.1	5.1	3.3	3.7	10.3	103.8	5.5	6.2	4.2	3.8	6.9	9.5	3.6	3.2	3.2	4.7	21.7	4.9	19.0	5.5	7.8	8.1	6.6	26.8	3.8	4.4	6.5	13.0	9.1	3.9	1.2	13.0	0.8	1.9	5.9	5.0	4.6	0.5	3.1	1.1	7.2	4.4	4.4	0.7	6.0	6.6	4.2	5.7	0.0	0.3	0.7	0.4	4.0	0.2	0.4	2.8	0.2	3.0	0.3	1.2	0.4	0.1	2.7	6.7	0.8	0.7	3.0	0.3	1.3	0.3	0.8	1.9	2.7	0.3	0.2	2.6	0.4	1.1	1.3	4.4	0.4	0.0	4.4	0.2	0.5	9.8	0.2	0.4	5.5	0.3	0.1	0.7	1.5	0.3	1.6	4.4	0.2	0.9	2.2	0.4	0.7	0.3	0.2	4.3	1.1	0.4	1.6	2.1	2.1	0.7	1.6	0.9	4.0	1.8	1.1	2.6	9.0	7.4	5.2	1.6	4.2	0.7	1.9	0.4	1.7	3.3	3.8	3.3	3.3	3.3	3.7	4.2	3.8	4.7	4.4	3.9	4.6	10.1	3.2	11.0	18.3	7.5	9.6	17.7	9.2	23.3	2.5	20.9	26.4	11.6	57.2	9.9	18.4	8.4	12.0	3.1	41.3	21.5	18.0	99.0	6.1	16.3	8.1	3.0	21.7	1.4	23.6	20.6	16.3	33.6	7.6	40.0	13.4	16.1	173.3	24.0	0.0	2.8	32.6	4.1	13.5	6.4	22.2	18.0	13.1	24.9	12.2	4.6	55.0	5.2	17.6	1.6	12.6	32.5	9.8	6.6	36.5	576.7	31.7	6.9	23.6	19.7	17.2	12.7	90.6	8.7	20.7	8.0	4.5	3.0	30.0	21.1	22.3
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	26.6	38.2	61.9	13.0	60.1	23.8	27.1	58.7	76.8	25.1	57.4	26.9	15.0	28.1	24.4	36.1	29.6	19.2	34.5	61.2	65.4	32.8	49.4	22.4	16.1	61.7	64.4	26.6	28.6	30.6	38.4	13.0	62.3	39.0	14.4	10.6	26.7	23.9	36.8	28.9	23.8	18.8	60.7	25.0	30.1	28.8	63.8	21.1	29.4	20.7	14.1	27.6	24.2	59.5	26.2	31.2	25.7	42.3	39.2	28.2	20.7	39.6	45.1	52.9	44.8	13.0	53.5	16.5	30.2	42.4	24.6	35.3	28.3	38.5	21.9	22.0	54.4	27.6	24.7	30.1	58.0	27.8	26.5	49.4	21.5	50.8	28.7	24.3	35.7	32.4	21.2	37.1	33.6	23.4	40.1	29.2	48.3	27.0	38.6	32.8	17.7	33.5	51.6	15.2	54.8	48.4	30.6	42.6	39.7	9.2	42.3	44.2	33.1	31.1	26.1	50.6	38.1	39.8	38.5	17.6	47.1	53.3	45.8	38.2	20.6	27.7	32.5	32.5	24.8	37.4	29.7	24.6	18.5	30.0	29.1	30.2	56.3	31.9	35.3	30.4	37.4	25.6	61.9	60.1	58.7	76.8	61.2	65.4	61.7	64.4	62.3	60.7	63.8	59.5	22.9	9.6	13.5	8.5	25.4	11.7	13.3	26.2	15.9	42.1	24.0	29.2	8.9	18.6	13.3	12.9	14.6	30.9	20.9	24.5	39.2	39.1	25.5	13.2	17.2	20.6	29.9	43.8	12.4	40.5	33.9	22.6	18.8	12.4	17.1	22.0	11.0	15.1	28.3	43.7	15.0	21.0	40.7	8.5	12.9	76.9	20.2	12.2	26.6	6.5	20.6	51.9	22.6	17.1	14.4	48.6	22.7	19.9	18.6	19.9	28.8	19.2	7.9	18.7	13.1	19.6	20.3	27.2	18.0	19.3	13.5	30.8	20.5	22.4	23.1	12.4
TMEM234	"C1orf91, dJ622L5.7, FLJ90779, RP4-622L5"	ENSG00000160055	"Transmembrane protein 234"	Q8WY98	1	32214472-32222359	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA015049	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA015049: AB_1856409"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.37e-2)"	6.5	7.4	5.7	2.6	5.8	2.8	6.8	5.0	6.4	7.9	7.4	6.4	2.2	7.6	9.4	9.0	7.3	3.4	9.2	5.7	6.1	9.7	6.3	6.4	3.5	5.9	6.7	9.9	5.8	6.9	12.3	5.9	6.0	8.5	4.1	6.1	7.2	7.0	3.0	4.8	5.2	4.4	5.2	7.5	5.6	9.0	5.8	3.1	12.3	1.7	3.5	6.6	7.6	5.4	10.0	7.5	4.2	4.4	12.0	9.4	4.4	14.6	10.5	7.3	5.5	5.4	9.8	3.1	16.1	13.5	5.7	8.0	5.4	10.5	6.2	6.4	5.9	6.1	11.9	6.2	8.7	7.4	4.0	11.9	10.5	7.6	5.5	12.8	10.7	3.3	5.9	1.9	12.4	3.0	2.9	6.2	7.6	2.5	5.7	4.0	3.3	3.6	16.3	5.1	5.3	5.4	10.6	5.7	5.0	13.6	2.8	2.3	12.9	2.6	4.1	10.3	10.6	3.1	1.8	1.3	8.0	2.6	9.8	25.9	11.9	19.1	5.8	13.3	9.3	6.9	4.6	6.6	11.4	6.9	3.3	4.2	35.8	10.8	9.3	8.6	3.1	6.7	5.7	5.8	5.0	6.4	5.7	6.1	5.9	6.7	6.0	5.2	5.8	5.4	7.5	9.6	1.5	10.4	8.3	2.7	6.6	14.5	5.2	5.3	9.0	9.1	3.6	4.3	11.4	23.9	2.1	26.0	5.0	17.4	1.9	20.9	27.8	17.9	9.1	7.5	6.0	7.4	10.8	15.5	23.0	9.1	16.3	10.0	3.8	10.8	6.4	5.6	19.3	1.7	7.8	11.8	10.2	8.3	3.2	55.6	9.3	8.2	14.2	8.4	11.4	8.6	9.2	3.5	2.8	18.4	12.2	7.9	5.1	5.6	12.5	11.0	23.7	13.5	6.6	5.7	9.2	31.8	15.0	5.9	3.1	21.3	6.9	15.2	9.9	8.0
TMEM252	"C9orf71, MGC34760"	ENSG00000181778	"Transmembrane protein 252"	Q8N6L7	9	68536580-68540883	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 22.0;kidney: 35.7"	"Group enriched"	"Detected in some"	5	"Proximal enterocytes: 21.6;Proximal tubular cells: 20.6"	"Cancer enriched"	"Detected in many"	17	"renal cancer: 35.7"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Immune cell enriched"	"Detected in single"	8	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.2;RPTEC TERT1: 2.2;SK-BR-3: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079457	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA079457: "	"unprognostic (2.64e-1)"		"unprognostic (3.28e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"		"unprognostic (6.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.75e-7)"	"unprognostic (7.63e-2)"	"unprognostic (6.15e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.50e-1)"	1.1	2.9	0.1	1.1	0.0	0.0	0.6	1.2	0.0	1.5	0.0	8.4	1.6	5.5	0.0	6.0	3.3	1.3	4.5	0.0	0.0	35.7	1.6	0.3	0.3	0.0	0.1	0.5	0.1	0.0	0.0	0.2	0.1	2.8	0.2	1.3	0.2	0.0	1.3	0.5	22.0	0.0	0.1	0.5	2.0	0.1	0.4	0.0	0.4	0.2	0.0	6.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	20.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0
TMEM256	"C17orf61, MGC40107"	ENSG00000205544	"Transmembrane protein 256"	Q8N2U0	17	7402975-7404097	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 573.1;Proximal enterocytes: 972.0;Proximal tubular cells: 801.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062732			Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA062732: AB_2684852"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.69e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-2)"	92.2	84.3	63.9	22.2	66.4	36.7	86.7	67.7	73.0	85.6	63.5	72.6	76.3	63.5	48.2	74.7	77.6	24.0	99.8	62.1	65.2	122.4	173.9	51.8	34.5	67.3	64.2	75.4	113.8	42.6	45.9	14.3	67.1	81.5	25.2	15.1	60.3	24.4	67.4	64.3	90.0	17.6	67.6	67.9	91.7	12.4	64.5	30.8	51.5	41.6	28.5	69.7	67.6	72.4	67.0	89.3	47.3	64.3	78.6	99.0	43.0	30.7	43.9	49.4	46.3	36.1	38.0	59.0	54.0	31.2	39.4	56.4	29.9	93.6	35.7	30.5	99.4	37.5	32.0	95.1	54.0	13.0	49.0	87.1	44.2	64.1	53.0	66.4	73.1	63.8	28.9	39.1	64.1	36.5	44.1	42.5	21.4	29.4	58.6	69.9	41.5	68.8	121.2	28.8	5.5	37.9	47.6	36.7	51.2	46.0	66.6	23.4	43.7	22.8	42.7	46.5	39.3	32.6	45.2	31.2	60.2	18.0	44.4	12.9	63.1	14.8	35.7	48.5	44.5	77.4	42.3	41.3	59.7	69.0	48.5	45.2	3.9	39.3	36.3	82.3	46.0	77.8	63.9	66.4	67.7	73.0	62.1	65.2	67.3	64.2	67.1	67.6	64.5	72.4	103.1	44.8	55.8	0.0	134.5	87.4	93.3	100.1	94.4	24.0	212.4	216.9	62.5	131.5	76.9	132.4	8.4	77.2	78.4	162.9	297.4	132.8	6.0	80.2	84.6	85.1	125.3	100.5	0.0	190.8	223.6	83.3	88.7	84.5	68.4	50.3	114.5	573.1	205.5	20.2	0.0	186.6	81.4	164.7	128.2	6.8	137.3	108.4	144.1	0.0	166.7	134.0	88.6	0.0	0.0	171.3	214.0	71.1	173.1	87.3	972.0	801.9	96.3	42.0	59.2	80.2	160.2	10.1	39.1	179.5	134.0	46.7	91.7	64.5	210.0	90.9
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284948	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	62.9	57.0	60.3	59.1	70.2	53.7	54.0	65.2	67.5	61.3	72.8	64.7	43.9	62.0	50.2	58.1	47.4	60.0	45.3	67.2	73.5	77.3	99.6	91.7	53.5	63.3	64.5	47.6	70.8	96.2	47.6	48.5	64.6	64.7	70.8	57.0	55.2	58.6	29.2	38.3	46.4	79.1	73.5	62.1	59.4	28.8	69.5	47.6	84.5	40.4	60.9	66.4	34.8	82.1	54.2	60.6	91.5	77.6	228.2	212.0	76.3	217.9	171.3	82.3	128.2	56.3	129.1	61.9	148.3	194.8	82.7	62.4	41.5	120.4	211.5	84.9	63.8	60.4	55.1	56.7	129.2	73.7	104.6	197.2	116.5	116.9	63.7	175.2	262.4	59.1	59.4	107.8	158.4	37.2	27.1	54.2	32.7	46.1	46.7	44.4	65.6	78.5	315.3	131.1	64.9	62.9	111.9	52.8	74.9	105.8	58.6	224.8	234.5	103.8	116.9	65.6	153.3	90.3	136.1	27.9	81.7	137.2	165.7	44.5	85.8	59.0	37.1	84.7	44.8	27.1	37.3	36.7	78.6	22.6	34.8	34.5	138.3	42.5	87.5	33.2	53.0	61.5	60.3	70.2	65.2	67.5	67.2	73.5	63.3	64.5	64.6	73.5	69.5	82.1	73.2	163.5	132.5	7.5	38.8	71.2	33.7	67.6	42.1	24.5	53.1	27.6	43.8	40.0	96.1	66.2	45.9	39.6	51.0	67.6	11.7	51.0	11.1	46.7	57.0	68.0	36.2	20.8	15.8	111.2	52.1	65.7	43.3	76.0	39.8	31.4	66.0	79.1	54.3	20.2	14.5	44.3	54.9	89.3	79.1	9.5	45.4	57.8	48.0	10.3	62.4	40.7	35.0	17.1	15.6	101.6	38.5	62.4	55.8	80.9	31.1	33.2	95.2	24.0	32.9	56.1	77.2	45.0	21.2	41.8	78.3	94.4	43.3	62.5	28.8	65.9
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438504	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.1;liver: 100.0;parathyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.9;Hepatocytes: 184.5;Muller glia cells: 146.8;Proximal enterocytes: 575.7;Proximal tubular cells: 188.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 57.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"EFO-21: 26.9;Hep G2: 74.7;RPTEC TERT1: 60.0"	"Low region specificity"	"Detected in all"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	53.1	11.1	2.1	6.6	2.0	0.7	25.6	1.8	3.6	21.9	2.5	37.3	53.5	6.4	4.8	6.8	3.4	23.2	4.8	1.5	1.8	101.1	100.0	15.4	10.2	2.5	2.1	12.7	13.3	124.7	1.0	14.9	2.3	3.9	19.0	23.6	7.0	7.6	2.4	10.5	76.1	4.8	2.5	25.7	18.1	5.1	3.7	3.0	31.1	4.2	4.9	7.0	5.6	3.2	0.0	7.3	0.7	0.3	4.3	0.4	1.0	0.2	0.1	0.0	0.1	11.4	6.4	0.0	26.9	3.4	0.6	1.7	3.0	0.0	0.0	0.0	2.9	1.0	4.0	74.7	5.9	0.0	0.1	9.7	0.0	0.0	0.0	0.2	5.9	0.0	0.2	10.9	0.0	0.7	0.0	0.8	5.4	0.1	0.2	0.0	0.1	9.9	60.0	4.9	0.9	0.4	0.3	2.9	0.0	5.0	1.2	1.7	3.8	0.0	10.4	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.1	2.0	1.8	3.6	1.5	1.8	2.5	2.1	2.3	2.5	3.7	3.2	12.2	25.6	9.6	0.0	3.2	2.0	0.3	11.1	0.0	2.4	1.8	1.5	2.1	82.9	13.6	18.4	0.0	64.9	0.1	179.9	50.9	36.1	0.3	7.7	98.8	15.1	9.1	5.3	0.0	52.3	3.8	17.9	11.7	10.3	1.3	16.4	61.8	184.5	64.6	6.7	0.0	22.0	14.2	65.5	5.0	1.9	49.7	19.5	1.8	0.0	0.6	146.8	0.0	0.0	0.6	15.3	68.1	3.8	0.0	0.1	575.7	188.1	7.6	17.4	0.0	0.9	14.8	0.0	0.8	1.0	2.8	104.1	2.4	45.3	23.3	2.3
TMEM86A	FLJ90119	ENSG00000151117	"Transmembrane protein 86A"	Q8N2M4	11	18693122-18704785	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 17.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.6;Theca cells: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057119	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA057119: AB_2683342"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.24e-1)"	2.8	2.7	2.6	2.2	2.2	0.3	3.2	2.1	2.8	2.3	3.8	1.5	1.4	2.2	1.0	2.3	2.6	4.0	2.9	2.1	2.6	9.5	2.6	3.5	4.7	3.1	2.7	7.1	3.4	5.4	2.2	4.3	2.5	1.6	1.8	5.7	2.7	1.4	2.9	17.6	2.0	1.9	2.7	4.9	2.1	2.3	4.0	1.6	2.1	2.5	2.5	2.3	3.6	4.5	0.0	0.2	0.6	3.1	2.7	0.0	0.1	0.6	0.5	0.5	0.5	0.0	0.4	0.0	1.2	0.6	3.0	0.3	0.2	0.1	0.3	0.2	1.9	0.2	0.1	0.0	2.1	0.0	2.8	3.8	1.2	0.1	0.2	0.7	1.7	1.8	0.6	0.0	1.3	1.7	0.0	0.0	0.2	0.5	1.6	0.0	5.1	0.0	17.5	3.8	1.0	1.3	1.0	3.2	1.4	1.1	3.9	0.4	1.9	0.5	0.2	0.1	0.1	3.2	2.7	0.0	1.1	0.0	1.1	0.0	1.9	0.1	0.2	1.4	0.5	0.0	0.2	0.4	3.4	0.1	0.4	0.8	0.0	0.1	0.5	2.0	0.5	0.8	2.6	2.2	2.1	2.8	2.1	2.6	3.1	2.7	2.5	2.7	4.0	4.5	1.9	0.0	0.0	0.3	0.0	0.1	0.8	0.4	0.0	5.2	3.5	1.8	2.2	0.0	0.7	11.0	8.4	0.5	1.4	0.6	7.9	7.8	12.2	1.1	1.9	2.1	3.5	0.0	0.5	8.0	0.3	1.7	1.1	1.0	0.0	3.0	3.9	1.6	40.6	0.0	0.8	0.8	0.0	12.7	0.8	12.1	2.1	8.3	0.0	3.7	2.3	2.6	0.0	2.0	0.1	7.4	0.1	1.9	0.4	0.6	0.0	8.3	0.4	4.8	6.6	0.4	1.2	7.8	2.6	0.2	0.3	2.3	0.7	17.4	0.2	0.4
TMSB4Y	TB4Y	ENSG00000154620	"Thymosin beta 4 Y-linked"	O14604	Y	13703899-13706024	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.4"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.8;HEL: 14.7;RPTEC TERT1: 23.4;RT4: 7.9;U-698: 8.2"					"Low region specificity"	"Detected in all"									NA	NA		2400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 51: Myeloid cells - Hemostasis"					"unprognostic (7.27e-2)"	"unprognostic (1.31e-1)"		"unprognostic (5.79e-2)"	"unprognostic (1.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	0.9	0.8	0.6	0.5	0.9	2.8	0.8	0.6	1.4	0.0	0.3	2.8	1.0	0.0	3.1	2.0	0.0	0.9	0.5	0.6	1.0	2.0	1.1	0.5	0.4	1.4	0.7	0.0	1.2	1.0	1.2	0.4	1.5	3.8	6.4	0.5	1.2	2.2	0.2	1.0	2.7	0.0	0.9	0.8	1.0	3.8	0.8	0.0	1.2	0.4	1.1	1.7	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	17.8	0.6	1.2	0.0	0.0	0.0	0.0	0.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	4.2	0.0	1.2	0.0	0.0	0.0	0.0	2.8	23.4	7.9	5.6	0.0	0.0	0.0	1.1	1.5	0.0	0.9	0.4	0.8	0.0	0.0	0.1	1.7	3.9	8.2	0.0	0.0	0.0	0.0	1.3	0.5	1.3	1.3	0.7	1.0	1.4	0.2	2.9	0.7	0.9	0.4	0.6	0.8	0.4	0.7	0.5	1.4	0.6	0.9	0.6	1.4	0.6	1.0	1.4	0.7	1.5	0.9	0.8	1.2	0.0	0.0	2.6	0.0	1.9	2.5	4.5	4.5	3.4	3.4	0.0	0.0	1.2	1.5	1.7	1.8	4.2	5.7	2.7	1.7	3.9	1.6	0.5	0.0	0.0	1.4	0.0	5.7	0.4	0.0	1.0	1.4	2.6	0.0	2.5	0.0	1.1	0.2	3.2	3.3	0.4	3.4	0.0	7.2	9.2	2.3	1.5	5.2	0.0	0.0	2.5	5.5	3.1	1.0	0.6	0.2	4.4	1.9	0.9	3.0	2.2	6.2	1.4	1.1	0.0	1.1	1.2	1.1	3.5	3.4	2.8	1.1	2.1	0.0	4.6	6.8
TNFRSF6B	"DcR3, M68, TR6"	ENSG00000243509	"TNF receptor superfamily member 6b"	O95407	20	63696652-63698684	"Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 51.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 21.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 21.6"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 28.3;RPTEC TERT1: 110.7;TIME: 69.0"									HPA047154	Approved				"Secreted to blood"	NA	NA	406000		"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA047154: AB_2679959"																		30.9	5.1	14.4	14.3	11.9	0.2	24.7	11.5	18.2	7.8	7.4	13.7	0.0	8.0	0.0	11.7	9.6	0.5	7.7	11.4	14.7	16.6	5.5	51.2	1.2	17.0	12.9	7.3	8.3	0.0	15.4	0.0	16.8	10.6	0.1	0.0	10.2	0.0	7.1	13.8	16.1	0.9	15.0	39.3	9.8	6.8	18.7	0.0	12.3	0.0	3.4	16.0	9.6	11.4	0.0	0.5	0.0	0.0	0.0	0.2	1.5	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.8	0.0	0.0	0.0	110.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	69.0	0.0	1.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	1.3	21.6	0.1	0.1	14.4	11.9	11.5	18.2	11.4	14.7	17.0	12.9	16.8	15.0	18.7	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 141.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 10.4;Basal squamous epithelial cells: 8.0;Erythroid cells: 5.9;Gastric mucus-secreting cells: 11.2;Macrophages: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 438.1;intermediate monocyte: 420.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 283.5;granulocytes: 158.9;monocytes: 438.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 43.6;RPMI-8226: 39.9;RPTEC TERT1: 110.6;U-937: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	NA	NA	6770000	35000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	27.7	31.6	39.5	37.7	43.7	48.4	29.5	39.7	47.3	33.5	66.7	45.9	74.7	13.3	19.2	12.5	31.8	54.1	18.0	35.3	37.6	55.6	16.2	100.7	33.1	44.8	43.3	24.8	41.1	18.0	19.7	14.7	41.1	22.6	41.9	13.0	141.9	32.1	5.3	10.5	39.5	24.8	40.0	30.6	54.0	4.6	44.8	14.1	27.0	10.1	24.5	26.0	15.5	38.8	20.8	8.3	2.8	5.5	3.2	1.7	3.4	3.7	2.7	1.5	1.3	4.6	12.8	9.1	43.6	3.8	5.2	13.1	0.1	3.6	1.6	16.2	7.0	5.9	18.2	9.7	6.7	5.1	5.9	3.6	3.6	1.0	5.7	8.8	4.7	6.5	4.6	3.5	1.3	3.1	2.3	16.6	2.7	20.3	6.0	16.5	3.4	39.9	110.6	13.5	5.1	4.9	7.2	18.8	2.5	4.1	25.2	12.4	2.4	4.8	5.8	2.1	8.1	0.8	2.8	2.4	1.9	44.1	9.5	75.2	438.1	158.9	0.9	420.9	0.8	13.7	0.5	0.7	283.5	25.0	2.4	1.5	56.9	7.9	265.4	130.8	0.9	257.1	39.5	43.7	39.7	47.3	35.3	37.6	44.8	43.3	41.1	40.0	44.8	38.8	0.2	6.4	10.4	0.0	2.1	0.0	0.2	0.2	8.0	0.1	0.4	0.1	0.0	0.0	2.0	1.8	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.2	0.1	0.0	1.2	5.9	0.0	0.2	0.0	2.9	11.2	0.4	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	19.5	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.7	0.3	1.5	0.2	0.0	0.1	0.2	0.0	0.0	2.6	0.0	0.0	0.8	0.1	0.6	0.2
TRAM1	"TRAM, TRAMP"	ENSG00000067167	"Translocation associated membrane protein 1"	Q15629	8	70573218-70608416	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Translocation, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 670.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023929	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA023929: AB_1858239"	"unprognostic (3.85e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (8.34e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.85e-2)"	93.2	82.8	26.6	95.9	28.9	102.3	115.8	27.6	42.1	139.2	47.7	85.4	91.7	93.4	148.5	65.2	78.5	117.7	59.8	24.8	31.1	120.7	190.2	146.3	103.5	32.5	27.9	73.4	175.5	117.3	38.8	146.8	32.4	87.2	79.7	33.3	193.9	86.0	26.7	49.2	93.6	96.7	29.1	90.0	94.7	61.0	29.1	98.6	170.7	54.9	114.3	120.2	47.7	34.5	171.1	172.5	73.6	45.2	352.6	367.8	105.2	302.9	301.7	231.7	279.1	109.9	275.8	169.1	58.5	259.6	91.3	219.3	67.6	262.1	221.8	112.2	76.1	118.5	54.6	125.7	515.4	91.3	66.3	441.5	249.6	114.2	410.8	238.5	196.7	85.0	77.8	430.3	288.6	47.2	210.4	65.7	48.3	132.3	81.0	100.9	55.3	113.8	610.5	160.4	53.4	54.2	195.0	389.0	180.5	103.1	144.1	102.0	195.3	141.0	117.5	162.4	102.0	338.7	140.1	85.5	160.3	92.9	105.0	150.1	97.3	64.9	120.8	107.7	153.5	107.9	132.1	137.6	114.3	87.9	119.6	125.2	28.2	130.7	113.7	190.4	146.8	232.7	26.6	28.9	27.6	42.1	24.8	31.1	32.5	27.9	32.4	29.1	29.1	34.5	138.3	275.7	132.0	19.6	166.4	85.5	85.2	214.0	69.4	23.7	114.2	62.4	43.0	131.5	209.3	178.4	14.6	154.3	200.5	69.3	68.4	174.5	142.8	77.9	140.7	134.3	44.2	59.7	27.4	247.7	236.7	177.0	70.8	186.6	72.4	59.0	137.8	202.9	182.7	23.5	26.1	95.5	156.6	134.9	251.0	222.2	127.4	123.7	202.7	29.0	132.1	65.6	128.8	34.2	40.3	290.5	51.0	94.4	670.6	199.6	78.0	147.0	110.2	32.9	124.9	76.4	99.5	134.8	56.8	72.3	88.5	194.3	154.2	78.2	65.5	130.6
TRAPPC1	"BET5, MUM2"	ENSG00000170043	"Trafficking protein particle complex 1"	Q9Y5R8	17	7930345-7932123	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052398	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"			"HPA052398: AB_2681813"	"unprognostic (1.07e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.64e-1)"	111.7	145.2	130.1	91.9	128.2	100.6	100.8	133.8	142.5	99.3	124.8	119.5	83.0	129.8	124.8	156.7	94.0	74.4	169.6	129.1	139.2	158.7	123.6	132.4	140.5	136.4	134.0	79.7	101.1	109.4	124.3	114.6	134.1	93.7	87.9	67.5	103.7	65.8	139.1	110.1	121.9	102.4	127.5	170.7	118.0	72.6	145.6	166.0	101.4	94.4	153.0	108.9	104.6	134.2	178.9	306.2	161.1	186.5	262.9	258.9	101.5	221.7	233.9	206.2	233.3	172.3	104.1	192.0	164.7	337.5	203.1	159.6	173.8	282.3	235.9	279.3	278.6	93.4	165.5	193.6	196.0	114.3	243.0	302.5	197.9	218.6	162.2	262.2	240.4	174.3	74.9	130.4	314.4	166.7	246.3	157.9	101.2	130.4	138.6	122.7	137.7	165.5	392.3	131.0	68.4	165.7	150.6	78.3	166.5	217.3	163.8	124.2	271.5	146.6	105.3	138.0	179.9	139.6	130.9	100.2	294.5	132.4	176.5	315.1	235.5	427.0	190.0	225.2	157.4	243.2	189.5	196.8	270.7	215.8	158.4	177.2	244.3	192.5	235.5	293.0	288.7	304.6	130.1	128.2	133.8	142.5	129.1	139.2	136.4	134.0	134.1	127.5	145.6	134.2	90.4	67.3	46.7	11.4	160.1	54.0	81.2	257.4	78.0	32.8	120.1	158.7	13.0	131.5	124.3	240.9	8.4	375.1	182.9	135.1	340.4	280.8	33.6	60.5	76.3	97.5	118.1	105.2	10.1	259.0	427.6	84.2	67.2	74.1	102.1	78.0	153.8	136.1	362.8	45.4	9.9	155.1	193.3	210.5	135.3	72.6	115.5	195.9	149.4	8.4	374.8	97.8	303.8	6.0	15.5	256.6	162.0	83.5	120.1	62.9	200.0	530.3	87.6	33.7	39.5	31.8	117.1	67.8	69.3	139.5	72.6	271.4	169.7	113.0	144.3	100.2
TRBV7-3	"TCRBV6S1A1N1, TCRBV7S3, TRBV73"	ENSG00000211714	"T cell receptor beta variable 7-3"		7	142384329-142384841	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9;testis: 2.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 32.5;Late spermatids: 39.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 31.9"	"Lineage enriched"	"Detected in single"	48	"T-cells: 31.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;HBF TERT88: 2.3;HL-60: 1.6;RPTEC TERT1: 7.4;U-937: 3.8"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.78e-3)"	"unprognostic (5.75e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.28e-4)"	"unprognostic (4.17e-3)"	"unprognostic (2.34e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.49e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.10e-1)"	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.6	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.0	0.0	1.9	0.2	2.7	0.0	6.9	0.2	0.0	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.6	0.0	1.9	0.1	3.6	0.0	31.9	7.8	0.5	0.6	7.3	9.9	0.0	0.0	0.0	0.4	16.4	5.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	3.7	0.1	0.0	0.0
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.3;placenta: 20.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 10.5;Excitatory neurons: 19.3;Inhibitory neurons: 47.2;Microglial cells: 12.2;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.9;ASC diff: 8.8;BJ hTERT+: 4.9;HEL: 4.8;RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045098	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	4.3	0.5	1.2	0.7	1.5	0.2	3.3	0.6	1.3	3.4	5.8	2.8	1.2	4.8	1.6	5.7	5.4	2.3	0.5	1.5	1.9	1.4	0.1	13.3	1.1	1.8	3.4	1.2	0.7	0.9	0.2	20.8	1.2	2.2	1.6	0.3	0.9	5.4	0.4	1.9	1.2	4.0	1.6	2.2	1.6	0.6	2.0	0.2	9.4	1.0	0.8	1.8	2.0	1.2	0.0	4.9	0.2	0.0	8.8	2.1	0.0	3.2	4.9	0.7	0.1	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.8	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	1.2	1.5	0.6	1.3	1.5	1.9	1.8	3.4	1.2	1.6	2.0	1.2	3.4	0.0	2.6	2.0	0.0	2.3	1.9	0.0	0.0	1.4	0.4	2.9	0.7	0.0	10.5	3.7	0.0	1.3	0.0	0.1	0.0	0.0	1.0	3.0	4.0	1.6	0.0	0.0	19.3	0.2	0.0	3.1	0.0	8.0	0.0	0.1	0.0	0.0	0.3	0.0	47.2	0.0	0.0	0.0	5.3	0.5	6.2	1.8	1.8	12.2	0.1	0.0	0.0	2.0	0.3	0.0	5.1	0.7	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.3	20.2	0.1	0.7	0.1	3.4	0.4	0.1	2.1	0.0	1.5
TRPT1	MGC11134	ENSG00000149743	"TRNA phosphotransferase 1"	Q86TN4	11	64223799-64226254	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 173.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038705, HPA038706"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria		"HPA038705: AB_2676161, HPA038706: AB_10671863"	"unprognostic (2.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.58e-3)"	27.6	38.8	33.1	14.1	34.9	8.4	27.5	36.3	36.2	26.3	33.8	35.2	22.2	23.1	21.4	35.2	26.3	15.4	88.3	31.7	34.6	52.0	46.5	20.3	16.3	35.0	34.0	26.0	51.3	19.2	35.2	10.9	33.7	36.0	18.4	12.7	38.9	28.4	173.8	27.4	30.3	12.0	34.1	30.8	41.9	51.1	36.7	21.1	33.5	116.1	17.6	30.0	25.8	34.3	25.1	24.5	26.5	43.0	32.0	23.5	32.2	16.4	31.6	28.7	24.0	16.1	37.1	24.7	63.6	27.4	22.2	34.1	11.8	35.7	10.1	23.8	14.2	12.7	23.8	28.0	46.4	16.2	21.4	17.7	20.7	31.6	28.1	52.7	20.4	49.0	22.3	27.1	24.2	59.4	30.3	33.7	16.8	33.3	26.1	39.3	19.5	71.4	74.4	29.1	23.0	33.4	13.2	32.1	47.5	18.0	37.1	25.8	23.9	19.4	14.9	37.9	16.4	53.0	14.3	16.3	46.7	8.3	32.1	11.0	16.9	28.5	18.8	31.2	15.0	38.0	18.5	19.9	24.4	39.9	20.1	23.3	15.8	26.1	27.4	59.0	25.2	12.0	33.1	34.9	36.3	36.2	31.7	34.6	35.0	34.0	33.7	34.1	36.7	34.3	17.1	9.6	23.1	9.8	31.4	13.3	18.7	32.7	28.5	8.9	40.4	45.3	42.5	32.9	25.5	27.6	0.0	44.4	17.0	66.3	95.9	41.4	147.5	41.3	20.1	17.5	26.9	14.9	2.8	58.4	46.7	19.8	41.8	27.5	24.6	10.0	21.0	30.0	25.5	10.1	4.9	111.3	30.5	18.9	12.8	82.1	19.9	15.0	37.4	2.8	27.2	32.1	15.5	7.5	6.8	46.6	60.5	17.0	47.1	24.0	92.0	82.9	48.2	11.6	6.6	22.4	29.3	59.6	13.4	42.8	18.5	36.0	21.8	20.2	40.3	22.6
TSGA10	"CEP4L, CT79"	ENSG00000135951	"Testis specific 10"	Q9BZW7	2	98997261-99154964	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 51.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 458.9;Late spermatids: 294.2;Oligodendrocytes: 144.9;Spermatocytes: 206.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036879			Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA036879: AB_10671715"	"unprognostic (1.71e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-6)"	"unprognostic (1.06e-2)"	"unprognostic (9.91e-3)"	"unprognostic (9.79e-2)"	"unprognostic (8.37e-4)"	1.1	1.0	1.8	0.6	1.6	0.7	1.4	1.6	1.9	1.3	3.7	0.9	1.0	1.1	1.6	0.6	12.6	1.1	0.2	1.8	1.6	3.0	0.5	1.6	1.0	3.4	3.5	0.5	1.7	1.6	2.5	0.4	2.5	1.0	1.3	2.6	1.1	0.6	0.1	1.9	0.6	0.3	2.7	0.8	1.4	51.5	1.5	1.1	3.1	0.2	0.8	0.6	0.4	3.7	0.8	0.2	1.2	0.5	0.6	0.7	0.9	0.0	0.1	0.3	0.2	0.2	0.8	0.7	0.2	0.0	0.5	0.2	0.2	0.2	0.3	1.0	0.8	0.1	0.0	0.3	0.0	0.5	1.7	0.9	1.0	0.1	0.1	0.7	0.0	0.9	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.2	0.3	0.1	0.2	4.2	0.7	1.7	0.2	0.9	0.7	0.2	1.3	0.2	0.3	0.4	0.2	0.4	0.0	0.1	0.6	0.3	0.3	0.3	1.0	0.4	0.1	0.2	0.2	0.6	0.0	0.7	0.7	0.7	0.8	0.0	0.8	1.1	0.7	0.0	1.0	0.0	0.4	0.7	0.3	1.8	1.6	1.6	1.9	1.8	1.6	3.4	3.5	2.5	2.7	1.5	3.7	3.1	3.2	9.2	35.3	13.3	3.6	10.3	8.6	6.2	19.3	13.9	15.4	7.1	17.2	14.5	23.9	29.2	9.7	5.6	4.7	25.4	8.4	458.9	80.6	4.5	4.0	15.5	8.6	73.4	10.5	4.3	5.8	8.6	10.9	5.1	5.3	4.2	7.1	4.6	20.2	57.9	6.7	12.2	3.1	1.4	294.2	11.1	5.1	1.8	23.4	4.5	21.1	15.5	27.6	144.9	4.7	12.2	9.8	8.1	7.8	8.0	12.9	107.9	36.6	6.6	5.7	6.2	206.8	36.6	5.6	4.4	9.3	8.9	5.9	8.4	7.9
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185962	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 593.8;kidney: 244.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 723.5;Distal enterocytes: 1983.8;Late spermatids: 838.1;Paneth cells: 1127.7;Respiratory ciliated cells: 1817.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	57	"plasmacytoid DC: 5.6"	"Lineage enriched"	"Detected in single"	57	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"A-431: 129.6;CAPAN-2: 216.7;HaCaT: 151.4;hTCEpi: 173.6;OE19: 257.9;RPTEC TERT1: 628.4;RT4: 308.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.9	4.3	0.5	53.2	0.7	0.0	6.2	1.7	1.1	78.2	1.4	523.3	25.4	17.7	34.7	5.5	122.4	28.9	0.9	0.5	0.5	244.3	3.9	32.1	0.4	1.2	0.6	0.4	3.1	72.0	17.3	1.1	1.1	194.7	593.8	0.0	101.0	65.9	0.8	2.5	96.7	20.8	1.0	0.7	213.1	27.3	0.6	1.9	121.9	0.1	4.9	104.9	9.9	1.8	129.6	2.0	0.0	0.0	0.2	0.0	1.8	0.1	2.7	0.1	0.0	0.0	216.7	0.0	40.2	0.3	0.2	151.4	0.0	111.2	0.1	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.2	0.0	173.6	0.7	60.9	3.6	0.3	1.3	0.0	0.0	1.6	4.9	0.0	0.5	0.1	257.9	8.1	0.1	0.1	1.6	628.4	308.2	1.9	0.0	0.3	13.0	0.5	0.5	9.0	0.1	1.4	0.0	0.7	0.4	0.7	1.5	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.5	0.7	1.7	1.1	0.5	0.5	1.2	0.6	1.1	1.0	0.6	1.8	2.5	25.6	29.5	0.3	7.4	1.0	194.4	499.9	4.0	0.0	14.5	11.0	0.7	11.5	723.5	579.4	0.0	0.3	0.2	1983.8	46.9	61.3	141.3	268.3	14.1	4.5	201.8	0.0	1.2	525.1	0.1	6.0	223.3	144.3	11.4	0.0	1.4	3.6	0.3	0.0	1.3	648.1	242.1	0.3	0.3	838.1	5.0	5.3	5.4	1.0	1.6	0.0	0.0	0.5	1.6	484.4	1127.7	1.9	0.7	211.7	505.4	477.8	1817.6	0.0	0.0	0.4	54.1	4.7	2.6	2.9	1.3	0.0	7.4	0.0	275.9	517.0
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 44.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	11.9	65.9	4.1	5.3	4.4	0.4	8.7	5.2	5.2	21.4	2.8	24.0	39.4	10.5	14.9	5.0	10.9	20.4	47.7	3.3	4.7	91.6	35.8	45.8	4.5	8.0	6.2	1.7	17.4	10.7	7.5	20.3	5.2	6.8	20.4	1.8	46.8	22.4	3.3	1.6	42.0	11.9	4.6	28.2	22.1	3.9	8.1	2.7	23.4	5.5	4.3	17.5	4.0	3.6	0.0	1.4	15.1	0.2	3.1	1.0	14.7	0.3	0.6	1.2	5.0	2.5	4.0	0.0	10.4	0.4	1.8	0.2	7.7	1.6	1.9	0.0	53.0	2.8	14.5	2.2	8.1	0.1	2.5	0.3	0.0	0.4	0.3	2.1	58.3	0.0	0.7	1.8	6.8	2.0	0.2	0.4	24.5	11.1	9.4	0.1	52.2	2.0	90.5	65.4	12.5	7.4	0.7	1.3	0.0	20.0	8.0	1.9	2.5	12.3	3.8	0.1	6.5	15.8	0.0	0.2	1.7	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.4	5.2	5.2	3.3	4.7	8.0	6.2	5.2	4.6	8.1	3.6	40.0	118.6	45.0	18.6	1.7	2.5	20.3	1.8	14.8	0.0	19.4	3.8	62.5	64.3	19.9	103.0	0.0	40.5	0.0	18.0	189.8	6.8	0.6	63.4	9.0	38.0	9.6	2.7	1.8	7.2	53.5	10.0	14.8	87.5	2.5	1.8	18.2	32.9	4.1	0.0	2.9	16.9	6.1	0.8	3.6	1.5	4.1	1.5	5.4	3.7	0.0	0.5	0.0	10.1	0.4	4.7	30.5	0.7	2.2	9.1	68.3	111.1	5.7	0.1	0.0	11.6	16.6	0.6	8.9	13.8	2.0	24.2	1.9	9.6	35.5	28.3
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 705.9;Muller glia cells: 508.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2"	"Group enriched"	"Detected in all"	5	"B-cells: 488.1;dendritic cells: 313.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	333.8	143.9	257.2	87.3	248.9	33.3	143.3	253.4	292.4	138.2	288.7	364.2	342.1	130.9	432.8	78.4	249.8	186.2	108.8	247.8	296.3	211.3	87.4	202.1	88.0	250.0	267.7	148.1	140.2	283.4	189.7	111.6	260.2	96.2	386.3	418.6	152.2	187.3	429.1	78.3	349.2	128.3	266.7	84.8	221.2	84.8	282.5	71.6	200.3	374.4	106.9	170.1	67.4	281.3	130.6	347.6	282.8	179.3	484.7	295.8	93.3	203.7	220.2	245.1	265.7	213.5	264.7	126.9	294.8	211.6	234.0	289.0	271.2	139.5	182.9	143.4	410.4	91.0	252.5	204.4	234.5	118.4	64.3	280.9	165.5	135.8	120.1	372.6	304.8	83.1	98.0	109.2	243.3	49.5	105.7	112.1	200.5	414.7	152.4	130.8	351.0	135.3	408.0	73.0	255.0	282.1	139.8	116.9	393.7	269.3	125.0	220.8	292.1	225.7	88.4	138.0	290.7	237.4	346.6	67.1	200.1	173.5	131.9	8.8	51.3	10.4	32.6	69.6	34.1	481.0	16.5	23.9	99.2	488.1	42.6	39.3	4.8	60.3	77.1	313.2	4.6	95.2	257.2	248.9	253.4	292.4	247.8	296.3	250.0	267.7	260.2	266.7	282.5	281.3	76.1	112.2	213.4	69.5	83.8	34.7	77.5	114.6	36.5	247.7	43.6	32.3	98.2	108.7	169.0	68.0	183.5	89.9	41.3	705.9	25.4	250.2	28.5	86.1	63.4	57.6	91.3	19.4	47.8	354.0	35.6	90.8	85.1	41.7	23.4	88.6	53.6	29.5	65.4	127.9	54.3	290.4	97.6	58.0	27.5	57.9	64.3	38.2	72.9	29.0	35.1	508.9	36.0	116.6	32.7	245.1	410.7	51.6	81.2	220.1	364.3	65.5	201.7	185.1	26.3	44.8	189.0	108.0	64.6	34.2	34.2	75.9	19.4	149.5	205.2	381.4
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"kidney: 1299.8;liver: 1612.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.6;Glandular and luminal cells: 234.7;Hepatocytes: 550.8;Proximal tubular cells: 1249.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 310.8"									HPA045108	Uncertain					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.2	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	32.0	0.0	3.8	68.7	8.9	24.2	0.2	49.9	10.4	0.0	0.0	0.0	1299.8	1612.1	0.4	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.1	0.0	0.3	6.9	0.0	3.6	27.5	0.0	0.3	66.6	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.3	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	41.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.6	0.1	310.8	2.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	43.2	0.0	0.0	0.0	0.2	0.3	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.6	1.6	0.0	0.0	1.2	0.6	0.1	38.6	2.1	125.0	0.0	0.0	0.0	5.7	97.8	6.6	0.3	150.6	14.0	1.0	3.5	2.7	0.4	10.6	0.0	0.1	0.0	234.7	0.0	0.0	8.9	550.8	0.1	0.0	0.3	37.3	0.0	13.8	0.0	0.0	1.8	7.6	3.6	0.0	0.0	0.0	0.0	1.5	0.4	13.0	10.7	0.0	0.0	0.6	70.6	1249.5	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	6.3	0.1	5.9	2.3
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093308-106194301	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 323.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		24000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	16.3	17.6	20.4	25.0	18.7	40.4	15.3	30.4	29.3	19.6	20.6	21.7	15.5	24.3	33.1	24.1	29.2	19.6	29.3	25.9	20.3	60.0	15.7	46.0	27.9	15.0	23.0	24.4	15.8	37.3	16.3	54.6	19.3	23.2	24.0	10.5	14.6	25.9	31.9	14.0	14.3	21.4	18.5	25.0	26.2	31.9	31.0	22.2	30.0	28.6	30.4	29.5	18.3	23.7	66.5	48.8	50.9	39.0	88.4	65.2	110.2	71.4	66.9	49.9	61.5	96.9	110.4	12.0	87.0	74.1	111.2	32.8	22.6	58.2	54.5	64.2	40.5	37.0	21.4	110.6	34.9	30.5	39.0	42.8	63.8	50.3	33.5	57.5	52.5	22.8	22.1	28.5	103.6	46.8	34.3	66.8	60.1	64.2	65.4	70.3	38.6	34.3	323.0	60.9	16.7	19.0	51.5	45.7	44.3	67.7	17.0	93.7	48.0	55.1	58.5	45.4	45.4	34.4	51.4	17.9	55.0	70.1	103.8	11.3	24.7	28.5	23.1	20.8	25.7	15.3	64.3	41.4	19.1	30.5	68.8	49.1	6.1	37.5	16.0	13.5	130.4	44.3	20.4	18.7	30.4	29.3	25.9	20.3	15.0	23.0	19.3	18.5	31.0	23.7	15.4	89.8	88.8	18.9	22.1	16.8	26.8	117.3	14.8	9.9	11.6	10.5	18.7	17.2	61.6	86.5	4.2	71.2	17.7	20.5	50.9	46.9	80.2	41.5	19.3	25.5	6.6	12.0	49.8	25.0	74.1	34.2	16.8	40.6	29.8	13.1	10.8	15.0	33.2	8.4	37.5	15.6	34.6	20.1	12.5	18.5	15.2	33.9	14.2	33.7	56.2	10.8	18.6	24.1	11.7	30.4	16.2	12.8	10.2	35.7	9.6	17.5	38.8	7.9	19.7	19.0	35.1	17.0	81.6	22.6	13.2	24.6	33.7	51.6	18.0	19.8
VPS25	"DERP9, EAP20, MGC10540"	ENSG00000131475	"Vacuolar protein sorting 25 homolog"	Q9BRG1	17	42773449-42779599	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004978, HPA021992, HPA052217, HPA057284"	Uncertain		Supported	Vesicles		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB004978: AB_426095, HPA021992: , HPA052217: AB_2681765, HPA057284: AB_2683397"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (7.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.76e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	36.6	40.3	32.8	32.5	33.0	44.3	53.3	34.8	36.8	41.6	36.6	61.9	53.8	35.5	65.3	91.4	58.9	33.4	43.5	32.9	33.2	70.1	68.6	31.8	37.8	32.9	32.8	33.2	49.0	72.3	27.6	46.7	33.5	40.2	68.4	31.2	48.7	36.5	51.3	50.5	45.4	42.8	33.5	37.1	50.0	27.4	33.8	51.3	40.9	41.3	57.2	44.8	44.3	34.0	67.2	136.6	101.8	62.1	126.9	86.5	94.5	83.0	117.1	167.5	116.3	117.9	77.0	66.8	135.8	122.0	88.5	68.7	142.2	181.8	107.9	61.2	178.7	50.6	87.0	177.5	131.0	95.7	64.6	118.2	115.4	148.9	158.0	99.1	106.7	79.0	175.6	65.5	102.1	96.5	138.8	105.2	78.9	152.0	95.3	51.1	123.3	108.7	202.6	75.8	86.3	66.7	46.8	60.1	129.6	155.8	138.4	100.2	58.0	105.7	68.4	60.0	90.3	64.0	39.4	97.9	92.7	64.5	79.6	85.1	76.9	106.7	38.8	89.0	39.9	48.8	42.4	46.4	80.3	46.6	42.3	40.7	44.9	78.9	82.7	54.1	43.1	59.6	32.8	33.0	34.8	36.8	32.9	33.2	32.9	32.8	33.5	33.5	33.8	34.0	26.3	25.6	36.3	4.2	25.3	13.9	41.0	88.3	16.5	24.1	44.4	46.6	26.9	51.5	65.7	62.5	14.6	136.1	22.0	74.3	133.1	135.9	2.6	61.8	48.5	35.4	41.0	47.9	3.5	152.4	186.5	40.8	40.8	55.9	29.2	21.5	29.6	46.4	102.3	23.5	3.5	70.5	85.5	34.5	12.7	5.6	27.7	33.0	42.7	0.0	46.7	56.1	44.3	2.5	4.7	134.4	75.7	30.5	40.9	44.4	83.5	93.6	74.9	29.5	32.9	13.5	69.9	42.8	46.7	61.9	22.9	121.6	22.8	69.9	63.4	53.5
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115404-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"granulocytes: 563.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 57.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 57.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	17.2	24.9	18.7	12.8	16.1	3.1	24.2	12.8	19.4	22.4	14.3	37.9	26.5	13.9	25.3	15.0	15.0	31.1	6.8	16.9	44.0	21.7	6.4	30.8	12.2	21.3	25.6	10.2	20.7	4.4	37.4	10.2	27.9	17.8	43.3	11.9	30.0	19.2	4.3	28.5	36.6	16.0	17.0	8.3	28.2	9.6	47.1	8.0	11.5	12.3	14.6	22.8	12.6	16.2	0.0	0.6	7.6	0.5	7.9	7.4	2.8	1.1	0.6	0.6	0.3	0.4	59.7	0.0	7.2	1.3	10.3	0.4	1.5	13.6	0.0	20.9	0.2	44.1	10.5	1.4	32.1	0.6	19.8	21.8	1.5	1.3	4.4	2.9	39.5	5.8	2.4	7.3	2.4	0.2	0.9	0.7	11.9	0.0	1.5	0.0	26.2	0.3	43.0	0.5	6.7	0.7	1.1	0.4	2.1	17.3	5.4	1.9	1.0	0.2	5.5	0.3	0.0	2.7	2.5	0.0	24.1	0.9	0.4	57.8	7.9	0.9	4.7	5.5	1.1	7.1	5.0	2.7	8.0	3.8	6.3	4.1	0.6	8.1	9.3	4.3	12.7	6.1	18.7	16.1	12.8	19.4	16.9	44.0	21.3	25.6	27.9	17.0	47.1	16.2	5.0	9.6	28.3	4.6	1.3	17.2	14.6	14.9	4.6	3.8	12.6	8.8	2.6	5.7	33.2	33.1	2.1	7.9	2.0	25.0	9.8	27.8	50.6	11.5	4.8	4.3	15.0	3.4	4.0	28.1	2.5	11.4	17.3	7.6	563.0	3.8	3.9	3.2	35.7	32.0	17.1	22.3	30.5	6.6	7.2	6.0	2.8	6.7	5.4	1.9	3.6	14.3	3.1	8.0	2.6	17.7	16.8	0.4	2.5	6.5	50.6	15.1	59.1	1.4	0.0	9.5	5.7	0.7	4.1	4.8	12.5	1.9	9.4	5.9	23.7	13.6
WDR91	"HSPC049, SORF-1"	ENSG00000105875	"WD repeat domain 91"	A4D1P6	7	135183839-135211534	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 32.2;THP-1: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024260	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA024260: AB_1844392"	"unprognostic (5.37e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	6.4	5.1	6.9	3.7	7.3	6.0	6.4	7.3	7.8	7.8	17.8	4.3	2.0	5.2	6.7	10.2	9.0	3.2	3.5	8.3	6.5	19.3	7.1	9.7	5.5	7.2	6.9	12.5	18.7	3.4	5.7	7.7	6.7	5.9	2.2	2.6	6.3	6.8	4.7	6.8	5.1	3.3	6.3	8.6	7.6	6.1	7.2	5.2	3.8	2.7	5.2	5.5	7.1	7.2	3.0	1.2	2.8	7.9	5.0	3.8	3.6	3.4	4.0	3.0	3.7	1.3	1.1	2.0	5.1	2.5	4.1	2.3	4.6	11.8	3.4	10.3	3.8	1.9	3.4	4.9	7.3	3.4	1.6	5.3	6.4	2.7	2.3	2.6	4.0	4.9	7.9	3.1	3.0	2.2	6.5	9.1	4.1	2.5	3.1	8.3	4.3	4.8	32.2	1.8	1.7	3.3	4.3	4.0	10.0	2.8	2.2	23.3	1.4	6.8	1.6	4.8	3.2	6.7	2.8	6.3	6.2	6.6	4.9	0.4	3.7	3.4	1.4	1.3	1.5	1.8	1.7	0.9	2.1	1.6	2.6	1.6	2.1	2.5	1.2	0.9	2.4	1.8	6.9	7.3	7.3	7.8	8.3	6.5	7.2	6.9	6.7	6.3	7.2	7.2	4.5	6.4	9.3	14.7	7.1	4.2	3.8	11.8	16.5	6.8	4.8	6.1	2.9	8.6	8.8	7.3	6.2	23.2	6.5	1.1	19.6	9.1	33.4	18.7	6.3	5.2	1.2	4.4	11.4	7.1	5.0	5.0	5.6	25.3	16.5	8.6	6.4	7.7	36.4	3.3	12.5	1.8	2.0	11.6	12.3	54.2	5.9	9.9	3.6	7.5	6.8	3.4	0.0	7.1	10.2	3.9	4.8	15.4	5.0	2.4	1.5	18.5	6.8	3.4	13.1	5.6	5.7	9.1	8.6	7.1	4.0	29.0	5.0	7.6	1.2	1.4
WNT7A	Wnt-7a	ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880071	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;gallbladder: 2.3;placenta: 2.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2;ovarian cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.0	0.0	3.6	0.1	3.1	0.1	0.0	1.0	3.7	0.2	0.3	0.0	0.0	1.1	0.2	0.4	0.1	2.3	0.0	2.4	2.1	0.2	0.0	2.0	0.2	5.1	1.9	0.0	0.1	0.0	0.0	2.7	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	3.4	1.3	0.0	1.3	2.5	0.0	0.0	0.0	0.1	0.3	0.1	2.8	8.6	0.0	0.8	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	7.6	0.0	56.0	0.0	0.1	11.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	1.7	100.3	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.6	3.1	1.0	3.7	2.4	2.1	5.1	1.9	2.5	3.4	2.5	2.8	0.0	12.8	0.0	8.5	0.0	5.9	2.8	2.6	0.0	0.0	0.0	0.0	0.7	8.6	1.4	0.0	0.0	68.7	0.0	0.0	0.0	13.8	17.3	14.5	0.4	0.6	0.0	0.0	4.0	9.1	147.5	0.4	0.0	17.9	0.0	0.0	0.0	0.0	7.4	0.0	2.4	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	1.0	0.0	0.0	0.0	4.5	0.3	98.8	0.0	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	6.0	2.3	0.0	1.3	185.7	1.5	0.0	0.0	6.0
WWC1	"KIAA0869, KIBRA, PPP1R168"	ENSG00000113645	"WW and C2 domain containing 1"	Q8IX03	5	168291645-168472303	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 142.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.2;Cone photoreceptor cells: 91.8;Endometrial ciliated cells: 81.8;Glandular and luminal cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 120.2;RPTEC TERT1: 260.4;SK-BR-3: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038016, HPA038017"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA038016: AB_10697091, HPA038017: AB_10669513"	"unprognostic (3.60e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-1)"	7.8	0.6	41.8	2.9	43.3	0.1	21.2	41.0	39.7	6.0	50.4	6.4	24.3	2.8	6.8	22.9	17.2	8.7	1.6	40.3	41.3	73.3	38.1	20.2	3.0	56.8	47.0	0.8	28.3	23.5	7.8	10.2	43.6	16.4	6.1	17.8	142.3	11.8	0.0	19.9	20.2	1.1	46.6	0.7	22.9	1.7	54.3	1.3	29.7	0.0	6.9	9.3	10.1	38.6	50.6	56.4	9.2	0.4	0.0	0.0	96.8	3.7	0.9	17.1	15.3	120.2	73.6	0.0	58.6	1.2	47.4	35.0	18.9	46.1	20.1	0.1	18.6	0.0	28.6	29.9	0.9	4.4	0.0	6.0	13.9	32.3	28.5	13.2	0.0	3.0	0.0	7.2	1.3	56.4	0.0	0.1	13.3	60.8	8.2	0.0	0.4	29.1	260.4	68.8	30.7	11.4	66.5	136.4	17.1	11.6	67.8	4.3	0.0	3.0	34.2	0.4	36.9	0.8	0.4	0.2	3.4	0.1	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.8	43.3	41.0	39.7	40.3	41.3	56.8	47.0	43.6	46.6	54.3	38.6	0.3	64.1	72.3	162.2	1.3	11.9	14.7	6.0	1.8	1.4	35.7	25.7	1.8	34.3	42.1	58.8	91.8	11.6	0.6	17.9	13.7	44.9	0.4	81.8	10.8	1.3	7.8	0.0	50.1	40.5	2.3	5.3	15.3	149.2	1.3	5.6	1.1	16.9	1.3	0.0	27.9	7.8	6.1	0.6	1.1	0.1	1.2	4.2	10.6	8.4	1.1	18.1	0.0	17.6	1.9	73.1	10.9	0.7	0.1	38.8	18.9	61.8	36.7	9.1	0.0	0.2	5.6	0.3	5.0	7.3	13.9	18.2	2.1	2.5	12.2	16.5
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102028-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.1"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 306.3;Inhibitory neurons: 1019.5;Oligodendrocyte precursor cells: 721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"REH: 2.6;RPTEC TERT1: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	0.1	0.2	7.6	0.5	7.1	0.0	0.0	0.9	8.1	0.3	0.0	1.7	0.2	0.1	0.2	0.5	0.1	0.2	0.7	7.0	2.2	0.1	0.0	0.0	0.4	0.1	2.2	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.6	0.3	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.3	0.1	5.8	0.5	0.0	0.0	0.4	0.3	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.6	7.1	0.9	8.1	7.0	2.2	0.1	2.2	0.0	0.0	5.8	1.1	0.5	9.6	18.7	7.8	0.1	0.4	0.6	0.0	0.6	12.5	0.1	0.3	2.1	0.0	9.3	3.7	35.5	0.1	0.4	0.1	0.0	0.1	0.9	0.6	0.2	2.4	0.0	0.0	306.3	0.9	0.1	2.3	0.0	1.1	0.0	0.2	1.1	0.4	0.1	0.0	1019.5	0.0	0.0	0.0	1.0	0.0	0.0	1.4	8.8	30.0	1.8	0.6	0.0	721.3	9.4	0.4	0.0	0.0	0.4	0.6	0.0	0.1	5.2	1.6	0.0	2.6	0.4	1.1	0.1	0.2	0.9	0.1	0.5	0.1	0.0	0.7
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;gallbladder: 2.2;retina: 2.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 4.3;Ductal cells: 3.6;Early spermatids: 2.8;Late spermatids: 5.9;Muller glia cells: 16.0;Pancreatic endocrine cells: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.5"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 2.8"	"Low region specificity"	"Detected in many"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.2	1.1	0.2	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.1	0.3	0.5	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	1.1	0.2	0.1	0.3	1.6	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.8	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0